# ::snt A mouse model of sitosterolemia : absence of Abcg8/sterolin -2 results in failure to secrete biliary cholesterol .
# ::tok A mouse model of sitosterolemia : absence of Abcg8/sterolin -2 results in failure to secrete biliary cholesterol .
# ::alignments 16-17|0.1 15-16|0.1.0 14-15|0 12-13|0.2 10-11|0.0.1+0.0 8-9|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 6-7|0.0.0 4-5|0.0.0.0 2-3|0.0.0.0.0 1-2|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:38.112
(s / secrete-01 
      :ARG0 (t / thing 
            :ARG2-of (a / absent-01 
                  :ARG1 (s2 / sitosterolemia 
                        :mod-of (m / model 
                              :mod (m2 / mouse)))) 
            :ARG2-of (r / result-01 
                  :ARG0 (c2 / country 
                        :name (n / name 
                              :op1 "Abcg8/sterolin")))) 
      :ARG1 (c / cholesterol 
            :mod (b / biliary)) 
      :ARG2-of (f / fail-01))

# ::snt Mutations in either of two genes comprising the STSL locus , ATP-binding cassette ( ABC ) - transporters ABCG5 ( encoding sterolin-1 ) and ABCG8 ( encoding sterolin-2 ) , result in sitosterolemia , a rare autosomal recessive disorder of sterol trafficking characterized by increased plasma plant sterol levels .
# ::tok Mutations in either of two genes comprising the STSL locus , ATP-binding cassette ( ABC ) - transporters ABCG5 ( encoding sterolin-1 ) and ABCG8 ( encoding sterolin-2 ) , result in sitosterolemia , a rare autosomal recessive disorder of sterol trafficking characterized by increased plasma plant sterol levels .
# ::alignments 48-49|0.1.1.0 47-48|0.1.1.0.0.0.1 46-47|0.1.1.0.1 45-46|0.1.1.0.1.0 44-45|0.1.1 42-43|0.1.1.0.0 41-42|0.1.1.0.0.0 40-41|0.1.1.1 38-39|0.1.1.0.0.0.3 37-38|0.1.1.0.0.0.3.1 36-37|0.1.1.0.0.0.3.2 35-36|0.1.1.0.0.0.3.0 32-33|0.1.1.0.0.0.3.1.0 30-31|0.1.1.0.0.0.0.1.0 26-27|0.1 24-25|0.1.1.0.0.0.0.1.3.0.0+0.1.1.0.0.0.0.1.3.0+0.1.1.0.0.0.0.1.3 23-24|0.1.1.0.0.0.0.1 20-21|0.1.1.0.0.0.2 18-19|0.1.1.0.0.0.0.0.0+0.1.1.0.0.0.0.0+0.1.1.0.0.0.0 17-18|0.1.1.0.0.0.0.1.2 14-15|0.1.1.0.0.0.0.1.2.0.0+0.1.1.0.0.0.0.1.2.0 12-13|0.2 11-12|0.2.0 9-10|0.2.1 8-9|0.1.1.0.0.0.0.1.0.0.0.0+0.1.1.0.0.0.0.1.0.0.0+0.1.1.0.0.0.0.1.0.0 6-7|0 5-6|0.0 4-5|0.0.0 2-3|0.1.0 0-1|0.1.1.0.0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:42.074
(c3 / comprise-01 
      :ARG1 (g / gene 
            :quant 2) 
      :ARG1-of (e / encode-01 
            :ARG0 (e3 / either) 
            :purpose-of (i / increase-01 
                  :ARG1 (l / level 
                        :ARG0-of (c / characterize-01 
                              :ARG1 (t / traffic-01 
                                    :ARG0 (p3 / person 
                                          :name (n2 / name 
                                                :op1 "ABCG5") 
                                          :op3-of (a2 / and 
                                                :ARG1-of (r3 / result-01 
                                                      :ARG2 (t4 / thing 
                                                            :name (n4 / name 
                                                                  :op1 "STSL"))) 
                                                :op1 (m / mutation) 
                                                :op2 (t3 / transporter 
                                                      :name (n3 / name 
                                                            :op1 "ABC")) 
                                                :op4 (t2 / thing 
                                                      :name (n / name 
                                                            :op1 "ABCG8")))) 
                                    :ARG1 (s / sterol) 
                                    :ARG2 (e2 / encode-01) 
                                    :mod-of (d / disord 
                                          :ARG1-of (r2 / rare-02) 
                                          :mod (r / recessive 
                                                :mod-of (s3 / sitosterolemia)) 
                                          :mod (a / autosomal)))) 
                        :location (p / plant 
                              :mod (p2 / plasma))) 
                  :topic-of (s2 / sterol))) 
      :ARG2 (c2 / cassette 
            :mod (a3 / atp-bind) 
            :mod (l2 / locu)))

# ::snt Based upon the genetics of sitosterolemia , ABCG5/sterolin -1 and ABCG8/sterolin -2 are hypothesized to function as obligate heterodimers .
# ::tok Based upon the genetics of sitosterolemia , ABCG5/sterolin -1 and ABCG8/sterolin -2 are hypothesized to function as obligate heterodimers .
# ::alignments 18-19|0.2.0 17-18|0.2.0.0 15-16|0.2 13-14|0 9-10|0.0 7-8|0.0.0.0.0+0.0.0.0+0.0.0 5-6|0.1.0.0 3-4|0.1.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:42.276
(h2 / hypothesize-01 
      :ARG1 (a / and 
            :op1 (p / person 
                  :name (n / name 
                        :op1 "ABCG5/sterolin"))) 
      :ARG1-of (b / base-02 
            :ARG2 (g / genetic 
                  :mod (s / sitosterolemia))) 
      :ARG2 (f / function-01 
            :ARG1 (h / heterodimer 
                  :ARG1-of (o / obligate-01))))

# ::snt No phenotypic difference has yet been described in humans with complete defects in either ABCG5 or ABCG8 .
# ::tok No phenotypic difference has yet been described in humans with complete defects in either ABCG5 or ABCG8 .
# ::alignments 16-17|0.1.0.2.0.0+0.1.0.2.0+0.1.0.2 15-16|0.1.0 14-15|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 13-14|0.1.0.0 11-12|0.1 10-11|0.1.1 8-9|0.2 6-7|0 4-5|0.4 2-3|0.0 1-2|0.0.0 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:42.898
(d2 / describe-01 
      :ARG1 (d3 / differ-02 
            :mod (p2 / phenotypic)) 
      :ARG2 (d / defect-01 
            :ARG1 (o / or 
                  :mod (e / either) 
                  :op1 (p / person 
                        :name (n2 / name 
                              :op1 "ABCG5")) 
                  :op2 (t / thing 
                        :name (n / name 
                              :op1 "ABCG8"))) 
            :ARG1-of (c / complete-02)) 
      :manner (h / human) 
      :polarity - 
      :time (y / yet))

# ::snt These proteins , based upon the defects in humans , are responsible for regulating dietary sterol entry and biliary sterol secretion .
# ::tok These proteins , based upon the defects in humans , are responsible for regulating dietary sterol entry and biliary sterol secretion .
# ::alignments 20-21|0.2 19-20|0.2.0 18-19|0.0.0.0.0.0.0 17-18|0 16-17|0.1 15-16|0.1.0 14-15|0.1.1 13-14|0.0 11-12|0.0.0 8-9|0.0.0.0.0.0.1 6-7|0.0.0.0.0.0 3-4|0.0.0.0.0 1-2|0.0.0.0 0-1|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:43.429
(a / and 
      :ARG1-of (r / regulate-01 
            :ARG1-of (r2 / responsible-01 
                  :ARG0 (p / protein 
                        :ARG1-of (b2 / base-02 
                              :ARG2 (d2 / defect-01 
                                    :ARG1 (b / biliary) 
                                    :location (h / human))) 
                        :mod (t / this)))) 
      :op1 (e / entry 
            :mod (s3 / sterol) 
            :mod (d / dietary)) 
      :op2 (s / secretion 
            :mod (s2 / sterol)))

# ::snt In order to mimic the human disease , we created , by a targeted disruption , a mouse model of sitosterolemia resulting in Abcg8/sterolin -2 deficiency alone .
# ::tok In order to mimic the human disease , we created , by a targeted disruption , a mouse model of sitosterolemia resulting in Abcg8/sterolin -2 deficiency alone .
# ::alignments 26-27|0.1.0.1 25-26|0.0.0.0.1.0.0.0 23-24|0.0.0.0.1.0.0.1.0+0.0.0.0.1.0.0.1+0.0.0.0.1.0.0 21-22|0.1.0 20-21|0.1.0.0 18-19|0.1 17-18|0.1.1 14-15|0.0.0.0.1 13-14|0.0.0.0.1.0 9-10|0 8-9|0.0 6-7|0.0.0.0 5-6|0.0.0.0.0 3-4|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:44.223
(c2 / create-01 
      :ARG0 (w / we 
            :ARG0-of (m3 / mimic-01 
                  :ARG1 (d3 / disease 
                        :mod (h / human) 
                        :poss-of (d2 / disruption 
                              :ARG0-of (t / target-01 
                                    :ARG1 (c / country 
                                          :mod-of (d / deficiency) 
                                          :name (n / name 
                                                :op1 "Abcg8/sterolin"))))))) 
      :ARG1 (m / model 
            :ARG1-of (r / result-01 
                  :ARG0 (s / sitosterolemia) 
                  :manner (a / alone)) 
            :mod (m2 / mouse)))

# ::snt Homozygous knockout mice are viable and exhibit sitosterolemia .
# ::tok Homozygous knockout mice are viable and exhibit sitosterolemia .
# ::alignments 7-8|0.0.1 6-7|0.0 5-6|0 4-5|0.0.0.0 2-3|0.0.0 1-2|0.0.0.1 0-1|0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:44.281
(a / and 
      :op1 (e / exhibit-01 
            :ARG0 (m / mouse 
                  :domain-of (v / viable) 
                  :mod (k / knockout) 
                  :mod (h / homozygou)) 
            :ARG1 (s / sitosterolemia)))

# ::snt Mice deficient in Abcg8 have significantly increased plasma and tissue plant sterol levels ( sitosterol and campesterol ) consistent with sitosterolemia .
# ::tok Mice deficient in Abcg8 have significantly increased plasma and tissue plant sterol levels ( sitosterol and campesterol ) consistent with sitosterolemia .
# ::alignments 20-21|0.2.0.1.0.0.0 18-19|0.2.0.1.0.0 15-16|0.2.0.2 12-13|0.2.0.1.0 11-12|0.2.0.1.0.1 10-11|0.2 9-10|0.1 8-9|0 7-8|0.0 6-7|0.2.0 5-6|0.2.0.1 3-4|0.2.0.0.0.0.0+0.2.0.0.0.0+0.2.0.0.0 1-2|0.2.0.0 0-1|0.2.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:45.321
(a2 / and 
      :op1 (p2 / plasma) 
      :op2 (t / tissue) 
      :op3 (p / plant 
            :ARG1-of (i / increase-01 
                  :ARG0 (d / deficient 
                        :location (c2 / country 
                              :name (n / name 
                                    :op1 "Abcg8")) 
                        :mod (m / mouse)) 
                  :ARG2 (s3 / significant-02 
                        :ARG1 (l / level 
                              :ARG1-of (c / consistent-01 
                                    :ARG2 (s / sitosterolemia)) 
                              :mod (s2 / sterol))) 
                  :op1-of (a / and))))

# ::snt Interestingly , Abcg5/sterolin -1 was expressed in both liver and intestine in Abcg8/sterolin -2 deficient mice and continued to show an apical expression .
# ::tok Interestingly , Abcg5/sterolin -1 was expressed in both liver and intestine in Abcg8/sterolin -2 deficient mice and continued to show an apical expression .
# ::alignments 22-23|0.3.0.0.0 21-22|0.3.0.0.0.0 19-20|0.3.0.0 17-18|0.3.0 16-17|0.3 15-16|0.3.0.1.2 14-15|0.3.0.1.2.1 12-13|0.3.0.1.2.0.0.0+0.3.0.1.2.0.0+0.3.0.1.2.0 10-11|0.3.0.1.1 9-10|0.3.0.1 8-9|0.1 7-8|0.3.0.1.0 5-6|0 2-3|0.0.0.0+0.0.0+0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:46.505
(e2 / express-01 
      :ARG1 (p / person 
            :name (n2 / name 
                  :op1 "Abcg5/sterolin")) 
      :manner (l / liver) 
      :mod (i2 / interesting) 
      :op1-of (a2 / and 
            :op2 (c / continue-01 
                  :ARG1 (s / show-01 
                        :ARG1 (e / express-01 
                              :mod (a / apical))) 
                  :op3-of (a3 / and 
                        :mod (b / both) 
                        :op1 (i / intestine) 
                        :op2 (m / mouse 
                              :mod (c2 / country 
                                    :name (n / name 
                                          :op1 "Abcg8/sterolin")) 
                              :mod (d / deficient))))))

# ::snt Remarkably , Abcg8 deficient mice had an impaired ability to secrete cholesterol into bile , but still maintained the ability to secrete sitosterol .
# ::tok Remarkably , Abcg8 deficient mice had an impaired ability to secrete cholesterol into bile , but still maintained the ability to secrete sitosterol .
# ::alignments 22-23|0.1.1.0.0 21-22|0.1.1.0 19-20|0.1.1 17-18|0.1 16-17|0.1.2 15-16|0 13-14|0.1.0.0.1 11-12|0.1.0.0.0 10-11|0.1.0.0 8-9|0.1.0.0.2 7-8|0.1.0.0.2.0 4-5|0.1.0 3-4|0.1.0.1 2-3|0.1.0.2.0.0+0.1.0.2.0+0.1.0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:46.814
(c / contrast-01 
      :ARG1 (r / remarkably) 
      :ARG2 (m / maintain-01 
            :ARG0 (m2 / mouse 
                  :ARG0-of (s4 / secrete-01 
                        :ARG1 (c2 / cholesterol) 
                        :ARG2 (b / bile) 
                        :purpose-of (a2 / ability 
                              :ARG1-of (i / impair-01))) 
                  :mod (d / deficient) 
                  :mod (c3 / country 
                        :name (n / name 
                              :op1 "Abcg8"))) 
            :ARG1 (a / ability 
                  :purpose (s2 / secrete-01 
                        :ARG1 (s / sitosterol))) 
            :mod (s3 / still)))

# ::snt We also report an intermediate phenotype in the heterozygous Abcg8 + / - mice that are not sitosterolemic , but have a decreased level of biliary sterol secretion relative to wild-type mice .
# ::tok We also report an intermediate phenotype in the heterozygous Abcg8 + / - mice that are not sitosterolemic , but have a decreased level of biliary sterol secretion relative to wild-type mice .
# ::alignments 31-32|0.2.1.1.0.0 28-29|0.2.1.1.0 27-28|0.2.1 26-27|0.2.1.0 25-26|0.2.1.1 23-24|0.2 22-23|0.2.0 19-20|0 16-17|0.2.0.0 13-14|0.0 11-12|0.1.1.0 9-10|0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 8-9|0.1.1.0.1 5-6|0.1.1 4-5|0.1.1.1 2-3|0.1 1-2|0.1.2 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:47.233
(c / contrast-01 
      :ARG0 (m2 / mouse) 
      :ARG1 (r2 / report-01 
            :ARG0 (w / we) 
            :ARG1 (p / phenotype 
                  :location (s3 / slash 
                        :mod (c2 / country 
                              :name (n / name 
                                    :op1 "Abcg8")) 
                        :mod (h / heterozygou)) 
                  :mod (i / intermediate)) 
            :mod (a / also)) 
      :ARG2 (l / level 
            :ARG1-of (d / decrease-01 
                  :ARG0 -) 
            :poss (s / secretion 
                  :mod (s2 / sterol) 
                  :mod (b / biliary 
                        :mod-of (r / relative 
                              :prep-to (m / mouse))))))

# ::snt These data indicate that Abcg8/sterolin -2 is necessary for biliary sterol secretion and that loss of Abcg8/sterolin -2 has a more profound effect upon biliary cholesterol secretion than sitosterol .
# ::tok These data indicate that Abcg8/sterolin -2 is necessary for biliary sterol secretion and that loss of Abcg8/sterolin -2 has a more profound effect upon biliary cholesterol secretion than sitosterol .
# ::alignments 28-29|0.2 26-27|0.1.0.1 25-26|0.1.0.1.0 24-25|0.1.0.1.1 22-23|0.1.0 21-22|0.1.0.3 20-21|0.1.0.3.0 14-15|0.1.0.0 12-13|0.1 11-12|0.1.0.2.0 10-11|0.1.0.2.0.0 9-10|0.1.0.2 4-5|0.3.0.0+0.3.0+0.3 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:48.136
(i / indicate-01 
      :ARG0 (d / data 
            :mod (t / this)) 
      :ARG1 (a / and 
            :op1 (e / effect-03 
                  :ARG0 (l / loss) 
                  :ARG1 (s2 / secretion 
                        :mod (c / cholesterol) 
                        :mod (b / biliary)) 
                  :ARG2 (b2 / biliary 
                        :mod-of (s3 / secretion 
                              :mod (s4 / sterol))) 
                  :mod (p / profound 
                        :degree (m / more)))) 
      :ARG2 (s / sitosterol) 
      :location (c2 / country 
            :name (n / name 
                  :op1 "Abcg8/sterolin")))

# ::snt Since biliary sitosterol secretion is preserved , although not elevated in the sitosterolemic mice , this observation suggests that mechanisms other than by Abcg8/sterolin -2 may be responsible for its secretion into bile .
# ::tok Since biliary sitosterol secretion is preserved , although not elevated in the sitosterolemic mice , this observation suggests that mechanisms other than by Abcg8/sterolin -2 may be responsible for its secretion into bile .
# ::alignments 32-33|0.2.0.2.0 30-31|0.1.0.1 27-28|0.1.0 25-26|0.1 23-24|0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 20-21|0.1.0.0.0 19-20|0.1.0.0 17-18|0 16-17|0.0 15-16|0.0.0 13-14|0.2.0.2.1 9-10|0.2.0.2 8-9|0.2.0.2.2 5-6|0.2.0 3-4|0.2.0.1 1-2|0.2.0.1.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:48.543
(s2 / suggest-01 
      :ARG0 (o2 / observation 
            :mod (t / this)) 
      :ARG1 (p / possible-01 
            :ARG1 (r / responsible-01 
                  :ARG0 (m / mechanism 
                        :mod (o / other)) 
                  :ARG1 (s / secretion))) 
      :time (s4 / since 
            :op1 (p2 / preserve-01 
                  :ARG0 (c / country 
                        :name (n / name 
                              :op1 "Abcg8/sterolin")) 
                  :ARG1 (s3 / secretion 
                        :mod (b2 / biliary)) 
                  :condition (e / elevate-01 
                        :ARG0 (b / bile) 
                        :ARG1 (m2 / mouse) 
                        :degree -))))

# ::snt Absorption of dietary cholesterol from the intestine is an important part of cholesterol homeostasis and represents the initial step that allows dietary cholesterol to exert its metabolic effects .
# ::tok Absorption of dietary cholesterol from the intestine is an important part of cholesterol homeostasis and represents the initial step that allows dietary cholesterol to exert its metabolic effects .
# ::alignments 27-28|0.2.1.0.0.1 26-27|0.2.1.0.0.1.0 24-25|0.2.1.0.0 22-23|0.2.1.0.0.0 21-22|0.2.1.0.0.0.0 20-21|0.2.1.0 18-19|0.2.1 17-18|0.2.1.1 15-16|0.2 14-15|0 13-14|0.1 12-13|0.1.0 9-10|0.0 6-7|0.2.1.2 3-4|0.2.0.0 2-3|0.2.0.0.0 0-1|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:49.286
(a2 / and 
      :mod (i2 / important) 
      :op1 (h / homeostasi 
            :mod (c2 / cholesterol)) 
      :op2 (r / represent-01 
            :ARG0 (a3 / absorption 
                  :mod (c3 / cholesterol 
                        :mod (d2 / dietary))) 
            :ARG1 (s / step 
                  :ARG0-of (a / allow-01 
                        :ARG1 (e2 / exert-01 
                              :ARG0 (c / cholesterol 
                                    :mod (d / dietary)) 
                              :ARG1 (e / effect 
                                    :mod (m / metabolic)))) 
                  :mod (i / initial) 
                  :poss (i3 / intestine))))

# ::snt A typical western diet contains relatively equal amounts of cholesterol and non-cholesterol sterols , mainly plant sterols , of which about 55 % of the dietary cholesterol is absorbed and retained compared to ~ 1 % of the dietary non-cholesterol sterols [ 1-3 ] .
# ::tok A typical western diet contains relatively equal amounts of cholesterol and non-cholesterol sterols , mainly plant sterols , of which about 55 % of the dietary cholesterol is absorbed and retained compared to ~ 1 % of the dietary non-cholesterol sterols [ 1-3 ] .
# ::alignments 40-41|0.2.0 38-39|0.1.1.2.0 35-36|0.1.1.2.1 34-35|0.1.1.2.1.0 31-32|0.1.1.2 30-31|0.1.1 29-30|0.1 28-29|0.1.0 26-27|0.1.0.1 25-26|0.1.0.1.0 22-23|0.1.1.1 21-22|0.1.1.1.1 20-21|0.1.1.1.0 16-17|0.0.0.0 15-16|0.0.0.0.0 14-15|0.1.0.0 12-13|0.1.1.0 10-11|0.1.1.0.0 9-10|0.1.1.0.0.0 7-8|0.2.1 6-7|0.2 5-6|0.2.2 4-5|0 3-4|0.0 2-3|0.0.0.1.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:51.920
(c4 / contain-01 
      :ARG0 (d3 / diet 
            :ARG1-of (t / typical-02 
                  :ARG0 (s2 / sterol 
                        :mod (p3 / plant)) 
                  :ARG2 (w / world-region 
                        :name (n / name 
                              :op1 "West") 
                        :wiki "Western_world"))) 
      :ARG1 (a / and 
            :op1 (a2 / absorb-01 
                  :ARG0 (m / main) 
                  :ARG1 (c2 / cholesterol 
                        :mod (d2 / dietary))) 
            :op2 (r / retain-01 
                  :ARG0 (s3 / sterol 
                        :op2-of (a4 / and 
                              :op1 (c3 / cholesterol))) 
                  :ARG1 (p2 / percentage-entity 
                        :op1-of (a3 / about) 
                        :value 55) 
                  :ARG2 (c / compare-01 
                        :ARG1 (d / dietary) 
                        :ARG2 (p / percentage-entity 
                              :value 1)))) 
      :ARG2 (e / equal-01 
            :ARG0 (s / sterol) 
            :ARG1 (a5 / amount) 
            :mod (r2 / relative)))

# ::snt Schoenheimer recognized more than 75 years ago that only cholesterol , not non-cholesterol sterols , is absorbed in the intestine , although the exact molecular mechanisms by which preferential cholesterol absorption occurs has not been fully elucidated [ 4 ] .
# ::tok Schoenheimer recognized more than 75 years ago that only cholesterol , not non-cholesterol sterols , is absorbed in the intestine , although the exact molecular mechanisms by which preferential cholesterol absorption occurs has not been fully elucidated [ 4 ] .
# ::alignments 38-39|0.1 36-37|0.3.0.0.0 35-36|0.3.0.0.0.1 33-34|0.3.0.0.0.1.0 31-32|0.3.0 30-31|0.3 29-30|0.3.1 28-29|0 25-26|0.3.0.0 24-25|0.3.0.0.1 23-24|0.3.0.0.1.0 19-20|0.3.0.0.0.0.2 16-17|0.3.0.0.0.0 13-14|0.0.0 11-12|0.0 9-10|0.3.0.0.0.0.0 8-9|0.3.0.0.0.0.0.0 5-6|0.2.1+0.2 4-5|0.2.0 2-3|0.3.0.0.0.0.1.1 1-2|0.3.0.0.0.0.1 0-1|0.3.0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:53.578
(p / prefer-01 
      :ARG0 (-2 / - 
            :polarity-of (s / sterol)) 
      :ARG1 4 
      :ARG2 (t / temporal-quantity 
            :quant 75 
            :unit (y / year)) 
      :mod-of (a / absorb-01 
            :ARG0-of (o / occur-01 
                  :ARG1 (m / mechanism 
                        :ARG1-of (e / elucidate-01 
                              :condition-of (a2 / absorb-01 
                                    :ARG1 (c2 / cholesterol 
                                          :mod (o2 / only)) 
                                    :ARG1-of (r / recognize-02 
                                          :ARG0 (s2 / schoenheim) 
                                          :ARG2 (m3 / more)) 
                                    :location (i / intestine)) 
                              :degree (f / full 
                                    :polarity -)) 
                        :mod (m2 / molecule 
                              :mod (e2 / exact)))) 
            :ARG1 (c / cholesterol)))

# ::snt Similarly , although the liver secretes free cholesterol into bile , it can preferentially excrete non-cholesterol sterols into bile and the mechanism ( s ) of this process has yet to be elucidated as well .
# ::tok Similarly , although the liver secretes free cholesterol into bile , it can preferentially excrete non-cholesterol sterols into bile and the mechanism ( s ) of this process has yet to be elucidated as well .
# ::alignments 32-33|0.0.2 29-30|0.0.2.1.0 27-28|0.0.2.0.0 26-27|0.0.2.0.0.1 21-22|0.0.2.0 19-20|0.0 18-19|0.0.1 16-17|0.0.2.1 13-14|0.0.2.0.0.0 12-13|0 9-10|0.0.0.2 7-8|0.0.0.1 6-7|0.0.0.1.0 5-6|0.0.0 4-5|0.0.0.0 0-1|0.0.2.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:54.378
(p3 / possible-01 
      :ARG1 (a / and 
            :op1 (s2 / secrete-01 
                  :ARG0 (l / liver) 
                  :ARG1 (c / cholesterol 
                        :ARG1-of (f / free-04)) 
                  :ARG2 (b2 / bile)) 
            :op2 (b / bile) 
            :op3 (e / elucidate-01 
                  :ARG0 (m / mechanism 
                        :poss (p / process-02 
                              :ARG0 (p2 / preferentially) 
                              :mod (t / this) 
                              :op1-of (s3 / similarly))) 
                  :ARG1 (s / sterol 
                        :mod (y / yet)))))

# ::snt Only recently , through the study of a rare human disease , have clues to this process been revealed .
# ::tok Only recently , through the study of a rare human disease , have clues to this process been revealed .
# ::alignments 18-19|0 16-17|0.1.1 15-16|0.1.1.1 13-14|0.0 10-11|0.1.0 9-10|0.1.0.1 8-9|0.1.0.0 5-6|0.1 1-2|0.1.1.0 0-1|0.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:54.530
(r / reveal-01 
      :ARG1 (c / clue) 
      :ARG3-of (s / study-01 
            :ARG1 (d / disease 
                  :ARG1-of (r2 / rare-02) 
                  :mod (h / human)) 
            :ARG1-of (p / process-02 
                  :ARG0 (r3 / recent 
                        :mod (o / only)) 
                  :mod (t / this))))

# ::snt Sitosterolemia ( MIM 210250 , also known as phytosterolemia ) is a rare autosomal , recessively inherited disorder characterized by elevated blood and tissue plant sterol levels [ 5 ] .
# ::tok Sitosterolemia ( MIM 210250 , also known as phytosterolemia ) is a rare autosomal , recessively inherited disorder characterized by elevated blood and tissue plant sterol levels [ 5 ] .
# ::alignments 28-29|0.0.0.1.1.0 26-27|0.0.0 25-26|0.0.0.0 24-25|0.0 23-24|0 22-23|0.0.0.1 21-22|0.0.0.1.2 20-21|0.0.0.1.2.0 18-19|0.0.0.1.0 17-18|0.0.0.1.0.0 16-17|0.0.0.1.0.0.0 13-14|0.0.0.1.0.0.2 12-13|0.0.0.1.0.0.1 8-9|0.0.0.1.1.2 6-7|0.0.0.1.1 5-6|0.0.0.1.1.1.0 3-4|0.0.0.1.2.0.0.2+0.0.0.1.2.0.0.1+0.0.0.1.2.0.0.0+0.0.0.1.2.0.0 2-3|0.0.0.1.1.1.1.0+0.0.0.1.1.1.1+0.0.0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:55.366
(t / tissue 
      :mod-of (p / plant 
            :location-of (l / level 
                  :mod (s / sterol) 
                  :op2-of (a / and 
                        :ARG0-of (c / characterize-01 
                              :ARG1 (d / disord 
                                    :ARG1-of (i / inherit-01) 
                                    :ARG1-of (r / rare-02) 
                                    :mod (a2 / autosomal))) 
                        :ARG3-of (k / know-02 
                              :ARG0 5 
                              :ARG1 (o / organization 
                                    :mod (a3 / also) 
                                    :name (n / name 
                                          :op1 "MIM")) 
                              :ARG2 (p2 / phytosterolemia)) 
                        :op1 (b / blood 
                              :ARG1-of (e / elevate-01 
                                    :ARG0 (d2 / date-entity 
                                          :day 50 
                                          :month 2 
                                          :year 21)))))))

# ::snt Affected individuals can develop tendon and/or tuberous xanthomas , hemolytic episodes , arthralgias , arthritis , and premature atherosclerosis [ 6,7 ] .
# ::tok Affected individuals can develop tendon and/or tuberous xanthomas , hemolytic episodes , arthralgias , arthritis , and premature atherosclerosis [ 6,7 ] .
# ::alignments 18-19|0.0.0.0.1 17-18|0.0.0.0.0 16-17|0.0.2 14-15|0.0.2.3 12-13|0.0.2.2 10-11|0.0.2.1 9-10|0.0.2.1.0 7-8|0.0.2.0 4-5|0.0.1 3-4|0.0 2-3|0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:55.998
(p2 / possible-01 
      :ARG1 (d / develop-02 
            :ARG0 (i / individual 
                  :ARG1-of (a5 / affect-01 
                        :ARG0 (p / premature) 
                        :ARG2 (a / atherosclerosi))) 
            :ARG1 (t / tendon) 
            :op1-of (a2 / and 
                  :op2 (x / xanthoma) 
                  :op3 (e / episod 
                        :mod (h / hemolytic)) 
                  :op4 (a4 / arthralgia) 
                  :op5 (a3 / arthritis))))

# ::snt Sitosterolemic patients have diagnostically elevated plasma plant sterol levels ( for example , sitosterol , campesterol , stigmasterol , and avenosterol , etc. ) and their 5-saturated stanol metabolites , particularly sitostanol , with normal or only moderately increased cholesterol levels .
# ::tok Sitosterolemic patients have diagnostically elevated plasma plant sterol levels ( for example , sitosterol , campesterol , stigmasterol , and avenosterol , etc. ) and their 5-saturated stanol metabolites , particularly sitostanol , with normal or only moderately increased cholesterol levels .
# ::alignments 40-41|0.0.3.1.2.1 39-40|0.0.3.1.2.1.0 38-39|0.0.3.1 37-38|0.0.3.1.0 36-37|0.0.3.1.1 35-36|0.0.3.1.2 34-35|0.0.3.1.2.0 30-31|0.0.2 28-29|0.0.3.0 26-27|0.0.3.0.0 24-25|0.0.3 20-21|0.5 19-20|0 17-18|0.4 15-16|0.3 13-14|0.2 11-12|0.0.3.1.2.0.0 8-9|0.1 7-8|0.1.1 6-7|0.1.1.0 5-6|0.1.1.0.0 4-5|0.1.0 1-2|0.0.0.0+0.0.0+0.0 0-1|0.0.1.0.0+0.0.1.0+0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:07:56.909
(a3 / and 
      :op1 (p4 / person 
            :ARG0-of (h / have-rel-role-91 
                  :ARG2 (p5 / patient)) 
            :mod (t / thing 
                  :name (n2 / name 
                        :op1 "Sitosterolemic")) 
            :mod (p / particular) 
            :op1-of (a / and 
                  :op2 (m2 / metabolit 
                        :mod 5-saturat) 
                  :op3 (i / increase-01 
                        :manner (m / moderate) 
                        :mod (o / only) 
                        :op2-of (o2 / or 
                              :op1 (n / normal-02 
                                    :ARG1 (e / example)) 
                              :op3 (l / level 
                                    :mod (c / cholesterol)))))) 
      :op2 (l2 / level 
            :ARG1-of (e2 / elevate-01) 
            :mod (s3 / sterol 
                  :mod (p2 / plant 
                        :mod (p3 / plasma)))) 
      :op3 (s2 / sitosterol) 
      :op4 (c2 / campesterol) 
      :op5 (s / stigmasterol) 
      :op6 (a2 / avenosterol))

# ::snt Clinical studies have shown that affected individuals hyperabsorb all dietary sterols ( thus have lost the ability to restrict the sterol species absorbed ) and have lost the ability to excrete sterols into bile [ 8,9 ] .
# ::tok Clinical studies have shown that affected individuals hyperabsorb all dietary sterols ( thus have lost the ability to restrict the sterol species absorbed ) and have lost the ability to excrete sterols into bile [ 8,9 ] .
# ::alignments 33-34|0.1.1.1.0.0 31-32|0.1.1.0 28-29|0.1.2.1 26-27|0.1.2 24-25|0.1 22-23|0.1.1.1.0.1.0 21-22|0.1.1.1.0.1 20-21|0.1.1.1.0.1.1 18-19|0.1.1.1.0 16-17|0.1.1.1 14-15|0.1.1 12-13|0.1.1.2 10-11|0.1.0 9-10|0.1.0.0 8-9|0.1.1.1.0.1.0.0 6-7|0.1.2.0 5-6|0.1.2.0.0 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:01.528
(s5 / show-01 
      :ARG0 (s6 / study-01 
            :ARG1 (c / clinic)) 
      :ARG1 (a2 / and 
            :op1 (s4 / sterol 
                  :mod (d / dietary)) 
            :op2 (l2 / lose-02 
                  :ARG0 (s / sterol) 
                  :ARG1 (a4 / ability 
                        :purpose (r / restrict-01 
                              :ARG0 (b / bile) 
                              :ARG1 (s2 / species 
                                    :ARG1-of (a3 / absorb-01 
                                          :ARG0 (a5 / all)) 
                                    :mod (s3 / sterol)))) 
                  :time (t / thus-far)) 
            :op3 (l / lose-02 
                  :ARG0 (i / individual 
                        :ARG1-of (a6 / affect-01)) 
                  :ARG1 (a / ability))))

# ::snt Infusion of sitosterol and cholesterol into normal individuals leads to a rapid and preferential excretion of sitosterol into bile , but in sitosterolemic individuals biliary sterol secretion is almost absent [ 7,9 ] .
# ::tok Infusion of sitosterol and cholesterol into normal individuals leads to a rapid and preferential excretion of sitosterol into bile , but in sitosterolemic individuals biliary sterol secretion is almost absent [ 7,9 ] .
# ::alignments 29-30|0.1 28-29|0.1.1 26-27|0.1.0 25-26|0.1.0.0 24-25|0.1.0.1 23-24|0.0.2.2 20-21|0 18-19|0.0.3 14-15|0.0.2.1.0 13-14|0.0.2.1 12-13|0.0.2 11-12|0.0.2.0 8-9|0.0 7-8|0.0.0.2.0 6-7|0.0.0.2 4-5|0.0.0.1 3-4|0.0.0 2-3|0.0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:02.239
(c / contrast-01 
      :ARG1 (l / lead-03 
            :ARG0 (a4 / and 
                  :op1 (s3 / sitosterol) 
                  :op2 (c2 / cholesterol) 
                  :op3 (n / normal-02 
                        :ARG1 (i2 / individual))) 
            :ARG1 (i3 / infusion) 
            :ARG2 (a3 / and 
                  :op1 (r / rapid) 
                  :op2 (p / prefer-01 
                        :ARG1 (e / excretion)) 
                  :op3 (i / individual)) 
            :ARG3 (b2 / bile)) 
      :ARG2 (a / absent-01 
            :ARG1 (s / secretion 
                  :mod (s2 / sterol) 
                  :mod (b / biliary)) 
            :degree (a2 / almost)))

# ::snt Previous studies on sitosterolemia have suggested a defect involving a putative sterol ` transporter ' expressed in the intestinal brush border and/or the hepatic canalicular membrane [ 10,11 ] .
# ::tok Previous studies on sitosterolemia have suggested a defect involving a putative sterol ` transporter ' expressed in the intestinal brush border and/or the hepatic canalicular membrane [ 10,11 ] .
# ::alignments 25-26|0.0 24-25|0.0.0 23-24|0.1.0.0.0.0 20-21|0.2 19-20|0.2.0 18-19|0.1.0.0.0.1 15-16|0 13-14|0.1 11-12|0.1.1 10-11|0.1.0.1.0 8-9|0.1.0.0.0.2 7-8|0.1.0.0.0 5-6|0.1.0.0 3-4|0.1.0.1 1-2|0.1.0 0-1|0.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:02.710
(e / express-01 
      :ARG0 (m / membrane 
            :mod (c / canalicular)) 
      :ARG1 (t / transport-01 
            :ARG0 (s4 / study-01 
                  :ARG0-of (s2 / suggest-01 
                        :ARG1 (d / defect-01 
                              :ARG0 (h / hepatic) 
                              :ARG1 (i / intestine) 
                              :ARG1-of (i2 / involve-01))) 
                  :ARG1 (s3 / sitosterolemia 
                        :domain-of (p / putative)) 
                  :mod (p2 / previou)) 
            :ARG1 (s / sterol)) 
      :manner (b / border-01 
            :ARG2 (b2 / brush)))

# ::snt Genetic analyses of sitosterolemia pedigrees allowed the mapping of the STSL locus to human chromosome 2p21 , between D2S2294 and D2S2298 [ 12,13 ] .
# ::tok Genetic analyses of sitosterolemia pedigrees allowed the mapping of the STSL locus to human chromosome 2p21 , between D2S2294 and D2S2298 [ 12,13 ] .
# ::alignments 20-21|0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 19-20|0.0.0.0 18-19|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 15-16|0.1 14-15|0 13-14|0.0 11-12|0.0.0.1 10-11|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 7-8|0.0.0 5-6|0.0.0.2 4-5|0.0.0.2.0.1 3-4|0.0.0.2.0.1.0 1-2|0.0.0.2.0 0-1|0.0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:04.318
(c3 / chromosome 
      :mod (h / human 
            :ARG2-of (m / map-01 
                  :ARG0 (a / and 
                        :op1 (c2 / country 
                              :name (n2 / name 
                                    :op1 "D2S2294")) 
                        :op2 (c / country 
                              :name (n / name 
                                    :op1 "D2S2298"))) 
                  :ARG1 (l / locu 
                        :mod (t / thing 
                              :name (n3 / name 
                                    :op1 "STSL"))) 
                  :ARG1-of (a2 / allow-01 
                        :ARG0 (a3 / analysis 
                              :mod (g / genetic) 
                              :mod (p / pedigre 
                                    :mod (s / sitosterolemia)))))) 
      :mod-of 2p21)

# ::snt By using positional cloning procedures or by screening for genes induced by exposure to LXR agonists , two groups identified not one but two genes , ABCG5 and ABCG8 , which encode the proteins sterolin-1 and sterolin-2 , mutations of which cause sitosterolemia [ 14-16 ] .
# ::tok By using positional cloning procedures or by screening for genes induced by exposure to LXR agonists , two groups identified not one but two genes , ABCG5 and ABCG8 , which encode the proteins sterolin-1 and sterolin-2 , mutations of which cause sitosterolemia [ 14-16 ] .
# ::alignments 42-43|0.1.1.0.0 41-42|0.1.1.0 38-39|0.1.1.0.1 35-36|0.1.0.1 33-34|0.1.0.0 31-32|0.1.0 28-29|0.1.1.2.0.0+0.1.1.2.0+0.1.1.2 27-28|0.1.1 26-27|0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 24-25|0.1 23-24|0.1.2 22-23|0 20-21|0.0.1 19-20|0.0 18-19|0.0.0 17-18|0.0.0.0 15-16|0.0.2 14-15|0.0.2.0.1.0.0+0.0.2.0.1.0+0.0.2.0.1 12-13|0.0.2.0 10-11|0.0.2.0.0 9-10|0.0.2.0.0.0 7-8|0.0.2.0.0.0.0 5-6|0.0.2.0.0.1.0.0.0 4-5|0.0.2.0.0.1.0 3-4|0.0.2.0.0.1 2-3|0.0.2.0.0.1.0.1 1-2|0.0.2.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:05.787
(c2 / contrast-01 
      :ARG1 (i / identify-01 
            :ARG0 (g2 / group 
                  :quant 2) 
            :ARG1 - 
            :manner (a3 / agonist 
                  :ARG1-of (e2 / expose-01 
                        :ARG0-of (i2 / induce-01 
                              :ARG1 (g3 / gene 
                                    :ARG1-of (s2 / screen-01)) 
                              :ARG2-of (c3 / clone-01 
                                    :ARG1 (p3 / procedure 
                                          :ARG1-of (u / use-01 
                                                :op1-of (o2 / or)) 
                                          :mod (p4 / positional)))) 
                        :ARG2 (o / organization 
                              :name (n3 / name 
                                    :op1 "LXR"))))) 
      :ARG2 (g / gene 
            :ARG0-of (e / encode-01 
                  :ARG1 (p / protein) 
                  :op1-of (a / and)) 
            :op1-of (a2 / and 
                  :ARG0-of (c / cause-01 
                        :ARG1 (s / sitosterolemia) 
                        :ARG2 (m / mutate-01)) 
                  :op2 (p2 / person 
                        :name (n2 / name 
                              :op1 "ABCG5")) 
                  :op3 (t / thing 
                        :name (n / name 
                              :op1 "ABCG8"))) 
            :quant 2))

# ::snt Interestingly , complete mutation in either ABCG5 alone or ABCG8 alone is not only necessary , but sufficient to cause the disease [ 14 ] .
# ::tok Interestingly , complete mutation in either ABCG5 alone or ABCG8 alone is not only necessary , but sufficient to cause the disease [ 14 ] .
# ::alignments 23-24|0.2.1 21-22|0.2.2.0.0.1 19-20|0.2 17-18|0.2.2 16-17|0 13-14|0.2.2.0.0.0 12-13|0.2.2.1 10-11|0.2.2.0.1.0.0 9-10|0.2.2.0.1.0.1.0+0.2.2.0.1.0.1+0.2.2.0.1.0 8-9|0.2.2.0.1 7-8|0.1 5-6|0.0 3-4|0.2.2.0 2-3|0.2.2.0.0 0-1|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:06.223
(c2 / contrast-01 
      :ARG0 (e / either) 
      :ARG1 (a2 / alone) 
      :ARG2 (c / cause-01 
            :ARG0 (i / interesting) 
            :ARG1 14 
            :ARG1-of (s / suffice-01 
                  :ARG0 (m / mutation 
                        :ARG1-of (c3 / complete-02 
                              :ARG0 (o / only) 
                              :ARG2 (d / disease)) 
                        :op1-of (o2 / or 
                              :op2 (t / thing 
                                    :domain-of (a / alone) 
                                    :name (n / name 
                                          :op1 "ABCG8")))) 
                  :polarity -)))

# ::snt To date , no patient with sitosterolemia has been identified with mutations in both genes .
# ::tok To date , no patient with sitosterolemia has been identified with mutations in both genes .
# ::alignments 14-15|0.1.0 13-14|0.1.0.0 11-12|0.1 9-10|0 6-7|0.0.0.0 4-5|0.0.0.1+0.0.0+0.0 3-4|0.3 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:06.286
(i / identify-01 
      :ARG1 (p / person 
            :ARG0-of (h / have-rel-role-91 
                  :ARG1 (s / sitosterolemia) 
                  :ARG2 (p2 / patient))) 
      :ARG2 (m / mutate-01 
            :ARG1 (g / gene 
                  :mod (b / both))) 
      :ARG3 (d / date) 
      :polarity -)

# ::snt Based upon these data , and the similarity of the clinical and biochemical phenotype , sterolin-1 and sterolin-2 are hypothesized to function as obligate heterodimers .
# ::tok Based upon these data , and the similarity of the clinical and biochemical phenotype , sterolin-1 and sterolin-2 are hypothesized to function as obligate heterodimers .
# ::alignments 24-25|0.3.0.2.0.0 23-24|0.3.0.2.0.0.0 21-22|0.3.0.2.0 19-20|0.3.0.2 16-17|0.3.0.1 13-14|0.2 12-13|0.1 11-12|0 10-11|0.0 7-8|0.3 5-6|0.3.0 3-4|0.3.0.0.0 2-3|0.3.0.0.0.0 0-1|0.3.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:06.609
(a2 / and 
      :op1 (c / clinical) 
      :op2 (b / biochemical) 
      :op3 (p / phenotype) 
      :quant (s / similarity 
            :op1-of (a3 / and 
                  :ARG2-of (b2 / base-02 
                        :ARG1 (d / data 
                              :mod (t / this))) 
                  :op2 (a / and) 
                  :op3 (h2 / hypothesize-01 
                        :ARG1 (f / function-01 
                              :ARG1 (h / heterodimer 
                                    :ARG1-of (o / obligate-01)))))))

# ::snt This is also supported by the fact that each of these proteins is a ` half-transporter ' , containing six transmembrane domains , and not the classical 12 transmembrane characteristic of functional ABC transporters .
# ::tok This is also supported by the fact that each of these proteins is a ` half-transporter ' , containing six transmembrane domains , and not the classical 12 transmembrane characteristic of functional ABC transporters .
# ::alignments 33-34|0.1.0.1.1.1 32-33|0.1.0.1.1.1.1.0+0.1.0.1.1.1.1 31-32|0.1.0.1.1.1.0 29-30|0.1.0.1.1 27-28|0.1.0.0.0.3 26-27|0.1.0.1.1.0 24-25|0.1.0.2 23-24|0.1.0.1 21-22|0.1.0.1.0 19-20|0.1.0.1.0.0 18-19|0.1.0 15-16|0.1.0.0 11-12|0 10-11|0.1 8-9|0.0 6-7|0.1.0.0.0.0 3-4|0.1.0.0.0 2-3|0.1.0.0.0.2 0-1|0.1.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:07.688
(p / protein 
      :mod (e / each) 
      :mod (t2 / this 
            :ARG2-of (c3 / contain-01 
                  :ARG0 (h / half-transport 
                        :ARG2-of (s / support-01 
                              :ARG0 (f2 / fact) 
                              :ARG1 (t3 / this) 
                              :mod (a2 / also) 
                              :op1-of 12)) 
                  :ARG1 (a / and 
                        :op1 (d / domain 
                              :quant 6) 
                        :op2 (c / characteristic 
                              :mod (c2 / classics) 
                              :mod (t / transporter 
                                    :mod (f / functional) 
                                    :name (n / name 
                                          :op1 "ABC")))) 
                  :polarity -)))

# ::snt The exact function of these two proteins still remains unknown but recent studies have shown that overexpression of ABCG5/ABCG8 in a transgenic mouse model results in an increased biliary cholesterol concentration and a 50 % reduction in the fractional absorption of dietary cholesterol [ 17 ] .
# ::tok The exact function of these two proteins still remains unknown but recent studies have shown that overexpression of ABCG5/ABCG8 in a transgenic mouse model results in an increased biliary cholesterol concentration and a 50 % reduction in the fractional absorption of dietary cholesterol [ 17 ] .
# ::alignments 44-45|0.1.0.0.0.0.0 42-43|0.1.0.0.0.0.1.1.0.0.0 41-42|0.1.0.0.0.0.1.1.0.0.0.0 39-40|0.1.0.0.0.0.1.1.0.0 38-39|0.1.0.0.0.0.1.1.0.0.1 35-36|0.1.0.0.0.0.1.1.0 34-35|0.1.0.0.0.0.1.1.0.1 33-34|0.1.0.0.0.0.1.1.0.1.0 31-32|0.1.0.0.0.0.1.1 30-31|0.1.0.0.0.0 29-30|0.1.0.0.0 28-29|0.1.0.0.0.0.2 27-28|0.1.0.0.0.0.1 24-25|0.1.0.0+0.1.0.0.1 23-24|0.1.0.0.2 22-23|0.1.0 18-19|0.0.0.0.0+0.0.0.0+0.0.0 16-17|0.0.0.1 14-15|0.1 12-13|0.1.1 11-12|0.1.1.0 10-11|0 9-10|0.0.1+0.0 8-9|0.1.2 7-8|0.1.2.1 6-7|0.1.2.0 5-6|0.1.2.0.1 4-5|0.1.0.0.0.0.1.0 2-3|0.1.2.0.0 1-2|0.1.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:10.623
(c4 / contrast-01 
      :ARG1 (k / know-01 
            :ARG1 (t2 / thing 
                  :name (n / name 
                        :op1 "ABCG5/ABCG8") 
                  :poss-of (o / overexpression)) 
            :polarity -) 
      :ARG2 (s / show-01 
            :ARG0 (m2 / mouse 
                  :mod-of (r2 / result-01 
                        :ARG1 (c3 / cholesterol 
                              :ARG1-of (c2 / concentrate-02 
                                    :ARG0 17 
                                    :ARG1-of (i / increase-01 
                                          :ARG0 (t3 / this) 
                                          :op1-of (a2 / and 
                                                :op2 (r / reduce-01 
                                                      :ARG1 (a / absorb-01 
                                                            :ARG1 (c / cholesterol 
                                                                  :mod (d / dietary)) 
                                                            :mod (f / fractional)) 
                                                      :ARG2 (p / percentage-entity 
                                                            :value 50)))) 
                                    :mod (b / biliary))) 
                        :ARG2 (t / thing) 
                        :mod (m / model))) 
            :ARG1 (s2 / study-01 
                  :mod (r3 / recent)) 
            :ARG1-of (r4 / remain-01 
                  :ARG0 (p2 / protein 
                        :ARG1-of (f2 / function-01 
                              :mod (e / exact)) 
                        :quant 2) 
                  :mod (s3 / still))))

# ::snt It has been suggested that ABCG5 and ABCG8 act as mutual chaperones for both maturation and correct apical targeting .
# ::tok It has been suggested that ABCG5 and ABCG8 act as mutual chaperones for both maturation and correct apical targeting .
# ::alignments 18-19|0.1.2.1.0 17-18|0.1.2.1 16-17|0.1.2 15-16|0.1.2.2 14-15|0.1.1 13-14|0.1.1.0 11-12|0.1.0.0 10-11|0.1.0.0.0 8-9|0.1.0 7-8|0.1.2.2.0.0.0+0.1.2.2.0.0+0.1.2.2.0 6-7|0.1 5-6|0.1.2.0.0.0+0.1.2.0.0+0.1.2.0 3-4|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:10.932
(s / suggest-01 
      :ARG1 (i / it) 
      :op1-of (a4 / and 
            :ARG0-of (a3 / act-02 
                  :ARG1 (c2 / chaperone-01 
                        :mod (m2 / mutual))) 
            :beneficiary (m / maturation 
                  :mod (b / both)) 
            :op2 (c / correct-02 
                  :ARG0 (p / person 
                        :name (n2 / name 
                              :op1 "ABCG5")) 
                  :ARG1 (a / apical 
                        :ARG1-of (t / target-01)) 
                  :op2-of (a2 / and 
                        :op1 (t2 / thing 
                              :name (n / name 
                                    :op1 "ABCG8"))))))

# ::snt Co-expression of both was required for apical trafficking in a polarized cell line , as well in vivo using Abcg5/Abcg8 double-knockout mice [ 18,19 ] .
# ::tok Co-expression of both was required for apical trafficking in a polarized cell line , as well in vivo using Abcg5/Abcg8 double-knockout mice [ 18,19 ] .
# ::alignments 21-22|0.3.1 19-20|0.0.0.0+0.0.0+0.0 18-19|0.3 17-18|0.3.0 12-13|0.2.0 11-12|0.2.0.1 10-11|0.2.0.0 7-8|0.2 6-7|0.3.2 4-5|0 2-3|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:11.201
(r / require-01 
      :ARG0 (t / thing 
            :name (n / name 
                  :op1 "Abcg5/Abcg8")) 
      :ARG1 (b / both) 
      :ARG3 (t2 / traffic-01 
            :ARG1 (l / line 
                  :ARG1-of (p / polarize-01) 
                  :mod (c / cell))) 
      :purpose-of (u / use-01 
            :ARG0 (v / vivo) 
            :ARG1 (m / mouse) 
            :ARG2 (a / apical)))

# ::snt However , no functional assay has yet been developed to demonstrate whether or not the two half-transporters function as homo - or heterodimers and whether they selectively pump sterols .
# ::tok However , no functional assay has yet been developed to demonstrate whether or not the two half-transporters function as homo - or heterodimers and whether they selectively pump sterols .
# ::alignments 28-29|0.1 27-28|0 26-27|0.2 25-26|0.0 23-24|0.3 22-23|0.3.0.1.0.1 21-22|0.3.0.1.0 19-20|0.3.0.1.0.0 17-18|0.3.0.1 16-17|0.3.0.1.1 15-16|0.3.0.1.3 13-14|0.3.0.1.2 12-13|0.3.0.0 10-11|0.3.0 8-9|0.3.0.2 6-7|0.3.0.2.2 4-5|0.3.0.2.0 3-4|0.3.0.2.0.0 2-3|0.3.0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:11.983
(p / pump-01 
      :ARG0 (t / they) 
      :ARG1 (s / sterol) 
      :manner (s2 / selectively) 
      :op1-of (a / and 
            :ARG1-of (d / demonstrate-01 
                  :ARG0 (o2 / or) 
                  :ARG2 (f / function-01 
                        :ARG0 (o / or 
                              :op1 (h2 / homo) 
                              :op2 (h / heterodimer)) 
                        :ARG1 (h3 / half-transporter) 
                        :polarity - 
                        :quant 2) 
                  :ARG2-of (d2 / develop-02 
                        :ARG1 (a2 / assay 
                              :mod (f2 / functional)) 
                        :polarity - 
                        :time (y / yet)))))

# ::snt Likewise , the cellular localization of these two proteins has yet to be shown in a model deficient in either Abcg5 or Abcg8 alone .
# ::tok Likewise , the cellular localization of these two proteins has yet to be shown in a model deficient in either Abcg5 or Abcg8 alone .
# ::alignments 23-24|0.2 22-23|0.6.0.0+0.6.0+0.6 21-22|0 20-21|0.5 19-20|0.1 16-17|0.4.1 13-14|0.4 10-11|0.4.2 8-9|0.0.0 7-8|0.0.0.0 6-7|0.0 4-5|0.4.0 3-4|0.4.0.0 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:12.234
(o / or 
      :domain (t / this 
            :mod-of (p / protein 
                  :quant 2)) 
      :mod (e / either) 
      :mod (a / alone) 
      :mod-of (l2 / likewise) 
      :op1 (s / show-01 
            :ARG0 (l / localization 
                  :mod (c2 / cell)) 
            :ARG1 (m / model) 
            :polarity (y / yet)) 
      :op2 (a2 / Abcg5) 
      :op3 (c / country 
            :name (n / name 
                  :op1 "Abcg8")))

# ::snt A mouse model disrupting both Abcg5 and Abcg8 simultaneously results in a phenotype similar to that of the human disease [ 20 ] .
# ::tok A mouse model disrupting both Abcg5 and Abcg8 simultaneously results in a phenotype similar to that of the human disease [ 20 ] .
# ::alignments 21-22|0.2.0.0 19-20|0.0.0 18-19|0.0 15-16|0.2.0.1 13-14|0.2.0 12-13|0.2 9-10|0 8-9|0.3 7-8|0.1.2.0.0+0.1.2.0+0.1.2 6-7|0.1 5-6|0.1.1 4-5|0.1.2.1 3-4|0.1.0 2-3|0.1.0.0 1-2|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:13.000
(r2 / result-01 
      :ARG0 (h / human 
            :mod-of (d / disease)) 
      :ARG1 (a / and 
            :ARG1-of (d2 / disrupt-01 
                  :ARG0 (m / model 
                        :mod (m2 / mouse))) 
            :op1 (a2 / Abcg5) 
            :op2 (c / country 
                  :name (n / name 
                        :op1 "Abcg8") 
                  :op1-of (b / both))) 
      :ARG2 (p / phenotype 
            :ARG1-of (r / resemble-01 
                  :ARG0 20 
                  :ARG2 (t / that))) 
      :time (s / simultaneous))

# ::snt However , it is important to point out that the human disease is caused by complete mutation in one or the other gene , but not both simultaneously .
# ::tok However , it is important to point out that the human disease is caused by complete mutation in one or the other gene , but not both simultaneously .
# ::alignments 27-28|0.1.0 26-27|0.0.0.0.0 25-26|0.2 24-25|0 22-23|0.0.0.1.0 21-22|0.0.0.1.0.0 19-20|0.0.0.1 16-17|0.0.0 15-16|0.0.0.0 13-14|0.0 11-12|0.0.1 10-11|0.0.1.0 6-7|0.1 4-5|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:13.436
(c / contrast-01 
      :ARG1 (c3 / cause-01 
            :ARG0 (m / mutation 
                  :ARG1-of (c2 / complete-02 
                        :ARG0 (b / both)) 
                  :op1-of (o2 / or 
                        :op2 (g / gene 
                              :mod (o / other)))) 
            :ARG1 (d / disease 
                  :mod (h / human))) 
      :ARG1-of (p / point-01 
            :ARG0 (s / simultaneous) 
            :domain-of (i / important)) 
      :ARG2 -)

# ::snt We hypothesized that disruption of only one of the half-transporters would result in sitosterolemia and selective loss of either sterolin may show a differential effect on the biliary secretion of sterols or intestinal absorption of sterols .
# ::tok We hypothesized that disruption of only one of the half-transporters would result in sitosterolemia and selective loss of either sterolin may show a differential effect on the biliary secretion of sterols or intestinal absorption of sterols .
# ::alignments 35-36|0.1.1 33-34|0.1 32-33|0.1.0 31-32|0 30-31|0.0 28-29|0.2.1 27-28|0.2.1.0 24-25|0.2 23-24|0.2.3 21-22|0.2.2 20-21|0.2.2.1 19-20|0.2.0.1 18-19|0.2.0.1.0 16-17|0.2.0 15-16|0.2.0.0 14-15|0.2.2.2 13-14|0.2.2.2.1.1 11-12|0.2.2.2.1 9-10|0.2.2.2.1.0 5-6|0.2.2.2.0.1 3-4|0.2.2.0 1-2|0.2.2.2.0 0-1|0.2.2.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:15.373
(o / or 
      :op1 (s2 / sterol) 
      :op2 (a / absorb-01 
            :ARG0 (i / intestine) 
            :ARG1 (s / sterol)) 
      :subevent-of (e / effect-03 
            :ARG0 (l / loss 
                  :mod (s6 / selective) 
                  :poss (s5 / sterolin 
                        :mod (e2 / either))) 
            :ARG1 (s3 / secretion 
                  :mod (b / biliary)) 
            :ARG1-of (s4 / show-01 
                  :ARG0 (d2 / disruption) 
                  :ARG1-of (p / possible-01) 
                  :op2-of (a2 / and 
                        :ARG1-of (h2 / hypothesize-01 
                              :ARG0 (w / we) 
                              :time (o2 / only)) 
                        :op1 (r / result-01 
                              :ARG1 (h / half-transporter) 
                              :ARG2 (s7 / sitosterolemia)))) 
            :mod (d / differential)))

# ::snt These studies are difficult to test in humans , as the target organs are relatively inaccessible .
# ::tok These studies are difficult to test in humans , as the target organs are relatively inaccessible .
# ::alignments 15-16|0.0.0.1.0.0.0 14-15|0.0.0.0 12-13|0.0.0.1.0.0 11-12|0.0.0.1.0 7-8|0.0.1 5-6|0.0 3-4|0 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:15.452
(d / difficult 
      :domain (t2 / test-01 
            :ARG1 (s / study-01 
                  :ARG1 (r / relative) 
                  :mod (t3 / this 
                        :ARG0-of (t / target-01 
                              :ARG1 (o / organ 
                                    :ARG1-of (a / access-01))))) 
            :manner (h / human)))

# ::snt In order to test this hypothesis , we report a mouse model that has a selective genetic mutation of Abcg8 .
# ::tok In order to test this hypothesis , we report a mouse model that has a selective genetic mutation of Abcg8 .
# ::alignments 19-20|0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 17-18|0.1.1 16-17|0.2.0 15-16|0.1.1.0 11-12|0.1 10-11|0.1.0 8-9|0 7-8|0.0 5-6|0.2.1 4-5|0.2.1.0 3-4|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:15.631
(r / report-01 
      :ARG0 (w / we) 
      :ARG1 (m2 / model 
            :mod (m3 / mouse) 
            :poss-of (m / mutation 
                  :mod (s / selective) 
                  :poss (c / country 
                        :name (n / name 
                              :op1 "Abcg8")))) 
      :condition (t2 / test-01 
            :ARG0 (g / gene) 
            :ARG1 (h / hypothesi 
                  :mod (t / this))))

# ::snt Mice homozygous for Abcg8 loss exhibit many of the characteristics of the human disease sitosterolemia .
# ::tok Mice homozygous for Abcg8 loss exhibit many of the characteristics of the human disease sitosterolemia .
# ::alignments 14-15|0.0.0 13-14|0.0.0.0 12-13|0.0.0.0.0 9-10|0.0+0.0.1 6-7|0.0.1.0 5-6|0.0.1.0.0 4-5|0.0.1.0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:15.813
(m2 / mouse 
      :ARG0-of (c / characteristic-02 
            :ARG1 (s / sitosterolemia 
                  :mod (d / disease 
                        :mod (h / human))) 
            :ARG2 (t / thing 
                  :quant (m / many 
                        :quant-of (e / exhibit-01 
                              :ARG1 (l / loss))))))

# ::snt In addition , we report studies of biliary sterol secretion that show that despite forced secretion , Abcg8-deficient animals can not secrete cholesterol into bile , although sitosterol secretion seemed unaffected .
# ::tok In addition , we report studies of biliary sterol secretion that show that despite forced secretion , Abcg8-deficient animals can not secrete cholesterol into bile , although sitosterol secretion seemed unaffected .
# ::alignments 30-31|0.2+0 29-30|0.1 28-29|0.0 24-25|0.1.0.0.2 22-23|0.1.0.0.1 21-22|0.1.0.0 20-21|0.1.0.2 19-20|0.1.0 18-19|0.1.0.0.0 15-16|0.1.0.0.3.0 14-15|0.1.0.0.3 11-12|0.1.0.1 9-10|0.1.0.1.0.0 8-9|0.1.0.1.0.0.0 7-8|0.1.0.1.0.0.1 5-6|0.1.0.1.0 4-5|0.1.0.1.0.1 3-4|0.1.0.1.0.1.0 1-2|0.1.0.1.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:16.379
(a / affect-01 
      :ARG1 (s2 / secretion) 
      :ARG1-of (s / seem-01 
            :condition-of (p / possible-01 
                  :ARG1 (s3 / secrete-01 
                        :ARG0 (a2 / animal) 
                        :ARG1 (c / cholesterol) 
                        :ARG2 (b / bile) 
                        :manner (f / force-01 
                              :ARG1 (s4 / secretion))) 
                  :ARG1-of (s5 / show-01 
                        :ARG0 (s8 / study-01 
                              :ARG1 (s6 / secretion 
                                    :mod (s7 / sterol) 
                                    :mod (b2 / biliary)) 
                              :ARG1-of (r / report-01 
                                    :ARG0 (w / we) 
                                    :prep-in (a3 / addition)))) 
                  :polarity -)) 
      :polarity -)

# ::snt Targeting vector construction and generation of knockout mice .
# ::tok Targeting vector construction and generation of knockout mice .
# ::alignments 7-8|0.0.0 6-7|0.0.0.0 4-5|0.1 3-4|0 2-3|0.0 1-2|0.0.1 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:16.484
(a / and 
      :op1 (c / construct-01 
            :ARG0 (m / mouse 
                  :mod (k / knockout)) 
            :ARG1 (v / vector) 
            :ARG1-of (t / target-01)) 
      :op2 (g / generation))

# ::snt A mouse genomic bacterial artificial chromosome ( BAC ) library ( CitbCJ7 , ES cell line/129Sv , Research Genetics , Inc. , Huntsville , AL , USA ) was screened by using primers designed from the sequences of mouse Abcg5 and Abcg8 cDNA as previously reported [ 21 ] .
# ::tok A mouse genomic bacterial artificial chromosome ( BAC ) library ( CitbCJ7 , ES cell line/129Sv , Research Genetics , Inc. , Huntsville , AL , USA ) was screened by using primers designed from the sequences of mouse Abcg5 and Abcg8 cDNA as previously reported [ 21 ] .
# ::alignments 47-48|0.0 45-46|0.2.0.0.1.7 44-45|0.2.1 42-43|0.2.0.0.1.6 40-41|0.2.0.0.1 39-40|0.2.0.0.1.5 38-39|0.2.0.0.1.5.0 36-37|0.2.0.0.1.4 33-34|0.2.0.0 32-33|0.2.0 31-32|0.2 29-30|0 26-27|0.2.0.0.1.3.1+0.2.0.0.1.3.0.0+0.2.0.0.1.3.0+0.2.0.0.1.3 24-25|0.2.0.0.1.2.0.0+0.2.0.0.1.2.0+0.2.0.0.1.2 22-23|0.2.0.0.1.1.0.0+0.2.0.0.1.1.0+0.2.0.0.1.1 18-19|0.2.0.0.1.0.2 17-18|0.2.0.0.1.0 14-15|0.2.0.0.1.7.1 13-14|0.2.0.0.1.7.1.0 11-12|0.2.0.0.0 9-10|0.1 7-8|0.2.0.0.1.7.0.0.0+0.2.0.0.1.7.0.0+0.2.0.0.1.7.0 5-6|0.1.0 4-5|0.1.1 3-4|0.2.0.0.1.0.0 1-2|0.2.0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:17.543
(s2 / screen-01 
      :ARG0 21 
      :ARG1 (l / library 
            :mod (c7 / chromosome) 
            :mod (a3 / artificial)) 
      :manner (u / use-01 
            :ARG1 (p2 / primer 
                  :ARG1-of (d / design-01 
                        :ARG0 (c6 / CitbCJ7) 
                        :op5-of (a / and 
                              :op1 (r2 / research-01 
                                    :ARG0 (b / bacterial) 
                                    :ARG1 (m2 / mouse) 
                                    :mod-of (g / genetic)) 
                              :op2 (c4 / country 
                                    :name (n3 / name 
                                          :op1 "Huntsville")) 
                              :op3 (c3 / country 
                                    :name (n2 / name 
                                          :op1 "AL")) 
                              :op4 (c2 / country 
                                    :name (n / name 
                                          :op1 "USA") 
                                    :wiki "United_States") 
                              :op6 (s / sequence) 
                              :op7 (a2 / Abcg5 
                                    :mod (m / mouse)) 
                              :op8 (c / cdna) 
                              :op9 (r / report-01 
                                    :ARG0 (o / organization 
                                          :name (n4 / name 
                                                :op1 "BAC")) 
                                    :ARG1 (c5 / cell 
                                          :mod (e / e)))))) 
            :time (p / previous)))

# ::snt A positive BAC clone was used as a template to amplify genomic DNA fragments of Abcg8 .
# ::tok A positive BAC clone was used as a template to amplify genomic DNA fragments of Abcg8 .
# ::alignments 15-16|0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 13-14|0.1.0.0 12-13|0.1.0.0.0 10-11|0.1.0 8-9|0.1 5-6|0 3-4|0.0 2-3|0.0.0.0.0+0.0.0.0+0.0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:17.744
(u / use-01 
      :ARG1 (c2 / clone 
            :mod (o / organization 
                  :name (n2 / name 
                        :op1 "BAC")) 
            :mod (p / positive)) 
      :ARG2 (t / template 
            :ARG0-of (a / amplify-01 
                  :ARG1 (f / fragment-01 
                        :ARG0 (d / DNA) 
                        :ARG1 (c / country 
                              :name (n / name 
                                    :op1 "Abcg8"))))))

# ::snt Long-fragment polymerase chain reaction ( PCR ) was performed using Expanded Long Template PCR system kit ( Roche Applied Science , Indianapolis , IA , USA ) .
# ::tok Long-fragment polymerase chain reaction ( PCR ) was performed using Expanded Long Template PCR system kit ( Roche Applied Science , Indianapolis , IA , USA ) .
# ::alignments 25-26|0.3.0.1+0.3.0.0.0+0.3.0.0+0.3.0 23-24|0.0.0.0+0.0.0+0.0 21-22|0.3.2.1+0.3.2.0.0+0.3.2.0+0.3.2 17-20|0.1.0.0.0.2+0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 15-16|0.1 14-15|0.1.1 12-14|0.1.0.1.0.0.1+0.1.0.1.0.0.0+0.1.0.1.0.0+0.1.0.1.0 11-12|0.1.0 10-11|0.1.0.1 9-10|0 8-9|0.2 3-4|0.3 2-3|0.3.3 1-2|0.3.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:18.961
(u / use-01 
      :ARG0 (c2 / country 
            :name (n2 / name 
                  :op1 "IA")) 
      :ARG1 (k / kit 
            :ARG1-of (l / long-03 
                  :ARG0 (o / organization 
                        :name (n4 / name 
                              :op1 "Roche" 
                              :op2 "Applied" 
                              :op3 "Science")) 
                  :ARG2 (e / expand-01 
                        :ARG1 (t / thing 
                              :name (n5 / name 
                                    :op1 (t2 / Template) 
                                    :op2 (p / PCR))))) 
            :mod (s / system)) 
      :ARG1-of (p2 / perform-02) 
      :ARG2 (r / react-01 
            :ARG0 (c / country 
                  :name (n / name 
                        :op1 "USA") 
                  :wiki "United_States") 
            :ARG1 (p3 / polymerase) 
            :ARG2 (c3 / city 
                  :name (n3 / name 
                        :op1 "Indianapolis") 
                  :wiki "Indianapolis") 
            :mod (c4 / chain)))

# ::snt An approximately 4.5 kb ` long-arm ' genomic fragment containing partial exon 1 to partial exon 3 was inserted into the Pml I restriction-cloning site A of OSDUPDEL vector .
# ::tok An approximately 4.5 kb ` long-arm ' genomic fragment containing partial exon 1 to partial exon 3 was inserted into the Pml I restriction-cloning site A of OSDUPDEL vector .
# ::alignments 28-29|0.0.0.0.2.1 24-25|0.0.0.2 23-24|0.0.0.3 22-23|0.0.0.0.2.2 18-19|0.0.0.0.2 16-17|0.0.0.0.0 15-16|0.0 14-15|0 12-13|0.0.0.0.2.0 11-12|0.0.0.1 10-11|0.0.0.1.0 9-10|0.0.0 8-9|0.0.0.0 3-4|0.0.0.0.1 2-3|0.0.0.3.0 1-2|0.0.0.0.2.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:19.312
(p / partial 
      :mod-of (e / exon 
            :ARG2-of (c / contain-01 
                  :ARG0 (f / fragment-01 
                        :ARG0 3 
                        :ARG1 (k / kb) 
                        :ARG1-of (i2 / insert-01 
                              :ARG0 1 
                              :ARG2 (v / vector) 
                              :ARG3 (i / i 
                                    :mod (a / approximately)))) 
                  :ARG1 (e2 / exon 
                        :mod (p2 / partial)) 
                  :op1-of (s / site) 
                  :op1-of (r / restriction-clon 
                        :mod 4.5))))

# ::snt The ` short-arm ' genomic fragment , containing partial exon 4 to partial exon 6 , was cloned into the Not I-Kpn I of cloning site B. Homologous targeting would result in complete intron 3 , partial exon 3 and partial exon 4 replacement by the neomycin-resistance cassette , resulting in the disruption of the ABC Walker A motif ( Figure 1a ) .
# ::tok The ` short-arm ' genomic fragment , containing partial exon 4 to partial exon 6 , was cloned into the Not I-Kpn I of cloning site B. Homologous targeting would result in complete intron 3 , partial exon 3 and partial exon 4 replacement by the neomycin-resistance cassette , resulting in the disruption of the ABC Walker A motif ( Figure 1a ) .
# ::alignments 60-61|0.0.2.0.1.2.1.2 58-59|0.0.2.0.1.1.0 56-58|0.0.2.0.1.1.0.0.0.1+0.0.2.0.1.1.0.0.0.0+0.0.2.0.1.1.0.0.0+0.0.2.0.1.1.0.0 55-56|0.0.2.0.1.1.0.1.0+0.0.2.0.1.1.0.1 52-53|0.0.2.0.1.1 49-50|0.0.2.0.1 47-48|0.0.2.0.0 43-44|0.0.2.0 42-43|0.0.2.0.2 41-42|0.0.2.0.1.2.1.1 40-41|0.0.2.0.1.2.1.1.0 39-40|0.0.2.0.1.2.1 38-39|0.0.2.0.1.2.2.0.0.0 37-38|0.0.2.0.1.2.1.0 36-37|0.0.2.0.1.2.1.0.0 34-35|0.0.0 33-34|0.0.2.0.1.2.3 32-33|0.0.2.0.1.2.3.0 30-31|0.0.2.0.1.2 28-29|0.0.2.0.1.2.2 27-28|0.0.2.0.1.2.2.0 25-26|0.0.2.2 24-25|0.0.2.0.1.2.2.0.0 22-23|0.0.2.1 20-21|0.0.2.0.1.0 17-18|0.0.2 14-15|0.0.2.0.1.2.0 13-14|0.2 12-13|0.2.0 10-11|0.0.2.0.1.2.3.0.0 9-10|0.1 8-9|0.1.0 7-8|0 5-6|0.0 4-5|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:21.907
(c5 / contain-01 
      :ARG0 (f2 / fragment-01 
            :ARG0 3 
            :ARG1 (g / genomic) 
            :ARG1-of (c4 / clone-01 
                  :ARG0 (r2 / replace-01 
                        :ARG0 (c / cassette) 
                        :ARG0-of (r / result-01 
                              :ARG1 - 
                              :ARG2 (d / disruption 
                                    :poss (m / motif 
                                          :mod (t / thing 
                                                :name (n / name 
                                                      :op1 (w / Walker) 
                                                      :op2 (a / A))) 
                                          :name (n2 / name 
                                                :op1 "ABC"))) 
                              :purpose-of (r3 / result-01 
                                    :ARG0 6 
                                    :ARG1 (a2 / and 
                                          :op1 (e2 / exon 
                                                :mod (p2 / partial)) 
                                          :op2 (e / exon 
                                                :mod (p / partial)) 
                                          :op3 (f / figure)) 
                                    :ARG1-of (t2 / target-01 
                                          :ARG0 (h / homologou 
                                                :ARG1-of (c3 / clone-01 
                                                      :ARG0 3))) 
                                    :ARG2 (i / intron 
                                          :ARG1-of (c2 / complete-02 
                                                :ARG0 4)))) 
                        :quant 4) 
                  :ARG2 (i2 / i) 
                  :direction (s / site))) 
      :ARG1 (e4 / exon 
            :mod (p4 / partial)) 
      :ARG2 (e3 / exon 
            :mod (p3 / partial)))

# ::snt ES cells ( 129/SvEvTac-cell line ) were electroporated with the linearized targeting vector DNA and cultured on sub-confluent embryonic fibroblasts .
# ::tok ES cells ( 129/SvEvTac-cell line ) were electroporated with the linearized targeting vector DNA and cultured on sub-confluent embryonic fibroblasts .
# ::alignments 19-20|0.1.1 18-19|0.1.1.0 15-16|0.1 14-15|0 13-14|0.0.1 12-13|0.0.1.0 11-12|0.0 10-11|0.1.0 4-5|0.0.2 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:22.113
(a / and 
      :op1 (t / target-01 
            :ARG0 (c2 / cell 
                  :mod (e2 / e)) 
            :ARG1 (d / DNA 
                  :mod (v / vector)) 
            :ARG2 (l2 / line)) 
      :op2 (c / culture-01 
            :ARG0 (l / linearize) 
            :ARG1 (f / fibroblast 
                  :mod (e / embryonic))))

# ::snt Transfected cell colonies were selected by culturing cells in medium containing 200 g/mL G418 ( Life Technologies , Rockville , MD , USA ) .
# ::tok Transfected cell colonies were selected by culturing cells in medium containing 200 g/mL G418 ( Life Technologies , Rockville , MD , USA ) .
# ::alignments 22-23|0.0.0.2.1+0.0.0.2.0.0+0.0.0.2.0+0.0.0.2 20-21|0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 18-19|0.0.2.0.0+0.0.2.0+0.0.2 16-17|0 15-16|0.1 13-14|0.0.1.2.0.0.0+0.0.1.2.0.0+0.0.1.2.0 11-12|0.0.3 10-11|0.0.1.2 9-10|0.0.1.2.1 7-8|0.0.1.0 6-7|0.0.1 4-5|0.0 2-3|0.0.0 1-2|0.0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:23.231
(t / technologi 
      :ARG0-of (s / select-01 
            :ARG1 (c6 / colony 
                  :mod (c7 / cell) 
                  :mod (t2 / transfect) 
                  :poss (c / country 
                        :name (n / name 
                              :op1 "USA") 
                        :wiki "United_States")) 
            :manner (c5 / culture-01 
                  :ARG1 (c4 / cell) 
                  :op1-of (c2 / country 
                        :name (n2 / name 
                              :op1 "MD")) 
                  :purpose (c3 / contain-01 
                        :ARG1 (p / person 
                              :name (n4 / name 
                                    :op1 "G418")) 
                        :manner (m / medium))) 
            :op1-of (o / organization 
                  :name (n3 / name 
                        :op1 "Rockville")) 
            :time 200) 
      :mod (l / life))

# ::snt The ES cells were screened for homologous recombination by PCR with the forward primer , neoF ( 5 ' - GGGTCGTTTGTTCGGATCAA-3 ' ) from neo cassette , and reverse primer intron 6R ( 5 ' - ACCAGTTGGTCCTAGCTCGA-3 ' ) , which is located outside the targeting construct in mouse Abcg8 intron 6 .
# ::tok The ES cells were screened for homologous recombination by PCR with the forward primer , neoF ( 5 ' - GGGTCGTTTGTTCGGATCAA-3 ' ) from neo cassette , and reverse primer intron 6R ( 5 ' - ACCAGTTGGTCCTAGCTCGA-3 ' ) , which is located outside the targeting construct in mouse Abcg8 intron 6 .
# ::alignments 51-52|0.3.0.2 50-51|0.3.0.3.0.3.0.0 49-50|0.3.0.3.0.1 48-49|0.3.0.3.0.1.0 46-47|0.3.0.3.0 45-46|0.3.0.3.0.2 43-44|0.3.0.3.0.3 42-43|0.3.0.3.0.3.0 33-34|0.3.0.3.0.0 30-31|0.3.0.0 29-30|0.3.0.0.0 28-29|0.3.0 27-28|0.3.0.3 25-26|0.3.0.3.0.2.0.0 24-25|0.3.0.3.0.2.0 17-18|0.0 13-14|0.3 12-13|0.3.1 7-8|0.2 6-7|0.3.0.1 4-5|0 2-3|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:23.939
(s / screen-01 
      :ARG0 5 
      :ARG1 (c3 / cell 
            :mod (e / e)) 
      :ARG2 (r2 / recombination) 
      :prep-with (p2 / primer 
            :ARG0-of (r / reverse-01 
                  :ARG1 (i2 / intron 
                        :mod (p / primer)) 
                  :op1-of (h / homologou) 
                  :op1-of 6 
                  :op1-of (a2 / and 
                        :op2 (c / construct-01 
                              :ARG0 5 
                              :ARG1 (a / Abcg8 
                                    :mod (m / mouse)) 
                              :ARG1-of (t / target-01 
                                    :ARG0 (n / neo 
                                          :mod-of (c2 / cassette))) 
                              :op1-of (o / outside 
                                    :location-of (l / locate-01 
                                          :ARG0 (i / intron)))))) 
            :mod (f / forward)))

# ::snt Positively targeted ES cell clones were confirmed by Southern blotting , using ES cell DNA digested by BamHI and a probe comprising of a 562 bp PCR fragment from partial intron 2 and exon 3 of Abcg8 gene .
# ::tok Positively targeted ES cell clones were confirmed by Southern blotting , using ES cell DNA digested by BamHI and a probe comprising of a 562 bp PCR fragment from partial intron 2 and exon 3 of Abcg8 gene .
# ::alignments 37-38|0.0.1.0.2 36-37|0.0.1.0.2.0.0.0+0.0.1.0.2.0.0+0.0.1.0.2.0 34-35|0.0.1.0.1.0.0.0.0 33-34|0.1 32-33|0 31-32|0.0.1.0.1.1.0 30-31|0.0.0 29-30|0.0.0.0 27-28|0.0 21-22|0.0.1 20-21|0.0.1.0.1.1 18-19|0.0.1.0.1 17-18|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 15-16|0.0.1.0.1.0 14-15|0.0.1.0.1.0.0 13-14|0.0.1.0.1.0.0.1 11-12|0.0.1.0.1.0.0.0 9-10|0.0.1.0.1.0.0.0.1.1.0 8-9|0.0.1.0.1.0.0.0.1.1.0.0.0.0+0.0.1.0.1.0.0.0.1.1.0.0.0+0.0.1.0.1.0.0.0.1.1.0.0 6-7|0.0.1.0.1.0.0.0.1.1 4-5|0.0.1.0.1.0.0.0.1 3-4|0.0.1.0.1.0.0.0.1.0 2-3|0.0.1.0.1.0.0.0.1.0.0 1-2|0.0.1.0.1.0.0.0.1.2 0-1|0.0.1.0.1.0.0.0.1.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:24.908
(a / and 
      :ARG0-of (f / fragment-01 
            :ARG1 (i / intron 
                  :mod (p / partial)) 
            :ARG1-of (c2 / comprise-01 
                  :ARG0 (t / thing 
                        :name (n2 / name 
                              :op1 "BamHI") 
                        :op1-of (a2 / and 
                              :ARG0-of (d / digest-01 
                                    :ARG1 (d2 / DNA 
                                          :ARG1-of (u / use-01 
                                                :ARG0 3 
                                                :ARG2 (c5 / clone-01 
                                                      :ARG1 (c6 / cell 
                                                            :mod (e2 / e)) 
                                                      :ARG1-of (c4 / confirm-01 
                                                            :ARG0 (b / blot-01 
                                                                  :ARG1 (t2 / thing 
                                                                        :name (n3 / name 
                                                                              :op1 "Southern")))) 
                                                      :ARG1-of (t3 / target-01) 
                                                      :quant (p3 / positively))) 
                                          :mod (c3 / cell))) 
                              :op2 (p2 / probe-01 
                                    :ARG1 2)) 
                        :poss (g / gene 
                              :mod (c / country 
                                    :name (n / name 
                                          :op1 "Abcg8")))))) 
      :op1 (e / exon))

# ::snt Positively targeted ES cells were microinjected into C57BL6 blastocysts and transplanted into pseudopregnant recipients .
# ::tok Positively targeted ES cells were microinjected into C57BL6 blastocysts and transplanted into pseudopregnant recipients .
# ::alignments 13-14|0.1.1 10-11|0.1 9-10|0 8-9|0.0 7-8|0.0.0 3-4|0.1.0 2-3|0.1.0.1 1-2|0.1.0.0 0-1|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:24.973
(a / and 
      :op1 (b / blastocyst 
            :mod (c / C57BL6)) 
      :op2 (t / transplant-01 
            :ARG1 (c2 / cell 
                  :ARG1-of (t2 / target-01 
                        :mod (p / positively)) 
                  :mod (e / e)) 
            :ARG2 (r / recipient)))

# ::snt Five highly chimeric mice ( agouti coat color , three males and two females ) were isolated and bred with C57BL/6J mice to generate germ-line transmission heterozygous mice of Abcg8 gene disruption .
# ::tok Five highly chimeric mice ( agouti coat color , three males and two females ) were isolated and bred with C57BL/6J mice to generate germ-line transmission heterozygous mice of Abcg8 gene disruption .
# ::alignments 31-32|0.1.1.1.1 30-31|0.1.1.1.1.0 27-28|0.1.1.1 26-27|0.1.1.1.0 25-26|0.1.1.0 23-24|0.1.1 21-22|0.1.2 18-19|0.1 17-18|0 16-17|0.0 13-14|0.0.0.2.1 12-13|0.0.0.2.1.0 11-12|0.0.0.2 10-11|0.0.0.2.0 9-10|0.0.0.2.0.0 7-8|0.0.0 6-7|0.0.0.0 5-6|0.0.0.1 3-4|0.1.0 2-3|0.1.0.0 1-2|0.1.0.0.0 0-1|0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:25.585
(a / and 
      :op1 (i / isolate-01 
            :ARG1 (c / color 
                  :mod (c2 / coat) 
                  :mod (a3 / agouti) 
                  :op1-of (a2 / and 
                        :op2 (m3 / male 
                              :quant 3) 
                        :op3 (f / female 
                              :quant 2)))) 
      :op2 (b / breed-01 
            :ARG0 (m4 / mouse 
                  :mod (c3 / chimeric 
                        :degree (h2 / high))) 
            :ARG0-of (g2 / generate-01 
                  :ARG1 (t / transmission) 
                  :ARG2 (m / mouse 
                        :mod (h / heterozygou) 
                        :mod (d / disruption 
                              :mod (g / gene)))) 
            :ARG1 (m2 / mouse 
                  :mod 5)))

# ::snt Heterozygous offspring mice were back-crossed to C57BL/6J mice ( n > 5 ) to produce disrupted line and inter-crossed to generate knockout mice .
# ::tok Heterozygous offspring mice were back-crossed to C57BL/6J mice ( n > 5 ) to produce disrupted line and inter-crossed to generate knockout mice .
# ::alignments 22-23|0.0 21-22|0 20-21|0.0.0 17-18|0.0.0.1 16-17|0.0.0.1.1.0 15-16|0.0.0.1.1 14-15|0.0.0.1.0 11-12|0.0.0.0 7-8|0.0.0.1.0.1 2-3|0.0.0.1.0.0 1-2|0.0.0.1.0.0.0 0-1|0.0.0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:25.888
(k / knockout 
      :mod-of (m / mouse 
            :ARG1-of (g / generate-01 
                  :ARG0 5 
                  :op3-of (a / and 
                        :op1 (p / produce-01 
                              :ARG0 (m3 / mouse 
                                    :mod (o / offspr) 
                                    :mod (h / heterozygou)) 
                              :ARG2 (m2 / mouse)) 
                        :op2 (d / disrupt-01 
                              :ARG1 (l / line))))))

# ::snt All mice were maintained on a standard rodent chow ( Harlan Teklad mouse/rat diet LM-485 ) which contained 61 mg/kg cholesterol , 31 mg/kg campesterol , and 105 mg/kg sitosterol , given free access to water and maintained at 25 C with a 12-h light , 12-h dark cycle .
# ::tok All mice were maintained on a standard rodent chow ( Harlan Teklad mouse/rat diet LM-485 ) which contained 61 mg/kg cholesterol , 31 mg/kg campesterol , and 105 mg/kg sitosterol , given free access to water and maintained at 25 C with a 12-h light , 12-h dark cycle .
# ::alignments 48-49|0.1.0.1.0 47-48|0.1.0.1 44-45|0.2.1 40-41|0.1.0.0.0.1.0.0.0 39-40|0.1.0.0.0.1.0.0 37-38|0.2 36-37|0 35-36|0.1.1 33-34|0.1.0 32-33|0.1.0.2 31-32|0.1 29-30|0.1.0.0.0.1.2 27-28|0.1.0.1.0.0 26-27|0.1.0.0.0.1 24-25|0.1.0.0.0.1.1 22-23|0.1.0.0.0.1.1.0 20-21|0.1.0.0.0.1.0.1 18-19|0.1.0.2.0 17-18|0.1.0.0.0.1.0 13-14|0.2.0 10-12|0.0.0.1+0.0.0.0+0.0.0+0.0 8-9|0.1.0.0.0.0 7-8|0.1.0.0.0.0.1 6-7|0.1.0.0.0.0.0 3-4|0.1.0.0.0 1-2|0.1.0.0 0-1|0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:27.816
(a / and 
      :op1 (p / person 
            :name (n / name 
                  :op1 "Harlan" 
                  :op2 "Teklad")) 
      :op2 (g / give-01 
            :ARG1 (a2 / access-01 
                  :ARG0 (m3 / mouse 
                        :ARG1-of (m2 / maintain-01 
                              :ARG0 (c6 / chow 
                                    :ARG1-of (s2 / standard-02) 
                                    :mod (r / rodent)) 
                              :op1-of (a3 / and 
                                    :op2 (c5 / contain-01 
                                          :ARG0 (2 / 25 
                                                :era (c2 / C)) 
                                          :ARG1 (c4 / cholesterol)) 
                                    :op3 (c3 / campesterol 
                                          :quant 31) 
                                    :op4 (s / sitosterol))) 
                        :quant (a4 / all)) 
                  :ARG1 (d / dark-02 
                        :ARG1 (c / cycle-02 
                              :ARG0 105)) 
                  :ARG1-of (f / free-04 
                        :ARG0 61)) 
            :ARG2 (w / water)) 
      :op3 (m / maintain-01 
            :ARG1 (d2 / diet) 
            :ARG2 (l / light)))

# ::snt All animals were housed in the facilities for laboratory animals provided by the Division of Laboratory Animal Resources ACLAM .
# ::tok All animals were housed in the facilities for laboratory animals provided by the Division of Laboratory Animal Resources ACLAM .
# ::alignments 13-19|0.2.0.0.5+0.2.0.0.4+0.2.0.0.3+0.2.0.0.2+0.2.0.0.1+0.2.0.0.0+0.2.0.0+0.2.0 10-11|0.2 9-10|0.2.1 8-9|0.2.1.0 6-7|0.1 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:28.102
(h / house-01 
      :ARG1 (a2 / animal 
            :quant (a3 / all)) 
      :ARG2 (f / facility) 
      :manner (p / provide-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "Division" 
                        :op2 "of" 
                        :op3 "Laboratory" 
                        :op4 "Animal" 
                        :op5 "Resources" 
                        :op6 "ACLAM")) 
            :ARG1 (a / animal 
                  :topic (l / laboratory))))

# ::snt The Institutional Animal Care and Research Advisory Committee at Medical University of South Carolina approved all experiments .
# ::tok The Institutional Animal Care and Research Advisory Committee at Medical University of South Carolina approved all experiments .
# ::alignments 16-17|0.1 15-16|0.1.1 14-15|0 9-14|0.1.0.0.4+0.1.0.0.3+0.1.0.0.2+0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 1-8|0.0.0.6+0.0.0.5+0.0.0.4+0.0.0.3+0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:28.169
(a2 / approve-01 
      :ARG0 (o2 / organization 
            :name (n2 / name 
                  :op1 "Institutional" 
                  :op2 "Animal" 
                  :op3 "Care" 
                  :op4 "and" 
                  :op5 "Research" 
                  :op6 "Advisory" 
                  :op7 "Committee")) 
      :ARG1 (e / experiment-01 
            :ARG1 (o / organization 
                  :name (n / name 
                        :op1 "Medical" 
                        :op2 "University" 
                        :op3 "of" 
                        :op4 "South" 
                        :op5 "Carolina")) 
            :quant (a / all)))

# ::snt Mouse tail DNA was isolated and purified by cutting approximately 0.5 cm of mouse tail and digesting it in 500 l lysis buffer ( 50 mM Tris-HCl , pH8 .0 , 100 mM EDTA , 125 mM NaCl , 1 % SDS , 200 g Proteinase K ) with rocking overnight at 55 C .
# ::tok Mouse tail DNA was isolated and purified by cutting approximately 0.5 cm of mouse tail and digesting it in 500 l lysis buffer ( 50 mM Tris-HCl , pH8 .0 , 100 mM EDTA , 125 mM NaCl , 1 % SDS , 200 g Proteinase K ) with rocking overnight at 55 C .
# ::alignments 53-54|0.0.1.0.0 52-53|0.0.1.1.0 50-51|0.0.1.0.1 49-50|0.0.1.0 45-47|0.0.1.5.0.1+0.0.1.5.0.0+0.0.1.5.0+0.0.1.5 43-44|0.0.1.3.2.1 41-42|0.0.1.3.0.0.0.0.0+0.0.1.3.0.0.0.0+0.0.1.3.0.0.0 40-41|0.0.1.3.0.0 39-40|0.0.1.3.0 37-38|0.0.1.4.0.0+0.0.1.4.0+0.0.1.4 35-36|0.0.1.4.1 33-34|0.0.1.1.1.0.0.0+0.0.1.1.1.0.0+0.0.1.1.1.0 31-32|0.0.1.1.1 26-27|0.2.1.0+0.2.1+0.2 25-26|0.2.0 24-25|0.2.2 22-23|0.0.1.3.2 21-22|0.0.1.3.2.0 20-21|0.0.1.3.2.2 19-20|0.1.0 16-17|0.0.1.3 15-16|0.0.1 14-15|0.0.1.3.1 13-14|0.0.1.3.1.0 11-12|0.0.1.2 10-11|0.0.1.2.0.0 9-10|0.0.1.2.0 8-9|0.0.1.1 6-7|0.1 5-6|0 4-5|0.0 2-3|0.0.0 1-2|0.0.0.0 0-1|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:29.612
(a3 / and 
      :op1 (i / isolate-01 
            :ARG1 (d2 / DNA 
                  :ARG1-of (t2 / tail-01 
                        :ARG0 (p6 / person 
                              :name (n6 / name 
                                    :op1 "Mouse")))) 
            :manner (a / and 
                  :ARG0-of (r / rock-01 
                        :ARG1 (c / C) 
                        :time (o / overnight)) 
                  :op1 (c3 / cut-02 
                        :ARG0 55 
                        :ARG1 (13 / 100 
                              :quant-of (o3 / organization 
                                    :name (n4 / name 
                                          :op1 "EDTA")))) 
                  :op2 (c2 / cm 
                        :quant (a2 / approximately 
                              :op1 0.5)) 
                  :op3 (d / digest-01 
                        :ARG0 (1 / 1 
                              :value-of (p2 / percentage-entity 
                                    :mod-of (o2 / organization 
                                          :name (n2 / name 
                                                :op1 "SDS")))) 
                        :ARG1 (t / tail-01 
                              :ARG1 (m2 / mouse)) 
                        :ARG2 (b / buffer-01 
                              :ARG1 (l / lysi) 
                              :ARG2 200 
                              :mod (l2 / l))) 
                  :op4 (p3 / person 
                        :name (n3 / name 
                              :op1 "NaCl") 
                        :quant 125) 
                  :op5 (p / person 
                        :name (n / name 
                              :op1 "Proteinase" 
                              :op2 "K")))) 
      :op2 (p5 / purify-01 
            :ARG1 500) 
      :op3 (p4 / person 
            :mod (m / mm) 
            :name (n5 / name 
                  :op1 "Tris-HCl") 
            :quant 50))

# ::snt 200 l saturated NaCl was added into digested solution with vigorous shaking for at least 60 seconds .
# ::tok 200 l saturated NaCl was added into digested solution with vigorous shaking for at least 60 seconds .
# ::alignments 16-17|0.0.1+0.0 15-16|0.0.0 11-12|0.3 10-11|0.3.1 8-9|0.2 7-8|0.2.0 5-6|0 3-4|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 2-3|0.1.0 1-2|0.1 0-1|0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:30.001
(a / add-01 
      :ARG0 (t / temporal-quantity 
            :quant 60 
            :unit (s / second)) 
      :ARG1 (l / l 
            :ARG0-of (s4 / saturate-01 
                  :ARG1 (p / person 
                        :name (n / name 
                              :op1 "NaCl")))) 
      :ARG2 (s3 / solution 
            :mod (d / digest-01)) 
      :purpose (s2 / shake-01 
            :ARG0 200 
            :ARG1 (v / vigorou)))

# ::snt Mixed solution was spun down at maximum speed in top micro-centrifuge for 20 min .
# ::tok Mixed solution was spun down at maximum speed in top micro-centrifuge for 20 min .
# ::alignments 13-14|0.2 12-13|0.2.0 9-10|0.1.0.0 7-8|0.0 6-7|0.0.0 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:30.080
(s2 / spin-01 
      :ARG0 (s / speed 
            :mod (m2 / maximum)) 
      :ARG1 (s3 / solution 
            :ARG1-of (m3 / mix-01 
                  :ARG0 (t / top))) 
      :ARG2 (m / min 
            :quant 20))

# ::snt The supernatant was transferred to a new tube with equal volume 100 % EtOH and mixed by inversion .
# ::tok The supernatant was transferred to a new tube with equal volume 100 % EtOH and mixed by inversion .
# ::alignments 17-18|0 15-16|0.0 14-15|0.0.1 13-14|0.0.1.1 12-13|0.0.0 11-12|0.0.0.1 10-11|0.0.0.0 9-10|0.0.0.0.0 7-8|0.0.1.0.1 6-7|0.0.1.0.1.0 3-4|0.0.1.0 1-2|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:30.203
(i / inversion 
      :ARG0-of (m / mix-01 
            :ARG1 (p / percentage-entity 
                  :mod-of (v / volume 
                        :ARG1-of (e2 / equal-01)) 
                  :value 100) 
            :op2-of (a / and 
                  :ARG0-of (t2 / transfer-01 
                        :ARG1 (s / supernatant) 
                        :ARG2 (t / tube 
                              :mod (n / new))) 
                  :op1 (e / EtOH))))

# ::snt The DNA pellet was washed in 70 % EtOH and resuspended in 100 -- 150 l TE buffer .
# ::tok The DNA pellet was washed in 70 % EtOH and resuspended in 100 -- 150 l TE buffer .
# ::alignments 17-18|0.0.0.0 16-17|0.0.0 15-16|0.0.0.0.0 14-15|0.0.0.0.1 12-13|0.0.1.0.0 9-10|0 7-8|0.1 6-7|0.1.0 4-5|0.0 2-3|0.0.1 1-2|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:30.310
(a / and 
      :op1 (w / wash-01 
            :ARG0 (t / te 
                  :ARG1-of (b / buffer-01 
                        :mod (l / l) 
                        :quant 150)) 
            :ARG1 (p2 / pellet 
                  :mod (d / DNA 
                        :source-of 100))) 
      :op2 (p / percentage-entity 
            :value 70))

# ::snt UV spectrophotometry and electrophoresis were used to analyze the quality and quantity of the genomic DNA .
# ::tok UV spectrophotometry and electrophoresis were used to analyze the quality and quantity of the genomic DNA .
# ::alignments 15-16|0.2.0.0 11-12|0.0.1 10-11|0.0 9-10|0.2.0 7-8|0.2 5-6|0 3-4|0.0.0 2-3|0.1 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:30.736
(u / use-01 
      :ARG0 (a / and 
            :op1 (e / electrophoresi) 
            :op2 (q / quantity)) 
      :ARG1 (a3 / and 
            :op1 (s / spectrophotometry 
                  :mod (u2 / uv))) 
      :ARG2 (a2 / analyze-01 
            :ARG1 (q2 / quality 
                  :poss (d / DNA))))

# ::snt Genotyping was performed by multiplex PCR reaction using three separate primers ( two Abcg8 gene specific primers , mg8-in3F 5 ' - CCCAATGATGAATGAGACGCT-3 ' , mg8-R9 5 ' - TTTGTCACGCTGGGCCTGG-3 ' and neoF for identification of Abcg8 target status ) .
# ::tok Genotyping was performed by multiplex PCR reaction using three separate primers ( two Abcg8 gene specific primers , mg8-in3F 5 ' - CCCAATGATGAATGAGACGCT-3 ' , mg8-R9 5 ' - TTTGTCACGCTGGGCCTGG-3 ' and neoF for identification of Abcg8 target status ) .
# ::alignments 38-39|0.2.1 37-38|0.2.1.0 34-35|0.2 32-33|0.1 31-32|0 28-30|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 26-27|0.0.0.1 19-20|0.0.2.0.0 16-17|0.2.2.0 15-16|0.2.2 14-15|0.2.2.0.0 12-13|0.2.2.0.1 10-11|0.0.1 9-10|0.0.1.0 8-9|0.2.0 7-8|0.0 6-7|0.0.2.0 5-6|0.0.2.0.1 4-5|0.0.2.0.2 2-3|0.0.2 0-1|0.0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:31.935
(a / and 
      :op1 (u / use-01 
            :ARG0 (t2 / thing 
                  :name (n2 / name 
                        :op1 - 
                        :op2 (t3 / TTTGTCACGCTGGGCCTGG-3)) 
                  :poss 5) 
            :ARG1 (p2 / primer 
                  :ARG1-of (s3 / separate-02)) 
            :manner-of (p4 / perform-02 
                  :ARG0 (r / react-01 
                        :ARG0 5 
                        :ARG1 (p3 / PCR) 
                        :mod (m / multiplex)) 
                  :ARG1 (g2 / genotyp))) 
      :op2 (n / neoF) 
      :op3 (i / identify-02 
            :ARG0 3 
            :ARG1 (s / status 
                  :mod (t / target-01)) 
            :ARG2-of (s2 / specific-02 
                  :ARG1 (p / primer 
                        :mod (g / gene) 
                        :quant 2))))

# ::snt The PCR reaction consisted of 1x PCR buffer ( 1.5 mM MgCl2 , 16 mM ( NH4 ) 2SO4 , 0.1 mM dNTPs , 67 mM Tris-HCl ( pH8 .8 ) ) 1 M of each primer , water and 1.0 units of Taq polymerase .
# ::tok The PCR reaction consisted of 1x PCR buffer ( 1.5 mM MgCl2 , 16 mM ( NH4 ) 2SO4 , 0.1 mM dNTPs , 67 mM Tris-HCl ( pH8 .8 ) ) 1 M of each primer , water and 1.0 units of Taq polymerase .
# ::alignments 44-45|0.0.4.0 41-42|0.0.4 39-40|0.0 38-39|0.0.3 36-37|0.0.2 35-36|0.0.2.0 33-34|0.0.1.1+0.0.1.0.0+0.0.1.0+0.0.1 32-33|0.2.0 26-27|0.0.0.0.0+0.0.0.0+0.0.0 24-25|0.0.0.1 22-23|0.1.3 20-21|0.2.1 13-14|0.1.0 11-12|0.1.1 10-11|0.1.1.0 9-10|0.1.2 7-8|0.2 3-4|0 2-3|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:32.624
(c / consist-01 
      :ARG0 (a / and 
            :op1 (p3 / person 
                  :name (n2 / name 
                        :op1 "Tris-HCl") 
                  :quant 67) 
            :op2 (v / vehicle 
                  :name (n / name 
                        :op1 "M1") 
                  :wiki "M1_Abrams") 
            :op3 (p2 / primer 
                  :mod (e / each)) 
            :op4 (w / water) 
            :op5 (u / unit 
                  :quant-of (p / polymerase))) 
      :ARG1 (r / react-01 
            :ARG0 16 
            :ARG1 (m / MgCl2 
                  :mod (m2 / mm)) 
            :ARG2 1.5 
            :op1-of (d / dntp)) 
      :ARG2 (b / buffer-01 
            :ARG0 1 
            :ARG1 0.1))

# ::snt The reactions were cycled as follows : 94 C for 30 sec , 60 C for 30 sec , 72 C for 1 min for 35 cycles .
# ::tok The reactions were cycled as follows : 94 C for 30 sec , 60 C for 30 sec , 72 C for 1 min for 35 cycles .
# ::alignments 26-27|0.0.1.4.1 25-26|0.0.1.3 23-24|0 22-23|0.0.2 20-21|0.0.1.2 19-20|0.0.1.4.2 17-18|0.0.1.1 16-17|0.0.1.1.0 14-15|0.0.1.4.1.0 13-14|0.0.0 11-12|0.0.1.0.0 10-11|0.0.1.0 8-9|0.0.1.4.0.0 7-8|0.0.1.4.0 5-6|0.0.1.4 3-4|0.0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:32.955
(m / min 
      :op1 (r / react-01 
            :ARG0 60 
            :ARG1-of (c5 / cycle-01 
                  :ARG2 (33 / 30 
                        :quant-of (s2 / sec)) 
                  :op1-of (s / sec 
                        :quant 30) 
                  :op1-of (c2 / C) 
                  :op1-of 35 
                  :purpose (f / follow-01 
                        :ARG1 (9 / 94 
                              :mod (c4 / C)) 
                        :ARG2 (c / cycle-02 
                              :ARG0 (c3 / C)) 
                        :op1-of 72)) 
            :ARG2 1))

# ::snt The PCR products were identified by electrophoresis .
# ::tok The PCR products were identified by electrophoresis .
# ::alignments 6-7|0.1 4-5|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:32.975
(i / identify-01 
      :ARG1 (p / product 
            :mod (p2 / PCR)) 
      :manner (e / electrophoresi))

# ::snt To confirm PCR results , DNAs were digested with Bam HI , subjected to electrophoresis in a 0.6 % agarose gel and transferred to nylon membrane .
# ::tok To confirm PCR results , DNAs were digested with Bam HI , subjected to electrophoresis in a 0.6 % agarose gel and transferred to nylon membrane .
# ::alignments 25-26|0.1.1 24-25|0.1.1.0 22-23|0.1 21-22|0 20-21|0.0.2 18-19|0.1.0 14-15|0.0.1 12-13|0.0 9-11|0.0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 7-8|0.0.0.0 5-6|0.0.0 3-4|0.0.0.0.1.0.0+0.0.0.0.1.0 2-3|0.0.0.0.1.0.0.0 1-2|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:33.632
(a / and 
      :op1 (s / subject-01 
            :ARG1 (d2 / dna 
                  :ARG1-of (d / digest-01 
                        :ARG2 (t2 / thing 
                              :name (n2 / name 
                                    :op1 (b / Bam) 
                                    :op2 (h / HI))) 
                        :condition (c / confirm-01 
                              :ARG1 (t3 / thing 
                                    :ARG2-of (r / result-01 
                                          :ARG1 (p2 / PCR)))))) 
            :ARG2 (e / electrophoresi) 
            :location (g / gel)) 
      :op2 (t / transfer-01 
            :ARG1 (p / percentage-entity) 
            :ARG2 (m / membrane 
                  :mod (n / nylon))))

# ::snt Southern blot filters were hybridized with a 562 bp PCR fragment from partial intron 2 and exon 3 of Abcg8 32P-randomly-labeled probe as previously described [ 22 ] .
# ::tok Southern blot filters were hybridized with a 562 bp PCR fragment from partial intron 2 and exon 3 of Abcg8 32P-randomly-labeled probe as previously described [ 22 ] .
# ::alignments 26-27|0.0 24-25|0.2.1.1 23-24|0.2.1.1.1 21-22|0.2.1 20-21|0.2.1.2 17-18|0.1.0.0 16-17|0.2.0.0 15-16|0.2.0 14-15|0.2.1.0 13-14|0.2.2 12-13|0.2.2.0 10-11|0.2 4-5|0 2-3|0.1 1-2|0.1.0 0-1|0.2.1.1.0.0.0+0.2.1.1.0.0+0.2.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:34.033
(h / hybridize-01 
      :ARG0 22 
      :ARG1 (f2 / filter-02 
            :ARG1 (b / blot-01 
                  :ARG0 3)) 
      :ARG2 (f / fragment-01 
            :ARG0 (a / and 
                  :op1 (e / exon)) 
            :ARG1 (p2 / probe-01 
                  :ARG1 2 
                  :ARG2 (d / describe-01 
                        :ARG1 (t / thing 
                              :name (n / name 
                                    :op1 "Southern")) 
                        :time (p / previous)) 
                  :mod 32p-randomly-label) 
            :source (i / intron 
                  :mod (p3 / partial))))

# ::snt Isolation of liver and intestinal total RNA from Abcg8 + / + , Abcg8 + / - and Abcg8 - / - mice and Northern blot analyses were performed as previously described [ 23 ] .
# ::tok Isolation of liver and intestinal total RNA from Abcg8 + / + , Abcg8 + / - and Abcg8 - / - mice and Northern blot analyses were performed as previously described [ 23 ] .
# ::alignments 33-34|0.0.1.0.0.0 31-32|0.0.1 30-31|0.0.1.2 28-29|0.0 26-27|0.0.1.0 25-26|0.0.1.0.0 24-25|0.0.1.0.1 23-24|0 22-23|0.0.1.1 20-21|0.1.4 17-18|0.1.3 15-16|0.1.3.0 10-11|0.0.0 6-7|0.1.0.1 5-6|0.1.0 4-5|0.1.2 3-4|0.1 2-3|0.1.1 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:34.503
(a2 / and 
      :ARG1-of (p2 / perform-02 
            :ARG0 (s3 / slash) 
            :time (d / describe-01 
                  :ARG0 (a / analysis 
                        :ARG1-of (b / blot-01 
                              :ARG0 23) 
                        :mod "Northern_Ireland") 
                  :ARG1 (m / mouse) 
                  :time (p / previous))) 
      :op5-of (a4 / and 
            :ARG0-of (t / total-01 
                  :ARG1 (i2 / isolation) 
                  :ARG2 (r / rna)) 
            :op1 (l / liver) 
            :op2 (i / intestine) 
            :op3 (a3 / and 
                  :op1 (s2 / slash)) 
            :op4 (s / slash)))

# ::snt The probe for Abcg5 was 1964 bp ( nt 136 -- 2099 , GeneBank  accession no .
# ::tok The probe for Abcg5 was 1964 bp ( nt 136 -- 2099 , GeneBank  accession no .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:34.505
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt AH011511 ) and the probe for Abcg8 was 2019 bp ( nt 103 -- 2126 , GeneBank  accession no .
# ::tok AH011511 ) and the probe for Abcg8 was 2019 bp ( nt 103 -- 2126 , GeneBank  accession no .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:34.518
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt AH011518 ) .
# ::tok AH011518 ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:34.529
(a / amr-empty)

# ::snt To confirm that there was no alternative splicing of the disrupted allele , RT-PCR was performed on cDNAs of pooled mouse liver .
# ::tok To confirm that there was no alternative splicing of the disrupted allele , RT-PCR was performed on cDNAs of pooled mouse liver .
# ::alignments 21-22|0.1.0.0.0 20-21|0.1.0.0.0.0 19-20|0.1.0.0 17-18|0.1.0.1 15-16|0.1.0 11-12|0 10-11|0.0 7-8|0.1 6-7|0.1.1 5-6|0.1.0.2.0 1-2|0.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:34.678
(a / allele 
      :ARG1-of (d / disrupt-01) 
      :ARG1-of (s / splice-01 
            :ARG1-of (p2 / perform-02 
                  :ARG0-of (p / pool-01 
                        :ARG1 (l / liver 
                              :mod (m / mouse))) 
                  :ARG2 (c / cdna) 
                  :condition (c2 / confirm-01 
                        :polarity -)) 
            :mod (a2 / alternative)))

# ::snt Briefly , samples of total RNA ( 0.5 g ) from pooled mouse livers ( n = 4 ) were reverse transcribed according to the SuperScript  First-Strand Synthesis System ( Invitrogen , Carlsbad , CA , USA ) using random hexamers in a final total reaction volume of 20 l .
# ::tok Briefly , samples of total RNA ( 0.5 g ) from pooled mouse livers ( n = 4 ) were reverse transcribed according to the SuperScript  First-Strand Synthesis System ( Invitrogen , Carlsbad , CA , USA ) using random hexamers in a final total reaction volume of 20 l .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:34.681
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt RT-PCR was performed using primers located outside of the targeted region : F1 ( CCTCAGCTGGTGAGGAGGTG ) with R1 ( GATGGAGAAGGTGAAGTTGCC ) , F2 ( ATTTCCAATGACTTCCGGGAC ) with R1 and F3 ( CTGGAAGACGGGCTGTACACT ) with R1 , to produce expected product lengths of 1449 , 654 and 429 bp respectively in wild-type cDNA .
# ::tok RT-PCR was performed using primers located outside of the targeted region : F1 ( CCTCAGCTGGTGAGGAGGTG ) with R1 ( GATGGAGAAGGTGAAGTTGCC ) , F2 ( ATTTCCAATGACTTCCGGGAC ) with R1 and F3 ( CTGGAAGACGGGCTGTACACT ) with R1 , to produce expected product lengths of 1449 , 654 and 429 bp respectively in wild-type cDNA .
# ::alignments 51-52|0.0.0.0.0.0 48-49|0.2.0.0.1.1 45-46|0.2.0 42-43|0.2.0.2.0+0.2.0.2 40-41|0.0 39-40|0.1 38-39|0 37-38|0.2 29-30|0.2.0.0.1.2.0.0+0.2.0.0.1.2.0+0.2.0.0.1.2 28-29|0.2.0.0.1 22-23|0.2.0.1.0.0+0.2.0.1.0+0.2.0.1 19-20|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 17-18|0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 10-11|0.2.0.0.1.0.0 9-10|0.2.0.0.1.0 6-7|0.2.0.0.1.0.0.0 5-6|0.0.0.0.0 4-5|0.0.0.0 3-4|0.0.0 2-3|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:35.916
(e / expect-01 
      :ARG0 (l / length 
            :ARG0-of (u / use-01 
                  :ARG1 (p6 / primer 
                        :ARG1-of (l2 / locate-01 
                              :ARG0 (c / cdna))) 
                  :ARG1-of (p7 / perform-02 
                        :ARG0 (o / organization 
                              :name (n3 / name 
                                    :op1 "GATGGAGAAGGTGAAGTTGCC"))))) 
      :ARG1 (p / product) 
      :ARG1-of (p2 / produce-01 
            :op3-of (a / and 
                  :op1 (p5 / person 
                        :name (n4 / name 
                              :op1 "R1") 
                        :op1-of (a2 / and 
                              :ARG1-of (t / target-01 
                                    :ARG0 (r2 / region 
                                          :op1-of (o2 / outside))) 
                              :mod (r / respective) 
                              :op2 (p3 / person 
                                    :name (n / name 
                                          :op1 "F3")))) 
                  :op2 (p4 / person 
                        :name (n2 / name 
                              :op1 "F2")) 
                  :op4 (d / date-entity 
                        :year 1449))))

# ::snt Primers were based upon previously published primer sets [ 24-26 ] or designed using MacVector , which were designed from either mRNA or cDNA to avoid the amplification of potentially contaminating genomic DNA in the total RNA sample ( Table 1 ) .
# ::tok Primers were based upon previously published primer sets [ 24-26 ] or designed using MacVector , which were designed from either mRNA or cDNA to avoid the amplification of potentially contaminating genomic DNA in the total RNA sample ( Table 1 ) .
# ::alignments 40-41|0.2.0.3.0.0.0 39-40|0.2.0.0 37-38|0 36-37|0.0 35-36|0.2 32-33|0.1 30-31|0.1.0 29-30|0.1.0.0 27-28|0.2.0.3.1 25-26|0.2.0.3 23-24|0.2.0.3.0.3 22-23|0.2.0.3.0 21-22|0.2.0.3.0.2 20-21|0.2.0.3.0.1 18-19|0.2.0.3.0.0 14-15|0.2.0.1.0.0+0.2.0.1.0+0.2.0.1 13-14|0.2.0 12-13|0.2.0.2 11-12|0.2.0.2.1 7-8|0.2.0.2.0 6-7|0.2.0.2.0.1 5-6|0.2.0.2.0.0 4-5|0.2.0.2.0.0.1 2-3|0.2.0.2.0.0.0.0 0-1|0.2.0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:36.772
(s / sample-01 
      :ARG1 (r / rna) 
      :ARG2 (d / DNA 
            :ARG1-of (c / contaminate-01 
                  :mod (p / potential))) 
      :ARG2-of (t2 / total-01 
            :ARG1 (u / use-01 
                  :ARG0 (t / table) 
                  :ARG1 (c3 / country 
                        :name (n / name 
                              :op1 "MacVector")) 
                  :ARG1-of (d3 / design-01 
                        :ARG0 (s2 / set 
                              :ARG1-of (p3 / publish-01 
                                    :ARG0 (p5 / primer 
                                          :ARG1-of (b / base-02)) 
                                    :time (p4 / previous)) 
                              :mod (p2 / primer)) 
                        :op1-of (o2 / or)) 
                  :ARG2 (a2 / avoid-01 
                        :ARG0 (o / or 
                              :ARG2-of (d2 / design-01 
                                    :ARG0 1) 
                              :mod (e / either) 
                              :op1 (m / mrna) 
                              :op2 (c2 / cdna)) 
                        :ARG1 (a / amplification)))))

# ::snt Samples of total RNA ( 0.5 g ) from pooled mouse livers ( n = 4 ) were reverse transcribed according to the SuperScript  First-Strand Synthesis System ( Invitrogen , Carlsbad , CA , USA ) using random hexamers with a final total reaction volume of 20 l .
# ::tok Samples of total RNA ( 0.5 g ) from pooled mouse livers ( n = 4 ) were reverse transcribed according to the SuperScript  First-Strand Synthesis System ( Invitrogen , Carlsbad , CA , USA ) using random hexamers with a final total reaction volume of 20 l .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:36.775
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Quantitative RT-PCR was performed on a PE Biosystems GeneAmp  5700 sequence Detection System ( Forest City , CA , USA ) .
# ::tok Quantitative RT-PCR was performed on a PE Biosystems GeneAmp  5700 sequence Detection System ( Forest City , CA , USA ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:36.784
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Standard reaction volume was 10 l containing 1  QuantiTect SYBR Green PCR master mix ( Qiagen , Valencia , CA , USA ) , 0.002 U AmpErase UNG enzyme ( PE Biosystems , Forest City , CA , USA ) , 0.7 l of cDNA template from reverse transcription reaction as above and 100 -- 500 nM of oligonucleotide primers .
# ::tok Standard reaction volume was 10 l containing 1  QuantiTect SYBR Green PCR master mix ( Qiagen , Valencia , CA , USA ) , 0.002 U AmpErase UNG enzyme ( PE Biosystems , Forest City , CA , USA ) , 0.7 l of cDNA template from reverse transcription reaction as above and 100 -- 500 nM of oligonucleotide primers .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:36.787
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Initial steps of RT-PCR were two minutes at 50 C for UNG activation , followed by a 15 minute hold at 95 C .
# ::tok Initial steps of RT-PCR were two minutes at 50 C for UNG activation , followed by a 15 minute hold at 95 C .
# ::alignments 21-23|0.2.0.0.0.1+0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 19-20|0.2.0 18-19|0.2.0.2.1+0.2.0.2 17-18|0.2.0.2.0 14-15|0.2.0.1 12-13|0.2.0.1.0 9-10|0.0 8-9|0.0.0 6-7|0.1.1+0.1 5-6|0.1.0 1-2|0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:37.305
(s / step-01 
      :ARG0 (c2 / C 
            :quant 50) 
      :ARG1 (t3 / temporal-quantity 
            :quant 2 
            :unit (m2 / minute)) 
      :ARG1-of (i / initial-01 
            :ARG2 (h / hold-01 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 95 
                              :op2 (c / C))) 
                  :ARG1-of (f / follow-01 
                        :ARG0 (a / activation)) 
                  :duration (t2 / temporal-quantity 
                        :quant 15 
                        :unit (m / minute)))))

# ::snt Cycles ( n = 40 ) consisted of a 15 second melt at 95 C , followed by a 1 minute annealing/extension at 60 C .
# ::tok Cycles ( n = 40 ) consisted of a 15 second melt at 95 C , followed by a 1 minute annealing/extension at 60 C .
# ::alignments 23-25|0.1.2.0.0.1+0.1.2.0.0.0+0.1.2.0.0+0.1.2.0 20-21|0.0.1+0.0 19-20|0.0.0 16-17|0.1.2 14-15|0.2 13-14|0.1.1.1 11-12|0.1.1 9-10|0.1.1.0 6-7|0 4-5|0.1.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:37.571
(c3 / consist-01 
      :ARG0 (t2 / temporal-quantity 
            :quant 1 
            :unit (m / minute)) 
      :ARG1 (c4 / cycle-01 
            :ARG1 40 
            :ARG1-of (m2 / melt-01 
                  :quant 15 
                  :time 95) 
            :ARG1-of (f / follow-01 
                  :ARG2 (t / thing 
                        :name (n / name 
                              :op1 60 
                              :op2 (c / C))))) 
      :ARG2 (c2 / C))

# ::snt The final step was a 60 C incubation for 1 minute .
# ::tok The final step was a 60 C incubation for 1 minute .
# ::alignments 10-11|0.0.0.0.0.1+0.0.0.0.0 9-10|0.0.0.0 7-8|0 6-7|0.1 5-6|0.0.0.0.0.0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:37.610
(i / incubation 
      :domain (s / step 
            :mod (f / final 
                  :mod-of (1 / 1 
                        :quant-of (t / temporal-quantity 
                              :quant 60 
                              :unit (m / minute))))) 
      :quant (c / C))

# ::snt At the end of the run , samples were heated to 95 C with a ramp time of 20 minutes to construct dissociation curves to ensure that single PCR products were obtained .
# ::tok At the end of the run , samples were heated to 95 C with a ramp time of 20 minutes to construct dissociation curves to ensure that single PCR products were obtained .
# ::alignments 31-32|0.0.0.2.1 29-30|0.0.0.2.1.0 27-28|0.0.0.2.1.0.0 25-26|0.0.0.2 23-24|0.0.0.2.0 22-23|0.0.0.2.0.0 21-22|0.0.0 19-20|0.0.0.1.1+0.0.0.1 18-19|0.0.0.1.0 16-17|0.0.0.0 15-16|0.0.0.0.0 12-13|0.1 11-12|0.0.1.0 9-10|0 7-8|0.0.1+0.0 5-6|0.0.0.2.1.0.0.0 2-3|0.0.0.2.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:38.962
(h / heat-01 
      :ARG1 (t3 / thing 
            :ARG0-of (c2 / construct-01 
                  :ARG1 (t2 / time 
                        :purpose (r / ramp-01)) 
                  :ARG2 (t / temporal-quantity 
                        :quant 20 
                        :unit (m / minute)) 
                  :purpose (e / ensure-01 
                        :ARG0 (c / curve-01 
                              :ARG1 (d / dissociation)) 
                        :ARG1 (o / obtain-01 
                              :ARG1 (p / product 
                                    :ARG1-of (s / single-02 
                                          :ARG1-of (r2 / run-13 
                                                :ARG1-of (e2 / end-01))))))) 
            :ARG1-of (s2 / sample-01 
                  :time 95)) 
      :ARG2 (c3 / C))

# ::snt All reactions were performed in triplicate .
# ::tok All reactions were performed in triplicate .
# ::alignments 5-6|0.1 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:38.984
(p / perform-02 
      :ARG1 (r / react-01 
            :mod (a / all)) 
      :manner (t / triplicate))

# ::snt Threshold cycle ( CT ) analysis of all samples was set at 0.5 relative fluorescence units .
# ::tok Threshold cycle ( CT ) analysis of all samples was set at 0.5 relative fluorescence units .
# ::alignments 15-16|0.0.1 14-15|0.0.1.0 13-14|0.0.1.1 12-13|0.0.0.2.0 8-9|0+0.0 7-8|0.0.2 5-6|0.0.0 3-4|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 1-2|0.0.0.2 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:39.254
(s / sample-01 
      :ARG1 (t / thing 
            :ARG1-of (a2 / analyze-01 
                  :ARG0 (c / country 
                        :name (n / name 
                              :op1 "CT")) 
                  :manner (t2 / threshold) 
                  :mod (c2 / cycle-02 
                        :ARG1 0.5)) 
            :poss-of (u / unit 
                  :consist-of (f / fluorescence) 
                  :mod (r / relative)) 
            :quant (a / all)))

# ::snt The relative quantities of message of genes of interest from the mouse liver samples used in real-time RT-PCR were normalized to cyclophilin to compensate for variations in input RNA amounts .
# ::tok The relative quantities of message of genes of interest from the mouse liver samples used in real-time RT-PCR were normalized to cyclophilin to compensate for variations in input RNA amounts .
# ::alignments 29-30|0.1.1.0 28-29|0.1.1.0.0 27-28|0.1.1.0.0.0 25-26|0.1.1 23-24|0.1 21-22|0.1.2.1 19-20|0.1.2 16-17|0.0.1.0 14-15|0.0.1 13-14|0+0.0 12-13|0.2 11-12|0.1.2.0 8-9|0.0.0 6-7|0.0.0.0 4-5|0.1.0.1 2-3|0.1.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:39.904
(s / sample-01 
      :ARG1 (t / thing 
            :ARG0-of (i2 / interest-01 
                  :ARG1 (g / gene)) 
            :ARG1-of (u / use-01 
                  :manner (r2 / real-time))) 
      :ARG2 (c / compensate-01 
            :ARG0 (q / quantity 
                  :mod (r3 / relative) 
                  :mod (m2 / message)) 
            :ARG1 (v / variation 
                  :location (a / amount 
                        :quant-of (r / rna 
                              :mod (i / input)))) 
            :purpose-of (n / normalize-01 
                  :ARG1 (m / mouse) 
                  :ARG2 (c2 / cyclophilin))) 
      :mod (l / liver))

# ::snt The data were analyzed using the comparative threshold cycle method ( CT ) .
# ::tok The data were analyzed using the comparative threshold cycle method ( CT ) .
# ::alignments 11-12|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 9-10|0.0.0.0 8-9|0.0.0.0.0 7-8|0.0.0.0.0.0 6-7|0.0.0.0.1 4-5|0.0.0 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:39.970
(a / analyze-01 
      :ARG1 (d / data 
            :ARG0-of (u / use-01 
                  :ARG1 (m / method 
                        :mod (c2 / cycle-02 
                              :ARG1 (t / threshold)) 
                        :mod (c3 / comparative)) 
                  :ARG2 (c / country 
                        :name (n / name 
                              :op1 "CT")))))

# ::snt Briefly , the CT values are averaged , from the triplicates defining a -CT value calculated by taking the average CT of the gene of interest and subtracting it from the average CT of cyclophilin .
# ::tok Briefly , the CT values are averaged , from the triplicates defining a -CT value calculated by taking the average CT of the gene of interest and subtracting it from the average CT of cyclophilin .
# ::alignments 34-35|0.2.0 31-32|0.0.0.0.1.2 27-28|0.2 26-27|0 25-26|0.0.0.0.1.0.0 23-24|0.0.0.0.1.0.0.1 19-20|0.0.0.0.1.1 17-18|0.1 15-16|0.0 14-15|0.0.0 11-12|0.0.0.0 10-11|0.0.0.0.0 6-7|0.0.0.0.1 4-5|0.0.0.0.1.0 3-4|0.0.0.0.1.0.1.0.0+0.0.0.0.1.0.1.0+0.0.0.0.1.0.1 0-1|0.0.0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:40.174
(a2 / and 
      :manner-of (c2 / calculate-01 
            :ARG1 (v / value-01 
                  :ARG1-of (d / define-01 
                        :ARG0 (t2 / triplicate) 
                        :ARG2-of (a4 / average-01 
                              :ARG1 (v2 / value 
                                    :ARG0-of (i / interest-01 
                                          :ARG1 (b / briefly) 
                                          :ARG2 (g / gene)) 
                                    :mod (c3 / country 
                                          :name (n / name 
                                                :op1 "CT"))) 
                              :ARG1-of (a3 / average-01) 
                              :ARG1-of (a / average-01))))) 
      :op1 (t / take-01) 
      :op2 (s / subtract-01 
            :ARG2 (c / cyclophilin)))

# ::snt The -CT was calculated by subtracting the average -CT ( calibrator ) values from the -CT ( sample ) .
# ::tok The -CT was calculated by subtracting the average -CT ( calibrator ) values from the -CT ( sample ) .
# ::alignments 17-18|0 12-13|0.0.0.0 10-11|0.0.0.0.0 7-8|0.0.0 5-6|0.0 3-4|0.0.1 1-2|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:40.349
(s / sample-01 
      :ARG1 (s2 / subtract-01 
            :ARG1 (a / average-01 
                  :ARG1-of (v / value-01 
                        :ARG0 (c / calibrator))) 
            :ARG2-of (c2 / calculate-01 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 -CT)))))

# ::snt The relative quantification was then calculated by the expression 2-Average-CT .
# ::tok The relative quantification was then calculated by the expression 2-Average-CT .
# ::alignments 8-9|0.1 5-6|0 4-5|0.2 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:40.381
(c / calculate-01 
      :ARG1 (q / quantification 
            :mod (r / relative)) 
      :manner (e / express-01) 
      :time (t / then))

# ::snt The mRNA quantity for the calibrator ( wild type ) was expressed as 1 and all other quantities were expressed as a fold difference relative to the calibrator ( wild type ) .
# ::tok The mRNA quantity for the calibrator ( wild type ) was expressed as 1 and all other quantities were expressed as a fold difference relative to the calibrator ( wild type ) .
# ::alignments 30-31|0.0.0 29-30|0.0 24-25|0.1.0.2.3 23-24|0.1.0.2 22-23|0.1.0.2.2 19-20|0.1.0 17-18|0.1.0.1 16-17|0.1.0.1.0 15-16|0.1.0.1.1 14-15|0.1 13-14|0.1.0.2.4 11-12|0 8-9|0.1.0.2.0.0 7-8|0.1.0.2.0 5-6|0.1.0.2.1 2-3|0.1.0.0 1-2|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:40.703
(e2 / express-01 
      :ARG1 (w / wild 
            :mod-of (t / type)) 
      :op1-of (a2 / and 
            :op2 (e / express-01 
                  :ARG0 (q2 / quantity 
                        :mod (m / mrna)) 
                  :ARG1 (q / quantity 
                        :mod (o / other) 
                        :quant (a / all)) 
                  :ARG2 (d / differ-02 
                        :ARG0 (w2 / wild 
                              :mod-of (t2 / type)) 
                        :ARG1 (c / calibrator) 
                        :mod (f / fold) 
                        :mod (r / relative) 
                        :op1-of 1))))

# ::snt Plasma lipid analysis by fast protein liquid chromatography .
# ::tok Plasma lipid analysis by fast protein liquid chromatography .
# ::alignments 7-8|0.0.0 6-7|0.0.0.0 5-6|0.0.0.1 4-5|0.0.0.1.0 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:40.729
(p2 / plasma 
      :ARG1-of (a / analyze-01 
            :ARG0 (c / chromatography 
                  :mod (l / liquid) 
                  :mod (p / protein 
                        :mod (f / fast)))))

# ::snt Following 16 hrs of fasting , blood samples ( n = 3 ) from each of the Abcg8 + / + , Abcg8 + / - and Abcg8 - / - mice were collected from the retro-orbital venous plexus using heparinized capillary tubes under isoflurane anesthesia , and placed into precooled tubes containing 10 l of 0.5 M EDTA .
# ::tok Following 16 hrs of fasting , blood samples ( n = 3 ) from each of the Abcg8 + / + , Abcg8 + / - and Abcg8 - / - mice were collected from the retro-orbital venous plexus using heparinized capillary tubes under isoflurane anesthesia , and placed into precooled tubes containing 10 l of 0.5 M EDTA .
# ::alignments 58-59|0.4.2.2.0.0.0 57-58|0.4.2.2.0.0.0.0.2+0.4.2.2.0.0.0.0.1.0+0.4.2.2.0.0.0.0.1+0.4.2.2.0.0.0.0 56-57|0.4.2.2.0.0.0.0.0 54-55|0.4.2.2.0.0 53-54|0.3 52-53|0.4.2.2.0 51-52|0.4.2.2 50-51|0.4.2.2.1 48-49|0.4.2 47-48|0.4 45-46|0.2.0.0.0 44-45|0.2.0.0 42-43|0.4.2.1.0.0 41-42|0.4.2.1.0.0.0 40-41|0.4.2.1.0.0.1 39-40|0.4.2.1.0 38-39|0.2 37-38|0.2.0 33-34|0 31-32|0.1 29-30|0.4.2.2.0.1 26-27|0.4.2.3 24-25|0.4.1 19-20|0.4.0 14-15|0.4.2.2.0.2 11-12|0.0 7-8|0.4.2.1.1+0.4.2.1 6-7|0.4.2.1.1.0 4-5|0.4.2.0.0 2-3|0.4.2.0.1 1-2|0.4.2.0.1.0 0-1|0.4.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:42.533
(c3 / collect-01 
      :ARG0 3 
      :ARG1 (m / mouse) 
      :ARG2 (p3 / plexu 
            :mod (v2 / venou 
                  :poss (i / isoflurane 
                        :mod-of (a2 / anesthesia)))) 
      :op1-of 10 
      :op3-of (a / and 
            :op1 (s3 / slash) 
            :op2 (s2 / slash) 
            :op4 (p2 / place-01 
                  :ARG0 (f2 / follow-01 
                        :ARG1 (f / fast) 
                        :ARG2 (h2 / hr 
                              :quant 16)) 
                  :ARG1 (t3 / thing 
                        :ARG0-of (u / use-01 
                              :ARG1 (t2 / tube 
                                    :mod (c2 / capillary) 
                                    :mod (h / hepariniz))) 
                        :ARG1-of (s4 / sample-01 
                              :ARG2 (b / blood))) 
                  :ARG2 (t / tube 
                        :ARG0-of (c / contain-01 
                              :ARG1 (l / l 
                                    :beneficiary (e / edta 
                                          :mod (v / vehicle 
                                                :mod 0.5 
                                                :name (n / name 
                                                      :op1 "M1") 
                                                :wiki "M1_Abrams"))) 
                              :ARG2 (s / slash) 
                              :op1-of (e2 / each)) 
                        :mod (p / precool)) 
                  :op1-of (a3 / and))))

# ::snt Equal volumes of plasma from each genotype were pooled and 100 L of the pooled sample were injected and fractionated by fast protein liquid chromatography ( FPLC ) using a Superose 6 HR10/30 column ( Pharmacia Biotech Inc. , Piscataway , NJ , USA ) and analyzed as described [ 27 ] .
# ::tok Equal volumes of plasma from each genotype were pooled and 100 L of the pooled sample were injected and fractionated by fast protein liquid chromatography ( FPLC ) using a Superose 6 HR10/30 column ( Pharmacia Biotech Inc. , Piscataway , NJ , USA ) and analyzed as described [ 27 ] .
# ::alignments 50-51|0.1.0.2.0 48-49|0.1.0.3.1.1.0.1 46-47|0.1.0.3.1.1.0 45-46|0.1.0.3.1.1 43-44|0.1.0.3.3.1+0.1.0.3.3.0.0+0.1.0.3.3.0+0.1.0.3.3 41-42|0.1.0.3.2.0.0+0.1.0.3.2.0+0.1.0.3.2 39-40|0.1.0.3.0.0.0+0.1.0.3.0.0+0.1.0.3.0 35-38|0.1.0.3.1.1.0.1.0.0.2+0.1.0.3.1.1.0.1.0.0.1+0.1.0.3.1.1.0.1.0.0.0+0.1.0.3.1.1.0.1.0.0+0.1.0.3.1.1.0.1.0 33-34|0.1.0.2.1 32-33|0.1.0.2.1.0.0.0+0.1.0.2.1.0.0+0.1.0.2.1.0 31-32|0.1.0.3.1.0.0 30-31|0.1.0.2.1.1.0.0+0.1.0.2.1.1.0+0.1.0.2.1.1 28-29|0.1.0.2 26-27|0.1.0.3.1.1.0.0.0.0+0.1.0.3.1.1.0.0.0+0.1.0.3.1.1.0.0 24-25|0.1.0.0 23-24|0.1.0.0.0 22-23|0.1.0.0.1 21-22|0.1.0.1.0.0 18-19|0.1.0.3 17-18|0.1.0 15-16|0 14-15|0.0 11-12|0.1 10-11|0.1.0.1.0.1 9-10|0.1.0.3.1 8-9|0.1.0.3.1.0 6-7|0.1.0.3.1.0.1 5-6|0.1.0.3.1.0.1.0 3-4|0.1.0.1.1 1-2|0.1.0.1 0-1|0.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:45.349
(s / sample-01 
      :ARG1-of (p2 / pool-01) 
      :poss-of (l2 / L 
            :ARG2-of (i / inject-01 
                  :ARG0 (c5 / chromatography 
                        :mod (l / liquid) 
                        :mod (p / protein)) 
                  :ARG1 (v / volume 
                        :mod (e2 / equal-01 
                              :ARG0 (f / fast) 
                              :ARG1 100) 
                        :quant-of (p4 / plasma)) 
                  :manner (u / use-01 
                        :ARG0 27 
                        :ARG1 (c4 / column 
                              :mod (o2 / organization 
                                    :name (n5 / name 
                                          :op1 "HR10/30")) 
                              :mod (o3 / organization 
                                    :name (n6 / name 
                                          :op1 "Superose")))) 
                  :op1-of (a3 / and 
                        :op2 (c3 / country 
                              :name (n3 / name 
                                    :op1 "Piscataway")) 
                        :op2-of (a4 / and 
                              :op1 (p3 / pool-01 
                                    :ARG0 6 
                                    :ARG1 (g / genotype 
                                          :mod (e / each))) 
                              :op3 (a2 / and 
                                    :op1 (a / analyze-01 
                                          :ARG0 (o4 / organization 
                                                :name (n7 / name 
                                                      :op1 "FPLC")) 
                                          :ARG1 (d / describe-01 
                                                :ARG0 (o / organization 
                                                      :name (n4 / name 
                                                            :op1 "Pharmacia" 
                                                            :op2 "Biotech" 
                                                            :op3 "Inc.")))))) 
                        :op3 (c2 / country 
                              :name (n2 / name 
                                    :op1 "NJ")) 
                        :op4 (c / country 
                              :name (n / name 
                                    :op1 "USA") 
                              :wiki "United_States")))))

# ::snt Sterol composition of plasma and tissues .
# ::tok Sterol composition of plasma and tissues .
# ::alignments 5-6|0.1.1 4-5|0.1 3-4|0.1.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:45.400
(c / compose-01 
      :ARG0 (s / sterol) 
      :ARG1 (a / and 
            :op1 (p / plasma) 
            :op2 (t / tissue)))

# ::snt Following a four-hour fast of 12-week-old mice fed on regular rodent chow diet ; blood and tissues were collected under isofluorane anesthesia from each of the Abcg8 + / + , Abcg8 + / - and Abcg8 - / - mice ( n = 3 for each group ) .
# ::tok Following a four-hour fast of 12-week-old mice fed on regular rodent chow diet ; blood and tissues were collected under isofluorane anesthesia from each of the Abcg8 + / + , Abcg8 + / - and Abcg8 - / - mice ( n = 3 for each group ) .
# ::alignments 47-48|0.3.0 46-47|0.3 44-45|0.4 40-41|0.2 38-39|0.0.3 35-36|0.0.1.1 33-34|0.0.1.1.1 28-29|0.0.1.1.0 23-24|0.0.1.0.0 21-22|0.1 18-19|0 16-17|0.0.2 15-16|0.0 14-15|0.0.0 13-14|0.0.1 12-13|0.0.0.0.0 11-12|0.0.0.0.0.1 10-11|0.0.0.0.0.1.0 9-10|0.0.0.0 7-8|0.0.0.0.0.0 6-7|0.0.0.0.0.0.0 3-4|0.0.0.0.0.0.0.0 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:46.201
(c / collect-01 
      :ARG1 (a3 / and 
            :op1 (b / blood 
                  :ARG2-of (r2 / regular-02 
                        :ARG1 (d / diet 
                              :ARG2-of (f / feed-up-03 
                                    :ARG1 (m2 / mouse 
                                          :beneficiary-of (f2 / fast))) 
                              :mod (c2 / chow 
                                    :mod (r / rodent))))) 
            :op1-of (a4 / and 
                  :ARG1-of (f3 / follow-01 
                        :ARG0 (e2 / each)) 
                  :op2 (a / and 
                        :op1 (s3 / slash) 
                        :op2 (s2 / slash))) 
            :op2 (t / tissue) 
            :op3 (s / slash)) 
      :ARG2 (a2 / anesthesia) 
      :op1-of (m / mouse) 
      :op1-of (e / each 
            :mod-of (g / group)) 
      :op1-of 3)

# ::snt Blood was collected from the retro-orbital venous plexus by heparinized glass tube .
# ::tok Blood was collected from the retro-orbital venous plexus by heparinized glass tube .
# ::alignments 11-12|0.0 10-11|0.1.0 9-10|0.2.0 7-8|0.2 6-7|0.2.1 2-3|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:46.249
(c / collect-01 
      :ARG0 (t / tube) 
      :ARG1 (b / blood-01 
            :ARG1 (g / glass)) 
      :ARG2 (p / plexu 
            :location (h / hepariniz) 
            :mod (v / venou)))

# ::snt The animals were sacrificed by cervical dislocation for tissue collection .
# ::tok The animals were sacrificed by cervical dislocation for tissue collection .
# ::alignments 9-10|0.1 8-9|0.1.0 6-7|0.1.1 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:46.312
(s / sacrifice-01 
      :ARG1 (a / animal) 
      :ARG2 (c / collect-01 
            :ARG1 (t / tissue) 
            :topic-of (d / dislocation)))

# ::snt Plasma ( 100 l ) was saponified in 1 N NaOH for one hour , 1.5 mL water added and sterols extracted with three sequential portions of 1.5 mL ethyl acetate , containing 70 g 5-cholestane as an internal standard , pooled and dried .
# ::tok Plasma ( 100 l ) was saponified in 1 N NaOH for one hour , 1.5 mL water added and sterols extracted with three sequential portions of 1.5 mL ethyl acetate , containing 70 g 5-cholestane as an internal standard , pooled and dried .
# ::alignments 43-44|0.3.3.1 42-43|0.3.3 41-42|0.3.3.0 39-40|0.3.3.1.1.1 38-39|0.3.3.1.1 34-35|0.3.2.0.0 33-34|0.3.2.0.0.0 32-33|0.3.2.0 30-31|0.2 29-30|0.3.3.1.0 27-28|0.3.0.0 25-26|0.3.2 24-25|0.3.2.1 23-24|0.3.2.2 21-22|0.3.1 20-21|0.3.1.0 19-20|0.3 18-19|0 17-18|0.0 16-17|0.0.0 15-16|0.3.1.1 13-14|0.3.3.1.1.0.0+0.3.3.1.1.0 9-11|0.3.0.1.0.1+0.3.0.1.0.0+0.3.0.1.0+0.3.0.1 8-9|0.3.0.1.1 6-7|0.3.0 2-3|0.3.2.0.1 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:47.574
(a4 / add-01 
      :ARG0 (w / water 
            :mod (m / ml)) 
      :ARG1 (p3 / plasma) 
      :ARG2 (a2 / acetate) 
      :op2-of (a3 / and 
            :op1 (s4 / saponify-01 
                  :ARG0 1.5 
                  :ARG1 (t2 / thing 
                        :name (n / name 
                              :op1 (n2 / N) 
                              :op2 (n3 / NaOH)) 
                        :quant 1)) 
            :op3 (e2 / extract-01 
                  :ARG0 (s3 / sterol) 
                  :ARG1 1.5) 
            :op4 (p2 / portion 
                  :ARG0-of (c / contain-01 
                        :ARG1 (g / g 
                              :quant 70) 
                        :op1-of 100) 
                  :mod (s2 / sequential) 
                  :quant 3) 
            :op5 (a / and 
                  :op1 (p / pool-01) 
                  :op2 (d / dry-02 
                        :ARG0 (e / ethyl) 
                        :ARG1-of (i / internal-02 
                              :ARG0 (t / temporal-quantity 
                                    :unit (h / hour)) 
                              :mod-of (s / standard))))))

# ::snt Mouse tissues ( liver , spleen and brain ) were weighed , homogenized in 1 mL phosphate buffer saline ( PBS ) with a dounce homogenizer ( 15 strokes at 500 rpm ) and a small aliquot of the whole homogenate assayed for protein concentration .
# ::tok Mouse tissues ( liver , spleen and brain ) were weighed , homogenized in 1 mL phosphate buffer saline ( PBS ) with a dounce homogenizer ( 15 strokes at 500 rpm ) and a small aliquot of the whole homogenate assayed for protein concentration .
# ::alignments 44-45|0.1.1.0 43-44|0.1.1.0.0 40-41|0.1.1 39-40|0.1.1.1 36-37|0.1 35-36|0.1.0 33-34|0 31-32|0.1.1.0.2.2.1 30-31|0.1.1.0.2.0 28-29|0.1.1.0.2.2 27-28|0.1.1.0.2.2.3 25-26|0.0.0 20-21|0.1.1.0.1 18-19|0.1.1.0.2.1 17-18|0.1.1.0.2 16-17|0.1.1.0.2.1.1 15-16|0.1.1.0.2.1.0 14-15|0.1.1.0.2.2.0 10-11|0.0 7-8|0.1.1.0.2.2.2.2 6-7|0.1.1.0.2.2.2 5-6|0.1.1.0.2.2.2.1 3-4|0.1.1.0.2.2.2.0 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:48.993
(a2 / and 
      :op1 (w2 / weigh-01 
            :ARG0 (h2 / homogeniz) 
            :ARG1 (t / tissue 
                  :mod (m2 / mouse))) 
      :op2 (a / aliquot 
            :mod (s / small) 
            :poss (h / homogenate 
                  :ARG0-of (c / concentrate-02 
                        :ARG1 (p / protein) 
                        :ARG2 (p2 / pb) 
                        :ARG2-of (b / buffer-01 
                              :ARG0 500 
                              :ARG1 (s3 / saline 
                                    :mod (m / ml) 
                                    :mod (p3 / phosphate)) 
                              :purpose (s2 / stroke-01 
                                    :ARG0 1 
                                    :ARG2 (r / rpm) 
                                    :op4-of (a3 / and 
                                          :op1 (l / liver) 
                                          :op2 (s4 / spleen) 
                                          :op3 (b2 / brain)) 
                                    :quant 15))) 
                  :mod (w / whole))))

# ::snt Aliquots for sterol analysis from whole tissue homogenates were extracted as described above .
# ::tok Aliquots for sterol analysis from whole tissue homogenates were extracted as described above .
# ::alignments 12-13|0.0.1.0 11-12|0.0.1 9-10|0.0.1.1 7-8|0.0 6-7|0 5-6|0.0.2 3-4|0.0.0 2-3|0.0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:49.468
(t / tissue 
      :mod-of (h / homogenat 
            :ARG0-of (a2 / analyze-01 
                  :ARG1 (s / sterol) 
                  :topic-of (a3 / aliquot)) 
            :ARG0-of (d / describe-01 
                  :ARG1 (a / above) 
                  :ARG2-of (e / extract-01)) 
            :mod (w / whole)))

# ::snt Dried sterol samples were derivatized as trimethylsilylethers , redissolved in 10 L hexane and 2 L samples were injected into a capillary column ( 26 m length , 0.32 mm ID , 0.45 mm OD ) coated with liquid CpWAX 57 CB ( Chrompak , Bridgewater , NJ , USA ) in a Hewlett-Packard Gas Chromatograph equipped with a flame ionization detector [ 28 ] .
# ::tok Dried sterol samples were derivatized as trimethylsilylethers , redissolved in 10 L hexane and 2 L samples were injected into a capillary column ( 26 m length , 0.32 mm ID , 0.45 mm OD ) coated with liquid CpWAX 57 CB ( Chrompak , Bridgewater , NJ , USA ) in a Hewlett-Packard Gas Chromatograph equipped with a flame ionization detector [ 28 ] .
# ::alignments 63-64|0.2.2 61-62|0.1.0+0.1 60-61|0.1.0.0 59-60|0.1.0.0.0 56-57|0 53-56|0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 49-50|0.2.0.0.4.3.1+0.2.0.0.4.3.0.0+0.2.0.0.4.3.0+0.2.0.0.4.3 47-48|0.2.0.0.4.2.0.0+0.2.0.0.4.2.0+0.2.0.0.4.2 45-46|0.2.0.0.4.1.0.0+0.2.0.0.4.1.0+0.2.0.0.4.1 41-42|0.2.0.0.4.0.2.0+0.2.0.0.4.0.2 40-41|0.2.0.0.3 39-40|0.2.0.0.4.0.1.0+0.2.0.0.4.0.1+0.2.0.0.4.0 38-39|0.2.0.0.4.0.0 36-37|0.2 34-35|0.3 30-31|0.4 29-30|0.4.0 26-27|0.2.0.0.1.0.0.0 25-26|0.2.0.0.1.0.0.0.0 24-25|0.2.0.0.1.0.0 22-23|0.2.0 21-22|0.2.0.1 18-19|0.2.0.0 16-17|0.2.0.0.2.0+0.2.0.0.2 15-16|0.2.0.0.2.0.0 14-15|0.2.0.0.2.1 13-14|0.2.0.0.4 12-13|0.2.0.0.0 11-12|0.2.0.0.0.0 10-11|0.2.1 6-7|0.2.3 2-3|0.2.0.0.1.1+0.2.0.0.1 1-2|0.2.0.0.1.2 0-1|0.2.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:54.952
(e / equip-01 
      :ARG1 (o / organization 
            :name (n / name 
                  :op1 "Hewlett-Packard" 
                  :op2 "Gas" 
                  :op3 "Chromatograph")) 
      :ARG2 (t / thing 
            :ARG0-of (d / detect-01 
                  :ARG1 (i / ionization 
                        :mod (f / flame)))) 
      :manner-of (c3 / coat-01 
            :ARG1 (c4 / column 
                  :destination-of (i3 / inject-01 
                        :ARG0 (h / hexane 
                              :mod (l4 / L)) 
                        :ARG1 (t4 / thing 
                              :ARG1-of (d2 / dry-01 
                                    :ARG2 (22 / 26 
                                          :quant-of (l2 / length 
                                                :mod (m2 / m)))) 
                              :ARG1-of (s2 / sample-01) 
                              :mod (s3 / sterol)) 
                        :ARG2 (t2 / thing 
                              :ARG1-of (s / sample-01 
                                    :ARG0 (l3 / L)) 
                              :quant 2) 
                        :op1-of 57 
                        :op1-of (a / and 
                              :op2 (o2 / organization 
                                    :mod (l / liquid) 
                                    :name (n6 / name 
                                          :op1 "CpWAX") 
                                    :name (n5 / name 
                                          :op1 "CB003011")) 
                              :op3 (p / person 
                                    :name (n4 / name 
                                          :op1 "Bridgewater")) 
                              :op4 (c2 / country 
                                    :name (n3 / name 
                                          :op1 "NJ")) 
                              :op5 (c / country 
                                    :name (n2 / name 
                                          :op1 "USA") 
                                    :wiki "United_States"))) 
                  :mod (c5 / capillary)) 
            :ARG2 10 
            :op1-of 28 
            :op1-of (t3 / trimethylsilylether)) 
      :op1-of (o3 / od) 
      :op1-of (i2 / id 
            :mod (m / mm)))

# ::snt Concentrations of plasma and tissue sterols were reported as mg/dL and g/g wet weight tissue , respectively .
# ::tok Concentrations of plasma and tissue sterols were reported as mg/dL and g/g wet weight tissue , respectively .
# ::alignments 16-17|0.0.1.0 14-15|0.0.1.1 13-14|0.0.1.1.1 12-13|0.0.1.1.0 10-11|0.0.1 7-8|0.0 5-6|0.3 4-5|0.2 3-4|0 2-3|0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:55.076
(a2 / and 
      :ARG0-of (r2 / report-01 
            :ARG1 (c / concentration) 
            :ARG2 (a / and 
                  :mod (r / respective) 
                  :op1 (t / tissue 
                        :mod (w2 / wet-01) 
                        :mod (w / weight)))) 
      :op1 (p / plasma) 
      :op2 (t2 / tissue) 
      :op3 (s / sterol))

# ::snt Three separate polyclonal anti-Abcg5 / sterolin-1 antibodies have been raised as previously described [ 20,29,30 ] .
# ::tok Three separate polyclonal anti-Abcg5 / sterolin-1 antibodies have been raised as previously described [ 20,29,30 ] .
# ::alignments 12-13|0.1 11-12|0.1.1 9-10|0 6-7|0.0 4-5|0.0.1 1-2|0.0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:55.120
(r / raise-01 
      :ARG1 (a / antibodi 
            :ARG1-of (s2 / separate-02) 
            :poss (s / slash)) 
      :purpose (d / describe-01 
            :ARG1 3 
            :time (p / previous)))

# ::snt In experiments , anti-Abcg5 / sterolin-1 antibodies are labelled as follows : 1 ) SC -- from the Patel group , 2 ) AMC -- from the AMC Liver Center group , and 3 ) UTSW -- from the Hobbs group .
# ::tok In experiments , anti-Abcg5 / sterolin-1 antibodies are labelled as follows : 1 ) SC -- from the Patel group , 2 ) AMC -- from the AMC Liver Center group , and 3 ) UTSW -- from the Hobbs group .
# ::alignments 40-41|0.0.0.0.0 39-40|0.0.0.0.0.0 35-36|0.2.1.0.0+0.2.1.0+0.2.1 33-34|0.0.2 32-33|0 30-31|0.2 27-30|0.2.0.0.2+0.2.0.0.1+0.2.0.0.0+0.2.0.0+0.2.0 23-24|0.0.0.0.2.1.0+0.0.0.0.2.1+0.0.0.0.2 21-22|0.0.0.0.1.0 19-20|0.1.0 18-19|0.1.1.0+0.1.1+0.1 14-15|0.0.1.1+0.0.1.0.0+0.0.1.0+0.0.1 12-13|0.0.0.0.2.0 10-11|0.0 8-9|0.0.0.0 6-7|0.0.0 4-5|0.0.0.1 1-2|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:55.971
(a / and 
      :ARG2-of (f / follow-01 
            :ARG0 (a2 / antibodi 
                  :ARG1-of (l / label-01 
                        :ARG0 (g / group 
                              :mod (h / hobb)) 
                        :ARG1-of (e / experiment-01 
                              :ARG0 2) 
                        :ARG2 (o3 / organization 
                              :li 1 
                              :name (n3 / name 
                                    :op1 "AMC"))) 
                  :mod (s2 / slash)) 
            :ARG1 (s / state 
                  :name (n5 / name 
                        :op1 "SC") 
                  :wiki "South_Carolina") 
            :op1-of 3) 
      :op1 (p / person 
            :consist (g3 / group) 
            :name (n4 / name 
                  :op1 "Patel")) 
      :op2 (g2 / group 
            :mod (o2 / organization 
                  :name (n2 / name 
                        :op1 "AMC" 
                        :op2 "Liver" 
                        :op3 "Center")) 
            :source-of (o / organization 
                  :name (n / name 
                        :op1 "UTSW"))))

# ::snt Total membranes were prepared by taking approximately 500 mg of liver tissue cut into small pieces and homogenized in ice cold lysis buffer ( 5 mM Tris-pH7.5 , 250 mM sucrose with protease inhibitors ) by a dounce homogenizer times 10 strokes .
# ::tok Total membranes were prepared by taking approximately 500 mg of liver tissue cut into small pieces and homogenized in ice cold lysis buffer ( 5 mM Tris-pH7.5 , 250 mM sucrose with protease inhibitors ) by a dounce homogenizer times 10 strokes .
# ::alignments 41-42|0.0.2.0.0.1 40-41|0.0.4 38-39|0.0.0 33-34|0.0.3 32-33|0.0.3.0 30-31|0.0.2.0.0.1.0 28-29|0.0.1.1.0.0 25-26|0.0.2.0.0.0 24-25|0.0.1.1.0.1.1 22-23|0.0.2.0.0 21-22|0.0.2.0.0.3 20-21|0.0.2.0.0.2 19-20|0.0.2.0.0.4 16-17|0 15-16|0.0.2 14-15|0.0.2.0 12-13|0.0 11-12|0.0.1 10-11|0.0.1.0 8-9|0.0.1.1 7-8|0.0.1.1.1.0 6-7|0.0.1.1.1 5-6|0.0.1.1.0 3-4|0.0.1.1.0.1 1-2|0.0.1.1.0.1.0 0-1|0.0.1.1.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:56.998
(a / and 
      :op1 (c2 / cut-01 
            :ARG0 (h / homogeniz) 
            :ARG1 (t / tissue 
                  :mod (l2 / liver) 
                  :mod-of (m2 / mg 
                        :ARG1-of (t2 / take-01 
                              :ARG0 250 
                              :manner-of (p3 / prepare-02 
                                    :ARG1 (m3 / membran 
                                          :ARG1-of (t3 / total-01)) 
                                    :ARG2 5)) 
                        :quant (a2 / approximately 
                              :op1 500))) 
            :ARG2 (p2 / piece 
                  :mod (s3 / small 
                        :mod-of (b / buffer-01 
                              :ARG1 (m / mm) 
                              :ARG2 (s / stroke-01 
                                    :ARG0 (s2 / sucrose)) 
                              :mod (c / cold) 
                              :mod (l / lysi) 
                              :op1-of (i2 / ice)))) 
            :op1-of (i / inhibitor 
                  :mod (p / protease)) 
            :op1-of 10))

# ::snt Samples were then subjected to centrifugation -- 1300 g for 10 minutes at 4 C .
# ::tok Samples were then subjected to centrifugation -- 1300 g for 10 minutes at 4 C .
# ::alignments 14-15|0.0.0 13-14|0.0.0.0 11-12|0.0.1.0.0+0.0.1.0 10-11|0.0.1 8-9|0.1 7-8|0.1.0 5-6|0.2 3-4|0 2-3|0.3 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:57.460
(s / subject-01 
      :ARG0 (s2 / sample-01 
            :ARG0 (c / C 
                  :era-of 4) 
            :ARG2 (1 / 10 
                  :quant-of (t / temporal-quantity 
                        :unit (m / minute)))) 
      :ARG1 (g / g 
            :quant 1300) 
      :ARG2 (c2 / centrifugation) 
      :time (t2 / then))

# ::snt The supernant was saved and the pellet was resuspended and again subjected to dounce homogenization times 10 strokes then centrifuged 1000 g for 10 minutes at 4 C .
# ::tok The supernant was saved and the pellet was resuspended and again subjected to dounce homogenization times 10 strokes then centrifuged 1000 g for 10 minutes at 4 C .
# ::alignments 27-28|0.0.3 26-27|0.0.5 24-25|0.0.7.1+0.0.7 23-24|0.0.7.0 21-22|0.0.6 20-21|0.0.4 18-19|0.0.6.0 17-18|0.0.2 16-17|0.0.0 14-15|0.1.1 11-12|0.1.0 10-11|0.1.0.1 9-10|0.1 6-7|0.1.0.0 4-5|0 3-4|0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:57.774
(a3 / and 
      :op1 (s3 / save-02 
            :ARG0 10 
            :ARG1 (s4 / supernant) 
            :ARG1-of (s / stroke-01) 
            :op1-of (c / C) 
            :op1-of 1000 
            :op1-of 4 
            :op1-of (g / g 
                  :quant (t2 / then)) 
            :op1-of (t / temporal-quantity 
                  :quant 10 
                  :unit (m / minute))) 
      :op2 (a2 / and 
            :op1 (s2 / subject-01 
                  :ARG1 (p / pellet) 
                  :mod (a / again)) 
            :op2 (h / homogenization)))

# ::snt This step was repeated twice each time with the supernant being collected and kept on ice .
# ::tok This step was repeated twice each time with the supernant being collected and kept on ice .
# ::alignments 15-16|0.1.1 13-14|0.2 12-13|0 11-12|0.1 9-10|0.1.0 6-7|0.2.0 5-6|0.2.0.0 3-4|0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:57.895
(a / and 
      :ARG2-of (r / repeat-01 
            :ARG1 (s2 / step 
                  :mod (t2 / this))) 
      :op1 (c / collect-01 
            :ARG1 (s / supernant) 
            :location (i / ice)) 
      :op2 (k / keep-01 
            :ARG0 (t / time 
                  :mod (e / each))))

# ::snt The supernants were then pooled and subjected to ultracentrifugation at 100,000 g for 60 minutes at 4 C .
# ::tok The supernants were then pooled and subjected to ultracentrifugation at 100,000 g for 60 minutes at 4 C .
# ::alignments 17-18|0.0.0.0 16-17|0.0.0 14-15|0.1.0.0.0+0.1.0.0 13-14|0.1.0 11-12|0.0.3 8-9|0.0.1 6-7|0.1 5-6|0 4-5|0.0 3-4|0.0.2 1-2|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:58.104
(a / and 
      :op1 (p / pool-01 
            :ARG0 (4 / 4 
                  :era (c / C)) 
            :ARG1 (u / ultracentrifugation) 
            :time (t2 / then) 
            :time (g / g)) 
      :op2 (s / subject-01 
            :ARG0 (6 / 60 
                  :quant-of (t / temporal-quantity 
                        :unit (m / minute))) 
            :ARG1 (s2 / supernant)))

# ::snt The supernant was removed and the pellet was resuspended in lysis buffer .
# ::tok The supernant was removed and the pellet was resuspended in lysis buffer .
# ::alignments 11-12|0.0.1.0 10-11|0.0.1.0.0 6-7|0.0.0 4-5|0 3-4|0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:58.227
(a / and 
      :op1 (r / remove-01 
            :ARG0 (p / pellet) 
            :ARG1 (s / supernant 
                  :ARG0-of (b / buffer-01 
                        :ARG1 (l / lysi)))))

# ::snt Plasma membranes were prepared as previously described [ 31 ] .
# ::tok Plasma membranes were prepared as previously described [ 31 ] .
# ::alignments 8-9|0.0 6-7|0.1.0 5-6|0.1.0.0 3-4|0 1-2|0.1 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:58.284
(p2 / prepare-02 
      :ARG0 31 
      :ARG1 (m / membran 
            :ARG1-of (d / describe-01 
                  :time (p / previous)) 
            :mod (p3 / plasma)))

# ::snt Protein sample concentrations were then determined by Bio-Rad protein colormetric assay per manufacturer 's protocol ( BioRad , Hercules , CA , USA ) .
# ::tok Protein sample concentrations were then determined by Bio-Rad protein colormetric assay per manufacturer 's protocol ( BioRad , Hercules , CA , USA ) .
# ::alignments 22-23|0.1.0.1.1+0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 20-21|0.1.1.0.0.1+0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 18-19|0.1.0.2.0.0+0.1.0.2.0+0.1.0.2 16-17|0.1.0.3.0.0+0.1.0.3.0+0.1.0.3 14-15|0.1.1 12-13|0.1.1.0 10-11|0.0 8-9|0.0.0 7-8|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 5-6|0 4-5|0.2 2-3|0.1 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:59.258
(d / determined-02 
      :ARG0 (a / assay 
            :mod (p2 / protein 
                  :mod (o2 / organization 
                        :name (n5 / name 
                              :op1 "Bio-Rad")))) 
      :ARG1 (c3 / concentration 
            :ARG0-of (s2 / sample-01 
                  :ARG1 (p3 / protein) 
                  :ARG2 (c / country 
                        :name (n / name 
                              :op1 "USA") 
                        :wiki "United_States") 
                  :location (c2 / country 
                        :name (n3 / name 
                              :op1 "Hercules")) 
                  :op1-of (o / organization 
                        :name (n4 / name 
                              :op1 "BioRad"))) 
            :poss-of (p / protocol 
                  :poss (m / manufacture-01 
                        :ARG1 (s / state 
                              :name (n2 / name 
                                    :op1 "CA") 
                              :wiki "California")))) 
      :time (t / then))

# ::snt 50 g of membrane proteins were then resolved on 7.5 % SDS acrylamide gel .
# ::tok 50 g of membrane proteins were then resolved on 7.5 % SDS acrylamide gel .
# ::alignments 13-14|0.0.1.0 12-13|0.1 11-12|0.1.0 10-11|0.1.0.0 7-8|0 6-7|0.2 4-5|0.0.0 3-4|0.0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:59.328
(r / resolve-01 
      :ARG1 (g2 / g 
            :mod (p2 / protein 
                  :mod (m / membrane)) 
            :quant (5 / 50 
                  :poss-of (g / gel))) 
      :ARG2 (a / acrylamide 
            :mod (s / sd 
                  :mod (p / percentage-entity))) 
      :time (t / then))

# ::snt Proteins resolved by SDS-PAGE were transferred to nitrocellulose membranes .
# ::tok Proteins resolved by SDS-PAGE were transferred to nitrocellulose membranes .
# ::alignments 8-9|0.1 7-8|0.1.0 5-6|0 3-4|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 1-2|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:59.383
(t / transfer-01 
      :ARG1 (p2 / protein 
            :ARG1-of (r / resolve-01 
                  :ARG0 (p / person 
                        :name (n2 / name 
                              :op1 "SDS-PAGE")))) 
      :ARG2 (m / membran 
            :mod (n / nitrocellulose)))

# ::snt Membranes were then blocked for one hour in 5 % dry milk in PBS-T ( Phosphate Buffered saline and 0.1 % Tween 20 ) .
# ::tok Membranes were then blocked for one hour in 5 % dry milk in PBS-T ( Phosphate Buffered saline and 0.1 % Tween 20 ) .
# ::alignments 22-23|0.1.0.0 20-21|0.0.0.0 19-20|0.0.0 18-19|0 17-18|0.2 16-17|0.2.0 15-16|0.2.0.0 11-12|0.1 10-11|0.1.0 9-10|0.1.0.1 8-9|0.1.0.1.0 6-7|0.0.2.0+0.0.2 3-4|0.0 2-3|0.0.3 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:59.741
(a / and 
      :location-of (b2 / block-01 
            :ARG0 (0 / 0.1 
                  :value-of (p / percentage-entity)) 
            :ARG1 (m2 / membran) 
            :duration (t / temporal-quantity 
                  :unit (h / hour)) 
            :time (t2 / then)) 
      :op1 (m / milk 
            :ARG1-of (d / dry-08 
                  :ARG0 20 
                  :ARG2 (p3 / percentage-entity 
                        :quant 5))) 
      :op2 (s / saline 
            :ARG0-of (b / buffer-01 
                  :ARG1 (p2 / phosphate))))

# ::snt Blots were then probed with primary antibody against Abcg5 in 5 % milk in PBS-T overnight at 4 C .
# ::tok Blots were then probed with primary antibody against Abcg5 in 5 % milk in PBS-T overnight at 4 C .
# ::alignments 18-19|0.0.1 17-18|0.0.1.0 15-16|0.0.0 12-13|0.4.0.0 11-12|0.4.0 10-11|0.4 8-9|0.2.0.0+0.2.0+0.2 6-7|0.1 5-6|0.1.0 3-4|0 2-3|0.3 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:08:59.906
(p3 / probe-01 
      :ARG1 (b / blot-01 
            :ARG0 (o / overnight) 
            :ARG1 (c / C 
                  :era-of 4)) 
      :ARG2 (a / antibody 
            :mod (p2 / primary)) 
      :prep-against (t / thing 
            :name (n / name 
                  :op1 "Abcg5")) 
      :time (t2 / then) 
      :time (5 / 5 
            :quant-of (p / percentage-entity 
                  :mod-of (m / milk))))

# ::snt The blot was then washed three times for five minutes in TBS-T ( Tris Buffered Saline/0 .1 % Tween-20 ) with 150 mM NaCl , and secondarily stained with goat-anti-rabbit conjugated HRP 1:10,000 dilution in 5 % milk in PBS-T for one hour .
# ::tok The blot was then washed three times for five minutes in TBS-T ( Tris Buffered Saline/0 .1 % Tween-20 ) with 150 mM NaCl , and secondarily stained with goat-anti-rabbit conjugated HRP 1:10,000 dilution in 5 % milk in PBS-T for one hour .
# ::alignments 42-43|0.0.3.0+0.0.3 37-38|0.0.0.0 36-37|0.0.0 35-36|0.0.1.3.1.0 33-34|0.0.2 30-31|0.0.1.3 27-28|0.0 26-27|0.0.4 25-26|0 22-23|0.0.1.3.0 21-22|0.0.1.3.0.0 17-18|0.0.1.0 14-15|0.0.1.3.1 13-14|0.0.1.3.1.1 11-12|0.0.1.1.1.0+0.0.1.1.1+0.0.1.1 9-10|0.0.1.1.0.1+0.0.1.1.0 8-9|0.0.1.1.0.0 5-6|0.0.1.2.0 4-5|0.0.1.2 3-4|0.0.1.2.1 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:00.439
(a / and 
      :op1 (s / stain-01 
            :ARG0 (p / percentage-entity 
                  :mod-of (m / milk)) 
            :ARG1 (b2 / blot-01 
                  :ARG0 (p2 / percentage-entity) 
                  :ARG1 (c2 / country 
                        :location-of (t3 / temporal-quantity 
                              :quant 5 
                              :unit (m3 / minute)) 
                        :name (n / name 
                              :op1 "TBS-T")) 
                  :ARG1-of (w / wash-01 
                        :frequency 3 
                        :time (t4 / then)) 
                  :ARG2 (c / conjugate-01 
                        :ARG0 (m2 / mm 
                              :quant 150) 
                        :ARG2-of (b / buffer-01 
                              :ARG0 5 
                              :ARG1 (t2 / tri)))) 
            :ARG2 (d / dilution) 
            :duration (t / temporal-quantity 
                  :unit (h / hour)) 
            :manner (s2 / secondarily)))

# ::snt The blot was again washed three times for five minutes in TBS-T with 150 mM NaCl then covered in Western Lightning  Chemiluminescence Reagent Plus ( PerkinElmer Life Sciences , Inc. .
# ::tok The blot was again washed three times for five minutes in TBS-T with 150 mM NaCl then covered in Western Lightning  Chemiluminescence Reagent Plus ( PerkinElmer Life Sciences , Inc. .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:00.441
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Boston , MA , USA ) , wrapped in plastic , exposed to film and developed .
# ::tok Boston , MA , USA ) , wrapped in plastic , exposed to film and developed .
# ::alignments 15-16|0.2 14-15|0 13-14|0.1.1 11-12|0.1 9-10|0.0.0 7-8|0.0 4-5|0.2.0.1+0.2.0.0.0+0.2.0.0+0.2.0 2-3|0.2.1.0.0+0.2.1.0+0.2.1 0-1|0.1.0.1+0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:00.702
(a / and 
      :op1 (w / wrap-01 
            :ARG1 (p / plastic)) 
      :op2 (e / expose-01 
            :ARG0 (c3 / city 
                  :name (n3 / name 
                        :op1 "Boston") 
                  :wiki "Boston") 
            :ARG1 (f / film)) 
      :op3 (d / develop-02 
            :ARG0 (c / country 
                  :name (n / name 
                        :op1 "USA") 
                  :wiki "United_States") 
            :ARG1 (c2 / country 
                  :name (n2 / name 
                        :op1 "MA"))))

# ::snt Snap-frozen liver and intestine tissue were cut to produce 8 m thick frozen sections , air-dried for 30 minutes onto glass slides and stored at -80 C until required .
# ::tok Snap-frozen liver and intestine tissue were cut to produce 8 m thick frozen sections , air-dried for 30 minutes onto glass slides and stored at -80 C until required .
# ::alignments 28-29|0.0.2.1 27-28|0.0.2 26-27|0.0.1 23-24|0.0 22-23|0 21-22|0.0.2.1.0 20-21|0.0.2.1.0.0 19-20|0.0.2.1.0.1 18-19|0.0.2.0.1+0.0.2.0 17-18|0.0.2.0.0 13-14|0.0.0.0.0 12-13|0.0.0.0.0.0 11-12|0.0.0.0.0.0.0 10-11|0.0.0.0.0.1 9-10|0.0.0.0.0.2 8-9|0.0.0.0 6-7|0.0.0.0.1 4-5|0.0.0.0.1.0.0 3-4|0.0.0.0.1.0.0.0 2-3|0.0.0.0.1.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:01.673
(a / and 
      :op1 (s / store-01 
            :ARG1 (l / liver 
                  :ARG0-of (p / produce-01 
                        :ARG1 (s3 / section 
                              :ARG1-of (f / freeze-01 
                                    :ARG1-of (t2 / thick-03)) 
                              :mod (m2 / m) 
                              :quant 8) 
                        :ARG2-of (c2 / cut-01 
                              :ARG1 (a2 / and 
                                    :op1 (t3 / tissue 
                                          :mod (i / intestine)))))) 
            :ARG2 (c / C) 
            :time (u / until 
                  :op1 (t / temporal-quantity 
                        :quant 30 
                        :unit (m / minute)) 
                  :op2 (r / require-01 
                        :ARG1 (s2 / slide-01 
                              :ARG1 (g / glass) 
                              :op1-of (o / onto))))))

# ::snt The slides were stained with hematoxylin , rinsed three times with PBS , fixed for 10 min with cooled methanol at -20 C and then rinsed three times with PBS .
# ::tok The slides were stained with hematoxylin , rinsed three times with PBS , fixed for 10 min with cooled methanol at -20 C and then rinsed three times with PBS .
# ::alignments 26-27|0.2.0 25-26|0.2 24-25|0.2.1 23-24|0 22-23|0.0.0.1 19-20|0.3 18-19|0.3.0 16-17|0.1.0 15-16|0.0.0.0 13-14|0.1 11-12|0.0.1 8-9|0.3.0.0 7-8|0.0 5-6|0.0.0.2.0 3-4|0.0.0.2 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:02.002
(a / and 
      :op1 (r2 / rinse-01 
            :ARG0 (s2 / slide-01 
                  :ARG0 10 
                  :ARG1 (c / C) 
                  :ARG1-of (s / stain-01 
                        :ARG2 (h / hematoxylin))) 
            :ARG1 (p / pb)) 
      :op2 (f / fix-03 
            :ARG1 (m2 / min)) 
      :op3 (r / rinse-01 
            :ARG1 3 
            :time (t / then)) 
      :poss-of (m / methanol 
            :ARG1-of (c2 / cool-01 
                  :ARG0 3)))

# ::snt Slides for antibody staining were initially blocked in PBS/0 .1 M glycine/10 % goat serum for 60 min at room temperature then incubated with anti-sterolin-1 antibody ( 1:15 dilution ) overnight at 4 C .
# ::tok Slides for antibody staining were initially blocked in PBS/0 .1 M glycine/10 % goat serum for 60 min at room temperature then incubated with anti-sterolin-1 antibody ( 1:15 dilution ) overnight at 4 C .
# ::alignments 33-34|0.3.1.2 32-33|0.3.2.1 30-31|0.3.2.2 28-29|0.3.2.0 25-26|0.2 22-23|0 21-22|0.4 20-21|0.0 19-20|0.0.0 17-18|0.0.1 16-17|0.3.0 14-15|0.1 13-14|0.1.0 12-13|0.1.0.0 10-11|0.3.1.1.0.1+0.3.1.1.0.0.0+0.3.1.1.0.0+0.3.1.1.0 8-9|0.3.1.1.1.0+0.3.1.1.1+0.3.1.1 6-7|0.3.2 5-6|0.3.2.3 3-4|0.3.1 2-3|0.3.1.0 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:02.620
(i / incubate-01 
      :ARG0 (t2 / temperature 
            :consist-of (r / room) 
            :location-of (m / min)) 
      :ARG1 (s / serum 
            :mod (g / goat 
                  :quant (p / percentage-entity))) 
      :ARG2 (a / antibody) 
      :ARG2-of (s3 / slide-01 
            :ARG0 60 
            :ARG1 (s2 / stain-01 
                  :ARG1 (a2 / antibody) 
                  :domain-of (c2 / country 
                        :mod-of (v / vehicle 
                              :name (n / name 
                                    :op1 "M1") 
                              :wiki "M1_Abrams") 
                        :name (n2 / name 
                              :op1 "PBS/0")) 
                  :op1-of (c / C)) 
            :ARG1-of (b / block-01 
                  :op1-of (d / dilution) 
                  :op1-of 4 
                  :op1-of (o / overnight) 
                  :time (i2 / initial))) 
      :time (t / then))

# ::snt The slides were washed with 1  PBS and incubated with secondary antibody ( goat-anti-rabbit IgG conjugated with rhodamine , 1:1000 dilution ) for 30 min at room temperature , washed and then observed under an Olympus BX-5 confocal microscope with Fluoview .
# ::tok The slides were washed with 1  PBS and incubated with secondary antibody ( goat-anti-rabbit IgG conjugated with rhodamine , 1:1000 dilution ) for 30 min at room temperature , washed and then observed under an Olympus BX-5 confocal microscope with Fluoview .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:02.622
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The sections stained at the AMC Liver Center were fixed in 100 % acetone for 30 min at room temperature , blocked in a solution of PBS/0 .05 % Tween-20 / 5 % goat serum ( GS ) for one hour , then incubated with Anti-sterolin-1 ( 1:40 dilution ) and anti-Bsep ( 1:200 dilution ) diluted in PBS/Tween/GS , for one hour .
# ::tok The sections stained at the AMC Liver Center were fixed in 100 % acetone for 30 min at room temperature , blocked in a solution of PBS/0 .05 % Tween-20 / 5 % goat serum ( GS ) for one hour , then incubated with Anti-sterolin-1 ( 1:40 dilution ) and anti-Bsep ( 1:200 dilution ) diluted in PBS/Tween/GS , for one hour .
# ::alignments 62-63|0.1.3.0+0.1.3 58-59|0.1.4.0.0+0.1.4.0+0.1.4 56-57|0.1 54-55|0.1.0 50-51|0 48-49|0.1.1.0.1.3 45-46|0.0.1.0+0.0.1+0.0 43-44|0.0.0 42-43|0.1.1.0.1.1 40-41|0.0.3.0+0.0.3 36-37|0.1.1.0.2 34-35|0.1.2 33-34|0.1.2.0 32-33|0.1.2.0.0 31-32|0.1.2.0.0.0 30-31|0.0.2 28-29|0.1.1.0.1.0 24-25|0.1.1.0.1.2 21-22|0.1.1.0.1 19-20|0.1.1.0.1.2.0.0 18-19|0.1.1.0.1.2.0.0.0 16-17|0.1.1.0.1.2.0 15-16|0.1.1.0.1.2.0.1 13-14|0.1.1.1.0 12-13|0.1.1.0.0 11-12|0.1.1.0.0.0 9-10|0.1.1.0 5-8|0.1.1.1.1.0.2+0.1.1.1.1.0.1+0.1.1.1.1.0.0+0.1.1.1.1.0+0.1.1.1.1 2-3|0.1.1.1 1-2|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:04.824
(a / and 
      :op1 (p / person 
            :ARG1-of (i / incubate-01) 
            :name (n2 / name 
                  :op1 "Anti-sterolin-1") 
            :op1-of (s2 / slash) 
            :topic-of (t3 / temporal-quantity 
                  :unit (h2 / hour))) 
      :op2 (d / dilute-01 
            :ARG0 (d2 / dilution) 
            :ARG1 (s5 / section 
                  :ARG1-of (f / fix-03 
                        :ARG2 (p4 / percentage-entity 
                              :value 100) 
                        :manner (b / block-01 
                              :ARG1 (p3 / percentage-entity) 
                              :ARG2 (t2 / then) 
                              :location (s3 / solution 
                                    :mod (m / min 
                                          :location (t4 / temperature 
                                                :consist-of (r / room)) 
                                          :quant 30)) 
                              :op1-of (d3 / dilution)) 
                        :op1-of (g / g)) 
                  :ARG1-of (s4 / stain-01 
                        :ARG0 (a2 / acetone) 
                        :ARG2 (o / organization 
                              :name (n3 / name 
                                    :op1 "AMC" 
                                    :op2 "Liver" 
                                    :op3 "Center")))) 
            :ARG2 (s / serum 
                  :mod (g2 / goat 
                        :mod (p2 / percentage-entity 
                              :quant 5))) 
            :duration (t / temporal-quantity 
                  :unit (h / hour)) 
            :location (c / country 
                  :name (n / name 
                        :op1 "PBS/Tween/GS"))))

# ::snt Thereafter , slides were washed 3  10 min in PBS/Tween and the secondary antibody ( goat-anti-rabbit Alexa 488 ) was applied in 1:1000 dilution in PBST/GS for one hour at room temperature .
# ::tok Thereafter , slides were washed 3  10 min in PBS/Tween and the secondary antibody ( goat-anti-rabbit Alexa 488 ) was applied in 1:1000 dilution in PBST/GS for one hour at room temperature .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:04.826
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt After washing for 3  10 min the sections were mounted in Dapi/Dapco solution .
# ::tok After washing for 3  10 min the sections were mounted in Dapi/Dapco solution .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:04.834
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Fluorescence microscopy was done with a Leica DM RA2 microscope equipped with a Leica DC350F photo camera .
# ::tok Fluorescence microscopy was done with a Leica DM RA2 microscope equipped with a Leica DC350F photo camera .
# ::alignments 16-17|0.1.1 15-16|0.1.1.0 13-15|0.1.1.1.0.1+0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 10-11|0.1 9-10|0.1.0 7-9|0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 6-7|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:05.223
(d3 / do-02 
      :ARG1 (m2 / microscopy 
            :mod (f / fluorescence)) 
      :manner (e / equip-01 
            :ARG1 (m / microscope 
                  :mod (t2 / thing 
                        :name (n2 / name 
                              :op1 (d2 / DM) 
                              :op2 (r / RA2))) 
                  :mod (o / organization 
                        :name (n3 / name 
                              :op1 "Leica"))) 
            :ARG2 (c / camera 
                  :mod (p / photo) 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 (l / Leica) 
                              :op2 (d / DC350F))))))

# ::snt For Dapi staining , 359 nm ( 30.38 ms exposure ) was used and for Abcg5 and Bsep staining , 514 nm ( for both : 1654.34 ms exposure ) was used and the pictures were analyzed and overlaid using FW4000 software ( Leica ) .
# ::tok For Dapi staining , 359 nm ( 30.38 ms exposure ) was used and for Abcg5 and Bsep staining , 514 nm ( for both : 1654.34 ms exposure ) was used and the pictures were analyzed and overlaid using FW4000 software ( Leica ) .
# ::alignments 43-44|0.0.0.0.0+0.0.0.0+0.0.0 41-42|0.1.1.0.0.0 39-40|0.1.1.0.0 38-39|0.1.1.0 37-38|0.1.1 36-37|0.1 34-35|0.1.0 32-33|0 31-32|0.0 28-29|0.0.2 26-27|0.0.2.2.2+0.0.2.2.1+0.0.2.2.0+0.0.2.2 24-25|0.0.2.0 18-19|0.1.1.1.0.0.1.0 17-18|0.1.1.1.0.0.1.0.0.0.0+0.1.1.1.0.0.1.0.0.0+0.1.1.1.0.0.1.0.0 16-17|0.1.1.1.0.0.1 15-16|0.1.1.1.0.0.0.0+0.1.1.1.0.0.0+0.1.1.1.0.0 13-14|0.1.1.1 12-13|0.1.1.1.0 9-10|0.0.2.1 8-9|0.0.2.1.0 5-6|0.0.1 2-3|0.1.1.1.0.1 1-2|0.1.1.1.0.1.0.0.0+0.1.1.1.0.1.0.0+0.1.1.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:06.202
(a3 / and 
      :op1 (u2 / use-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "Leica")) 
            :ARG1 (n4 / nm) 
            :ARG1-of (e / expose-01 
                  :ARG0 (b / both) 
                  :ARG2-of (e2 / expose-01 
                        :ARG1 (m / m)) 
                  :time (d / date-entity 
                        :day 34 
                        :month 54 
                        :year 16))) 
      :op2 (a2 / analyze-01 
            :ARG1 (p / picture) 
            :op1-of (a / and 
                  :op2 (o2 / overlay-01 
                        :ARG1 (u / use-01 
                              :ARG1 (s / software))) 
                  :op2-of (a5 / and 
                        :op1 (u3 / use-01 
                              :ARG1 (t2 / thing 
                                    :name (n3 / name 
                                          :op1 "Abcg5") 
                                    :op1-of (a4 / and 
                                          :op2 (s2 / stain-01 
                                                :ARG1 (t / thing 
                                                      :name (n2 / name 
                                                            :op1 "Bsep"))))) 
                              :ARG2 (s3 / stain-01 
                                    :ARG1 (c / country 
                                          :name (n5 / name 
                                                :op1 "Dapi"))))))))

# ::snt Transfection and immunostaining of COS-1 cells .
# ::tok Transfection and immunostaining of COS-1 cells .
# ::alignments 5-6|0.0.0 2-3|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:06.218
(a / and 
      :op1 (i / immunostain 
            :poss (c / cell)))

# ::snt COS-1 cells were transiently transfected with pCMV-mouse Abcg5 and pCMV-mouse Abcg8 expression constructs using the Qiagen SuperFect reagent per protocol ( Valencia , CA , USA ) .
# ::tok COS-1 cells were transiently transfected with pCMV-mouse Abcg5 and pCMV-mouse Abcg8 expression constructs using the Qiagen SuperFect reagent per protocol ( Valencia , CA , USA ) .
# ::alignments 25-26|0.1.0.1.2.1+0.1.0.1.2.0.0+0.1.0.1.2.0+0.1.0.1.2 23-24|0.1.0.1.1.1+0.1.0.1.1.0.0+0.1.0.1.1.0+0.1.0.1.1 21-22|0.2.1+0.2.0.0+0.2.0+0.2 19-20|0.3 17-18|0.1.0.0 15-17|0.1.0.0.0.0.1+0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 13-14|0.1.0 12-13|0.4 11-12|0 8-9|0.1.0.1 7-8|0.1.0.1.0.0.0+0.1.0.1.0.0+0.1.0.1.0 3-4|0.0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:08.242
(e / express-01 
      :ARG0 (t3 / transiently) 
      :ARG1 (c3 / cell 
            :ARG0-of (u / use-01 
                  :ARG1 (r / reagent 
                        :mod (t / thing 
                              :name (n4 / name 
                                    :op1 "Qiagen" 
                                    :op2 "SuperFect"))) 
                  :op2-of (a / and 
                        :op1 (t2 / thing 
                              :name (n5 / name 
                                    :op1 "Abcg5")) 
                        :op3 (s / state 
                              :name (n2 / name 
                                    :op1 "CA") 
                              :wiki "California") 
                        :op4 (c / country 
                              :name (n / name 
                                    :op1 "USA") 
                              :wiki "United_States")))) 
      :ARG2 (p / province 
            :name (n3 / name 
                  :op1 "Valencia") 
            :wiki "Province_of_Valencia") 
      :ARG3 (p2 / protocol) 
      :mod-of (c2 / construct))

# ::snt Briefly , COS-1 cells were seeded onto a six-well plate the day prior to transfection to generate 60 % confluence when grown at 37 C and 5 % CO2 in DMEM supplemented with 10 % FBS , 100 U/ml penicillin , 100 g/ml streptomycin and 1  glutamine .
# ::tok Briefly , COS-1 cells were seeded onto a six-well plate the day prior to transfection to generate 60 % confluence when grown at 37 C and 5 % CO2 in DMEM supplemented with 10 % FBS , 100 U/ml penicillin , 100 g/ml streptomycin and 1  glutamine .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:08.252
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt On the day of transfection , 2 g of DNA was mixed with Qiagen SuperFect reagent and incubated for 10 minutes .
# ::tok On the day of transfection , 2 g of DNA was mixed with Qiagen SuperFect reagent and incubated for 10 minutes .
# ::alignments 20-21|0.1.0.0.0.0.0+0.1.0.0.0.0 19-20|0.1.0.0.0 17-18|0.1 16-17|0 15-16|0.1.0.0.1 13-15|0.1.0.0.1.0.0.1+0.1.0.0.1.0.0.0+0.1.0.0.1.0.0+0.1.0.0.1.0 11-12|0.1.0.0 9-10|0.0 7-8|0.1.0 6-7|0.1.0.1 4-5|0.1.0.0.2.0 2-3|0.1.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:08.395
(a / and 
      :op1 (d / DNA) 
      :op2 (i / incubate-01 
            :ARG1 (g / g 
                  :ARG1-of (m2 / mix-01 
                        :ARG0 (1 / 10 
                              :quant-of (t / temporal-quantity 
                                    :unit (m / minute))) 
                        :ARG2 (r / reagent 
                              :mod (t2 / thing 
                                    :name (n / name 
                                          :op1 "Qiagen" 
                                          :op2 "SuperFect"))) 
                        :time (d2 / day 
                              :time-of (t3 / transfection))) 
                  :quant 2)))

# ::snt This mixture was then added to serum-free media and placed on the cells to incubate for two hours .
# ::tok This mixture was then added to serum-free media and placed on the cells to incubate for two hours .
# ::alignments 17-18|0.1.0.0.1+0.1.0.0.1.0 16-17|0.1.0.0.1.0.0 14-15|0.1.0.0 12-13|0.1.0.1 9-10|0.1.0 8-9|0.1 7-8|0.1.0.0.0 4-5|0 3-4|0.2 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:08.490
(a2 / add-01 
      :ARG1 (m2 / mixture 
            :mod (t3 / this)) 
      :op1-of (a / and 
            :op2 (p / place-01 
                  :ARG1 (i / incubate-01 
                        :ARG0 (m / media) 
                        :ARG1 (h / hour 
                              :unit-of (t / temporal-quantity 
                                    :quant 2))) 
                  :ARG2 (c / cell))) 
      :time (t2 / then))

# ::snt The cells were washed once with 1x PBS and fresh media was added .
# ::tok The cells were washed once with 1x PBS and fresh media was added .
# ::alignments 12-13|0 10-11|0.1 9-10|0.1.0 8-9|0.2 7-8|0.2.1.0.0+0.2.1.0+0.2.1 4-5|0.2.0.0 3-4|0.2.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:08.748
(a / add-01 
      :ARG0 (c / cell) 
      :ARG1 (m / media 
            :ARG1-of (f / fresh-04)) 
      :op2-of (a2 / and 
            :ARG1-of (w / wash-01 
                  :time (o2 / once)) 
            :op1 (o / organization 
                  :name (n / name 
                        :op1 "PBS"))))

# ::snt The transfected cells were then incubated for 48 hours to ensure expression and subsequently fixed with a 1:1 mixture of acetone : methanol .
# ::tok The transfected cells were then incubated for 48 hours to ensure expression and subsequently fixed with a 1:1 mixture of acetone : methanol .
# ::alignments 22-23|0.1.0.0 20-21|0.2.0.0 18-19|0.2.0 14-15|0.2 13-14|0.2.1 12-13|0 11-12|0.1.0 10-11|0.1 8-9|0.0.1.1+0.0.1 7-8|0.0.1.0 5-6|0.0 4-5|0.0.2 2-3|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:09.043
(a2 / and 
      :op1 (i / incubate-01 
            :ARG1 (c / cell 
                  :mod (t3 / transfect)) 
            :duration (t / temporal-quantity 
                  :quant 48 
                  :unit (h / hour)) 
            :time (t2 / then)) 
      :op2 (e2 / ensure-01 
            :ARG1 (e / express-01 
                  :ARG1 (m / methanol))) 
      :op3 (f / fix-03 
            :ARG2 (m2 / mixture 
                  :mod (a / acetone)) 
            :time (s / subsequent)))

# ::snt In preparation for immunostaining , cells were blocked with 2 % goat serum in PBS for 30 minutes , then incubated with 1:50 dilution of primary antibody anti-Abcg5 in 2 % goat serum-PBS for 1.5 hours , and subsequently incubated with secondary rhodamine anti-rabbit IgG antibody for 30 minutes .
# ::tok In preparation for immunostaining , cells were blocked with 2 % goat serum in PBS for 30 minutes , then incubated with 1:50 dilution of primary antibody anti-Abcg5 in 2 % goat serum-PBS for 1.5 hours , and subsequently incubated with secondary rhodamine anti-rabbit IgG antibody for 30 minutes .
# ::alignments 48-49|0.0.0.1+0.0.0 47-48|0.0.0.0 45-46|0.2.2 44-45|0.2.2.0 41-42|0.2.2.0.0 39-40|0.2 38-39|0.2.3 37-38|0 35-36|0.2.1.0.0.0.0+0.2.1.0.0.0 34-35|0.2.1.0.0 32-33|0.1 31-32|0.1.0 30-31|0.1.0.0 29-30|0.1.0.0.0 26-27|0.2.0.0 25-26|0.2.0 23-24|0.0.1 20-21|0.0 19-20|0.0.2 17-18|0.2.1.0.1.0.1.1+0.2.1.0.1.0.1 16-17|0.2.1.0.1.0.1.0 14-15|0.2.1.0.1.1.0.0+0.2.1.0.1.1.0+0.2.1.0.1.1 12-13|0.2.1.0.1 11-12|0.2.1.0.1.2 10-11|0.2.1.0.1.2.0 9-10|0.2.1.0.1.2.0.0 7-8|0.2.1.0 5-6|0.2.1 3-4|0.2.1.0.1.0.0 1-2|0.2.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:10.957
(a2 / and 
      :op1 (i3 / incubate-01 
            :ARG0 (t / temporal-quantity 
                  :quant 30 
                  :unit (m / minute)) 
            :ARG1 (d / dilution) 
            :time (t3 / then)) 
      :op2 (s3 / serum-pb 
            :mod (g / goat 
                  :mod (p / percentage-entity 
                        :value 2))) 
      :op3 (i2 / incubate-01 
            :ARG0 (p2 / primary 
                  :mod-of (a3 / antibody)) 
            :ARG1 (c / cell 
                  :ARG1-of (b / block-01 
                        :ARG0 (1 / 1.5 
                              :quant-of (t2 / temporal-quantity 
                                    :unit (h / hour))) 
                        :ARG2 (s4 / serum 
                              :ARG0-of (p4 / prepare-02 
                                    :ARG1 (i4 / immunostain) 
                                    :ARG2 (t4 / temporal-quantity 
                                          :quant 30 
                                          :unit (m2 / minute))) 
                              :location (o / organization 
                                    :name (n / name 
                                          :op1 "PBS")) 
                              :mod (g2 / goat 
                                    :mod (p3 / percentage-entity 
                                          :value 2))))) 
            :ARG2 (a / antibody 
                  :mod (i / igg 
                        :mod (s / secondary))) 
            :time (s2 / subsequent)))

# ::snt Cells were then observed under an Olympus BX-5 confocal microscope with Fluoview .
# ::tok Cells were then observed under an Olympus BX-5 confocal microscope with Fluoview .
# ::alignments 11-12|0.0.1.0+0.0.1+0.0 9-10|0.2 8-9|0.2.0 6-7|0.0.0.0.0+0.0.0.0+0.0.0 3-4|0 2-3|0.3 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:11.007
(o2 / observe-01 
      :ARG0 (p / person 
            :location-of (o / organization 
                  :name (n2 / name 
                        :op1 "Olympus")) 
            :name (n / name 
                  :op1 "Fluoview")) 
      :ARG1 (c2 / cell) 
      :prep-under (m / microscope 
            :mod (c / confocal)) 
      :time (t / then))

# ::snt Dynamic biliary lipid collection and analysis .
# ::tok Dynamic biliary lipid collection and analysis .
# ::alignments 5-6|0.1 4-5|0 3-4|0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:11.030
(a2 / and 
      :op1 (c / collect-01 
            :ARG1 (b / biliary 
                  :mod (d / dynamic))) 
      :op2 (a / analyze-01))

# ::snt Mice were anaesthetized by intraperitoneal injection of 1 mL/kg fentanyl/fluanisone and 10 mg/kg Diazepam .
# ::tok Mice were anaesthetized by intraperitoneal injection of 1 mL/kg fentanyl/fluanisone and 10 mg/kg Diazepam .
# ::alignments 13-14|0.3.0.0+0.3.0+0.3 11-12|0.2.0 10-11|0 7-8|0.0 5-6|0.2 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:11.074
(a / and 
      :ARG1-of 1 
      :op1 (m / mouse) 
      :op2 (i / inject-01 
            :ARG1 10) 
      :op3 (p / person 
            :name (n / name 
                  :op1 "Diazepam")))

# ::snt The abdomen was opened and , after distal ligation of the bile duct , the gallbladder was cannulated .
# ::tok The abdomen was opened and , after distal ligation of the bile duct , the gallbladder was cannulated .
# ::alignments 17-18|0.1 15-16|0.1.0 12-13|0.0.1.1 11-12|0.0.1.1.0 8-9|0.0.1.0 7-8|0.0.1.0.0 6-7|0.0.1 4-5|0 3-4|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:11.133
(a2 / and 
      :op1 (o / open-01 
            :ARG1 (a3 / abdomen) 
            :time (a / after 
                  :op1 (l / ligation 
                        :mod (d2 / distal)) 
                  :op2 (d / duct 
                        :mod (b / bile)))) 
      :op2 (c / cannulate 
            :domain (g / gallbladd)))

# ::snt Bile sampling started directly after cannulation and was collected for 10 min .
# ::tok Bile sampling started directly after cannulation and was collected for 10 min .
# ::alignments 11-12|0.1.0.0.0 10-11|0.1.1.0.0 8-9|0.1.0.0 6-7|0.1.0 5-6|0.1.1.1 4-5|0.1.1 3-4|0.1.1.0 2-3|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:11.187
(s2 / sample-01 
      :ARG1 (b / bile) 
      :ARG1-of (s / start-01 
            :ARG0 (a / and 
                  :op1 (c / collect-01 
                        :ARG2 (m / min))) 
            :time (a2 / after 
                  :mod (d / direct-02 
                        :ARG1 10) 
                  :op1 (c2 / cannulation))))

# ::snt Bile flow was determined gravimetrically .
# ::tok Bile flow was determined gravimetrically .
# ::alignments 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:11.199
(d / determined-02 
      :ARG1 (f / flow-01 
            :mod (b / bile)))

# ::snt Biliary bile salt , sterol and phospholipid concentrations were determined as described previously [ 32 ] .
# ::tok Biliary bile salt , sterol and phospholipid concentrations were determined as described previously [ 32 ] .
# ::alignments 14-15|0.2.0.0.0 12-13|0.0.0.0 11-12|0.0.0 9-10|0 7-8|0.0 6-7|0.1.1 5-6|0.1 4-5|0.1.0 2-3|0.2 1-2|0.2.0 0-1|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:11.336
(d2 / determined-02 
      :ARG0 (c / concentration 
            :ARG1-of (d / describe-01 
                  :time (p / previous))) 
      :ARG1 (a / and 
            :op1 (s / sterol) 
            :op2 (p2 / phospholipid)) 
      :ARG2 (s2 / salt 
            :mod (b / bile 
                  :mod (b2 / biliary 
                        :mod-of 32))))

# ::snt To determine maximal secretion rates of biliary lipid secretion , bile was diverted for 90 min to deplete the endogenous bile salt pool .
# ::tok To determine maximal secretion rates of biliary lipid secretion , bile was diverted for 90 min to deplete the endogenous bile salt pool .
# ::alignments 22-23|0.1.0.0 21-22|0.1.0.0.0 20-21|0.1.0.0.1 19-20|0.2.0 17-18|0.1.0 15-16|0.1 14-15|0.2.1.1.0 12-13|0 10-11|0.0 8-9|0.1.0.1.0 7-8|0.1.0.1 6-7|0.1.0.1.0.0 4-5|0.2.1 3-4|0.2.1.0 2-3|0.2.1.1 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:11.712
(d2 / divert-01 
      :ARG1 (b2 / bile) 
      :ARG2 (m / min 
            :purpose (d / deplete-01 
                  :ARG1 (p / pool 
                        :mod (s / salt) 
                        :mod (b / bile)) 
                  :ARG2 (l / lipid 
                        :mod-of (s2 / secretion 
                              :mod (b3 / biliary))))) 
      :purpose (d3 / determine-01 
            :ARG0 (e / endogenou) 
            :ARG1 (r / rate 
                  :mod (s3 / secretion) 
                  :mod (m2 / maximum 
                        :poss 90))))

# ::snt Subsequently , tauroursodeoxycholate ( Sigma Chemical Co. , MO , USA ) dissolved in PBS was infused into the jugular vein in stepwise increasing rates from 600 -- 1,800 nmol/min/100 g body weight .
# ::tok Subsequently , tauroursodeoxycholate ( Sigma Chemical Co. , MO , USA ) dissolved in PBS was infused into the jugular vein in stepwise increasing rates from 600 -- 1,800 nmol/min/100 g body weight .
# ::alignments 32-33|0.0 31-32|0.0.1 30-31|0 26-27|0.0.0.0.4 24-25|0.0.0.0.1 23-24|0.0.0.0 22-23|0.0.0 20-21|0.0.0.0.3.2 19-20|0.0.0.0.3.2.1 16-17|0.0.0.0.3 14-15|0.0.0.0.3.1.0.0.0+0.0.0.0.3.1.0.0+0.0.0.0.3.1.0 12-13|0.0.0.0.3.1 10-11|0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 8-9|0.0.0.0.2.0.0+0.0.0.0.2.0+0.0.0.0.2 4-7|0.0.0.0.3.0.0.2+0.0.0.0.3.0.0.1+0.0.0.0.3.0.0.0+0.0.0.0.3.0.0+0.0.0.0.3.0 2-3|0.0.0.0.3.2.0 0-1|0.0.0.0.3.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:13.933
(g / g 
      :mod-of (w / weight 
            :mod (s / stepwise 
                  :manner-of (i / increase-01 
                        :ARG0 (c / country 
                              :name (n2 / name 
                                    :op1 "USA") 
                              :wiki "United_States") 
                        :ARG1 (r / rate) 
                        :beneficiary (c2 / country 
                              :name (n3 / name 
                                    :op1 "MO")) 
                        :purpose-of (i2 / infuse-01 
                              :ARG1 (o2 / organization 
                                    :name (n4 / name 
                                          :op1 "Sigma" 
                                          :op2 "Chemical" 
                                          :op3 "Co.")) 
                              :ARG1-of (d / dissolve-01 
                                    :ARG2 (o / organization 
                                          :name (n / name 
                                                :op1 "PBS"))) 
                              :ARG2 (v / vein-01 
                                    :ARG0 (t / tauroursodeoxycholate) 
                                    :ARG1 (j / jugular)) 
                              :time (s2 / subsequent)) 
                        :time 600)) 
            :part-of (b / body)))

# ::snt Bile was collected in 10 min fractions and analyzed for bile salt and lipid content .
# ::tok Bile was collected in 10 min fractions and analyzed for bile salt and lipid content .
# ::alignments 14-15|0.2.0.2.0 13-14|0.2.1 12-13|0.2.0.2 11-12|0.2.0.1 10-11|0.2.0.1.0 8-9|0.2.0 7-8|0.2 6-7|0.1 5-6|0.2.0.2.1 4-5|0.2.0.0 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:14.055
(c2 / collect-01 
      :ARG1 (b2 / bile) 
      :ARG2 (f / fraction-01) 
      :op1-of (a3 / and 
            :op2 (a2 / analyze-01 
                  :ARG0 10 
                  :ARG1 (s / salt 
                        :mod (b / bile)) 
                  :ARG2 (a / and 
                        :op1 (c / content) 
                        :quant (m / min))) 
            :op3 (l / lipid)))

# ::snt In separate experiments , following distal ligation of the bile duct and cannulation of gallbladder , bile was diverted for 30 minutes while mice were infused with sterile PBS .
# ::tok In separate experiments , following distal ligation of the bile duct and cannulation of gallbladder , bile was diverted for 30 minutes while mice were infused with sterile PBS .
# ::alignments 28-29|0.0.0.0.0.1.1.1.0+0.0.0.0.0.1.1.1+0.0.0.0.0.1.1 27-28|0.0.0.0.0.1.1.0 25-26|0.0.0.0.0.1 23-24|0.0.0.0.0.1.0 21-22|0.0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0.0 20-21|0.0.0.0.0.0.0.0 18-19|0.0.0.0.0 16-17|0.0.0.0.0.0 14-15|0.0.1 12-13|0 11-12|0.0 10-11|0.0.0 9-10|0.0.0.1 6-7|0.0.0.0.1 5-6|0.0.0.0.1.0 4-5|0.0.0.0 2-3|0.0.0.0.0.0.0 1-2|0.0.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:14.500
(c / cannulation 
      :op2-of (a / and 
            :op1 (d2 / duct 
                  :ARG0-of (f / follow-01 
                        :ARG1 (d / divert-01 
                              :ARG1 (b / bile 
                                    :ARG1-of (e / experiment-01 
                                          :ARG0 (3 / 30 
                                                :quant-of (t / temporal-quantity 
                                                      :unit (m2 / minute))) 
                                          :ARG1-of (s2 / separate-02))) 
                              :condition (i / infuse-01 
                                    :ARG1 (m / mouse) 
                                    :ARG2 (o / organization 
                                          :ARG1-of (s / sterile-02) 
                                          :name (n / name 
                                                :op1 "PBS")))) 
                        :ARG2 (l / ligation 
                              :mod (d3 / distal))) 
                  :mod (b2 / bile)) 
            :op3 (g / gallbladd)))

# ::snt Subsequently , the mice were infused continuously with 1,200 nmol/min/100 g body weight of tauroursodeoxycholate and two 30-minute fractions were collected .
# ::tok Subsequently , the mice were infused continuously with 1,200 nmol/min/100 g body weight of tauroursodeoxycholate and two 30-minute fractions were collected .
# ::alignments 20-21|0.1 18-19|0.1.0 16-17|0.1.0.1 15-16|0 14-15|0.0.0.0 12-13|0.0.0 11-12|0.0.0.1 10-11|0.1.0.0 6-7|0.0.2 5-6|0.0 3-4|0.0.1 0-1|0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:14.583
(a / and 
      :op1 (i / infuse-01 
            :ARG0 (w / weight 
                  :mod (t / tauroursodeoxycholate) 
                  :part-of (b / body)) 
            :ARG1 (m / mouse) 
            :ARG1-of (c2 / continue-01) 
            :time (s / subsequent)) 
      :op2 (c / collect-01 
            :ARG1 (f / fraction-01 
                  :ARG1 (g / g) 
                  :quant 2)))

# ::snt Sterol analyses of bile was performed by GC analysis as described above .
# ::tok Sterol analyses of bile was performed by GC analysis as described above .
# ::alignments 11-12|0.0.1 10-11|0.0 8-9|0.0.0.0 7-8|0.0.0.0.1 5-6|0.0.0 3-4|0.0.0.0.0 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:14.716
(a3 / analysis 
      :ARG1-of (d / describe-01 
            :ARG1-of (p / perform-02 
                  :ARG0 (a2 / analyze-01 
                        :ARG0 (b / bile) 
                        :ARG1 (g / gc))) 
            :ARG2 (a / above)) 
      :mod (s / sterol))

# ::snt Assay of HMG-CoA and cholesterol 7-hydroxylase enzyme activity .
# ::tok Assay of HMG-CoA and cholesterol 7-hydroxylase enzyme activity .
# ::alignments 7-8|0.0 6-7|0.0.0 4-5|0 3-4|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:14.737
(c / cholesterol 
      :ARG0-of (a / activity-06 
            :mod (e / enzyme) 
            :op2-of (a2 / and 
                  :op1 (a3 / assay))))

# ::snt Mouse liver microsomes were prepared by differential centrifugation [ 33 ] .
# ::tok Mouse liver microsomes were prepared by differential centrifugation [ 33 ] .
# ::alignments 9-10|0.1.1.0 7-8|0.0 6-7|0.0.0 4-5|0 2-3|0.1 1-2|0.1.0 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:14.812
(p / prepare-02 
      :ARG0 (c / centrifugation 
            :mod (d / differential)) 
      :ARG1 (m / microsom 
            :mod (l / liver) 
            :mod (m2 / mouse 
                  :mod-of 33)))

# ::snt Briefly , 0.1 -- 0.2 g liver was homogenized in a Potter-Elvjhem homogenizer with five volumes of buffer ( 0.25 M sucrose , 0.1 M Tris , 0.1 mM disodium EDTA , 0.1 mM DTT , pH 7.4 ) .
# ::tok Briefly , 0.1 -- 0.2 g liver was homogenized in a Potter-Elvjhem homogenizer with five volumes of buffer ( 0.25 M sucrose , 0.1 M Tris , 0.1 mM disodium EDTA , 0.1 mM DTT , pH 7.4 ) .
# ::alignments 37-38|0.1.3 36-37|0.1.0.0.0 32-33|0.1.6 30-31|0.1.5.0.0.0.0+0.1.5.0.0.0+0.1.5.0.0 29-30|0.1.5.0 28-29|0.1.5 27-28|0.1.5.0.0.1 25-26|0.1.0.1 24-25|0.1.0.3+0.1.0.2.0+0.1.0.2+0.1.0 23-24|0.1.1 21-22|0.1.0.0.1.0 20-21|0.1.0.0.1.2+0.1.0.0.1.1.0+0.1.0.0.1.1+0.1.0.0.1 17-18|0.1 15-16|0.1.8 14-15|0.1.2.0 12-13|0.1.0.0.2 11-12|0.1.0.0.3.0+0.1.0.0.3+0.1.0.0 6-7|0 5-6|0.0 4-5|0.1.4 2-3|0.1.7 0-1|0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:15.250
(l / liver 
      :mod (g / g) 
      :op1 (b / buffer-01 
            :manner (v / vehicle 
                  :mod (c / country 
                        :mod (p / ph) 
                        :mod-of (v2 / vehicle 
                              :mod-of (s / sucrose) 
                              :name (n3 / name 
                                    :op1 "M1") 
                              :wiki "M1_Abrams") 
                        :mod-of (h / homogeniz) 
                        :name (n4 / name 
                              :op1 "Potter-Elvjhem")) 
                  :mod-of (t / tri) 
                  :name (n2 / name 
                        :op1 "M1") 
                  :wiki "M1_Abrams") 
            :manner 0.1 
            :op1-of (b2 / briefly 
                  :mod-of 5) 
            :op1-of 7.4 
            :op1-of 0.2 
            :op1-of (m / mm 
                  :mod-of (d / disodium 
                        :mod-of (o / organization 
                              :name (n / name 
                                    :op1 "EDTA") 
                              :quant 0.1))) 
            :op1-of 0.1 
            :op1-of 0.1 
            :quant (v3 / volume)))

# ::snt Microsomes were isolated by differential centrifugation ( 10,000 g to 100,000 g ) .
# ::tok Microsomes were isolated by differential centrifugation ( 10,000 g to 100,000 g ) .
# ::alignments 8-9|0 5-6|0.0.0 4-5|0.0.0.0 2-3|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:15.356
(g / g 
      :ARG2-of (i / isolate-01 
            :ARG0 (c / centrifugation 
                  :mod (d / differential)) 
            :ARG1 (m / microsom)))

# ::snt The pellets were washed and resuspended in storage buffer ( 0.1 M dipotassium phosphate , 0.05 M KCl , 1 mM DTT , 5 mM disodium EDTA , 20 % glycerol , pH 7.4 ) at 25 -- 30 mg protein/ml .
# ::tok The pellets were washed and resuspended in storage buffer ( 0.1 M dipotassium phosphate , 0.05 M KCl , 1 mM DTT , 5 mM disodium EDTA , 20 % glycerol , pH 7.4 ) at 25 -- 30 mg protein/ml .
# ::alignments 39-40|0.1.1.0.1 38-39|0.2.0 36-37|0.1.1.0.0.1 33-34|0.1.3 32-33|0.0 30-31|0.1.4.0 29-30|0.1.4 28-29|0.1.6 26-27|0.3.1.0+0.3.1+0.3 25-26|0.3.0 23-24|0.3.2 20-21|0.1.2 19-20|0.1.5 16-18|0.2.1.1+0.2.1.0+0.2.1+0.2 13-14|0.1.1.0.0 12-13|0.1.1.0.0.0 11-12|0.1.1.0.0.0.0.1+0.1.1.0.0.0.0.0.0+0.1.1.0.0.0.0.0+0.1.1.0.0.0.0 10-11|0.1.1.0.0.1.0 8-9|0.1.1.0 7-8|0.1.1 4-5|0 3-4|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:16.364
(a / and 
      :mod-of (p / ph) 
      :op1 (w / wash-01 
            :ARG1 (p4 / pellet) 
            :location (s / storage 
                  :ARG1-of (b / buffer-01 
                        :ARG0 (p3 / phosphate 
                              :mod (d2 / dipotassium 
                                    :mod (v / vehicle 
                                          :name (n3 / name 
                                                :op1 "M1") 
                                          :wiki "M1_Abrams")) 
                              :mod (2 / 25 
                                    :mod-of 0.1)) 
                        :ARG2 (m / mg))) 
            :op1-of (m2 / mm) 
            :op1-of 7.4 
            :op1-of (p2 / percentage-entity 
                  :mod-of (g / glycerol)) 
            :op1-of 1 
            :op1-of 20) 
      :op2 (t / thing 
            :mod-of 30 
            :name (n2 / name 
                  :op1 (m3 / M) 
                  :op2 (k / KCl))) 
      :op3 (o / organization 
            :mod (d / disodium) 
            :name (n / name 
                  :op1 "EDTA") 
            :quant 5))

# ::snt Protein concentrations were determined according to the method of Lowry et al. [ 34 ] .
# ::tok Protein concentrations were determined according to the method of Lowry et al. [ 34 ] .
# ::alignments 13-14|0.1.2 9-12|0.1.1.0.2+0.1.1.0.1+0.1.1.0.0+0.1.1.0+0.1.1 7-8|0.0 4-5|0 3-4|0.1 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:16.638
(s / say-01 
      :ARG0 (m / method) 
      :ARG1 (d / determined-02 
            :ARG0 (c / concentration 
                  :mod (p / protein)) 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 "Lowry" 
                        :op2 "et" 
                        :op3 "al.")) 
            :ARG2 34))

# ::snt The activity of cholesterol 7-hydroxylase ( EC 1.14.12.17 ) was measured by an isotope incorporation method according to Shefer et al. [ 33 ] with some modifications .
# ::tok The activity of cholesterol 7-hydroxylase ( EC 1.14.12.17 ) was measured by an isotope incorporation method according to Shefer et al. [ 33 ] with some modifications .
# ::alignments 26-27|0.1.1.2 25-26|0.1.1.2.1 22-23|0.1.1.1 18-21|0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 16-17|0 15-16|0.1.0 14-15|0.1.0.0 13-14|0.1.0.1 10-11|0.1 6-7|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 3-4|0.1.1.2.0 1-2|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:16.884
(s2 / say-01 
      :ARG0 (t / thing 
            :name (n / name 
                  :op1 "Shefer" 
                  :op2 "et" 
                  :op3 "al.")) 
      :ARG1 (m3 / measure-01 
            :ARG0 (m2 / method 
                  :mod (i / incorporation) 
                  :mod (i2 / isotope)) 
            :ARG1 (a / activity-06 
                  :ARG0 (o / organization 
                        :name (n2 / name 
                              :op1 "EC")) 
                  :ARG1 33 
                  :ARG1-of (m / modify-01 
                        :ARG0 (c / cholesterol) 
                        :mod (s / some)))))

# ::snt The reaction mixture ( final volume 0.5 ml ) consisted of potassium phosphate buffer ( 100 mM K2HPO4 , 0.1 mM EDTA , 5 mM DTT , 30 mM nicotinamide , pH 7.4 ) , [ 14C ] - cholesterol ( 5  105 dpm ) solubilized in 50 l of 25 % ( wt/vol ) -cyclodextrin ( final concentration 0.8 % ) , and 50 -- 200 g of microsomal protein .
# ::tok The reaction mixture ( final volume 0.5 ml ) consisted of potassium phosphate buffer ( 100 mM K2HPO4 , 0.1 mM EDTA , 5 mM DTT , 30 mM nicotinamide , pH 7.4 ) , [ 14C ] - cholesterol ( 5  105 dpm ) solubilized in 50 l of 25 % ( wt/vol ) -cyclodextrin ( final concentration 0.8 % ) , and 50 -- 200 g of microsomal protein .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:16.889
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The reaction was initiated by the addition of NADPH or an NADPH-generating system ( 3.4 mM NADP + , 30 mM glucose-6-phosphate , 0.3 U of glucose-6-phosphate dehydrogenase ) and continued for 15 min at 37 C .
# ::tok The reaction was initiated by the addition of NADPH or an NADPH-generating system ( 3.4 mM NADP + , 30 mM glucose-6-phosphate , 0.3 U of glucose-6-phosphate dehydrogenase ) and continued for 15 min at 37 C .
# ::alignments 36-37|0.0.0.2.2.0 35-36|0.0.0.2.2 33-34|0.0.1 32-33|0.0.1.0 30-31|0.0 29-30|0 27-28|0.0.0.2.1.0 24-25|0.0.0.2.1 19-20|0.0.0.1 16-17|0.0.0.0.0 15-16|0.0.0.0 12-13|0.0.0.2.0.0.0 11-12|0.0.0.2.0.0.0.0 9-10|0.0.0.2.0.0 6-7|0.0.0.2.0 3-4|0.0.0.2 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:17.445
(a / and 
      :op1 (c2 / continue-01 
            :ARG1 (r / react-01 
                  :ARG0 (m2 / mm 
                        :mod-of (n / nadp)) 
                  :ARG1 30 
                  :ARG1-of (i / initiate-01 
                        :ARG0 (a2 / addition 
                              :poss (o / or 
                                    :op1 (s / system 
                                          :mod (n2 / nadph-generat)))) 
                        :ARG2 (u / u 
                              :mod (d / dehydrogenase)) 
                        :op1-of (3 / 37 
                              :era (c / C)))) 
            :ARG2 (m / min 
                  :quant 15)))

# ::snt The reaction was stopped with 0.5 ml of 1 N KOH , 5 g of butylated hydroxytoluene , and 10 l of ethanolic potassium hydroxide .
# ::tok The reaction was stopped with 0.5 ml of 1 N KOH , 5 g of butylated hydroxytoluene , and 10 l of ethanolic potassium hydroxide .
# ::alignments 24-25|0.1.0.1.0 23-24|0.1.0.1.0.0 20-21|0.1.0.1 19-20|0.1.0.2.0.0.0 18-19|0.1.0 16-17|0 15-16|0.0 13-14|0.1 12-13|0.1.0.2.0.0.1 9-11|0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 8-9|0.1.0.0.1 6-7|0.1.0.2 5-6|0.1.0.1.0.1 3-4|0.1.0.2.0 1-2|0.1.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:18.273
(h2 / hydroxytoluene 
      :mod (b / butylate) 
      :mod-of (g / g 
            :op2-of (a / and 
                  :op1 (t / thing 
                        :name (n / name 
                              :op1 (n2 / N) 
                              :op2 (k / KOH)) 
                        :quant 1) 
                  :op3 (l / l 
                        :mod (h / hydroxide 
                              :mod (p / potassium) 
                              :poss 0.5)) 
                  :time (m / ml 
                        :path-of (s / stop-01 
                              :ARG1 (r / react-01 
                                    :ARG0 10 
                                    :ARG1 5))))))

# ::snt [ 3H ] 7-hydroxycholesterol ( 1  104 dpm/5 g ) was added as an internal recovery standard .
# ::tok [ 3H ] 7-hydroxycholesterol ( 1  104 dpm/5 g ) was added as an internal recovery standard .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:18.276
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt After saponification at 37 C for one hour , sterols were extracted twice with 3 ml of n-hexane and the extracts were evaporated to dryness under nitrogen .
# ::tok After saponification at 37 C for one hour , sterols were extracted twice with 3 ml of n-hexane and the extracts were evaporated to dryness under nitrogen .
# ::alignments 26-27|0.1.0 24-25|0.1.2 22-23|0.1 20-21|0.1.1.0+0.1.1 18-19|0 15-16|0.0.2 14-15|0.0.2.0 11-12|0.0 9-10|0.0.1 7-8|0.1.3.0+0.1.3 4-5|0.0.0.0 3-4|0.0.0 1-2|0.2.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:18.812
(a / and 
      :op1 (e3 / extract-01 
            :ARG0 (32 / 37 
                  :era (c / C)) 
            :ARG1 (s / sterol) 
            :ARG2 (m / ml 
                  :quant 3)) 
      :op2 (e / evaporate-01 
            :ARG0 (n / nitrogen) 
            :ARG1 (t / thing 
                  :ARG1-of (e2 / extract-01)) 
            :ARG2 (d / drynes) 
            :op1-of (t2 / temporal-quantity 
                  :unit (h / hour))) 
      :time (a2 / after 
            :op1 (s2 / saponification)))

# ::snt The residue was dissolved in 0.3 ml of n-hexane : 2-propanol ( 97.3 vol/vol ) and applied to a silica column ( 500 mg ; sep-pak , by 4 ml of n-hexane : 2-propanol ( 97.3 vol/vol ) ) .
# ::tok The residue was dissolved in 0.3 ml of n-hexane : 2-propanol ( 97.3 vol/vol ) and applied to a silica column ( 500 mg ; sep-pak , by 4 ml of n-hexane : 2-propanol ( 97.3 vol/vol ) ) .
# ::alignments 28-29|0.0.0.0 24-25|0 23-24|0.1 22-23|0.0.0.2.0.0 20-21|0.0.0.1 19-20|0.0 16-17|0.0.0 15-16|0.0.0.2 6-7|0.0.0.2.0.2 3-4|0.0.0.2.0 1-2|0.0.0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:19.008
(a / and 
      :op1 (s / silica 
            :ARG1-of (a2 / apply-01 
                  :ARG0 4 
                  :ARG2 (c / column) 
                  :op2-of (a3 / and 
                        :op1 (d / dissolve-01 
                              :ARG0 500 
                              :ARG1 (r / residue) 
                              :ARG2 (m2 / ml))))) 
      :op2 (m / mg))

# ::snt 7-hydroxycholesterol was eluted with 3 ml of n-hexane : 2-propanol ( 80:20 vol : vol ) and further isolated by TLC on silica gel plates ( Silica gel 60 , EM Science , Gibbestown , NJ , USA ) with diethyl ether , and quantified by liquid scintillation counting using Ecolume ( ICN Radiochemicals Irvine , CA , USA ) .
# ::tok 7-hydroxycholesterol was eluted with 3 ml of n-hexane : 2-propanol ( 80:20 vol : vol ) and further isolated by TLC on silica gel plates ( Silica gel 60 , EM Science , Gibbestown , NJ , USA ) with diethyl ether , and quantified by liquid scintillation counting using Ecolume ( ICN Radiochemicals Irvine , CA , USA ) .
# ::alignments 58-59|0.0.4.2.1+0.0.4.2.0.0+0.0.4.2.0+0.0.4.2 56-57|0.0.1.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 52-55|0.0.4.1.0.0.0.1.0.2+0.0.4.1.0.0.0.1.0.1+0.0.4.1.0.0.0.1.0.0+0.0.4.1.0.0.0.1.0+0.0.4.1.0.0.0.1 50-51|0.0.4.1.0.0.1.0.0.0+0.0.4.1.0.0.1.0.0+0.0.4.1.0.0.1.0 49-50|0.0.4.1.0.0.1 48-49|0.0.4.1.0.0 47-48|0.0.4.1.0 46-47|0.0.4.1.0.1 44-45|0.0.4.1 43-44|0.0.4 41-42|0.0.4.0 37-38|0.2.1+0.2.0.0+0.2.0+0.2 35-36|0.0.1.1.0+0.0.1.1+0.0.1 33-34|0.1.0.0+0.1.0+0.1 30-32|0.0.4.1.0.0.0.0.1+0.0.4.1.0.0.0.0.0+0.0.4.1.0.0.0.0+0.0.4.1.0.0.0 28-29|0.0.4.1.0.0.1.1 27-28|0.0.4.1.0.0.2 26-27|0.0.4.1.0.0.2.0 24-25|0.0.4.1.1 23-24|0.0.4.1.1.0 22-23|0.0.4.1.1.0.0 20-21|0.0.0.0.0+0.0.0.0+0.0.0 18-19|0.0 17-18|0.0.3 16-17|0 12-13|0.0.4.1.2 5-6|0.0.2 4-5|0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:21.996
(a2 / and 
      :op1 (i / isolate-01 
            :ARG0 (o3 / organization 
                  :name (n9 / name 
                        :op1 "TLC")) 
            :ARG1 (c4 / country 
                  :domain-of (s / state 
                        :name (n2 / name 
                              :op1 "CA") 
                        :wiki "California") 
                  :name (n6 / name 
                        :op1 "NJ")) 
            :ARG2 (m / ml 
                  :quant 3) 
            :degree (f / further) 
            :op1-of (a / and 
                  :op2 (e / eth) 
                  :op3 (q / quantify-01 
                        :ARG0 (s2 / scintillation 
                              :ARG1-of (c2 / count-01 
                                    :ARG0 (o2 / organization 
                                          :name (n8 / name 
                                                :op1 "EM" 
                                                :op2 "Science") 
                                          :part (o / organization 
                                                :name (n3 / name 
                                                      :op1 "ICN" 
                                                      :op2 "Radiochemicals" 
                                                      :op3 "Irvine"))) 
                                    :ARG0-of (u / use-01 
                                          :ARG1 (t / thing 
                                                :name (n4 / name 
                                                      :op1 "Ecolume")) 
                                          :ARG2 60) 
                                    :ARG2 (g / gel 
                                          :mod (s3 / silica))) 
                              :mod (l / liquid)) 
                        :ARG1 (p / plate 
                              :mod (g2 / gel 
                                    :mod (s4 / silica))) 
                        :op1-of (v / vol)) 
                  :op4 (c / country 
                        :name (n / name 
                              :op1 "USA") 
                        :wiki "United_States"))) 
      :op2 (c5 / country 
            :name (n7 / name 
                  :op1 "Gibbestown")) 
      :op3 (c3 / country 
            :name (n5 / name 
                  :op1 "USA") 
            :wiki "United_States"))

# ::snt Assays were carried out in duplicate with correction for zero-time controls .
# ::tok Assays were carried out in duplicate with correction for zero-time controls .
# ::alignments 10-11|0.2.0 7-8|0.2 5-6|0.0 2-3|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:22.052
(c3 / carry-out-03 
      :ARG0 (d / duplicate-01) 
      :ARG1 (a / assay) 
      :ARG2 (c2 / correct-01 
            :ARG1 (c / control-01)))

# ::snt HMG-CoA reductase ( EC 1.1.1.3.4 ) activity was determined according to the method of Xu et al. [ 35 ] with modifications as described [ 36 ] .
# ::tok HMG-CoA reductase ( EC 1.1.1.3.4 ) activity was determined according to the method of Xu et al. [ 35 ] with modifications as described [ 36 ] .
# ::alignments 25-26|0.1.0.1.1 23-24|0.1.0.1 21-22|0.1.2 18-19|0.1.0.0 14-17|0.1.0.1.2.0.2+0.1.0.1.2.0.1+0.1.0.1.2.0.0+0.1.0.1.2.0+0.1.0.1.2 12-13|0.0 9-10|0 8-9|0.1 6-7|0.1.0 3-4|0.1.0.1.0.0.0+0.1.0.1.0.0+0.1.0.1.0 1-2|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:22.682
(s / say-01 
      :ARG0 (m2 / method) 
      :ARG1 (d2 / determined-02 
            :ARG0 (a / activity-06 
                  :ARG0 35 
                  :ARG2 (d / describe-01 
                        :ARG0 (o / organization 
                              :name (n2 / name 
                                    :op1 "EC")) 
                        :ARG1 36 
                        :ARG2 (t / thing 
                              :name (n / name 
                                    :op1 "Xu" 
                                    :op2 "et" 
                                    :op3 "al.")))) 
            :ARG1 (r / reductase) 
            :ARG1-of (m / modify-01)))

# ::snt Data are shown as means  SD .
# ::tok Data are shown as means  SD .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:22.684
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The Student 's t test was used to determine the statistical significance of differences between the groups of animals .
# ::tok The Student 's t test was used to determine the statistical significance of differences between the groups of animals .
# ::alignments 18-19|0.0 16-17|0.1.1.0.0 13-14|0.1.1.0 11-12|0.1.1 10-11|0.1.1.1 8-9|0.1 6-7|0 4-5|0.1.0 3-4|0.1.0.1 1-2|0.1.0.0.0+0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:22.788
(u / use-01 
      :ARG1 (a / animal) 
      :ARG2 (d2 / determine-01 
            :ARG0 (t / test-01 
                  :ARG0 (p / person 
                        :ARG0-of (s3 / study-01)) 
                  :ARG1 (t2 / t)) 
            :ARG1 (s / significant-02 
                  :ARG1 (d / differ-01 
                        :ARG0 (g / group)) 
                  :mod (s2 / statistic))))

# ::snt Significance was set at P values < 0.05 .
# ::tok Significance was set at P values < 0.05 .
# ::alignments 5-6|0.0 4-5|0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:22.804
(s / significance 
      :domain-of (v / value 
            :mod (p / P60)))

# ::snt Isolation of Abcg8/sterolin -2 deficient mice .
# ::tok Isolation of Abcg8/sterolin -2 deficient mice .
# ::alignments 5-6|0.1 2-3|0.0.0.0+0.0.0+0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:22.828
(i / isolation 
      :location (c / country 
            :name (n / name 
                  :op1 "Abcg8/sterolin")) 
      :poss-of (m / mouse))

# ::snt The targeting construct ( Figure 1a ) results in the potential disruption of normal splicing , as well as loss of some coding sequences involving exons 3 and 4 .
# ::tok The targeting construct ( Figure 1a ) results in the potential disruption of normal splicing , as well as loss of some coding sequences involving exons 3 and 4 .
# ::alignments 28-29|0.1.0.0 27-28|0.0.1 26-27|0.0.0 25-26|0.0.1.0.1 24-25|0.0.1.0 23-24|0.0.1.0.0 22-23|0.0.1.0.0.0 21-22|0.0.2.0 19-20|0.0.1.0.0.1 14-15|0.1.0 13-14|0.1.0.1 11-12|0.1 10-11|0.1.1 7-8|0 4-5|0.0.1.0.0.0.0 2-3|0.0 1-2|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:23.315
(r / result-01 
      :ARG1 (c2 / construct-01 
            :ARG0 3 
            :ARG1 (a / and 
                  :ARG2-of (i / involve-01 
                        :ARG0 (s / sequence 
                              :mod (c / code-01 
                                    :ARG1 (f / figure)) 
                              :poss-of (l / loss)) 
                        :ARG1 (e / exon))) 
            :ARG1-of (t / target-01 
                  :ARG0 (s2 / some))) 
      :ARG2 (d / disruption 
            :ARG1-of (s3 / splice-01 
                  :ARG0 4 
                  :ARG1-of (n / normal-02)) 
            :mod (p / potential)))

# ::snt After ES cell electroporation with the linearized targeted plasmid DNA , two homologous recombinant ES clones ( out of 58 ES clones screened ) were identified .
# ::tok After ES cell electroporation with the linearized targeted plasmid DNA , two homologous recombinant ES clones ( out of 58 ES clones screened ) were identified .
# ::alignments 25-26|0.1.1 22-23|0.1 21-22|0 19-20|0.1.1.1.0 15-16|0.1.1.0 13-14|0.1.1.0.1 12-13|0.1.1.0.0 11-12|0.0 9-10|0.1.1.1.1 8-9|0.1.1.1.1.0 7-8|0.1.1.1 6-7|0.1.1.1.1.1 3-4|0.1.0.0.0 2-3|0.1.0.0 1-2|0.1.0 0-1|0.1.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:24.126
(c / clone-01 
      :ARG0 2 
      :ARG1-of (s / screen-01 
            :ARG0 (e2 / e 
                  :mod-of (c3 / cell 
                        :mod-of (e / electroporation))) 
            :ARG2-of (i / identify-01 
                  :ARG1 (c2 / clone-01 
                        :ARG1 (h / homologou) 
                        :mod (r / recombinant)) 
                  :purpose (t / target-01 
                        :ARG0 58 
                        :ARG1 (d / DNA 
                              :mod (p / plasmid) 
                              :mod (l / linearize))) 
                  :time (a / after))))

# ::snt Blastocyst injection of these resulted in five highly chimeric mice ( three males , two females ) .
# ::tok Blastocyst injection of these resulted in five highly chimeric mice ( three males , two females ) .
# ::alignments 15-16|0.1.0 14-15|0.1 12-13|0.0.0.0.0 11-12|0.0.0.0 9-10|0.2 8-9|0.2.0 7-8|0.2.0.0 6-7|0.0.0.1.0 4-5|0 3-4|0.0 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:24.276
(r / result-01 
      :ARG0 (t / this 
            :ARG1-of (i / inject-01 
                  :ARG0 (3 / 3 
                        :quant-of (m / male)) 
                  :mod (b / blastocyst 
                        :op1 5))) 
      :ARG1 (2 / 2 
            :quant-of (f / female)) 
      :ARG2 (m2 / mouse 
            :mod (c / chimeric 
                  :degree (h / high))))

# ::snt One male and one female , both from the same ES clone , showed germline transmission and the female line was used to establish a multi-generational colony bred onto a C57Bl/6J background .
# ::tok One male and one female , both from the same ES clone , showed germline transmission and the female line was used to establish a multi-generational colony bred onto a C57Bl/6J background .
# ::alignments 31-32|0.1.0.0.1.0.1.0 28-29|0.1.0.0.1.0.1 27-28|0.1.0.0.1.0 26-27|0.1.0.0.1 23-24|0.1.0.0 21-22|0.1.0 19-20|0.1.2.0 18-19|0.1.2 16-17|0.1 15-16|0.1.0.0.0 13-14|0 11-12|0.1.1.0 10-11|0.1.1 9-10|0.1.1.0.0 6-7|0.1.0.0.1.0.0 4-5|0.0.1 2-3|0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:26.899
(s / show-01 
      :ARG0 (a2 / and 
            :op1 (m / male 
                  :quant 1) 
            :op2 (f2 / female)) 
      :ARG1 (a / and 
            :ARG1-of (u / use-01 
                  :ARG2 (e / establish-01 
                        :ARG0 (t / transmission) 
                        :ARG1 (c / colony 
                              :ARG1-of (b2 / breed-01 
                                    :ARG0 (b3 / both) 
                                    :time (o / onto 
                                          :op1 (b / background)))))) 
            :op1 (e2 / e 
                  :mod-of (c2 / clone 
                        :ARG1-of (s2 / same-01))) 
            :op2 (f / female 
                  :mod-of (l / line))))

# ::snt Heterozygous mice were fertile and gave rise to normal litter sizes .
# ::tok Heterozygous mice were fertile and gave rise to normal litter sizes .
# ::alignments 10-11|0.0.1.0 9-10|0.0.1.0.0 8-9|0.0.1.0.1 6-7|0.0.1 5-6|0.0 4-5|0 3-4|0.0.0.0 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:27.002
(a / and 
      :op1 (g / give-01 
            :ARG0 (m / mouse 
                  :domain-of (f / fertile) 
                  :mod (h / heterozygou)) 
            :ARG1 (r / rise-01 
                  :ARG1 (s / size 
                        :ARG1-of (l / litter-01) 
                        :ARG1-of (n / normal-02)))))

# ::snt Breeding heterozygous animals led to wild-type , heterozygous and homozygous knockout mice in the expected Mendelian distribution ( data not shown ) .
# ::tok Breeding heterozygous animals led to wild-type , heterozygous and homozygous knockout mice in the expected Mendelian distribution ( data not shown ) .
# ::alignments 20-21|0.0.0.1.0 19-20|0.0.0.1.0.0 18-19|0.0.0.1 16-17|0.0.0.2 15-16|0.0.0.2.0.0.0+0.0.0.2.0.0+0.0.0.2.0 14-15|0.0.0.2.1 11-12|0.0.1 10-11|0.0.1.0 9-10|0 8-9|0.0 3-4|0.0.0 2-3|0.0.0.0 1-2|0.0.0.0.1 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:27.546
(h / homozygou 
      :op1-of (a / and 
            :ARG2-of (l / lead-02 
                  :ARG0 (a2 / animal 
                        :ARG1-of (b / breed-01) 
                        :mod (h2 / heterozygou)) 
                  :ARG1 (d / data 
                        :ARG1-of (s / show-01 
                              :polarity -)) 
                  :purpose (d2 / distribute-01 
                        :ARG1 (t / thing 
                              :name (n / name 
                                    :op1 "Mendelian")) 
                        :ARG1-of (e / expect-01))) 
            :op2 (m / mouse 
                  :mod (k / knockout))))

# ::snt Although not quantitative , Northern analyses showed that while the knockout mice showed no detectable mRNA for Abcg8 , expression of Abcg5 appeared unaltered ( Figure 1c ) .
# ::tok Although not quantitative , Northern analyses showed that while the knockout mice showed no detectable mRNA for Abcg8 , expression of Abcg5 appeared unaltered ( Figure 1c ) .
# ::alignments 26-27|0.3 25-26|0.3.0 23-24|0.1.2 22-23|0.1 21-22|0.1.1.1.0+0.1.1.1+0.1.1 19-20|0.1.1.0 17-18|0.1.3.3.0.0+0.1.3.3.0+0.1.3.3 15-16|0.1.3.1 14-15|0.1.3.1.0 13-14|0.1.3.2 12-13|0.1.3 11-12|0.1.3.0 10-11|0.1.3.0.0 6-7|0 5-6|0.0 4-5|0.0.0 2-3|0.2 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:28.349
(s2 / show-01 
      :ARG0 (a2 / analysis 
            :mod "Northern_Ireland") 
      :ARG1 (a / appear-01 
            :ARG0 - 
            :ARG1 (c / country 
                  :ARG1-of (e / express-01) 
                  :name (n / name 
                        :op1 "Abcg5")) 
            :ARG2 (u / unalter) 
            :time (s / show-01 
                  :ARG0 (m2 / mouse 
                        :mod (k / knockout)) 
                  :ARG1 (m / mrna 
                        :mod (d / detectable)) 
                  :polarity - 
                  :purpose (t / thing 
                        :name (n2 / name 
                              :op1 "Abcg8")))) 
      :condition (q / quantitative) 
      :condition-of (1 / 1c 
            :mod-of (f / figure)))

# ::snt To exclude the possibility of alternative splicing with the production of a non-functional but truncated Abcg8/sterolin -2 protein that may serve as a chaperone for Abcg5/sterolin -1 , RT-PCR was performed on cDNA reverse transcribed from total liver RNA from Abcg8-deficient mice .
# ::tok To exclude the possibility of alternative splicing with the production of a non-functional but truncated Abcg8/sterolin -2 protein that may serve as a chaperone for Abcg5/sterolin -1 , RT-PCR was performed on cDNA reverse transcribed from total liver RNA from Abcg8-deficient mice .
# ::alignments 41-42|0.1.0.0.0.1.1 38-39|0.1.0.0.0.1.0 37-38|0.1.0.0.0.1.0.0 36-37|0.0 34-35|0.1.0.0.0.1 33-34|0.1.0.0.0 32-33|0.1.0.0.0.0 30-31|0.1.0.0 25-26|0.1.0.0.1.0.0.0+0.1.0.0.1.0.0+0.1.0.0.1.0 23-24|0.1.0.0.1 20-21|0.1.0.0.1.1 19-20|0.1.0.0.1.1.1 17-18|0.1.0.0.1.1.0 15-16|0.1.0.0.1.1.0.0.1.0+0.1.0.0.1.1.0.0.1+0.1.0.0.1.1.0.0 14-15|0.1.0.0.1.1.0.0.0 13-14|0 9-10|0.1.0.1.0 6-7|0.1 5-6|0.1.1 3-4|0.1.0 1-2|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:28.944
(c4 / contrast-01 
      :ARG2 (t / total-01) 
      :concession-of (s2 / splice-01 
            :ARG1-of (p5 / possible-01 
                  :ARG1-of (p / perform-02 
                        :ARG2 (r2 / reverse-01 
                              :ARG1 (c / cdna) 
                              :ARG1-of (t2 / transcribe-01 
                                    :ARG0 (r / rna 
                                          :mod (l / liver)) 
                                    :ARG2 (m / mouse))) 
                        :time (c2 / chaperone-01 
                              :ARG1 (t3 / thing 
                                    :name (n / name 
                                          :op1 "Abcg5/sterolin")) 
                              :ARG1-of (s / serve-01 
                                    :ARG0 (p3 / protein 
                                          :mod (c3 / country 
                                                :ARG1-of (t4 / truncate-01) 
                                                :name (n2 / name 
                                                      :op1 "Abcg8/sterolin"))) 
                                    :ARG1-of (p2 / possible-01)))) 
                  :ARG1-of (e / exclude-01 
                        :ARG2 (p4 / produce-01))) 
            :mod (a / alternative)))

# ::snt No mRNA for Abcg8/sterolin -2 was detected containing any sequences downstream of exon 4 in the Abcg8-deficient mice , whether primers were located in exons 4 and 13 , exons 9 and 13 or exons 10 and 13 ( Figure 1d ,1 e ) .
# ::tok No mRNA for Abcg8/sterolin -2 was detected containing any sequences downstream of exon 4 in the Abcg8-deficient mice , whether primers were located in exons 4 and 13 , exons 9 and 13 or exons 10 and 13 ( Figure 1d ,1 e ) .
# ::alignments 39-40|0.0 37-38|0.1.3.0.1.5 36-37|0 35-36|0.1.3.0.1.3 34-35|0.1.4 33-34|0.1 32-33|0.1.3.0.1.4 31-32|0.1.3 30-31|0.1.3.0.0 29-30|0.1.2 27-28|0.1.3.0.1.2 26-27|0.1.0.2 25-26|0.1.3.0.1.6 24-25|0.1.1 22-23|0.1.0 20-21|0.1.0.1 17-18|0.1.3.0.1.1.0.0 13-14|0.1.3.0.2 12-13|0.1.3.0.1.1.0.0.0 10-11|0.1.0.0 9-10|0.1.3.0.1.1 8-9|0.1.3.0.1.1.0 7-8|0.1.3.0.1 6-7|0.1.3.0 3-4|0.1.3.0.1.0.0.0.0+0.1.3.0.1.0.0.0+0.1.3.0.1.0.0 1-2|0.1.3.0.1.0 0-1|0.1.3.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:30.412
(a / and 
      :op1 (f / figure) 
      :op5-of (o / or 
            :location-of (l / locate-01 
                  :ARG0 (d / downstream) 
                  :ARG1 (p / primer) 
                  :time (a3 / and)) 
            :op1 (e3 / exon) 
            :op2 (e2 / exon) 
            :op3 (a2 / and 
                  :op1 (d2 / detect-01 
                        :ARG0 9 
                        :ARG1 (c / contain-01 
                              :ARG0 (m2 / mrna 
                                    :beneficiary (c2 / country 
                                          :name (n / name 
                                                :op1 "Abcg8/sterolin"))) 
                              :ARG1 (s / sequence 
                                    :mod (a4 / any 
                                          :mod-of (m / mouse 
                                                :time (e4 / exon)))) 
                              :op1-of 13 
                              :op1-of 10 
                              :op1-of 13 
                              :op1-of 13 
                              :op1-of 4) 
                        :ARG2 4 
                        :polarity -)) 
            :op4 (e / exon)))

# ::snt This demonstrates that if an alternatively spliced message could potentially code for a truncated protein , it is not detectable in the Abcg8-deficient mice .
# ::tok This demonstrates that if an alternatively spliced message could potentially code for a truncated protein , it is not detectable in the Abcg8-deficient mice .
# ::alignments 23-24|0.0.1.0.0.1.0 19-20|0.0.1.0.0.1 18-19|0.0.1.0.0.1.1 14-15|0.0.1 13-14|0.0.1.0 10-11|0.0 9-10|0.0.2 8-9|0 7-8|0.0.0 6-7|0.0.0.0 5-6|0.0.0.1 1-2|0.0.1.0.0 0-1|0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:30.582
(p3 / possible-01 
      :ARG1 (c / code-01 
            :ARG0 (m2 / message 
                  :ARG1-of (s / splice-01) 
                  :mod (a / alternatively)) 
            :ARG1 (p / protein 
                  :mod (t / truncate-01 
                        :ARG1 (d2 / demonstrate-01 
                              :ARG0 (t2 / this) 
                              :ARG1 (d / detectable 
                                    :domain (m / mouse) 
                                    :polarity -)))) 
            :manner (p2 / potential)))

# ::snt The membrane-spanning domains of Abcg8/sterolin -2 are encoded by exons 9 -- 13 .
# ::tok The membrane-spanning domains of Abcg8/sterolin -2 are encoded by exons 9 -- 13 .
# ::alignments 12-13|0.1.0.1 10-11|0.1.0.0 9-10|0.0 7-8|0 4-5|0.2.0.0+0.2.0+0.2 2-3|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:30.671
(e2 / encode-01 
      :ARG0 (e / exon) 
      :ARG1 (d / domain 
            :mod (m / membrane-spann 
                  :mod 9 
                  :poss 13)) 
      :ARG2 (c / country 
            :name (n / name 
                  :op1 "Abcg8/sterolin")))

# ::snt Sterol levels in Abcg8/sterolin -2 deficient animals .
# ::tok Sterol levels in Abcg8/sterolin -2 deficient animals .
# ::alignments 6-7|0 3-4|0.0.1.0.0+0.0.1.0+0.0.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:30.687
(a / animal 
      :poss (l / level 
            :mod (s / sterol) 
            :poss (c / country 
                  :name (n / name 
                        :op1 "Abcg8/sterolin"))))

# ::snt Elevated plant sterols in tissue and plasma are diagnostic of sitosterolemia .
# ::tok Elevated plant sterols in tissue and plasma are diagnostic of sitosterolemia .
# ::alignments 10-11|0.0.0.0 8-9|0.0.0 6-7|0.2 5-6|0 4-5|0.1 2-3|0.0 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:30.728
(a / and 
      :location-of (s2 / sterol 
            :domain-of (d / diagnostic 
                  :mod (s / sitosterolemia)) 
            :location (p2 / plant 
                  :mod (e / elevate-01))) 
      :op1 (t / tissue) 
      :op2 (p / plasma))

# ::snt Sterol levels , as determined by gas chromatography ( GC ) analysis , in plasma and tissues of the Abcg8 - / - mice are shown in Table 2 .
# ::tok Sterol levels , as determined by gas chromatography ( GC ) analysis , in plasma and tissues of the Abcg8 - / - mice are shown in Table 2 .
# ::alignments 28-29|0.0.0 27-28|0.0 25-26|0 23-24|0.1 21-22|0.0.0.0.1.1 19-20|0.2.3.0.0+0.2.3.0+0.2.3 16-17|0.2.2 15-16|0.2 14-15|0.2.1 11-12|0.0.0.0 9-10|0.0.0.0.0 7-8|0.0.0.0.1.0 6-7|0.0.0.0.1.0.0 4-5|0.0.0.0.1 1-2|0.2.0 0-1|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:31.343
(s / show-01 
      :ARG0 (t / table 
            :mod (2 / 2 
                  :ARG0-of (a2 / analyze-01 
                        :ARG1 (g / gc) 
                        :ARG3-of (d / determined-02 
                              :ARG0 (c / chromatography 
                                    :mod (g2 / gas)) 
                              :ARG1 (s2 / slash))))) 
      :ARG1 (m / mouse) 
      :concession (a / and 
            :extent (l / level 
                  :mod (s3 / sterol)) 
            :op1 (p / plasma) 
            :op2 (t3 / tissue) 
            :op3 (t2 / thing 
                  :name (n / name 
                        :op1 "Abcg8"))))

# ::snt There were no differences in tissue weights between wild types , heterozygotes and knockouts .
# ::tok There were no differences in tissue weights between wild types , heterozygotes and knockouts .
# ::alignments 13-14|0.1 12-13|0 11-12|0.0.0.1.0 9-10|0.0 8-9|0.0.1 6-7|0.0.0 5-6|0.0.0.0 3-4|0.0.0.1 2-3|0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:31.480
(a / and 
      :op1 (t / type 
            :ARG2-of (w2 / weight-01 
                  :ARG1 (t2 / tissue) 
                  :ARG2-of (d / differ-01 
                        :ARG1 (h / heterozygot) 
                        :polarity -)) 
            :mod (w / wild)) 
      :op2 (k / knockout))

# ::snt Plasma cholesterol levels of the homozygous and heterozygous mice were decreased by 52 % and 26 % , respectively , compared to those of wild-type mice ( n = 3 all groups , Table 2 ) .
# ::tok Plasma cholesterol levels of the homozygous and heterozygous mice were decreased by 52 % and 26 % , respectively , compared to those of wild-type mice ( n = 3 all groups , Table 2 ) .
# ::alignments 34-35|0.0.3.0 33-34|0.0.3 31-32|0.0.4 30-31|0.0.1.2 29-30|0.0.2.1 25-26|0 20-21|0.0.1.1.0 18-19|0.0.1.1 16-17|0.0.1.1.0.0 15-16|0.0.1.1.0.0.0 14-15|0.0.0 13-14|0.0.2 12-13|0.0.2.0 10-11|0.0 8-9|0.0.1.4 7-8|0.0.1.4.0 6-7|0.0.1 5-6|0.0.1.3 2-3|0.0.1.0 1-2|0.0.1.0.0 0-1|0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:31.796
(m / mouse 
      :op1 (d / decrease-01 
            :ARG0 (a2 / and) 
            :ARG1 (a3 / and 
                  :extent (l / level 
                        :mod (c2 / cholesterol 
                              :mod (p3 / plasma))) 
                  :mod (r / respective 
                        :mod-of (c / compare-01 
                              :ARG2 (p / percentage-entity 
                                    :value 26))) 
                  :mod (a / all) 
                  :op1 (h2 / homozygou) 
                  :op2 (m2 / mouse 
                        :mod (h / heterozygou))) 
            :ARG2 (p2 / percentage-entity 
                  :value 52 
                  :value 3) 
            :op1-of (t / table 
                  :mod 2) 
            :op1-of (g / group)))

# ::snt Plant sterols were almost undetectable in wild-type and heterozygous mice , but were significantly elevated in Abcg8 - / - mice .
# ::tok Plant sterols were almost undetectable in wild-type and heterozygous mice , but were significantly elevated in Abcg8 - / - mice .
# ::alignments 20-21|0.0.2.1.1 18-19|0.0.2.0.0 16-17|0.0.2.0.1.0.0+0.0.2.0.1.0+0.0.2.0.1 14-15|0.0.2.1 13-14|0.0.2.1.0 11-12|0 9-10|0.0.0.1 8-9|0.0.0.0 7-8|0.0.0 4-5|0.0 3-4|0.0.1 1-2|0.0.2 0-1|0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:31.950
(c2 / contrast-01 
      :ARG1 (u / undetectable 
            :compared-to (a / and 
                  :op1 (h / heterozygou) 
                  :op2 (m2 / mouse)) 
            :degree (a2 / almost) 
            :domain (s3 / sterol 
                  :ARG1-of (p / plant-01 
                        :ARG0 (s / slash) 
                        :location (c / country 
                              :name (n / name 
                                    :op1 "Abcg8"))) 
                  :ARG1-of (e / elevate-01 
                        :ARG1-of (s2 / significant-02) 
                        :manner (m / mouse)))))

# ::snt Plasma campesterol and sitosterol levels were eight - and 36-fold higher in Abcg8 - / - mice compared to wild-type mice ( 8.76  2.10 and 18.52  5.03 mg/dL , respectively , versus 1.14  0.69 and 0.50  0.55 mg/dL ) .
# ::tok Plasma campesterol and sitosterol levels were eight - and 36-fold higher in Abcg8 - / - mice compared to wild-type mice ( 8.76  2.10 and 18.52  5.03 mg/dL , respectively , versus 1.14  0.69 and 0.50  0.55 mg/dL ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:31.952
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt There was no significant difference in the plasma plant sterol levels between heterozygous and wild-type mice .
# ::tok There was no significant difference in the plasma plant sterol levels between heterozygous and wild-type mice .
# ::alignments 15-16|0.3 13-14|0 12-13|0.2 10-11|0.1 9-10|0.1.0 8-9|0.1.0.0 7-8|0.1.0.0.0 4-5|0.0 3-4|0.0.0 2-3|0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:32.029
(a / and 
      :ARG1-of (d / differ-02 
            :ARG1-of (s2 / significant-02)) 
      :extent (l / level 
            :mod (s / sterol 
                  :mod (p / plant 
                        :mod (p2 / plasma)))) 
      :op1 (h / heterozygou) 
      :op2 (m / mouse 
            :poss-of -))

# ::snt Liver cholesterol content of the Abcg8 - / - mice was reduced by ~ 50 % relative to wild-type liver ( 1202  264 g/g wet weight tissue , versus 2280  310 g/g wet weight tissue , respectively ) .
# ::tok Liver cholesterol content of the Abcg8 - / - mice was reduced by ~ 50 % relative to wild-type liver ( 1202  264 g/g wet weight tissue , versus 2280  310 g/g wet weight tissue , respectively ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:32.031
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The reduced cholesterol content was offset by a five-fold increase in campesterol and a 22-fold increase in sitosterol ( 233.9  48.1 and 376.3  96.1 g/g wet weight tissue , respectively ) in Abcg8 - / - knockout mice compared to wild-type mice ( 52.2  15.0 and 16.7  8.6 g/g wet weight tissue , respectively , Table 2 ) .
# ::tok The reduced cholesterol content was offset by a five-fold increase in campesterol and a 22-fold increase in sitosterol ( 233.9  48.1 and 376.3  96.1 g/g wet weight tissue , respectively ) in Abcg8 - / - knockout mice compared to wild-type mice ( 52.2  15.0 and 16.7  8.6 g/g wet weight tissue , respectively , Table 2 ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:32.036
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt There were no significant differences of liver cholesterol or plant sterol contents between Abcg8 + / + and Abcg8 + / - mice .
# ::tok There were no significant differences of liver cholesterol or plant sterol contents between Abcg8 + / + and Abcg8 + / - mice .
# ::alignments 22-23|0.0.0.0.0.2 20-21|0.0.0.0.0.1.1 17-18|0 15-16|0.0.0.0.0.1.0 13-14|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 11-12|0.0+0.0.0 10-11|0.0.1 9-10|0.0.0.0.2 8-9|0.0.0.0 7-8|0.0.0.0.1 6-7|0.0.0.0.1.0 4-5|0.0.0.0.0 3-4|0.0.0.0.0.1 2-3|0.0.0.0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:32.363
(a / and 
      :ARG0-of (c2 / contain-01 
            :ARG1 (t / thing 
                  :op3-of (o / or 
                        :ARG1-of (d / differ-01 
                              :ARG0 (c / country 
                                    :name (n / name 
                                          :op1 "Abcg8")) 
                              :ARG1-of (s4 / significant-02 
                                    :ARG0 (s2 / slash) 
                                    :ARG2 (s / slash 
                                          :poss-of -)) 
                              :ARG2 (m / mouse)) 
                        :op1 (c3 / cholesterol 
                              :mod (l / liver)) 
                        :op2 (p / plant))) 
            :mod (s3 / sterol)))

# ::snt Spleen sterol contents reflected the liver profiles ( Table 2 ) .
# ::tok Spleen sterol contents reflected the liver profiles ( Table 2 ) .
# ::alignments 9-10|0.1.0.0 8-9|0.1.0.0.0 6-7|0.1.0.1 5-6|0.1.0.1.0 3-4|0.1.0 2-3|0+0.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:32.481
(c / contain-01 
      :ARG0 (s / sterol 
            :mod (s2 / spleen)) 
      :ARG1 (t2 / thing 
            :ARG1-of (r / reflect-01 
                  :ARG0 (2 / 2 
                        :mod-of (t / table)) 
                  :ARG2 (p / profile-01 
                        :ARG1 (l / liver)))))

# ::snt No significant differences in brain sterol contents were observed , as would be expected , since the blood brain barrier is intact and prevents entry of these sterols in sitosterolemia ( Table 2 ) .
# ::tok No significant differences in brain sterol contents were observed , as would be expected , since the blood brain barrier is intact and prevents entry of these sterols in sitosterolemia ( Table 2 ) .
# ::alignments 32-33|0.0.0.0.0 31-32|0.0.0.0 29-30|0 27-28|0.0.1.1.0 26-27|0.0.1.1.0.0 24-25|0.0.1.1 23-24|0.0.1 22-23|0.0 21-22|0.0.1.0.0 19-20|0.0.1.0 18-19|0.0.1.0.1.0 17-18|0.0.1.0.1 15-16|0.0.0.3 13-14|0.0.0.1.0 8-9|0.0.0 6-7|0.0.0.1.2.0+0.0.0.1.2 5-6|0.0.0.1.2.0.0 4-5|0.0.0.1.2.0.0.0 2-3|0.0.0.1 1-2|0.0.0.1.1 0-1|0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:32.899
(s / sitosterolemia 
      :op3-of (a / and 
            :op1 (o / observe-01 
                  :ARG0 (t / table 
                        :mod 2) 
                  :ARG1 (d / differ-01 
                        :ARG1-of (e2 / expect-01) 
                        :ARG1-of (s5 / significant-02) 
                        :ARG2 (t3 / thing 
                              :ARG1-of (c / contain-01 
                                    :ARG0 (s4 / sterol 
                                          :mod (b4 / brain))))) 
                  :polarity - 
                  :time (s3 / since)) 
            :op2 (p / prevent-01 
                  :ARG0 (b / barrier 
                        :domain-of (i / intact) 
                        :mod (b3 / blood 
                              :mod-of (b2 / brain))) 
                  :ARG1 (e / entry 
                        :poss (s2 / sterol 
                              :mod (t2 / this))))))

# ::snt There were only traces of plant sterols in the brains from knockout animals , reflecting blood contamination during tissue harvesting .
# ::tok There were only traces of plant sterols in the brains from knockout animals , reflecting blood contamination during tissue harvesting .
# ::alignments 19-20|0.0.1 18-19|0.0.1.0 16-17|0.0.0 15-16|0.0.0.0 14-15|0.0 12-13|0.0.0.1 11-12|0.0.0.1.0 9-10|0.2 6-7|0.1 5-6|0.1.0 3-4|0 2-3|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:32.977
(t2 / trace 
      :ARG0-of (r / reflect-01 
            :ARG1 (c / contaminate-01 
                  :ARG1 (b / blood) 
                  :ARG2 (a / animal 
                        :mod (k / knockout))) 
            :ARG2 (h / harvest-01 
                  :ARG1 (t / tissue))) 
      :consist-of (s / sterol 
            :location (p / plant)) 
      :location (b2 / brain) 
      :mod (o / only))

# ::snt Interestingly , the majority of the elevated tissue plant sterols are unesterified .
# ::tok Interestingly , the majority of the elevated tissue plant sterols are unesterified .
# ::alignments 11-12|0 9-10|0.0.0 8-9|0.0.0.1 7-8|0.0.0.1.0 6-7|0.0.0.0 3-4|0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:33.028
(u / unesterifi 
      :mod-of (m / majority 
            :poss (s / sterol 
                  :ARG1-of (e / elevate-01 
                        :ARG0 (i / interesting)) 
                  :location (p / plant 
                        :mod (t / tissue)))))

# ::snt The livers of Abcg8 + / + , + / - and - / - mice have relatively similar levels of esterified cholesterol ( Figure 2a ) .
# ::tok The livers of Abcg8 + / + , + / - and - / - mice have relatively similar levels of esterified cholesterol ( Figure 2a ) .
# ::alignments 24-25|0.3 22-23|0.2.0.0.0 21-22|0.2.0.0.0.0 19-20|0.2.0.0 18-19|0.2.0 17-18|0.2.0.1 15-16|0.2 13-14|0.1 11-12|0 9-10|0.2.0.3 5-6|0.2.0.2 3-4|0.3.0.0.0+0.3.0.0+0.3.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:33.248
(a / and 
      :op1 (l2 / liver) 
      :op2 (s / slash) 
      :op3 (m / mouse 
            :ARG0-of (r / resemble-01 
                  :ARG1 (l / level 
                        :mod (c / cholesterol 
                              :mod (e / esterify))) 
                  :degree (r2 / relative) 
                  :op1-of (s3 / slash) 
                  :op1-of (s2 / slash))) 
      :op4 (f / figure 
            :mod (c2 / country 
                  :name (n / name 
                        :op1 "Abcg8"))))

# ::snt However , there is little if any esterification of sitosterol or campesterol ( Figure 2b ,2 c ) consistent with previous findings [ 37,38 ] .
# ::tok However , there is little if any esterification of sitosterol or campesterol ( Figure 2b ,2 c ) consistent with previous findings [ 37,38 ] .
# ::alignments 21-22|0.0.2.0+0.0.2 20-21|0.0.2.0.0 18-19|0.0.2.1 16-17|0.0.2.1.1 13-14|0.0.2.1.0 11-12|0 10-11|0.0 9-10|0.0.1 7-8|0.0.3 6-7|0.0.3.0 4-5|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:33.402
(c3 / campesterol 
      :op3-of (o / or 
            :op1 (l / little) 
            :op2 (s / sitosterol) 
            :op4 (t / thing 
                  :ARG1-of (f / find-01 
                        :time (p / previous)) 
                  :ARG2-of (c / consistent-01 
                        :ARG0 (f2 / figure) 
                        :ARG1 (c2 / c))) 
            :poss-of (e / esterification 
                  :mod (a / any))))

# ::snt Thus all of the expansion of tissue sterol pools are as free sterols .
# ::tok Thus all of the expansion of tissue sterol pools are as free sterols .
# ::alignments 12-13|0.0.1 11-12|0.0.1.0 8-9|0 7-8|0.1 6-7|0.2 4-5|0.0 1-2|0.0.2 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:33.485
(p / pool 
      :ARG1-of (e / expand-01 
            :ARG0 (t2 / thu) 
            :manner (s / sterol 
                  :ARG1-of (f / free-04)) 
            :quant (a / all)) 
      :mod (s2 / sterol) 
      :mod (t / tissue))

# ::snt FPLC analyses for sterols ( measured enzymatically and thus reflecting total sterols ) and triglycerides were performed on plasma samples from fasted animals fed a regular chow diet .
# ::tok FPLC analyses for sterols ( measured enzymatically and thus reflecting total sterols ) and triglycerides were performed on plasma samples from fasted animals fed a regular chow diet .
# ::alignments 27-28|0.2.0.1.0.0 26-27|0.2.0.1.0.0.1 25-26|0.2.0.1.0.0.0 23-24|0.2.0.1.0 22-23|0.2.0.1 21-22|0.2.0.1.1 19-20|0.2.0.0.0+0.2.0.0 18-19|0.2.0.0.0.0 16-17|0.2.0 14-15|0.2.1 13-14|0.2 11-12|0.1.1 10-11|0.1.1.0 9-10|0.1 8-9|0.1.2 7-8|0 5-6|0.0 3-4|0.1.1.0.0 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:34.547
(a3 / and 
      :op1 (m / measure-01) 
      :op2 (r2 / reflect-01 
            :ARG1 (a4 / analysis 
                  :mod (f3 / FPLC)) 
            :ARG2 (s2 / sterol 
                  :ARG2-of (t3 / total-01 
                        :ARG1 (s3 / sterol))) 
            :time (t4 / thus-far)) 
      :op3 (a2 / and 
            :ARG1-of (p2 / perform-02 
                  :ARG2 (t / thing 
                        :ARG1-of (s / sample-01 
                              :ARG0 (p / plasma))) 
                  :ARG3 (a / animal 
                        :ARG0-of (f / feed-up-03 
                              :ARG1 (d / diet 
                                    :ARG1-of (r / regular-02) 
                                    :mod (c / chow))) 
                        :mod (f2 / fast))) 
            :op1 (t2 / triglycerid)))

# ::snt No significant differences were observed for the sterol profiles ( Figure 3a ) , but surprisingly , the Abcg8 - / - knockout mice had a significantly higher triglyceride level in the LDL lipoprotein fractions compared to wild-type and heterozygous mice ( Figure 3b ) .
# ::tok No significant differences were observed for the sterol profiles ( Figure 3a ) , but surprisingly , the Abcg8 - / - knockout mice had a significantly higher triglyceride level in the LDL lipoprotein fractions compared to wild-type and heterozygous mice ( Figure 3b ) .
# ::alignments 43-44|0.1.1.0.1 42-43|0.1.1.0.1.0 40-41|0.1.1 39-40|0.1.1.0.0 38-39|0.1.1.0 35-36|0.1 34-35|0.0.0.0 33-34|0.0.0.0.0 32-33|0.0.0.0.0.0 29-30|0.0.0.2 28-29|0.0.0.2.1 27-28|0.0.0.2.0 26-27|0.0.0.2.0.1 23-24|0.0.0.2.0.0 22-23|0.0.0.2.0.0.0 20-21|0.0.3.0 18-19|0.0.0.1.0+0.0.0.1+0.0.0 15-16|0.0.1 14-15|0 10-11|0.1.0 8-9|0.0.3 7-8|0.0.3.1 4-5|0.0 2-3|0.0.2 1-2|0.0.2.0 0-1|0.0.4 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:35.321
(c3 / contrast-01 
      :ARG1 (o / observe-01 
            :ARG0 (c2 / country 
                  :ARG0-of (f2 / fraction-01 
                        :ARG1 (l / lipoprotein 
                              :mod (l2 / ldl))) 
                  :name (n / name 
                        :op1 "Abcg8") 
                  :poss-of (l3 / level 
                        :ARG1-of (h2 / high-02 
                              :ARG0 (m2 / mouse 
                                    :mod (k / knockout)) 
                              :ARG1-of (s / significant-02)) 
                        :mod (t / triglyceride))) 
            :ARG0-of (s3 / surprise-01) 
            :ARG1 (d / differ-01 
                  :ARG1-of (s5 / significant-02)) 
            :ARG2 (p / profile-01 
                  :ARG0 (s2 / slash) 
                  :mod (s4 / sterol)) 
            :polarity -) 
      :ARG2 (c / compare-01 
            :ARG1 (f3 / figure) 
            :ARG2 (m / mouse 
                  :op2-of (a / and 
                        :op1 (h / heterozygou) 
                        :op3 (3 / 3b 
                              :mod-of (f / figure))))))

# ::snt The size of this peak was variable between different littermate analyses , but is always increased in the knockout animals .
# ::tok The size of this peak was variable between different littermate analyses , but is always increased in the knockout animals .
# ::alignments 19-20|0.1.1 18-19|0.1.1.0 15-16|0.1 14-15|0.1.2 12-13|0 10-11|0.1.0.0.0 9-10|0.1.0.0.0.1 8-9|0.1.0.0.0.0 6-7|0.0 4-5|0.1.0.0 3-4|0.1.0.0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:35.409
(c / contrast-01 
      :ARG1 (v / variable) 
      :ARG2 (i / increase-01 
            :ARG0 (s / size 
                  :poss (p / peak-01 
                        :ARG1 (a3 / analysis 
                              :ARG1-of (d / differ-02) 
                              :mod (l / littermate)) 
                        :mod (t / this))) 
            :ARG1 (a / animal 
                  :mod (k / knockout)) 
            :time (a2 / always)))

# ::snt Total plasma triglyceride levels of the Abcg8 - / - mice were slightly higher ( 79.2  14 mg/dL compared to the wild type 63.4  13 mg/dL and heterozygotes 46.6  12 mg/dL , n = 3 for all genotypes ) .
# ::tok Total plasma triglyceride levels of the Abcg8 - / - mice were slightly higher ( 79.2  14 mg/dL compared to the wild type 63.4  13 mg/dL and heterozygotes 46.6  12 mg/dL , n = 3 for all genotypes ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:35.411
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Preliminary analyses of proteins in the isolated FPLC fractions did not show any qualitative changes in apolipoproteins B , E , AI , or AII .
# ::tok Preliminary analyses of proteins in the isolated FPLC fractions did not show any qualitative changes in apolipoproteins B , E , AI , or AII .
# ::alignments 24-25|0.0.1.3.0.0+0.0.1.3.0+0.0.1.3 23-24|0.0.1 21-22|0.0.1.2 19-20|0.0.1.1 17-18|0.0.1.0.2+0.0.1.0.1.0+0.0.1.0.1+0.0.1.0 16-17|0.0.1.0.0 14-15|0.0 13-14|0.0.3 12-13|0.0.2 11-12|0 10-11|0.1 8-9|0.0.1.0.0.0 6-7|0.0.1.0.0.0.0 3-4|0.0.0.1 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:35.710
(s / show-01 
      :ARG1 (c / change-01 
            :ARG0 (a4 / analysis 
                  :mod (p2 / preliminary) 
                  :mod (p / protein)) 
            :ARG1 (o2 / or 
                  :op1 (l / location 
                        :mod (a2 / apolipoprotein 
                              :ARG1-of (f / fraction-01 
                                    :ARG1-of (i / isolate-01))) 
                        :name (n2 / name 
                              :op1 "B") 
                        :wiki -) 
                  :op2 (e / E) 
                  :op3 (a / ai) 
                  :op4 (o / organization 
                        :name (n / name 
                              :op1 "AII"))) 
            :mod (a3 / any) 
            :mod (q / qualitative)) 
      :polarity -)

# ::snt The significance of this triglyceride rich peak remains unclear at present .
# ::tok The significance of this triglyceride rich peak remains unclear at present .
# ::alignments 10-11|0.0.0.0.1 8-9|0.0.0.0.0.0+0.0.0.0.0 7-8|0.0.0.0 6-7|0.0 5-6|0.0.1 4-5|0 3-4|0.0.2 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:35.755
(t / triglyceride 
      :mod-of (p2 / peak-01 
            :ARG1-of (s / significant-02 
                  :ARG1-of (r / remain-01 
                        :ARG3 (c / clear-06 
                              :polarity -) 
                        :time (p / present))) 
            :mod (r2 / rich) 
            :mod (t2 / this)))

# ::snt Liver gene expression and enzyme activity change in Abcg8/sterolin -2 deficient mice .
# ::tok Liver gene expression and enzyme activity change in Abcg8/sterolin -2 deficient mice .
# ::alignments 11-12|0.0.1.1.0 10-11|0.0.1.1 8-9|0.0.1.1.0.0.0.0+0.0.1.1.0.0.0+0.0.1.1.0.0 6-7|0.0.1 5-6|0.0.1.0 4-5|0.0.1.2 3-4|0.0 2-3|0.0.0 1-2|0.0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:35.849
(l / liver 
      :op1-of (a2 / and 
            :op2 (e2 / express-01 
                  :mod (g / gene)) 
            :op3 (c2 / change-01 
                  :ARG1 (a / activity-06) 
                  :ARG2 (d / deficient 
                        :mod-of (m / mouse 
                              :mod (c / country 
                                    :name (n / name 
                                          :op1 "Abcg8/sterolin")))) 
                  :mod (e / enzyme))))

# ::snt To investigate the effects of a deficiency of Abcg8/sterolin -2 on the genes that regulate sterol metabolism , quantitative RT-PCR was performed looking at the expression levels of Abcg5 , Abcg8 , Hmgr , Cyp7a1 , Abca1 , Mdr2 , Lxr , Srebp-1c , and Srebp-2 mRNA in the livers of mice fed a regular chow diet ( Figure 4a ) .
# ::tok To investigate the effects of a deficiency of Abcg8/sterolin -2 on the genes that regulate sterol metabolism , quantitative RT-PCR was performed looking at the expression levels of Abcg5 , Abcg8 , Hmgr , Cyp7a1 , Abca1 , Mdr2 , Lxr , Srebp-1c , and Srebp-2 mRNA in the livers of mice fed a regular chow diet ( Figure 4a ) .
# ::alignments 58-59|0.0.1.7 56-57|0.0.1.6.0.0 55-56|0.0.1.6.0.0.1 54-55|0.0.1.6.0.0.0 52-53|0.0.1.6.0 51-52|0.0.1.6 49-50|0.0.1.8 46-47|0.0.1.5.0 45-46|0.0.1.5.1.0+0.0.1.5.1+0.0.1.5 44-45|0.0.1 40-41|0.0.1.4 38-39|0.0.1.3 36-37|0.0.1.0.1.0 34-35|0.0.1.2 32-33|0.0.1.8.0.0.0+0.0.1.8.0.0+0.0.1.8.0 30-31|0.0.1.6.1.0.0+0.0.1.6.1.0+0.0.1.6.1 28-29|0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 26-27|0.0.1.0 25-26|0.0.1.0.0 22-23|0.0.1.0.1 21-22|0.0.1.0.1.1 18-19|0.0.1.6.0.0.0.0 16-17|0 15-16|0.1 14-15|0.0 12-13|0.0.0 8-9|0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0 6-7|0.0.0.0.0.0 3-4|0.0.0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:37.914
(m4 / metabolism 
      :ARG1-of (r2 / regulate-01 
            :ARG0 (g / gene 
                  :ARG0-of (i / investigate-01 
                        :ARG1 (e2 / effect 
                              :poss (d2 / deficiency 
                                    :poss (c6 / country 
                                          :name (n5 / name 
                                                :op1 "Abcg8/sterolin")))))) 
            :op1-of (a / and 
                  :extent (l3 / level 
                        :ARG1-of (e / express-01) 
                        :ARG1-of (l4 / look-01 
                              :ARG0 (a2 / Abca1) 
                              :ARG1-of (p / perform-02))) 
                  :op2 (c5 / country 
                        :name (n4 / name 
                              :op1 "Abcg5")) 
                  :op3 (c2 / Cyp7a1) 
                  :op4 (m3 / Mdr2) 
                  :op5 (l2 / Lxr) 
                  :op6 (t / thing 
                        :mod-of (m2 / mrna) 
                        :name (n / name 
                              :op1 "Srebp-2")) 
                  :op7 (m / mouse 
                        :ARG0-of (f2 / feed-up-03 
                              :ARG1 (d / diet 
                                    :ARG1-of (r / regular-02 
                                          :ARG0 (q / quantitative)) 
                                    :mod (c / chow))) 
                        :poss-of (c4 / country 
                              :name (n3 / name 
                                    :op1 "Abcg8"))) 
                  :op8 (f / figure) 
                  :source (l / liver 
                        :poss-of (c3 / country 
                              :name (n2 / name 
                                    :op1 "Hmgr"))))) 
      :mod (s / sterol))

# ::snt As expected , Abcg8 mRNA expression levels were undetectable in the Abcg8 - / - mice and were reduced by ~ 50 % in the heterozygous mice , relative to wild-type mice .
# ::tok As expected , Abcg8 mRNA expression levels were undetectable in the Abcg8 - / - mice and were reduced by ~ 50 % in the heterozygous mice , relative to wild-type mice .
# ::alignments 31-32|0.2.1 28-29|0.2.1.0 26-27|0.2.0.1.2 25-26|0.2.0.1.2.0 22-23|0.2.0.0.0 21-22|0.2.0.0.0.0 18-19|0.2 16-17|0 15-16|0.2.0.2 13-14|0.2.0.1.0 8-9|0.1 6-7|0.2.0 5-6|0.2.0.1 4-5|0.2.0.1.1 3-4|0.0.0.0+0.0.0+0.0 1-2|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:38.312
(a / and 
      :op1 (c / country 
            :name (n / name 
                  :op1 "Abcg8")) 
      :op2 (u / undetectable) 
      :op3 (r2 / reduce-01 
            :ARG0 (l / level 
                  :ARG1-of (e2 / expect-01 
                        :ARG2 (p / percentage-entity 
                              :value 50)) 
                  :mod (e / express-01 
                        :ARG0 (s / slash) 
                        :ARG1 (m4 / mrna) 
                        :ARG2 (m2 / mouse 
                              :mod (h / heterozygou))) 
                  :poss-of (m3 / mouse)) 
            :ARG1 (m / mouse 
                  :prep-to-of (r / relative))))

# ::snt Interestingly , by quantitative RT-PCR , the mRNA expression of Abcg5 in the knock-out mice was also reduced by more than 60 % compared to the wild-type mice , although no changes were noted in the heterozygous mice .
# ::tok Interestingly , by quantitative RT-PCR , the mRNA expression of Abcg5 in the knock-out mice was also reduced by more than 60 % compared to the wild-type mice , although no changes were noted in the heterozygous mice .
# ::alignments 37-38|0.0.1 36-37|0.0.1.0 33-34|0.0 31-32|0.0.0 30-31|0.0.0.1 27-28|0 23-24|0.1 22-23|0.1.0 21-22|0.0.2.2.0 19-20|0.0.2.2 17-18|0.0.2 16-17|0.0.2.4 14-15|0.0.2.0 10-11|0.0.2.1.1.0.0+0.0.2.1.1.0+0.0.2.1.1 8-9|0.0.2.1 7-8|0.0.2.1.0 3-4|0.0.0.0 0-1|0.0.2.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:38.977
(m2 / mouse 
      :ARG0-of (n / note-01 
            :ARG1 (c / change-01 
                  :ARG0 (q / quantitative) 
                  :polarity -) 
            :condition (m / mouse 
                  :mod (h / heterozygou)) 
            :condition-of (r / reduce-01 
                  :ARG0 (m4 / mouse) 
                  :ARG1 (e / express-01 
                        :ARG0 (m5 / mrna) 
                        :ARG1 (c3 / country 
                              :name (n2 / name 
                                    :op1 "Abcg5"))) 
                  :ARG2 (m3 / more 
                        :op1 60) 
                  :manner (i / interesting) 
                  :mod (a / also))) 
      :ARG2-of (c2 / compare-01 
            :ARG1 (p / percentage-entity)))

# ::snt Expression of HMG-CoA reductase mRNA was decreased by ~ 50 % and ~ 80 % in the heterozygote and knockout mice respectively , in keeping with limited observations in human patients with this disorder [ 7 ] .
# ::tok Expression of HMG-CoA reductase mRNA was decreased by ~ 50 % and ~ 80 % in the heterozygote and knockout mice respectively , in keeping with limited observations in human patients with this disorder [ 7 ] .
# ::alignments 35-36|0.3.0.1.0.2 33-34|0.3.1.0 32-33|0.3.0.1.0.0.0.0 30-31|0.3.1.1+0.3.1+0.3 29-30|0.3.2 27-28|0.3.0.1.0.0 26-27|0.3.0.1.0.0.0 24-25|0.3.0.1.0 21-22|0.0.0 20-21|0.2 19-20|0.1 18-19|0 17-18|0.0 14-15|0.3.0.1.0.3 13-14|0.3.0.1.0.3.0.0.0 11-12|0.3.0.1 10-11|0.3.0.1.0.3.0.0 9-10|0.3.0.1.0.3.0 6-7|0.3.0 4-5|0.3.0.0.0 3-4|0.3.0.0.0.0 2-3|0.3.0.1.0.1.0.0+0.3.0.1.0.1.0+0.3.0.1.0.1 0-1|0.3.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:39.849
(a / and 
      :op1 (h3 / heterozygote 
            :mod-of (r / respective)) 
      :op2 (k2 / knockout) 
      :op3 (m / mouse) 
      :op4 (p / person 
            :ARG0-of (d2 / decrease-01 
                  :ARG1 (e / expression 
                        :mod (m2 / mrna 
                              :mod (r2 / reductase))) 
                  :manner (a2 / and 
                        :ARG0-of (k / keep-02 
                              :ARG1 (o / observation 
                                    :ARG1-of (l / limit-01 
                                          :ARG2 (t / this))) 
                              :ARG2 (t2 / thing 
                                    :name (n / name 
                                          :op1 "HMG-CoA")) 
                              :op1-of 7 
                              :topic-of (p3 / percentage-entity 
                                    :value (5 / 50 
                                          :value-of (p4 / percentage-entity 
                                                :value 80)))))) 
            :ARG0-of (h / have-rel-role-91 
                  :ARG1 (d / disord) 
                  :ARG2 (p2 / patient)) 
            :mod (h2 / human)))

# ::snt To verify whether the mRNA changes resulted in alteration of the enzyme activity changes , liver samples were analyzed for HMG-CoA reductase activity and Cyp7a1 activity ( Figure 4b ) .
# ::tok To verify whether the mRNA changes resulted in alteration of the enzyme activity changes , liver samples were analyzed for HMG-CoA reductase activity and Cyp7a1 activity ( Figure 4b ) .
# ::alignments 28-29|0.0.1.2.0.1.0.0 27-28|0.0.1.2.0.1.0 25-26|0.0.1.0.0 23-24|0.0.1.0 22-23|0.0 21-22|0.0.0 20-21|0.0.1.2.0.1.1.0.0+0.0.1.2.0.1.1.0+0.0.1.2.0.1.1 18-19|0.0.1 16-17|0.0.1.1.0+0.0.1.1 15-16|0.0.1.1.0.0 13-14|0.0.1.2.0.1.2 12-13|0.0.1.2.0.1 11-12|0 8-9|0.0.1.2.0.2 6-7|0.0.1.2.0 5-6|0.0.1.2.0.0 4-5|0.0.1.2.0.0.0 1-2|0.0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:40.993
(e / enzyme 
      :ARG0-of (a3 / activity-06 
            :ARG1 (r / reductase) 
            :ARG2-of (a4 / analyze-01 
                  :ARG0 (a2 / and 
                        :op1 (a / activity-06)) 
                  :ARG1 (t2 / thing 
                        :ARG1-of (s / sample-01 
                              :mod (l / liver))) 
                  :purpose (v / verify-01 
                        :ARG1 (r2 / result-01 
                              :ARG0 (c2 / change-01 
                                    :ARG1 (m / mrna)) 
                              :ARG1 (a5 / activity-06 
                                    :ARG0 (f / figure 
                                          :mod 4b) 
                                    :ARG1 (t / thing 
                                          :name (n / name 
                                                :op1 "HMG-CoA")) 
                                    :ARG1-of (c / change-01)) 
                              :ARG2 (a6 / alteration))))))

# ::snt HMG-CoA reductase activity was reduced by 30 % and 60 % in the Abcg8 + / - and Abcg8 - / - mice , respectively ( Figure 4b ) , and thus reflected the changes in mRNA expression .
# ::tok HMG-CoA reductase activity was reduced by 30 % and 60 % in the Abcg8 + / - and Abcg8 - / - mice , respectively ( Figure 4b ) , and thus reflected the changes in mRNA expression .
# ::alignments 37-38|0.1.0.1.0.1 36-37|0.1.0.1.0.1.0 34-35|0.1.0.1.0 32-33|0.1.0.1 31-32|0.1.0.1.2 30-31|0.1.0.1.1 26-27|0.1.0.1.0.1.1 24-25|0.1.0.0 22-23|0.1.1.1 20-21|0.2 17-18|0 15-16|0.2.0 13-14|0.1.0.1.0.0.0.0+0.1.0.1.0.0.0+0.1.0.1.0.0 10-11|0.1.0.1.1.0 9-10|0.1.0.1.1.0.0 8-9|0.1.0 7-8|0.1.2 6-7|0.1.2.0 4-5|0.1 2-3|0.1.1 1-2|0.1.1.0 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:41.954
(a2 / and 
      :op1 (t2 / thing 
            :name (n2 / name 
                  :op1 "HMG-CoA")) 
      :op2 (r3 / reduce-01 
            :ARG0 (a3 / and 
                  :mod (r2 / respective) 
                  :op1 (r / reflect-01 
                        :ARG1 (c / change-01 
                              :ARG0 (c2 / country 
                                    :name (n / name 
                                          :op1 "Abcg8")) 
                              :ARG1 (e / express-01 
                                    :ARG0 (m / mrna) 
                                    :ARG1 (f / figure))) 
                        :op1-of (a / and 
                              :purpose-of (p / percentage-entity 
                                    :value 60)) 
                        :time (t / thus-far))) 
            :ARG1 (a4 / activity-06 
                  :ARG0 (r4 / reductase) 
                  :ARG1 (m2 / mouse)) 
            :ARG2 (p2 / percentage-entity 
                  :value 30)) 
      :op3 (s / slash 
            :mod (s2 / slash)))

# ::snt In contrast , although the Cyp7a1 mRNA expression levels were essentially unchanged in the knockout mouse , Cyp7a1 activity was significantly decreased by 37 % ( P < 0.01 ) .
# ::tok In contrast , although the Cyp7a1 mRNA expression levels were essentially unchanged in the knockout mouse , Cyp7a1 activity was significantly decreased by 37 % ( P < 0.01 ) .
# ::alignments 26-27|0.1.0.0.0 24-25|0.1.0.2 23-24|0.1.0.2.0 21-22|0.1.0 20-21|0.1.0.1 18-19|0.1.0.0 15-16|0.1.0.3.0 14-15|0.1.0.3.0.0 11-12|0.1.0.3.3+0.1.0.3 10-11|0.1.0.3.2 8-9|0.1.0.3.1 7-8|0 6-7|0.0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:42.186
(e2 / express-01 
      :ARG1 (m2 / mrna) 
      :purpose-of (c2 / contrast-01 
            :ARG1 (d / decrease-01 
                  :ARG1 (a / activity-06 
                        :ARG1 (p / P60)) 
                  :ARG1-of (s / significant-02) 
                  :ARG2 (p2 / percentage-entity 
                        :value 37) 
                  :condition (c / change-01 
                        :ARG0 (m / mouse 
                              :mod (k / knockout)) 
                        :ARG1 (l / level) 
                        :degree (e / essential) 
                        :polarity -))))

# ::snt In the heterozygous mice , both the mRNA and activity of Cyp7a1 were decreased .
# ::tok In the heterozygous mice , both the mRNA and activity of Cyp7a1 were decreased .
# ::alignments 13-14|0 11-12|0.0.2.0 9-10|0.0.2 8-9|0.0 7-8|0.0.1 5-6|0.0.0 3-4|0.1 2-3|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:42.342
(d / decrease-01 
      :ARG1 (a2 / and 
            :mod (b / both) 
            :op1 (m / mrna) 
            :op2 (a / activity-06 
                  :ARG1 (c / Cyp7a1))) 
      :ARG2 (m2 / mouse 
            :mod (h / heterozygou)))

# ::snt Sitosterol is known to be a direct competitive inhibitor of Cyp7a1 and it is likely that the elevated plant sterols in the liver are responsible for the inhibition in the knockout mouse [ 39 ] .
# ::tok Sitosterol is known to be a direct competitive inhibitor of Cyp7a1 and it is likely that the elevated plant sterols in the liver are responsible for the inhibition in the knockout mouse [ 39 ] .
# ::alignments 33-34|0.0.0.0 31-32|0.2.0.0.0.0.0.0 30-31|0.2.0.0.0.0.0 27-28|0.1 24-25|0 22-23|0.0.2 19-20|0.0 18-19|0.0.1 17-18|0.0.0 14-15|0.2 11-12|0.2.0 10-11|0.2.0.0.1.1 8-9|0.2.0.0.1 7-8|0.2.0.0.0.0 6-7|0.2.0.0.1.0 2-3|0.2.0.0 0-1|0.2.0.0.0.1.0+0.2.0.0.0.1+0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:43.395
(r / responsible-01 
      :ARG0 (s / sterol 
            :ARG1-of (e / elevate-01 
                  :ARG0 39) 
            :location (p / plant) 
            :location (l / liver)) 
      :ARG1 (i / inhibition) 
      :ARG1-of (l2 / likely-01 
            :op1-of (a / and 
                  :ARG3-of (k2 / know-02 
                        :ARG1 (c3 / country 
                              :ARG1-of (c2 / compete-02 
                                    :ARG0 (k / knockout 
                                          :mod-of (m / mouse))) 
                              :name (n / name 
                                    :op1 "Sitosterol")) 
                        :ARG2 (i2 / inhibitor 
                              :ARG1-of (d / direct-02) 
                              :mod (c / Cyp7a1))))))

# ::snt Localization of Abcg5 protein in Abcg8 - / - knockout mice .
# ::tok Localization of Abcg5 protein in Abcg8 - / - knockout mice .
# ::alignments 10-11|0.0 9-10|0.0.0 7-8|0.3 5-6|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 3-4|0.1 2-3|0.2.0+0.2+0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:43.438
(t / thing 
      :mod (m / mouse 
            :mod (k / knockout)) 
      :mod-of (p / protein 
            :mod-of (l / localization 
                  :location (c / country 
                        :name (n / name 
                              :op1 "Abcg8")))) 
      :name (n2 / name 
            :op1 "Abcg5") 
      :op1-of (s / slash))

# ::snt Does the loss of Abcg8/sterolin -2 result in loss of Abcg5/sterolin -1 expression , as might be predicted from the genetic studies and more recently from the in vitro and in vivo expression studies ?
# ::tok Does the loss of Abcg8/sterolin -2 result in loss of Abcg5/sterolin -1 expression , as might be predicted from the genetic studies and more recently from the in vitro and in vivo expression studies ?
# ::alignments 34-35|0.0.0.1.0 33-34|0.1 32-33|0 29-30|0.0.0.2.1 28-29|0.0.0.2.1.1 24-25|0.0.0.1.0.0.0.0 23-24|0.0.0.1.0.0.0 22-23|0.0 21-22|0.0.0.2 20-21|0.0.0.2.0 17-18|0.0.0 15-16|0.0.0.1 12-13|0.0.0.2.1.0 10-11|0.0.0.2.1.0.0.0.0+0.0.0.2.1.0.0.0+0.0.0.2.1.0.0 6-7|0.0.0.0 4-5|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 2-3|0.0.0.0.1 0-1|0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:44.051
(e / express-01 
      :ARG1 (a2 / and 
            :ARG1-of (p / predict-01 
                  :ARG0 (r2 / result-01 
                        :ARG0 (c2 / country 
                              :name (n2 / name 
                                    :op1 "Abcg8/sterolin")) 
                        :ARG1 (l / loss)) 
                  :ARG1-of (p2 / possible-01 
                        :mode (i / interrogative 
                              :mode-of (d / do-01 
                                    :ARG1 (m / more 
                                          :degree-of (r / recent))))) 
                  :ARG2 (s2 / study-01 
                        :mod (g / gene) 
                        :op1-of (a / and 
                              :ARG1-of (e2 / express-01 
                                    :mod (c / country 
                                          :name (n / name 
                                                :op1 "Abcg5/sterolin"))) 
                              :op2 (v / vitro))))) 
      :ARG1-of (s / study-01))

# ::snt A robust antibody to mouse Abcg8/sterolin -2 is not currently available .
# ::tok A robust antibody to mouse Abcg8/sterolin -2 is not currently available .
# ::alignments 10-11|0.0 9-10|0.0.2 8-9|0.0.1 5-6|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 4-5|0 2-3|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:44.090
(m / mouse 
      :ARG1-of (a / available-02 
            :ARG2 (a2 / antibody 
                  :mod (r / robust) 
                  :mod-of (c2 / country 
                        :name (n / name 
                              :op1 "Abcg8/sterolin"))) 
            :polarity - 
            :time (c / current)))

# ::snt However , three separate groups have developed rabbit polyclonal antibody to mouse Abcg5/sterolin -1 .
# ::tok However , three separate groups have developed rabbit polyclonal antibody to mouse Abcg5/sterolin -1 .
# ::alignments 12-13|0.2.1.0+0.2.1+0.2 11-12|0.2.0 9-10|0.1 7-8|0.1.0 6-7|0 4-5|0.0 3-4|0.0.0 2-3|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:44.279
(d / develop-02 
      :ARG0 (g / group 
            :ARG1-of (s / separate-02) 
            :quant 3) 
      :ARG1 (a / antibody 
            :ARG1-of (r / rabbit-01)) 
      :ARG2 (c / country 
            :mod (m / mouse) 
            :name (n / name 
                  :op1 "Abcg5/sterolin")))

# ::snt These three antibodies were used in Western blotting and immunohistochemistry experiments on the liver and intestine of Abcg8 - / - mice .
# ::tok These three antibodies were used in Western blotting and immunohistochemistry experiments on the liver and intestine of Abcg8 - / - mice .
# ::alignments 21-22|0.2.0 19-20|0.2.1.0 17-18|0.0.0.0.0+0.0.0.0+0.0.0 15-16|0.0.2.1 14-15|0.0.2 13-14|0.0.2.0 10-11|0.2 9-10|0.1 8-9|0 7-8|0.2.1 6-7|0.2.2.1+0.2.2.0.0+0.2.2.0+0.2.2 4-5|0.0 2-3|0.0.1 1-2|0.0.1.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:44.537
(a2 / and 
      :op1 (u / use-01 
            :ARG0 (c / country 
                  :name (n / name 
                        :op1 "Abcg8")) 
            :ARG1 (a3 / antibodi 
                  :mod (t / this) 
                  :quant 3) 
            :ARG2 (a / and 
                  :op1 (l / liver) 
                  :op2 (i / intestine))) 
      :op2 (i2 / immunohistochemistry) 
      :op3 (e / experiment-01 
            :ARG1 (m / mouse) 
            :ARG1-of (b / blot-01 
                  :ARG0 (s / slash)) 
            :mod (w / world-region 
                  :name (n2 / name 
                        :op1 "West") 
                  :wiki "Western_world")))

# ::snt Western blotting of liver total membrane preparations using the three separately-developed anti-Abcg5 / sterolin-1 antibodies showed different results .
# ::tok Western blotting of liver total membrane preparations using the three separately-developed anti-Abcg5 / sterolin-1 antibodies showed different results .
# ::alignments 17-18|0.0.0.2.1.1+0.0.0.2.1 16-17|0.0.0.2.1.0 15-16|0.0.0.2 14-15|0.0.0.2.0 12-13|0.0.0.2.2 10-11|0 9-10|0.0.0.2.1.0.0 7-8|0.0.0.1 6-7|0.0.0 5-6|0.0.0.0 4-5|0.0.0.3 3-4|0.0.0.3.0 1-2|0.0 0-1|0.0.1.1+0.0.1.0.0+0.0.1.0+0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:45.584
(s3 / separately-develop 
      :ARG0-of (b / blot-01 
            :ARG1 (p / prepare-02 
                  :ARG1 (m / membrane) 
                  :ARG1-of (u / use-01) 
                  :ARG2 (s / show-01 
                        :ARG0 (a / antibodi) 
                        :ARG1 (t / thing 
                              :ARG1-of (d / differ-02 
                                    :ARG0 3) 
                              :ARG2-of (r / result-01)) 
                        :op1-of (s2 / slash)) 
                  :ARG2-of (t2 / total-01 
                        :ARG1 (l / liver))) 
            :mod (w / world-region 
                  :name (n / name 
                        :op1 "West") 
                  :wiki "Western_world")))

# ::snt As has been previously published , Abcg5/sterolin -1 exists in two separate forms , the ` immature ' 75 kDa protein and a fully glycosylated ` mature ' 93 kDa protein [ 18,30 ] .
# ::tok As has been previously published , Abcg5/sterolin -1 exists in two separate forms , the ` immature ' 75 kDa protein and a fully glycosylated ` mature ' 93 kDa protein [ 18,30 ] .
# ::alignments 30-31|0 28-29|0.0.0.0.0.0 26-27|0.0.0.0 24-25|0.0.0.1.0.0.0 23-24|0.0.0.1.0.0 21-22|0.0.0 20-21|0.0.0.2 19-20|0.0.0.2.0 18-19|0.0.0.2.2 16-17|0.0.0.2.1 12-13|0.0.0.1 11-12|0.0.0.1.0 10-11|0.0.0.1.1 8-9|0.0 4-5|0.0.0.0.0 3-4|0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:45.885
(p / protein 
      :ARG0-of (e / exist-01 
            :ARG1 (a / and 
                  :ARG1-of (m / mature-02 
                        :ARG2 (p3 / publish-01 
                              :ARG0 93 
                              :time (p4 / previous))) 
                  :op1 (f2 / form 
                        :ARG1-of (s / separate-02 
                              :ARG0 (f / full 
                                    :mod-of (g / glycosylat))) 
                        :quant 2) 
                  :op2 (p2 / protein 
                        :mod (k / kDa) 
                        :poss (i / immature) 
                        :quant 75))))

# ::snt Using the SC anti-Abcg5 / sterolin-1 peptide antibody , a 75 kDa band is detected ( Figure 5a ) .
# ::tok Using the SC anti-Abcg5 / sterolin-1 peptide antibody , a 75 kDa band is detected ( Figure 5a ) .
# ::alignments 17-18|0.1 16-17|0.1.0 14-15|0 12-13|0.0 11-12|0.2.1 10-11|0.0.0 7-8|0.2.0 6-7|0.2.0.0 4-5|0.2.0.1 2-3|0.2.0.1.0.1+0.2.0.1.0.0.0+0.2.0.1.0.0+0.2.0.1.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:46.556
(d / detect-01 
      :ARG1 (b / band 
            :quant 75) 
      :ARG2 (5 / 5a 
            :mod-of (f / figure)) 
      :purpose (u / use-01 
            :ARG1 (a / antibody 
                  :mod (p / peptide) 
                  :op2-of (s / slash 
                        :op1 (s2 / state 
                              :name (n / name 
                                    :op1 "SC") 
                              :wiki "South_Carolina"))) 
            :ARG2 (k / kDa)))

# ::snt This antibody does not detect a ` mature ' 93 kDa band in either wild-type or knockout animals nor is the 75 kDa band sensitive to either Endo-H or PNGaseF ( lower panel shows same aliquots probed with anti-transferrin ) .
# ::tok This antibody does not detect a ` mature ' 93 kDa band in either wild-type or knockout animals nor is the 75 kDa band sensitive to either Endo-H or PNGaseF ( lower panel shows same aliquots probed with anti-transferrin ) .
# ::alignments 36-37|0.1.0 35-36|0.1 34-35|0.1.1 33-34|0 32-33|0.0 31-32|0.0.0 28-29|0.0.0.1.2.0.0.1.1.0 26-27|0.0.0.1.2.0.0.1.1.0.0 24-25|0.0.0.1.2 23-24|0.0.0.1.2.0 21-22|0.0.0.1.0 17-18|0.0.0.1.2.0.0 16-17|0.0.0.1.2.0.0.0 15-16|0.0.0.1.2.0.0.1 13-14|0.0.0.1.2.0.0.1.1 11-12|0.0.0.1.2.0.0.1.0.1 10-11|0.0.0.1.1 9-10|0.0.0.0 7-8|0.0.0.1 4-5|0.0.0.1.2.0.0.1.0 3-4|0.0.0.1.2.0.0.1.0.2 1-2|0.0.0.1.2.0.0.1.0.0 0-1|0.0.0.1.2.0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:47.008
(s2 / show-01 
      :ARG0 (p2 / panel 
            :ARG1-of (l / low-04 
                  :ARG0 93 
                  :ARG2-of (m / mature-02 
                        :ARG0 75 
                        :ARG1 (k2 / kDa) 
                        :ARG1-of (s3 / sensitive-03 
                              :ARG0 (b / band 
                                    :op1 (a2 / animal 
                                          :mod (k / knockout) 
                                          :op1-of (o2 / or 
                                                :ARG2-of (d / detect-01 
                                                      :ARG0 (a3 / antibody 
                                                            :mod (t / this)) 
                                                      :ARG1 (b2 / band) 
                                                      :polarity -) 
                                                :mod (e2 / either 
                                                      :mod-of (o / or 
                                                            :mod (e / either)))))))))) 
      :ARG1 (a / aliquot 
            :ARG1-of (p / probe-01) 
            :ARG1-of (s / same-01)))

# ::snt The AMC antibody detects the ` mature ' form of Abcg5/sterolin -1 in wild-type animals but not the knockouts .
# ::tok The AMC antibody detects the ` mature ' form of Abcg5/sterolin -1 in wild-type animals but not the knockouts .
# ::alignments 18-19|0.1 16-17|0.1.0 15-16|0 14-15|0.0 8-9|0.0.0.1 6-7|0.0.0.1.0 3-4|0.0.0 2-3|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:47.145
(c / contrast-01 
      :ARG1 (a / animal 
            :ARG2-of (d / detect-01 
                  :ARG0 (a2 / antibody) 
                  :ARG1 (f / form 
                        :mod (m / mature-02)))) 
      :ARG2 (k / knockout 
            :polarity -))

# ::snt Interestingly , the ` immature ' 75 kDa band is detected by this antibody but the band shifts with Endo-H and PNGase F treatment ( Figure 5b ) .
# ::tok Interestingly , the ` immature ' 75 kDa band is detected by this antibody but the band shifts with Endo-H and PNGase F treatment ( Figure 5b ) .
# ::alignments 26-27|0.0 25-26|0.0.0 23-24|0.2.1.0 22-23|0.2.1.0.0.1+0.2.1.0.0.0.0+0.2.1.0.0.0+0.2.1.0.0 20-21|0.2.1 17-18|0.2 16-17|0.2.0 14-15|0 13-14|0.1.0 12-13|0.1.0.0 10-11|0.1 8-9|0.1.1 7-8|0.2.1.0.1 6-7|0.1.1.1 4-5|0.1.1.0 0-1|0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:48.153
(c / contrast-01 
      :ARG0 (5 / 5b 
            :mod-of (f / figure)) 
      :ARG1 (d / detect-01 
            :ARG0 (a3 / antibody 
                  :mod (t2 / this)) 
            :ARG1 (b2 / band 
                  :domain-of (i / immature) 
                  :quant 75) 
            :manner (i2 / interesting)) 
      :ARG2 (s / shift-01 
            :ARG1 (b / band) 
            :op1-of (a2 / and 
                  :op2 (t / treat-03 
                        :ARG0 (a / aircraft-type 
                              :name (n / name 
                                    :op1 "F22") 
                              :wiki "Lockheed_Martin_F-22_Raptor") 
                        :ARG1 (k / kDa)))))

# ::snt The UTSW antibody detects the ` mature ' and ` immature ' forms of Abcg5/sterolin -1 in wild-type animals but detects no forms in the knockout mouse ( Figure 5c ) .
# ::tok The UTSW antibody detects the ` mature ' and ` immature ' forms of Abcg5/sterolin -1 in wild-type animals but detects no forms in the knockout mouse ( Figure 5c ) .
# ::alignments 28-29|0.1.1.0.0 26-27|0.2.0 25-26|0.2 22-23|0.1.0 21-22|0.1.2 20-21|0.1 19-20|0 18-19|0.0.1 12-13|0.1.1.1.0 10-11|0.1.1.1 8-9|0.1.1 6-7|0.1.1.0 3-4|0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:48.468
(c / contrast-01 
      :ARG1 (d2 / detect-01 
            :ARG0 (a3 / antibody) 
            :ARG1 (a / animal)) 
      :ARG2 (d / detect-01 
            :ARG1 (f2 / form) 
            :op3-of (a2 / and 
                  :op1 (m2 / mature-02 
                        :ARG1 (f / figure)) 
                  :op2 (i / immature 
                        :mod-of (f3 / form))) 
            :polarity -) 
      :manner (k / knockout 
            :mod-of (m / mouse)))

# ::snt What does hold true for all antibodies used against Abcg5/sterolin -1 is the detection of a 75 kDa band .
# ::tok What does hold true for all antibodies used against Abcg5/sterolin -1 is the detection of a 75 kDa band .
# ::alignments 18-19|0.0.0 17-18|0.0.1 16-17|0.0.0.0 13-14|0.0 9-10|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 7-8|0.1 6-7|0 5-6|0.2 3-4|0.1.1.1 2-3|0.1.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:48.575
(a / antibodi 
      :ARG0-of (d / detect-01 
            :ARG1 (b / band 
                  :quant 75) 
            :ARG2 (k / kDa)) 
      :ARG1-of (u / use-01 
            :ARG0 (a3 / amr-unknown) 
            :manner-of (h / hold-04 
                  :ARG0 (c / country 
                        :name (n / name 
                              :op1 "Abcg5/sterolin")) 
                  :ARG1 (t / true))) 
      :quant (a2 / all))

# ::snt Immunohistochemistry experiments were carried out using all three antibodies .
# ::tok Immunohistochemistry experiments were carried out using all three antibodies .
# ::alignments 8-9|0.0.0.0 7-8|0.0.0.0.0 6-7|0.0.0.0.1 5-6|0.0.0 3-4|0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:48.660
(c / carry-out-03 
      :ARG1 (e / experiment-01 
            :ARG2-of (u / use-01 
                  :ARG1 (a / antibodi 
                        :quant 3 
                        :quant (a2 / all))) 
            :mod (i / immunohistochemistry)))

# ::snt In acute transfection studies , the SC antibody recognized over-expressed mouse Abcg5/sterolin -1 in COS-1 cells , but not mouse Abcg8/sterolin -2 ( Figure 6b ,6 c ) .
# ::tok In acute transfection studies , the SC antibody recognized over-expressed mouse Abcg5/sterolin -1 in COS-1 cells , but not mouse Abcg8/sterolin -2 ( Figure 6b ,6 c ) .
# ::alignments 26-27|0.2.3 23-24|0.1 20-21|0.2.1.1.0+0.2.1.1+0.2.1 19-20|0.2.1.0 18-19|0.2.4 17-18|0 15-16|0.2.5.2 11-12|0.2.5.1.1.0+0.2.5.1.1+0.2.5.1 10-11|0.2.5.1.0 9-10|0.0 8-9|0.2.5 7-8|0.2.5.0 6-7|0.2.5.0.0.1+0.2.5.0.0.0.0+0.2.5.0.0.0+0.2.5.0.0 3-4|0.2 2-3|0.2.0 1-2|0.2.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:49.121
(c3 / contrast-01 
      :ARG0 (o / over-express) 
      :ARG1 (f / figure) 
      :ARG2 (s2 / study-01 
            :ARG1 (t / transfection) 
            :location (c2 / country 
                  :mod (m / mouse) 
                  :name (n / name 
                        :op1 "Abcg8/sterolin")) 
            :mod (a2 / acute) 
            :op1-of (c / c) 
            :op1-of - 
            :time-of (r / recognize-02 
                  :ARG0 (a / antibody 
                        :mod (s / state 
                              :name (n3 / name 
                                    :op1 "SC") 
                              :wiki "South_Carolina")) 
                  :ARG1 (c5 / country 
                        :mod (m2 / mouse) 
                        :name (n2 / name 
                              :op1 "Abcg5/sterolin")) 
                  :time (c4 / cell))))

# ::snt Co-transfection of COS-1 cells with both Abcg5 and Abcg8 cDNAs did not alter the pattern of immunofluorescence , although we are not able to confirm simultaneous expression of Abcg8 in cells expressing Abcg5/sterolin -1 , as we have no suitable antibody for Abcg8/sterolin -2 ( Figure 6d ) .
# ::tok Co-transfection of COS-1 cells with both Abcg5 and Abcg8 cDNAs did not alter the pattern of immunofluorescence , although we are not able to confirm simultaneous expression of Abcg8 in cells expressing Abcg5/sterolin -1 , as we have no suitable antibody for Abcg8/sterolin -2 ( Figure 6d ) .
# ::alignments 46-47|0.0.0.1.1.0.0 45-46|0.0.0.1.1.0 42-43|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 40-41|0.0.0.0.0 39-40|0.0.0.0 38-39|0.0.0.1.1.2.4 36-37|0.0.0.1.1.2.0 32-33|0.1.0.0+0.1.0+0.1 31-32|0 30-31|0.0 26-27|0.0.0 25-26|0.0.0.2 24-25|0.0.0.1 22-23|0.0.0.1.1 21-22|0.0.0.1.1.1 19-20|0.0.0.1.0 16-17|0.0.0.1.1.2.1.0 14-15|0.0.0.1.1.2.1 12-13|0.0.0.1.1.2 11-12|0.0.0.1.1.2.3 9-10|0.0.0.1.1.2.2.2 8-9|0.0.0.1.1.2.2.2.0.0.0+0.0.0.1.1.2.2.2.0.0+0.0.0.1.1.2.2.2.0 7-8|0.0.0.1.1.2.2 6-7|0.0.0.1.1.2.2.1.0.0+0.0.0.1.1.2.2.1.0+0.0.0.1.1.2.2.1 5-6|0.0.0.1.1.2.2.1.1 3-4|0.0.0.1.1.2.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:51.179
(e / express-01 
      :ARG0 (c3 / cell 
            :location-of (e2 / express-01 
                  :ARG1 (s / suitable-04 
                        :ARG1 (a / antibody 
                              :beneficiary (c / country 
                                    :name (n / name 
                                          :op1 "Abcg8/sterolin")))) 
                  :ARG1-of (c4 / confirm-01 
                        :ARG0 (w2 / we) 
                        :ARG1-of (p / possible-01 
                              :ARG0 (f / figure 
                                    :mod 6d) 
                              :polarity - 
                              :purpose-of (a2 / alter-01 
                                    :ARG0 (w / we) 
                                    :ARG1 (p2 / pattern 
                                          :mod (i / immunofluorescence)) 
                                    :op4-of (a3 / and 
                                          :op1 (c8 / cell) 
                                          :op2 (c7 / country 
                                                :name (n4 / name 
                                                      :op1 "Abcg5") 
                                                :op1-of (b / both)) 
                                          :op3 (c5 / cdna 
                                                :mod (c6 / country 
                                                      :name (n3 / name 
                                                            :op1 "Abcg8")))) 
                                    :polarity - 
                                    :polarity -))) 
                  :mod (s2 / simultaneous))) 
      :ARG1 (c2 / country 
            :name (n2 / name 
                  :op1 "Abcg5/sterolin")))

# ::snt Nevertheless , this experiment indicates that the SC antibody can recognize Abcg5/sterolin -1 but does not cross-react with Abcg8/sterolin -2 .
# ::tok Nevertheless , this experiment indicates that the SC antibody can recognize Abcg5/sterolin -1 but does not cross-react with Abcg8/sterolin -2 .
# ::alignments 18-19|0.1.0.2.0.1.0.0+0.1.0.2.0.1.0+0.1.0.2.0.1 15-16|0.1.0.2.0.0 13-14|0 11-12|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 10-11|0.1.0 9-10|0.1 8-9|0.1.0.0 7-8|0.1.0.0.0.1+0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 4-5|0.1.0.2 3-4|0.1.0.2.0 2-3|0.1.0.2.0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:51.458
(c2 / contrast-01 
      :ARG0 (n4 / nevertheles) 
      :ARG1 (p / possible-01 
            :ARG1 (r / recognize-02 
                  :ARG0 (a / antibody 
                        :mod (s / state 
                              :name (n3 / name 
                                    :op1 "SC") 
                              :wiki "South_Carolina")) 
                  :ARG1 (c3 / country 
                        :name (n2 / name 
                              :op1 "Abcg5/sterolin")) 
                  :ARG1-of (i / indicate-01 
                        :ARG0 (e / experiment-01 
                              :ARG0 - 
                              :ARG1 (c / country 
                                    :name (n / name 
                                          :op1 "Abcg8/sterolin")) 
                              :mod (t / this))))))

# ::snt Serial sections of intestinal tissue were incubated with anti-Abcg5 / sterolin-1 to determine the cellular location of Abcg5/sterolin -1 .
# ::tok Serial sections of intestinal tissue were incubated with anti-Abcg5 / sterolin-1 to determine the cellular location of Abcg5/sterolin -1 .
# ::alignments 17-18|0.0.0.0+0.0.0+0.0 15-16|0.3.1 14-15|0.3.1.0 12-13|0.3 9-10|0.2 6-7|0 4-5|0.1 3-4|0.1.0 1-2|0.3.0 0-1|0.3.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:51.604
(i / incubate-01 
      :ARG0 (c / country 
            :name (n / name 
                  :op1 "Abcg5/sterolin")) 
      :ARG1 (t / tissue 
            :mod (i2 / intestine)) 
      :ARG2 (s / slash) 
      :purpose (d / determine-01 
            :ARG0 (s2 / section 
                  :mod (s3 / serial)) 
            :ARG1 (l / location 
                  :mod (c2 / cell))))

# ::snt The pattern of staining of Abcg5/sterolin -1 in the intestinal sections is clearly apical and localized to the villi of the enterocytes ( Figure 6g ,6 h ,6 i ) .
# ::tok The pattern of staining of Abcg5/sterolin -1 in the intestinal sections is clearly apical and localized to the villi of the enterocytes ( Figure 6g ,6 h ,6 i ) .
# ::alignments 28-29|0.3 26-27|0.2.0.0.0 23-24|0.2.0.0.2 21-22|0.0.0 18-19|0.0 15-16|0.2 14-15|0 13-14|0.1 12-13|0.1.0 10-11|0.2.1 9-10|0.2.1.0 5-6|0.2.0.0.1.0.0+0.2.0.0.1.0+0.2.0.0.1 3-4|0.2.0.0 1-2|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:51.885
(a / and 
      :beneficiary (v / villus 
            :poss (e / enterocyt)) 
      :op1 (a2 / apical 
            :ARG1-of (c / clear-06)) 
      :op2 (l / localize-01 
            :ARG1 (p / pattern 
                  :mod (s2 / stain-01 
                        :ARG0 (h / h) 
                        :ARG1 (c2 / country 
                              :name (n / name 
                                    :op1 "Abcg5/sterolin")) 
                        :op1-of (f / figure))) 
            :ARG2 (s / section 
                  :mod (i2 / intestine))) 
      :op3 (i / i))

# ::snt Loss of Abcg8/sterolin -2 does not seem to affect this pattern of staining .
# ::tok Loss of Abcg8/sterolin -2 does not seem to affect this pattern of staining .
# ::alignments 12-13|0.0.1.0 10-11|0.0.1 9-10|0.0.1.1 8-9|0.0 6-7|0 5-6|0.1 2-3|0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:51.965
(s2 / seem-01 
      :ARG1 (a / affect-01 
            :ARG0 (l / los) 
            :ARG1 (p / pattern 
                  :mod (s / stain-01 
                        :ARG1 (c / country 
                              :name (n / name 
                                    :op1 "Abcg8/sterolin"))) 
                  :mod (t / this))) 
      :polarity -)

# ::snt To further confirm that the antibody used recognizes Abcg5/sterolin -1 ; this pattern is blocked if the antibody is pre-incubated with the peptide to which it was raised ( Figure 6f ) .
# ::tok To further confirm that the antibody used recognizes Abcg5/sterolin -1 ; this pattern is blocked if the antibody is pre-incubated with the peptide to which it was raised ( Figure 6f ) .
# ::alignments 30-31|0.0.0.0 29-30|0.0.0 27-28|0.1.0 22-23|0.1.0.0 17-18|0.0.1.1 14-15|0.2.0 12-13|0.2.0.0 11-12|0.2.0.0.0 10-11|0.2 8-9|0.1.1.0+0.1.1+0.1 7-8|0 6-7|0.0.1 5-6|0.0.1.0 2-3|0.0 1-2|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:52.579
(r2 / recognize-02 
      :ARG0 (c2 / confirm-01 
            :ARG0 (f / figure 
                  :mod 6f) 
            :ARG1 (u / use-01 
                  :ARG0 (a3 / antibody) 
                  :ARG1 (a / antibody)) 
            :mod (f2 / further)) 
      :ARG1 (c / country 
            :ARG0-of (r / raise-01 
                  :ARG1 (p / peptide)) 
            :name (n / name 
                  :op1 "Abcg5/sterolin")) 
      :op1-of (a2 / and 
            :op2 (b / block-01 
                  :ARG1 (p2 / pattern 
                        :mod (t / this)))))

# ::snt To further confirm that Abcg5/sterolin -1 expression is preserved and may be apical , immunohistochemistry was performed in Amsterdam using the AMC antibody to stain liver sections from wild-type and knockout mice [ 30 ] .
# ::tok To further confirm that Abcg5/sterolin -1 expression is preserved and may be apical , immunohistochemistry was performed in Amsterdam using the AMC antibody to stain liver sections from wild-type and knockout mice [ 30 ] .
# ::alignments 33-34|0.1 31-32|0.2.0.0.0.0.1.1.1 30-31|0.2.0.0.0.0.1.1.0 29-30|0.2.0.0.0.0.1.1 26-27|0.2.0.0.0.0.1.0 25-26|0.2.0.0.0.0.1.0.0 24-25|0.2.0.0.0.0.1 22-23|0.2.0.0.0.0.0 21-22|0.2.0.0.0.0.0.0.0.0+0.2.0.0.0.0.0.0.0+0.2.0.0.0.0.0.0 19-20|0.2.0.0.0.0 18-19|0.2.0.0.1.0.0+0.2.0.0.1.0+0.2.0.0.1 16-17|0.2.0.0 14-15|0.2.0.0.0 12-13|0.2.1.0.0 10-11|0.2.1.0 9-10|0.2.1 8-9|0.2 6-7|0 4-5|0.0.0.0+0.0.0+0.0 2-3|0.2.0 1-2|0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:53.273
(e / express-01 
      :ARG0 (c2 / country 
            :name (n3 / name 
                  :op1 "Abcg5/sterolin")) 
      :ARG1 30 
      :ARG1-of (p3 / preserve-01 
            :ARG1-of (c3 / confirm-01 
                  :condition-of (p / perform-02 
                        :ARG1 (i / immunohistochemistry 
                              :ARG0-of (u / use-01 
                                    :ARG1 (a2 / antibody 
                                          :mod (o / organization 
                                                :name (n / name 
                                                      :op1 "AMC"))) 
                                    :ARG2 (s2 / stain-01 
                                          :ARG1 (s / section 
                                                :mod (l / liver)) 
                                          :ARG2 (a / and 
                                                :op1 (k / knockout) 
                                                :op2 (m / mouse))))) 
                        :location (c / country 
                              :name (n2 / name 
                                    :op1 "Amsterdam"))) 
                  :mod (f / further)) 
            :op1-of (a4 / and 
                  :op2 (p2 / possible-01 
                        :ARG1 (a3 / apical)))))

# ::snt As a control , the expression of Abcb11 , an ABC transporter known to be responsible for the export of bile salts , was compared to that of Abcg5/sterolin -1 ( Figure 6j ,6 k ) .
# ::tok As a control , the expression of Abcb11 , an ABC transporter known to be responsible for the export of bile salts , was compared to that of Abcg5/sterolin -1 ( Figure 6j ,6 k ) .
# ::alignments 34-35|0.1.0 32-33|0.1.1.0 31-32|0.1.1.0.0 28-29|0.1.1.1.0.1.1.0.0+0.1.1.1.0.1.1.0+0.1.1.1.0.1.1 26-27|0.1.1.1.0.1.0 24-25|0.1.1.1.0.1 21-22|0.0.0 20-21|0.0.0.0 18-19|0.0 15-16|0 12-13|0.1 11-12|0.1.1 10-11|0.1.1.2.0+0.1.1.2 7-8|0.1.1.1.0.0.0.0+0.1.1.1.0.0.0+0.1.1.1.0.0 5-6|0.1.1.1.0 2-3|0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:54.933
(r / responsible-01 
      :ARG1 (e / export-01 
            :ARG1 (s / salt-01 
                  :ARG1 (b / bile))) 
      :ARG1-of (k2 / know-02 
            :ARG0 (k / k) 
            :ARG2 (t2 / transport-01 
                  :ARG1 (6 / 6j 
                        :mod-of (f / figure)) 
                  :ARG2 (c4 / control-01 
                        :ARG1 (e2 / express-01 
                              :ARG1 (c3 / country 
                                    :name (n3 / name 
                                          :op1 "Abcb11")) 
                              :ARG1-of (c2 / compare-01 
                                    :ARG0 (t / that) 
                                    :ARG2 (c / country 
                                          :name (n / name 
                                                :op1 "Abcg5/sterolin"))))) 
                  :name (n2 / name 
                        :op1 "ABC"))))

# ::snt Again , both proteins are apically localized in liver sections from wild-type mice and this pattern is essentially unperturbed in liver from knockout mice , although the expression level of Abcg5/sterolin -1 seems to be less robust qualitatively ( Figure 6l ,6 m ) .
# ::tok Again , both proteins are apically localized in liver sections from wild-type mice and this pattern is essentially unperturbed in liver from knockout mice , although the expression level of Abcg5/sterolin -1 seems to be less robust qualitatively ( Figure 6l ,6 m ) .
# ::alignments 42-43|0.0 40-41|0.2.0.0 39-40|0.2.0.0.0 37-38|0.2.0.1 36-37|0.2.0.1.0 35-36|0.2.0.2 32-33|0.2.0 30-31|0.2.1.0.0+0.2.1.0+0.2.1 28-29|0.2 27-28|0 23-24|0.2.2.0 22-23|0.2.2 20-21|0.1.0.0 18-19|0.1.1 17-18|0.1.1.0 15-16|0.1.1.1 14-15|0.1.1.1.0 13-14|0.1 12-13|0.1.0.2.1 9-10|0.1.0.2 8-9|0.1.0.2.0 6-7|0.1.0 3-4|0.1.0.1 2-3|0.1.0.1.0 0-1|0.1.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:56.333
(e / express-01 
      :ARG0 (m / m) 
      :ARG1 (a / and 
            :op1 (l5 / localize-01 
                  :ARG0 (l3 / liver) 
                  :ARG1 (p2 / protein 
                        :mod (b / both)) 
                  :manner (s2 / section 
                        :mod (l4 / liver) 
                        :source (m3 / mouse)) 
                  :mod (a2 / again)) 
            :op2 (u / unperturb 
                  :degree (e2 / essential) 
                  :domain (p / pattern 
                        :mod (t / this)))) 
      :mod-of (l2 / level 
            :ARG3-of (s / seem-01 
                  :ARG0 (6 / 6l 
                        :mod-of (f / figure)) 
                  :ARG1 (q / qualitatively 
                        :mod (r / robust)) 
                  :ARG2 (l / less)) 
            :mod (c / country 
                  :name (n / name 
                        :op1 "Abcg5/sterolin")) 
            :name (k / knockout 
                  :mod-of (m2 / mouse))))

# ::snt To further confirm the apical expression of Abcg5/sterolin -1 in the knockout mice , the UTSW antibody was used to stain liver sections of wild-type and knockout mice .
# ::tok To further confirm the apical expression of Abcg5/sterolin -1 in the knockout mice , the UTSW antibody was used to stain liver sections of wild-type and knockout mice .
# ::alignments 27-28|0.0 26-27|0.0.0 25-26|0 22-23|0.1 21-22|0.1.1 20-21|0.1.0 18-19|0.1.0.1 16-17|0.1.0.0 15-16|0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 12-13|0.1.0.1.1.0 11-12|0.1.0.1.1.0.0 7-8|0.1.0.1.0.0.0+0.1.0.1.0.0+0.1.0.1.0 5-6|0.1.0.1.1 4-5|0.1.0.1.1.2 2-3|0.1.0.1.1.1 1-2|0.1.0.1.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:56.705
(a / and 
      :op1 (m / mouse 
            :mod (k / knockout)) 
      :quant (s / section 
            :ARG1-of (s2 / stain-01 
                  :ARG0 (a2 / antibody 
                        :mod (o / organization 
                              :name (n / name 
                                    :op1 "UTSW"))) 
                  :ARG2-of (u / use-01 
                        :ARG0 (c / country 
                              :name (n2 / name 
                                    :op1 "Abcg5/sterolin")) 
                        :ARG1 (e / express-01 
                              :ARG1 (m2 / mouse 
                                    :mod (k2 / knockout)) 
                              :ARG1-of (c2 / confirm-01 
                                    :degree (f / further)) 
                              :mod (a3 / apical)))) 
            :mod (l / liver)))

# ::snt Again , there is apical expression of Abcg5/sterolin -1 in both wild-type and knockout livers ( Figure 7a ,7 b ) .
# ::tok Again , there is apical expression of Abcg5/sterolin -1 in both wild-type and knockout livers ( Figure 7a ,7 b ) .
# ::alignments 19-20|0.0.0 16-17|0.0.1 14-15|0.4 13-14|0.3 12-13|0 10-11|0.1 7-8|0.2.0.0+0.2.0+0.2 5-6|0.0 4-5|0.0.2 0-1|0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:56.854
(a / and 
      :ARG2-of (e / express-01 
            :ARG0 (b / b) 
            :ARG1 (f / figure) 
            :mod (a2 / apical) 
            :time (a3 / again)) 
      :mod (b2 / both) 
      :op1 (c / country 
            :name (n / name 
                  :op1 "Abcg5/sterolin")) 
      :op2 (k / knockout) 
      :op3 (l / liver))

# ::snt Biliary secretion of bile salts , sterol and phospholipids in Abcg8/sterolin -2 deficient mice .
# ::tok Biliary secretion of bile salts , sterol and phospholipids in Abcg8/sterolin -2 deficient mice .
# ::alignments 13-14|0.1.0 12-13|0.1.0.0 10-11|0.1.1.0+0.1.1+0.1 7-8|0 4-5|0.0 3-4|0.0.0 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:56.922
(a / and 
      :op1 (s / salt-01 
            :ARG0 (b / bile) 
            :ARG1 (s2 / secretion 
                  :mod (b2 / biliary))) 
      :op2 (c / country 
            :mod-of (m / mouse 
                  :mod (d / deficient)) 
            :name (n / name 
                  :op1 "Abcg8/sterolin")))

# ::snt Sitosterolemic individuals have an impaired ability to secrete cholesterol and plant sterols into bile [ 40,41 ] .
# ::tok Sitosterolemic individuals have an impaired ability to secrete cholesterol and plant sterols into bile [ 40,41 ] .
# ::alignments 13-14|0.0.2 11-12|0.0.0.1 10-11|0 9-10|0.0 8-9|0.0.1 7-8|0.0.0 5-6|0.0.0.2 4-5|0.0.0.2.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:57.020
(p / plant 
      :op3-of (a / and 
            :op1 (s2 / secrete-01 
                  :ARG0 (i2 / individual) 
                  :ARG1 (s / sterol) 
                  :purpose-of (a2 / ability 
                        :ARG1-of (i / impair-01))) 
            :op2 (c / cholesterol) 
            :poss (b / bile)))

# ::snt We analyzed the knockout mice for any alterations in biliary sterol handling .
# ::tok We analyzed the knockout mice for any alterations in biliary sterol handling .
# ::alignments 11-12|0.2.1 10-11|0.2.1.0 9-10|0.2.1.1 7-8|0.2 6-7|0.2.0 4-5|0.1 3-4|0.1.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:57.133
(a3 / analyze-01 
      :ARG0 (w / we) 
      :ARG1 (m / mouse 
            :mod (k / knockout)) 
      :purpose (a / alteration 
            :mod (a2 / any) 
            :purpose (h / handle-01 
                  :ARG1 (s / sterol) 
                  :mod (b / biliary))))

# ::snt Analyses of the initial basal bile secretion showed that the sterol and phospholipid contents in Abcg8 - / - mice were reduced as compared to wild-type mice , ( Figure 8a ,8 b ,8 c , bile salt secretion not statistically significant , for sterol secretion P = 0.01 and for phospholipid secretion P = 0.03 ) .
# ::tok Analyses of the initial basal bile secretion showed that the sterol and phospholipid contents in Abcg8 - / - mice were reduced as compared to wild-type mice , ( Figure 8a ,8 b ,8 c , bile salt secretion not statistically significant , for sterol secretion P = 0.01 and for phospholipid secretion P = 0.03 ) .
# ::alignments 53-54|0.2.3.0.0.0.2.0 52-53|0.2.3.0.0.0.2.0.0 51-52|0.2.3.0.0.0.2.0.1 49-50|0.2.5 46-47|0.2.3.1.1.0 45-46|0.2.3.1.1.1 44-45|0.2.3.1.1 41-42|0.2.3.0.0.0.2 40-41|0.2.3.0.0.0.2.2 39-40|0.2.3.0.0.0.2.3 38-39|0.2.3.0.0.0.2.1 37-38|0.2.3.0.0.0.2.1.0 36-37|0.2.3.0.0.0.2.1.0.0 34-35|0.2.2.0 32-33|0.2.3.1.0 29-30|0.2.3.0.0.0.0 26-27|0.2.3.0.0.0.1 23-24|0.2.3.0.0.0 21-22|0.2.3.1 19-20|0.2.3.0.0 17-18|0.2.5.0 15-16|0.2.4.0.0+0.2.4.0+0.2.4 13-14|0.2.3.0+0.2.3 12-13|0.2.2 11-12|0.2 10-11|0.2.1 7-8|0 6-7|0.1 5-6|0.1.0 4-5|0.1.0.0 3-4|0.2.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:09:59.528
(s10 / show-01 
      :ARG0 (a3 / analyse) 
      :ARG1 (s11 / secretion 
            :mod (b3 / bile 
                  :mod (b4 / basal))) 
      :op2-of (a2 / and 
            :op1 (i / initial) 
            :op3 (s9 / sterol) 
            :op4 (p4 / phospholipid 
                  :mod-of (c / c)) 
            :op5 (t / thing 
                  :ARG1-of (c4 / contain-01 
                        :ARG0 (m2 / mouse 
                              :ARG0-of (c2 / compare-01 
                                    :ARG1 (f / figure) 
                                    :ARG2 (m / mouse) 
                                    :purpose-of (s4 / significant-02 
                                          :ARG0 (p / P60 
                                                :mod (s / secretion) 
                                                :mod (p2 / phospholipid)) 
                                          :ARG1 (s6 / secretion 
                                                :mod (s7 / salt 
                                                      :mod (b / bile))) 
                                          :mod (s5 / statistics) 
                                          :polarity -)))) 
                  :ARG1-of (r / reduce-01 
                        :ARG0 (b2 / b) 
                        :ARG2 (s3 / sterol 
                              :mod-of (p3 / P60) 
                              :mod-of (s2 / secretion)))) 
            :op6 (c3 / country 
                  :name (n / name 
                        :op1 "Abcg8")) 
            :op7 (a / and 
                  :op1 (s8 / slash))))

# ::snt To investigate whether the defect in biliary sterol secretion could be ( partly ) restored by forced biliary sterol secretion , we infused mice with stepwise increasing doses of tauroursodeoxycholic acid ( TUDC ) .
# ::tok To investigate whether the defect in biliary sterol secretion could be ( partly ) restored by forced biliary sterol secretion , we infused mice with stepwise increasing doses of tauroursodeoxycholic acid ( TUDC ) .
# ::alignments 32-33|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 30-31|0.0.0.0.1.1.0.0.2 27-28|0.0.0.0.1.1.0.0 26-27|0.0.0.0.1.1.0.0.1 25-26|0.0.0.0.1.1.0.0.1.0 23-24|0.0.0.0.1.1.0.1.0 22-23|0.0.0.0.1.1.0.1 21-22|0.0.0.0.1.1.0 19-20|0.0.0.0.2.0 18-19|0.0.0.0.2.0.0 17-18|0.0.0.0.1.1.0.0.0 16-17|0.0.0.0.2 14-15|0.0.0.0 12-13|0.0.0.0.1.0 9-10|0.0.0.0.1 8-9|0.0 7-8|0 6-7|0.0.1 4-5|0.0.0 1-2|0.0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:00.714
(s5 / sterol 
      :mod-of (s4 / secretion 
            :ARG1-of (d2 / defect-01 
                  :ARG1-of (r / restore-01 
                        :ARG0 (o / organization 
                              :name (n / name 
                                    :op1 "TUDC")) 
                        :ARG1-of (p2 / possible-01 
                              :ARG0 (p / part) 
                              :ARG1-of (i3 / investigate-01 
                                    :ARG0 (w / we 
                                          :ARG0-of (d / dose-01 
                                                :ARG1 (b / biliary) 
                                                :ARG1-of (i / increase-01 
                                                      :manner (s / stepwise)) 
                                                :ARG2 (a / acid)) 
                                          :ARG0-of (i2 / infuse-01 
                                                :ARG1 (m / mouse))))) 
                        :ARG2 (f / force-01 
                              :ARG1 (s2 / secretion 
                                    :mod (s3 / sterol))))) 
            :mod (b2 / biliary)))

# ::snt Mice were first depleted of their endogenous bile salt pools for 90 min and subsequently infused via the jugular vein with increasing doses of TUDC .
# ::tok Mice were first depleted of their endogenous bile salt pools for 90 min and subsequently infused via the jugular vein with increasing doses of TUDC .
# ::alignments 24-25|0.1.1.0.2.0.0+0.1.1.0.2.0+0.1.1.0.2 22-23|0.1.1.0 21-22|0.1.1 19-20|0.1.0 18-19|0.1.0.0 15-16|0.1 14-15|0.1.2 13-14|0 12-13|0.0.2 11-12|0.1.1.0.1 9-10|0.0.0 8-9|0.0.0.0 7-8|0.0.0.1 6-7|0.1.1.0.0 3-4|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:01.311
(a / and 
      :op1 (d2 / deplete-01 
            :ARG0 (p / pool 
                  :mod (s2 / salt) 
                  :mod (b / bile)) 
            :ARG1 (m2 / mouse) 
            :purpose (m / min)) 
      :op2 (i2 / infuse-01 
            :ARG1 (v / vein-01 
                  :ARG1 (j / jugular)) 
            :ARG2 (i / increase-01 
                  :ARG1 (d / dose-01 
                        :ARG0 (e / endogenou) 
                        :ARG1 90 
                        :ARG2 (o / organization 
                              :name (n / name 
                                    :op1 "TUDC")))) 
            :time (s / subsequent)))

# ::snt As shown in Figure 8d , bile salt secretion was no different between the different genotypes during the depletion or the TUDC infusion phases of the experiment .
# ::tok As shown in Figure 8d , bile salt secretion was no different between the different genotypes during the depletion or the TUDC infusion phases of the experiment .
# ::alignments 26-27|0 23-24|0.0 22-23|0.0.0 21-22|0.0.1.0.0+0.0.1.0+0.0.1 19-20|0.0.2 18-19|0.0.2.1 15-16|0.0.2.0.1 14-15|0.0.2.0.1.0 11-12|0.0.2.0 10-11|0.0.2.0.2 8-9|0.0.2.0.0 7-8|0.0.2.0.0.1 6-7|0.0.2.0.0.1.0 4-5|0.0.2.0.0.0.0 3-4|0.0.2.0.0.0.0.0 1-2|0.0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:01.852
(e / experiment-01 
      :part (p / phase 
            :mod (i / infusion) 
            :mod (o / organization 
                  :name (n / name 
                        :op1 "TUDC")) 
            :op2-of (o2 / or 
                  :ARG0-of (d3 / differ-02 
                        :ARG1 (s / secretion 
                              :ARG1-of (s3 / show-01 
                                    :ARG0 (8 / 8d 
                                          :mod-of (f / figure))) 
                              :mod (s2 / salt 
                                    :mod (b / bile))) 
                        :ARG2 (g / genotyp 
                              :ARG1-of (d2 / differ-02)) 
                        :polarity -) 
                  :op1 (d / depletion))))

# ::snt However , a different pattern emerged for the secretion of phospholipid ( Figure 8f ) .
# ::tok However , a different pattern emerged for the secretion of phospholipid ( Figure 8f ) .
# ::alignments 13-14|0.1.0 12-13|0.1.0.0 10-11|0.2.0 8-9|0.2 5-6|0 4-5|0.0 3-4|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:01.935
(e / emerge-02 
      :ARG0 (p2 / pattern) 
      :ARG1 (d / differ-02 
            :ARG1 (8 / 8f 
                  :mod-of (f / figure))) 
      :ARG2 (s / secretion 
            :mod (p / phospholipid)))

# ::snt There was no difference between wild-type and heterozygous mice , but knockout mice showed a trend of lower phospholipid secretion during both the depletion and infusion phase .
# ::tok There was no difference between wild-type and heterozygous mice , but knockout mice showed a trend of lower phospholipid secretion during both the depletion and infusion phase .
# ::alignments 26-27|0.1.2.0 25-26|0.1.2.0.0 24-25|0.1.2.1 23-24|0.1.2 21-22|0.1.2.1.0 19-20|0.1.1.0 18-19|0.1.1.0.1 17-18|0.1.1.0.0 15-16|0.1.1 13-14|0.1 12-13|0.1.0 11-12|0.1.0.0 10-11|0 8-9|0.0.0.1 7-8|0.0.0.0 6-7|0.0.0 3-4|0.0 2-3|0.1.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:02.522
(c / contrast-01 
      :ARG1 (d2 / differ-02 
            :ARG1 (a2 / and 
                  :op1 (h / heterozygou) 
                  :op2 (m2 / mouse))) 
      :ARG2 (s2 / show-01 
            :ARG0 (m / mouse 
                  :mod (k / knockout)) 
            :ARG1 (t / trend-01 
                  :ARG1 (s / secretion 
                        :ARG1-of (l / low-04 
                              :ARG0 -) 
                        :mod (p2 / phospholipid))) 
            :time (d / depletion 
                  :mod-of (p / phase 
                        :mod (i / infusion)) 
                  :op1-of (a / and 
                        :mod (b / both)))))

# ::snt Even more dramatic was the effect on biliary sterol secretion although the sterol contents were determined enzymatically and no distinction is made as to whether this is sitosterol or cholesterol ( Figure 8e , but see below ) .
# ::tok Even more dramatic was the effect on biliary sterol secretion although the sterol contents were determined enzymatically and no distinction is made as to whether this is sitosterol or cholesterol ( Figure 8e , but see below ) .
# ::alignments 36-37|0.1.2 35-36|0.1 34-35|0 31-32|0.1.0 29-30|0.1.1.1.0 28-29|0.1.1.1 27-28|0.1.1 25-26|0.1.1.0 19-20|0.0.1.1 18-19|0.0.1.1.0 17-18|0.0 15-16|0.0.1 13-14|0.0.1.0.0+0.0.1.0 12-13|0.0.1.0.1 9-10|0.0.0.0 8-9|0.0.0.0.0 7-8|0.0.0.0.1 5-6|0.0.0 2-3|0.0.0.1 1-2|0.0.0.1.0 0-1|0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:03.364
(c / contrast-01 
      :ARG1 (a / and 
            :ARG0-of (e / effect-03 
                  :ARG1 (s4 / secretion 
                        :mod (s5 / sterol) 
                        :mod (b2 / biliary)) 
                  :domain-of (d3 / dramatic 
                        :degree (m / more 
                              :mod (e2 / even)))) 
            :op1 (d2 / determined-02 
                  :ARG0 (t2 / thing 
                        :ARG1-of (c3 / contain-01) 
                        :mod (s3 / sterol)) 
                  :ARG1 (d / distinguish-01 
                        :polarity -))) 
      :ARG2 (s / see-01 
            :ARG0 (f / figure) 
            :ARG1 (s2 / sitosterol 
                  :domain (t / this) 
                  :op1-of (o / or 
                        :op2 (c2 / cholesterol))) 
            :location (b / below)))

# ::snt In the knockout mice , almost no stimulated sterol secretion was noted , with an intermediate phenotype in the heterozygous mice .
# ::tok In the knockout mice , almost no stimulated sterol secretion was noted , with an intermediate phenotype in the heterozygous mice .
# ::alignments 20-21|0.0.1 19-20|0.0 16-17|0.2 15-16|0.2.0 11-12|0 9-10|0.1 8-9|0.1.1 7-8|0.1.0 6-7|0.1.0.0 5-6|0.0.0 3-4|0.3 2-3|0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:03.470
(n / note-01 
      :ARG0 (h / heterozygou 
            :mod (a / almost) 
            :mod-of (m / mouse)) 
      :ARG1 (s / secretion 
            :ARG1-of (s3 / stimulate-01 
                  :ARG0 -) 
            :mod (s2 / sterol)) 
      :ARG2 (p / phenotype 
            :mod (i / intermediate)) 
      :manner (m2 / mouse 
            :mod (k / knockout)))

# ::snt In the heterozygous mice , sterol secretion increased to reach a maximal level of about 50 % of the wild type suggesting that Abcg8/sterolin -2 is a rate-limiting step for biliary ` cholesterol ' secretion .
# ::tok In the heterozygous mice , sterol secretion increased to reach a maximal level of about 50 % of the wild type suggesting that Abcg8/sterolin -2 is a rate-limiting step for biliary ` cholesterol ' secretion .
# ::alignments 34-35|0.0.0.1.0.0 32-33|0.0.0.1.0.0.0 30-31|0.0.0.1.0 28-29|0.0.0.0 27-28|0.0.0.0.0 21-22|0.0.0 20-21|0.0 19-20|0 16-17|0.0.0.1.1.1.0 15-16|0.0.0.1.1.1.0.1 14-15|0.0.0.1.1.1.0.0 12-13|0.0.0.1.1.1 11-12|0.0.0.1.1.1.1 9-10|0.0.0.1.1 7-8|0.0.0.1 6-7|0.0.0.1.1.0 5-6|0.0.0.1.1.0.0 3-4|0.0.0.1.2 2-3|0.0.0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:03.922
(w / wild 
      :mod-of (t / type 
            :ARG0-of (s3 / suggest-01 
                  :ARG1 (s2 / step 
                        :mod (r / rate-limit)) 
                  :purpose (i / increase-01 
                        :ARG0 (b / biliary 
                              :mod-of (s / secretion 
                                    :mod (c / cholesterol))) 
                        :ARG1 (r2 / reach-01 
                              :ARG0 (s4 / secretion 
                                    :mod (s5 / sterol)) 
                              :ARG1 (l / level 
                                    :consist-of (p / percentage-entity 
                                          :op1-of (a / about) 
                                          :value 50) 
                                    :mod (m / maximum))) 
                        :time (m2 / mouse 
                              :mod (h / heterozygou))))))

# ::snt In the knockout mice , sterol secretion remained at a constant level during the depletion phase and increased minimally upon infusion of TUDC .
# ::tok In the knockout mice , sterol secretion remained at a constant level during the depletion phase and increased minimally upon infusion of TUDC .
# ::alignments 22-23|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 20-21|0.1.0 18-19|0.1.1 17-18|0.1 16-17|0 15-16|0.0.3 14-15|0.0.3.0 11-12|0.0.2 10-11|0.0.2.0 7-8|0.0 6-7|0.0.1 5-6|0.0.1.0 3-4|0.0.0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:04.140
(a / and 
      :op1 (r / remain-01 
            :ARG0 (k / knockout 
                  :mod-of (m2 / mouse)) 
            :ARG1 (s / secretion 
                  :mod (s2 / sterol)) 
            :location (l / level 
                  :mod (c / constant)) 
            :time (p / phase 
                  :mod (d / depletion))) 
      :op2 (i2 / increase-01 
            :ARG1 (i / infusion 
                  :poss (o / organization 
                        :name (n / name 
                              :op1 "TUDC"))) 
            :time (m / minimally)))

# ::snt Since the Abcg8 - / - mice still secreted some sterols we were interested in which biliary sterol species were being secreted .
# ::tok Since the Abcg8 - / - mice still secreted some sterols we were interested in which biliary sterol species were being secreted .
# ::alignments 21-22|0.2 18-19|0.2.1 17-18|0.2.1.0 16-17|0.2.1.1 13-14|0 11-12|0.1 10-11|0.2.2.0.1 9-10|0.2.2.0.1.0 8-9|0.2.2.0 7-8|0.2.2 6-7|0.2.2.0.0 4-5|0.0 2-3|0.2.1.1.0.0.0+0.2.1.1.0.0+0.2.1.1.0 0-1|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:04.575
(i / interest-01 
      :ARG0 (s8 / slash) 
      :ARG1 (w / we) 
      :ARG2 (s / secrete-01 
            :ARG0 (s9 / since) 
            :ARG1 (s2 / species 
                  :mod (s3 / sterol) 
                  :mod (b / biliary 
                        :mod-of (c / country 
                              :name (n / name 
                                    :op1 "Abcg8")))) 
            :op1-of (s7 / still 
                  :mod-of (s6 / secrete-01 
                        :ARG0 (m / mouse) 
                        :ARG1 (s4 / sterol 
                              :quant (s5 / some))))))

# ::snt Therefore bile was collected from mice during a constant infusion of TUDC and analyzed by GC .
# ::tok Therefore bile was collected from mice during a constant infusion of TUDC and analyzed by GC .
# ::alignments 15-16|0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 13-14|0.2.0 12-13|0.2 11-12|0.3.1.0.0+0.3.1.0+0.3.1 9-10|0.3 8-9|0.3.0 5-6|0.1 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:04.681
(c2 / collect-01 
      :ARG1 (b / bile 
            :mod (t / therefore)) 
      :ARG2 (m / mouse) 
      :op1-of (a2 / and 
            :op2 (a / analyze-01 
                  :ARG0 (o / organization 
                        :name (n / name 
                              :op1 "GC")))) 
      :prep-in (i / infusion 
            :mod (c / constant) 
            :poss (o2 / organization 
                  :name (n2 / name 
                        :op1 "TUDC"))))

# ::snt Mice were first depleted of their endogenous bile acid pools for 30 minutes then infused with a continuous dose of TUDC ( 1,200 nmol/min/100 g body weight ) .
# ::tok Mice were first depleted of their endogenous bile acid pools for 30 minutes then infused with a continuous dose of TUDC ( 1,200 nmol/min/100 g body weight ) .
# ::alignments 26-27|0.0.2.0 25-26|0.0.2 24-25|0 20-21|0.0.0.0.1.1.0.0+0.0.0.0.1.1.0+0.0.0.0.1.1 18-19|0.0.0.0.1 17-18|0.0.0.0.1.2 14-15|0.0.0.0 13-14|0.0.0.0.2 12-13|0.0.0.0.0.1+0.0.0.0.0 11-12|0.0.0.0.0.0 9-10|0.0.0 8-9|0.0.0.1 7-8|0.0.0.2 6-7|0.0.0.0.1.0 3-4|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:05.337
(g / g 
      :ARG2-of (d2 / deplete-01 
            :ARG0 (p / pool 
                  :ARG0-of (i / infuse-01 
                        :ARG1 (t2 / temporal-quantity 
                              :quant 30 
                              :unit (m / minute)) 
                        :ARG2 (d / dose-01 
                              :ARG0 (e / endogenou) 
                              :ARG1 (o / organization 
                                    :name (n / name 
                                          :op1 "TUDC")) 
                              :ARG1-of (c / continue-01)) 
                        :time (t / then)) 
                  :mod (a / acid) 
                  :mod (b2 / bile)) 
            :ARG1 (m2 / mouse) 
            :op1-of (b / body 
                  :part (w / weight))))

# ::snt The knockout mice showed a significantly diminished ability to secrete cholesterol , yet still maintained the ability to secrete sitosterol and campesterol compared to wild-type mice ( Figure 9 ) .
# ::tok The knockout mice showed a significantly diminished ability to secrete cholesterol , yet still maintained the ability to secrete sitosterol and campesterol compared to wild-type mice ( Figure 9 ) .
# ::alignments 28-29|0.0.0.0.0.0 27-28|0.0.0.0.0.1.0.0 25-26|0.0.0.0.0.1.0.1 22-23|0.0.0.0.0.1.0 20-21|0.0.0.0.0.1 18-19|0.0.0.0.0 16-17|0.0.0.0 14-15|0.0.0 13-14|0.0.0.1 12-13|0.0.0.2 10-11|0.1.1.0 9-10|0.1.1 7-8|0.1 6-7|0.1.0 5-6|0.1.0.0 3-4|0 2-3|0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:05.758
(s5 / show-01 
      :ARG0 (m3 / mouse 
            :ARG0-of (m2 / maintain-01 
                  :ARG1 (a2 / ability 
                        :purpose (s / secrete-01 
                              :ARG1 9 
                              :ARG2 (a / and 
                                    :op1 (c / compare-01 
                                          :ARG1 (f / figure) 
                                          :ARG2 (m / mouse))))) 
                  :mod (s2 / still) 
                  :op1-of (y / yet)) 
            :mod (k / knockout)) 
      :ARG1 (a3 / ability 
            :ARG1-of (d / diminish-01 
                  :ARG2 (s4 / significant-02)) 
            :purpose (s3 / secrete-01 
                  :ARG1 (c2 / cholesterol))))

# ::snt Surprisingly , the Abcg8 + / - mice tended to show an increased ability to secrete all sterols above the levels seen in the wild-type mice , although this was not statistically significant .
# ::tok Surprisingly , the Abcg8 + / - mice tended to show an increased ability to secrete all sterols above the levels seen in the wild-type mice , although this was not statistically significant .
# ::alignments 32-33|0.2.0.1.1.0.0.2 31-32|0.2.0.1.1.0.0.2.1 30-31|0.2.0.1.1.0.0.2.2 28-29|0.2.0.1.1.0.0.2.0 25-26|0.2.0.1.1.0.0.0 21-22|0.2.0.1.1.0.0 20-21|0.2.0.1.1.0 18-19|0.2.0.1.1 17-18|0.2.0.1.0 16-17|0.2.0.1.0.0 15-16|0.2.0.1 13-14|0.2.0 12-13|0.2.0.0 10-11|0.2 8-9|0 7-8|0.1 5-6|0.0 3-4|0.0.0.0.0+0.0.0.0+0.0.0 0-1|0.2.0.1.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:06.583
(t2 / tend-01 
      :ARG0 (s7 / slash 
            :mod (c / country 
                  :name (n / name 
                        :op1 "Abcg8"))) 
      :ARG1 (m2 / mouse) 
      :ARG2 (s6 / show-01 
            :ARG1 (a3 / ability 
                  :ARG1-of (i / increase-01) 
                  :purpose (s5 / secrete-01 
                        :ARG1 (s4 / sterol 
                              :quant (a2 / all)) 
                        :manner (a / above 
                              :op1 (l / level 
                                    :ARG1-of (s3 / see-01 
                                          :ARG0 (m / mouse) 
                                          :ARG2 (s8 / surprisingly) 
                                          :purpose-of (s / significant-02 
                                                :ARG1 (t / this) 
                                                :mod (s2 / statistics) 
                                                :polarity -))))))))

# ::snt The mechanism by which dietary cholesterol is specifically absorbed and dietary non-cholesterol sterols primarily excluded or the mechanism ( s ) by which the liver can selectively secrete sterols has not been elucidated .
# ::tok The mechanism by which dietary cholesterol is specifically absorbed and dietary non-cholesterol sterols primarily excluded or the mechanism ( s ) by which the liver can selectively secrete sterols has not been elucidated .
# ::alignments 32-33|0.0.2.0.1.0 30-31|0.0.2.0.1.0.0 28-29|0.0.1 27-28|0.0 26-27|0.0.3 25-26|0 24-25|0.0.0 17-18|0.0.2 15-16|0.0.2.0 14-15|0.0.2.0.0 13-14|0.0.2.0.0.1 12-13|0.0.2.0.0.0 10-11|0.0.2.0.1.1.2.0 9-10|0.0.2.0.1 8-9|0.0.2.0.1.1 7-8|0.0.2.0.1.1.2 5-6|0.0.2.0.1.1.1 4-5|0.0.2.0.1.1.1.0 1-2|0.0.2.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:08.497
(p / possible-01 
      :ARG1 (s2 / secrete-01 
            :ARG0 (l / liver) 
            :ARG1 (s / sterol) 
            :ARG2 (m / mechanism 
                  :op2-of (o / or 
                        :op1 (e2 / exclude-01 
                              :ARG1 (s4 / sterol) 
                              :mod (p2 / primary)) 
                        :op2-of (a / and 
                              :ARG1-of (e / elucidate-01 
                                    :polarity -) 
                              :op1 (a2 / absorb-01 
                                    :ARG0 (m2 / mechanism) 
                                    :ARG1 (c / cholesterol 
                                          :mod (d2 / dietary)) 
                                    :manner (s5 / specific-02 
                                          :mod-of (d / dietary)))))) 
            :manner (s3 / selectively)))

# ::snt Identification of the genetic defect ( s ) in a rare human disorder , sitosterolemia , where these processes are specifically disrupted , may finally have led to the identification of the ` transporters ' responsible for these processes .
# ::tok Identification of the genetic defect ( s ) in a rare human disorder , sitosterolemia , where these processes are specifically disrupted , may finally have led to the identification of the ` transporters ' responsible for these processes .
# ::alignments 38-39|0.0.1.0.0.0 37-38|0.0.1.0.0.0.0 35-36|0.0.1.0.0 33-34|0.0.1.0 29-30|0.0.1 26-27|0.0 24-25|0.0.2 23-24|0 21-22|0.1.0 20-21|0.1.0.1 18-19|0.1 17-18|0.1.1 14-15|0.1.0.0 12-13|0.0.3 11-12|0.0.3.1 10-11|0.0.3.0 4-5|0.0.0 3-4|0.1.0.1.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:09.176
(p2 / possible-01 
      :ARG1 (l / lead-02 
            :ARG1 (d3 / defect-01 
                  :poss-of (i2 / identification)) 
            :ARG2 (i / identify-02 
                  :ARG1 (t2 / transporter 
                        :ARG0-of (r / responsible-01 
                              :ARG1 (p / process-02 
                                    :mod (t / this))))) 
            :time (f / final) 
            :time (d2 / disord 
                  :ARG1-of (r2 / rare-02) 
                  :mod (h / human))) 
      :ARG1-of (p3 / process-02 
            :ARG1-of (d / disrupt-01 
                  :ARG0 (s2 / sitosterolemia) 
                  :manner (s / specific-02 
                        :ARG1 (g / gene))) 
            :mod (t3 / this)))

# ::snt Complete defects in one of two genes ( but not both ) , organized in a head-to-head configuration at the STSL locus , causes sitosterolemia .
# ::tok Complete defects in one of two genes ( but not both ) , organized in a head-to-head configuration at the STSL locus , causes sitosterolemia .
# ::alignments 24-25|0.2.0 23-24|0.2 21-22|0.1.0.0.1.1 20-21|0.1.0.0.1.1.0.0.0+0.1.0.0.1.1.0.0+0.1.0.0.1.1.0 17-18|0.1.0.0.1.0 16-17|0.1.0.0.1.0.0 13-14|0.1.0.0.1 10-11|0.0 9-10|0.1.0.0.0 8-9|0 6-7|0.1 5-6|0.1.0 1-2|0.1.0.0 0-1|0.1.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:09.486
(c3 / contrast-01 
      :ARG0 (b / both) 
      :ARG1 (g / gene 
            :quant (2 / 2 
                  :ARG1-of (d / defect-01 
                        :ARG0 - 
                        :ARG1-of (o / organize-01 
                              :ARG2 (c2 / configuration 
                                    :mod (h / head-to-head)) 
                              :manner (l / locu 
                                    :mod (t / thing 
                                          :name (n / name 
                                                :op1 "STSL")))) 
                        :ARG1-of (c4 / complete-02)))) 
      :ARG2 (c / cause-01 
            :ARG1 (s / sitosterolemia)))

# ::snt We report a mouse model of sitosterolemia , with a selective , but complete , defect in one of these genes , Abcg8 .
# ::tok We report a mouse model of sitosterolemia , with a selective , but complete , defect in one of these genes , Abcg8 .
# ::alignments 22-23|0.0.0.0.0.1.0.0+0.0.0.0.0.1.0+0.0.0.0.0.1 20-21|0.1.0 19-20|0.1.0.0 15-16|0.0.0 13-14|0.1 12-13|0 10-11|0.0 6-7|0.0.0.0.0.0.1 4-5|0.0.0.0.0.0 3-4|0.0.0.0.0.0.0 1-2|0.0.0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:09.706
(c3 / contrast-01 
      :ARG1 (s / selective 
            :mod-of (d / defect-01 
                  :ARG1 (w / we 
                        :ARG0-of (r / report-01 
                              :ARG1 (m / model 
                                    :mod (m2 / mouse) 
                                    :mod (s2 / sitosterolemia)) 
                              :topic (c / country 
                                    :name (n / name 
                                          :op1 "Abcg8")))))) 
      :ARG2-of (c2 / complete-02 
            :ARG1 (g / gene 
                  :mod (t / this))))

# ::snt This mouse reflects the known defects described in human sitosterolemia [ 5,7,42 ] .
# ::tok This mouse reflects the known defects described in human sitosterolemia [ 5,7,42 ] .
# ::alignments 9-10|0.0.0.0.0.0 8-9|0.0.0.0.0 6-7|0.0.0.1 5-6|0.0.0 4-5|0.0.0.0 2-3|0.0 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:09.744
(m / mouse 
      :ARG1-of (r / reflect-01 
            :ARG2 (d2 / defect-01 
                  :ARG1-of (k / know-02 
                        :ARG2 (h / human 
                              :mod-of (s / sitosterolemia))) 
                  :ARG1-of (d / describe-01))) 
      :mod (t / this))

# ::snt Plasma and all tissues , apart from the brain , have significantly elevated sitosterol levels .
# ::tok Plasma and all tissues , apart from the brain , have significantly elevated sitosterol levels .
# ::alignments 14-15|0.0.0.0.1 12-13|0.0.0.0 11-12|0.0.0 8-9|0 5-6|0.0 3-4|0.0.0.0.0.1 2-3|0.0.0.0.0.1.0 1-2|0.0.0.0.0 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:09.820
(b / brain 
      :quant (a / apart 
            :ARG1-of (s / significant-02 
                  :ARG2-of (e / elevate-01 
                        :ARG0 (a3 / and 
                              :op1 (p / plasma) 
                              :op2 (t / tissue 
                                    :quant (a2 / all))) 
                        :ARG1 (l / level)))))

# ::snt Homozygous knockout mice are viable , fertile and sitosterolemic .
# ::tok Homozygous knockout mice are viable , fertile and sitosterolemic .
# ::alignments 7-8|0 6-7|0.1 4-5|0.0.0.0.0 2-3|0.0.0.0 1-2|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:09.845
(a / and 
      :op1 (h / homozygou 
            :mod-of (k / knockout 
                  :mod-of (m / mouse 
                        :domain-of (v / viable)))) 
      :op2 (f / fertile))

# ::snt However , fertility seems to be reduced when homozygous mice are bred together ( S Patel and J Oatis , unpublished observation ) .
# ::tok However , fertility seems to be reduced when homozygous mice are bred together ( S Patel and J Oatis , unpublished observation ) .
# ::alignments 21-22|0.0.1.1.0.0 20-21|0.0.1.1.0 17-19|0.2.0.1+0.2.0.0+0.2.0+0.2 16-17|0 14-16|0.1.0.1+0.1.0.0+0.1.0+0.1 12-13|0.0.2 11-12|0.0 9-10|0.0.0 8-9|0.0.0.0 6-7|0.0.1 3-4|0.0.1.1 2-3|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:10.321
(a / and 
      :ARG0-of (b / breed-01 
            :ARG1 (m / mouse 
                  :mod (h / homozygou)) 
            :condition-of (r / reduce-01 
                  :ARG1 (f / fertility) 
                  :ARG1-of (s / seem-01 
                        :ARG0 (u / unpublish 
                              :mod-of (o / observation)))) 
            :manner (t / together)) 
      :op1 (p2 / person 
            :name (n2 / name 
                  :op1 "S" 
                  :op2 "Patel")) 
      :op2 (p / person 
            :name (n / name 
                  :op1 "J" 
                  :op2 "Oatis")))

# ::snt This model reflects many other observed changes described in limited studies in humans .
# ::tok This model reflects many other observed changes described in limited studies in humans .
# ::alignments 12-13|0.0.1.0.0 10-11|0.0.1.0 9-10|0.0.1.0.1 7-8|0.0.1 6-7|0.0 5-6|0.0.2 4-5|0.0.3 3-4|0.0.4 2-3|0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:10.440
(r / reflect-01 
      :ARG1 (c / change-01 
            :ARG0 (m2 / model 
                  :mod (t / this)) 
            :ARG1-of (d / describe-01 
                  :ARG2 (s / study-01 
                        :ARG0 (h / human) 
                        :ARG1-of (l / limit-01))) 
            :ARG1-of (o / observe-01) 
            :mod (o2 / other) 
            :quant (m / many)))

# ::snt For example , in humans , the activity of HMG-CoA reductase and CYP7a1 have been reported to be low [ 7,39 ] .
# ::tok For example , in humans , the activity of HMG-CoA reductase and CYP7a1 have been reported to be low [ 7,39 ] .
# ::alignments 18-19|0.0.2.0 15-16|0 12-13|0.0.2.1.0+0.0.2.1+0.0.2 11-12|0.0 10-11|0.0.1 9-10|0.0.2.2.0.0+0.0.2.2.0+0.0.2.2 7-8|0.0.0 4-5|0.0.2.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:10.620
(r / report-01 
      :ARG1 (a / and 
            :op1 (a2 / activity-06 
                  :ARG1 (e / example)) 
            :op2 (r2 / reductase) 
            :op3 (t / thing 
                  :ARG0-of (l / low-04 
                        :ARG2 (h / human)) 
                  :name (n / name 
                        :op1 "CYP7a1") 
                  :quant (o / organization 
                        :name (n2 / name 
                              :op1 "HMG-CoA")))))

# ::snt In this study , we show that the mRNA and enzyme activities in the livers from knockout animals are also significantly reduced .
# ::tok In this study , we show that the mRNA and enzyme activities in the livers from knockout animals are also significantly reduced .
# ::alignments 21-22|0.1 20-21|0.1.1 19-20|0.1.2 17-18|0.1.0.3.0 16-17|0.1.0.3.0.0 14-15|0.1.0.0 11-12|0.1.0.3 10-11|0.1.0.2 9-10|0.1.0 8-9|0.1.0.1 5-6|0 4-5|0.0 2-3|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:10.844
(s2 / show-01 
      :ARG0 (w / we 
            :ARG0-of (s3 / study-01 
                  :mod (t / this))) 
      :ARG1 (r / reduce-01 
            :ARG1 (a4 / and 
                  :example-of (l / liver) 
                  :op1 (m / mrna) 
                  :op2 (e / enzyme) 
                  :op3 (a3 / activity-06 
                        :ARG0 (a2 / animal 
                              :mod (k / knockout)))) 
            :ARG1-of (s / significant-02) 
            :mod (a / also)))

# ::snt Additionally , the activity of the rate-limiting enzyme for bile acid synthesis , CYP7a1 , is reduced , although no changes at the mRNA level are noted .
# ::tok Additionally , the activity of the rate-limiting enzyme for bile acid synthesis , CYP7a1 , is reduced , although no changes at the mRNA level are noted .
# ::alignments 26-27|0.0.0.1 24-25|0.0 23-24|0 20-21|0.0.0 19-20|0.0.0.2 16-17|0.0.0.1.1 13-14|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 11-12|0.0.0.1.1.0.1.0 10-11|0.0.0.1.1.0.0 9-10|0.0.0.1.1.0.0.0 7-8|0.0.0.1.1.0.1 6-7|0.0.0.1.1.0.1.1 3-4|0.0.0.1.1.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:11.111
(m / mrna 
      :mod-of (l / level 
            :location-of (c / change-01 
                  :ARG0 (a3 / additional) 
                  :ARG1-of (n / note-01 
                        :ARG0 (t / thing 
                              :name (n2 / name 
                                    :op1 "CYP7a1")) 
                        :condition-of (r / reduce-01 
                              :ARG1 (a2 / activity-06 
                                    :ARG0 (a / acid 
                                          :mod (b / bile)) 
                                    :ARG1 (e / enzyme 
                                          :beneficiary (s / synthesi) 
                                          :mod (r2 / rate-limit))))) 
                  :polarity -)))

# ::snt This is also in keeping with previous studies that show that sitosterol is a direct inhibitor of this enzyme in vitro [ 39 ] .
# ::tok This is also in keeping with previous studies that show that sitosterol is a direct inhibitor of this enzyme in vitro [ 39 ] .
# ::alignments 22-23|0.0.0.0.0 18-19|0.0.2 17-18|0.0.2.0 15-16|0.0 14-15|0.0.1 11-12|0 9-10|0.0.0 7-8|0.0.0.0 6-7|0.0.0.0.2 4-5|0.0.0.0.1 2-3|0.0.1.0 0-1|0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:11.270
(s / sitosterol 
      :domain-of (i / inhibitor 
            :ARG1-of (s2 / show-01 
                  :ARG0 (s3 / study-01 
                        :ARG0 39 
                        :ARG1-of (k / keep-02 
                              :ARG0 (t2 / this)) 
                        :time (p / previous))) 
            :ARG1-of (d / direct-02 
                  :ARG0 (a / also)) 
            :poss (e / enzyme 
                  :mod (t / this))))

# ::snt Biliary sterols of Abcg8-deficient mice were dramatically different compared to wild-type mice .
# ::tok Biliary sterols of Abcg8-deficient mice were dramatically different compared to wild-type mice .
# ::alignments 11-12|0 8-9|0.0 7-8|0.0.0.0 6-7|0.0.0.0.0 4-5|0.0.0.2 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:11.316
(m / mouse 
      :ARG2-of (c / compare-01 
            :ARG1 (s / sterol 
                  :ARG1-of (d / differ-02 
                        :mod (d2 / dramatic)) 
                  :mod (b / biliary) 
                  :mod (m2 / mouse))))

# ::snt Measurement of biliary sterol secretion rates in Abcg8 - / - mice demonstrated a failure to increase sterol secretion into bile despite exogenous infusion of bile acids .
# ::tok Measurement of biliary sterol secretion rates in Abcg8 - / - mice demonstrated a failure to increase sterol secretion into bile despite exogenous infusion of bile acids .
# ::alignments 26-27|0.1.0 25-26|0.1.0.0 23-24|0.1.0.1 22-23|0.1.0.1.0 20-21|0.1.0.2 18-19|0.1.1.1 17-18|0.0.0 16-17|0.1.1 14-15|0.1 12-13|0 11-12|0.0 9-10|0.1.1.2 7-8|0.1.2.0.0+0.1.2.0+0.1.2 5-6|0.1.1.0.0 4-5|0.1.1.0.0.0 3-4|0.1.1.0.0.2 2-3|0.1.1.0.0.1 0-1|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:11.960
(d / demonstrate-01 
      :ARG0 (m / mouse 
            :mod (s2 / sterol)) 
      :ARG1 (f / fail-01 
            :ARG0 (a / acid 
                  :mod (b / bile) 
                  :mod-of (i / infusion 
                        :mod (e / exogenou)) 
                  :prep-in-of (b2 / bile)) 
            :ARG2 (i2 / increase-01 
                  :ARG0 (m2 / measurement 
                        :mod (r / rate 
                              :mod (s4 / secretion) 
                              :mod (b3 / biliary) 
                              :mod (s5 / sterol))) 
                  :ARG1 (s / secretion) 
                  :ARG2 (s3 / slash)) 
            :location (c / country 
                  :name (n / name 
                        :op1 "Abcg8"))))

# ::snt Furthermore , complete loss of Abcg8/sterolin -2 results in an inability to secrete cholesterol into bile , although secretion of sitosterol seemed to be preserved .
# ::tok Furthermore , complete loss of Abcg8/sterolin -2 results in an inability to secrete cholesterol into bile , although secretion of sitosterol seemed to be preserved .
# ::alignments 24-25|0.1.0.0 21-22|0.1.0 18-19|0.1.0.0.0 15-16|0.2.0.2 13-14|0.2.0.1 12-13|0.2.0 10-11|0.2.1+0.2 7-8|0 5-6|0.0.0.0+0.0.0+0.0 3-4|0.1 2-3|0.1.1 0-1|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:12.187
(r / result-01 
      :ARG0 (c2 / country 
            :name (n / name 
                  :op1 "Abcg8/sterolin")) 
      :ARG1 (l / loss 
            :ARG0-of (s / seem-01 
                  :ARG1 (p / preserve-01 
                        :ARG1 (s2 / secretion))) 
            :ARG1-of (c3 / complete-02)) 
      :ARG2 (a / ability 
            :domain (s3 / secrete-01 
                  :ARG0 (f / furthermore) 
                  :ARG1 (c / cholesterol) 
                  :ARG2 (b / bile)) 
            :polarity -))

# ::snt Arguably , since the body pools and plasma sitosterol levels in the knockout mice are so considerably elevated , perhaps the biliary sitosterol levels could be considered to be inappropriately low .
# ::tok Arguably , since the body pools and plasma sitosterol levels in the knockout mice are so considerably elevated , perhaps the biliary sitosterol levels could be considered to be inappropriately low .
# ::alignments 30-31|0.1.1 29-30|0.1.1.2 26-27|0.1 24-25|0 23-24|0.1.1.1 21-22|0.1.1.1.0 19-20|0.1.1.0 17-18|0.1.0.0 16-17|0.1.0.0.0 13-14|0.0.0 12-13|0.0 9-10|0.1.0.2 8-9|0.1.0.2.1 7-8|0.1.0.2.1.0 6-7|0.1.0 5-6|0.1.0.1 4-5|0.1.0.2.0 2-3|0.2 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:12.562
(p / possible-01 
      :ARG0 (k / knockout 
            :mod-of (m / mouse 
                  :poss-of (a2 / arguably))) 
      :ARG1 (c / consider-01 
            :ARG0 (a / and 
                  :ARG1-of (e / elevate-01 
                        :degree (c2 / considerable)) 
                  :op1 (p4 / pool) 
                  :op2 (l3 / level 
                        :mod (b2 / body) 
                        :mod (s / sitosterol 
                              :mod (p3 / plasma)))) 
            :ARG1 (l / low-04 
                  :ARG0 (p2 / perhaps) 
                  :ARG1 (l2 / level 
                        :mod (b / biliary)) 
                  :mod (i / inappropriately))) 
      :op1-of (s2 / since))

# ::snt Despite this reservation , the finding that sitosterol is present in the bile suggests that plant sterols may be secreted independent of Abcg8/sterolin -2 .
# ::tok Despite this reservation , the finding that sitosterol is present in the bile suggests that plant sterols may be secreted independent of Abcg8/sterolin -2 .
# ::alignments 22-23|0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 20-21|0.1.1.3+0.1.1 19-20|0.1.1.2 17-18|0.1 16-17|0.1.1.0 15-16|0.1.1.0.0 13-14|0 12-13|0.1.0 9-10|0.0.0 7-8|0.0.0.0 5-6|0.0 2-3|0.2.0 1-2|0.2.0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:12.734
(s3 / suggest-01 
      :ARG0 (f / find-01 
            :ARG1 (p3 / present 
                  :domain (s4 / sitosterol))) 
      :ARG1 (p / possible-01 
            :ARG0 (b / bile) 
            :ARG1 (d / depend-01 
                  :ARG0 (s2 / sterol 
                        :location (p2 / plant)) 
                  :ARG1 (c / country 
                        :name (n / name 
                              :op1 "Abcg8/sterolin")) 
                  :ARG1-of (s / secrete-01) 
                  :polarity -)) 
      :time (d2 / despite 
            :op1 (r / reservation 
                  :mod (t / this))))

# ::snt The ability of Abcg8 - / - mice to secrete bile salt and phospholipid into bile as compared to wild-type mice was not significantly impaired .
# ::tok The ability of Abcg8 - / - mice to secrete bile salt and phospholipid into bile as compared to wild-type mice was not significantly impaired .
# ::alignments 24-25|0.0.2.1.0 23-24|0.0.2.1.0.0 22-23|0.0.2.1.0.1 20-21|0.0.2.1 17-18|0.0.2 15-16|0.1 12-13|0 11-12|0.0.1 10-11|0.0.1.0 9-10|0.0 7-8|0.0.0 5-6|0.0.3 3-4|0.0.2.0.0.0+0.0.2.0.0+0.0.2.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:12.874
(a / and 
      :op1 (s3 / secrete-01 
            :ARG0 (m2 / mouse 
                  :poss-of (a2 / ability)) 
            :ARG1 (s2 / salt 
                  :mod (b2 / bile)) 
            :ARG1-of (c / compare-01 
                  :ARG0 (c2 / country 
                        :name (n / name 
                              :op1 "Abcg8")) 
                  :ARG2 (m / mouse 
                        :ARG1-of (i / impair-01 
                              :ARG1-of (s / significant-02) 
                              :polarity -))) 
            :ARG2 (s4 / slash)) 
      :time (b / bile))

# ::snt Collectively these data suggest that Abcg8/sterolin -2 is necessary for hepatobiliary cholesterol secretion in mice .
# ::tok Collectively these data suggest that Abcg8/sterolin -2 is necessary for hepatobiliary cholesterol secretion in mice .
# ::alignments 14-15|0.1.1 12-13|0.1.1.0 11-12|0.1.1.0.0 5-6|0.2.0.0+0.2.0+0.2 3-4|0 2-3|0.1 1-2|0.1.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:13.024
(s2 / suggest-01 
      :ARG0 (c3 / collectively) 
      :ARG1 (d / data 
            :mod (t / this) 
            :part-of (m / mouse 
                  :location-of (s / secretion 
                        :mod (c / cholesterol)))) 
      :location (c2 / country 
            :name (n / name 
                  :op1 "Abcg8/sterolin")))

# ::snt Abcg8 - / - mice appeared normal and healthy maintained on a regular rodent chow diet .
# ::tok Abcg8 - / - mice appeared normal and healthy maintained on a regular rodent chow diet .
# ::alignments 15-16|0.1.2.0 14-15|0.1.2.0.1 13-14|0.1.2.0.1.0 12-13|0.1.2.0.0 9-10|0.1.2 8-9|0.1.1 7-8|0.1 6-7|0.1.0 5-6|0 4-5|0.1.0.0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:13.207
(a2 / appear-01 
      :ARG0 (s / slash) 
      :ARG1 (a / and 
            :op1 (n / normal-02 
                  :ARG1 (m2 / mouse)) 
            :op2 (h / healthy) 
            :op3 (m / maintain-01 
                  :ARG1 (d / diet 
                        :ARG1-of (r2 / regular-02) 
                        :mod (c / chow 
                              :mod (r / rodent))))))

# ::snt Their phenotypic features are very similar to those recently reported for a mouse deficient in both sterolins simultaneously [ 7,20 ] .
# ::tok Their phenotypic features are very similar to those recently reported for a mouse deficient in both sterolins simultaneously [ 7,20 ] .
# ::alignments 17-18|0.0.0.0.0.0.0 16-17|0.0.0 15-16|0.0.0.0 13-14|0.0 12-13|0.0.1 9-10|0 8-9|0.1 5-6|0.0.0.0.0.0 4-5|0.0.0.0.0.0.1 2-3|0.0.0.0.0 1-2|0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:13.307
(r / report-01 
      :ARG1 (d / deficient 
            :location (s2 / sterolin 
                  :mod (b / both 
                        :ARG1-of (f / feature-01 
                              :ARG1-of (r3 / resemble-01 
                                    :ARG0 (s / simultaneous) 
                                    :degree (v / very)) 
                              :mod (p / phenotypic)))) 
            :mod (m / mouse)) 
      :time (r2 / recent))

# ::snt Plasma and hepatic plant sterol levels in Abcg8 - / - and Abcg5/Abcg8 knockout are increased similarly with marked decreases in cholesterol levels .
# ::tok Plasma and hepatic plant sterol levels in Abcg8 - / - and Abcg5/Abcg8 knockout are increased similarly with marked decreases in cholesterol levels .
# ::alignments 22-23|0.2.1 21-22|0.2.1.0 19-20|0.2 18-19|0.2.2 16-17|0.1 15-16|0 13-14|0.0.2.0.1 11-12|0.0.2.0 9-10|0.0.2 7-8|0.0.2.0.0 5-6|0.0.1 4-5|0.0.1.0 3-4|0.0.1.0.0 2-3|0.2.0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:13.909
(i / increase-01 
      :ARG1 (a3 / and 
            :op1 (p2 / plasma) 
            :op2 (l2 / level 
                  :mod (s3 / sterol 
                        :mod (p / plant))) 
            :op3 (s2 / slash 
                  :op2-of (a / and 
                        :op1 (a2 / Abcg8) 
                        :op3 (k / knockout)))) 
      :ARG2 (s / similarly) 
      :accompanier (d / decrease-01 
            :ARG0 (h / hepatic) 
            :ARG1 (l / level 
                  :mod (c / cholesterol)) 
            :ARG1-of (m / mark-01)))

# ::snt Interestingly , plasma triglyceride levels of the Abcg8 - / - mice were slightly higher than wild-type animals and this increased triglyceride is carried in the LDL fraction range , as measured by FPLC .
# ::tok Interestingly , plasma triglyceride levels of the Abcg8 - / - mice were slightly higher than wild-type animals and this increased triglyceride is carried in the LDL fraction range , as measured by FPLC .
# ::alignments 33-34|0.1.0.1.0.0.0+0.1.0.1.0.0+0.1.0.1.0 31-32|0.1.0.1 28-29|0.1.0.2 27-28|0.1.0.2.0 26-27|0.1.0.2.0.0 23-24|0.1.0 21-22|0.1 20-21|0 19-20|0.1.1 18-19|0.1.0.3 17-18|0.1.0.3.0.1 14-15|0.1.0.3.0 13-14|0.1.0.3.0.2 11-12|0.1.0.3.0.0.1 9-10|0.1.0.0 4-5|0.1.0.3.0.0 3-4|0.1.0.3.0.0.0 2-3|0.1.0.3.0.0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:14.524
(i / increase-01 
      :ARG0 (i2 / interesting) 
      :ARG1 (t / triglyceride 
            :ARG1-of (c / carry-out-03 
                  :ARG0 (s2 / slash) 
                  :ARG1-of (m / measure-01 
                        :ARG0 (o / organization 
                              :name (n / name 
                                    :op1 "FPLC"))) 
                  :ARG2 (r / range-01 
                        :ARG1 (f / fraction 
                              :mod (l / ldl))) 
                  :op2-of (a / and 
                        :op1 (h / high-02 
                              :ARG1 (l2 / level 
                                    :mod (t3 / triglyceride 
                                          :mod (p / plasma)) 
                                    :part-of (m2 / mouse)) 
                              :compared-to (a2 / animal) 
                              :degree (s / slight)))) 
            :mod (t2 / this)))

# ::snt The significance of this is not clear , although preliminary SDS-PAGE analyses of all the fractions failed to reveal any differences between wild-type and knockout samples .
# ::tok The significance of this is not clear , although preliminary SDS-PAGE analyses of all the fractions failed to reveal any differences between wild-type and knockout samples .
# ::alignments 25-26|0+0.0 24-25|0.0.1 23-24|0.0.0.0.2 20-21|0.0.0 19-20|0.0.0.1 18-19|0.0.0.0 16-17|0.0.0.0.1 15-16|0.0.0.0.0.1 13-14|0.0.0.0.0.1.0 11-12|0.0.0.0.0 9-10|0.0.0.0.0.0 6-7|0.0.0.0.1.0.1 5-6|0.0.0.0.1.0.1.0 3-4|0.0.0.0.1.0.0 1-2|0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:14.843
(s / sample-01 
      :ARG1 (t / thing 
            :ARG0-of (d / differ-01 
                  :ARG1-of (r / reveal-01 
                        :ARG0 (a4 / analysis 
                              :mod (p / preliminary) 
                              :poss (f2 / fraction-01 
                                    :mod (a3 / all))) 
                        :ARG2-of (f / fail-01 
                              :ARG1 (s2 / significant-02 
                                    :ARG1 (t2 / this) 
                                    :ARG1-of (c / clear-06 
                                          :polarity -))) 
                        :op1-of (a / and)) 
                  :mod (a2 / any)) 
            :mod (k / knockout)))

# ::snt Hepatic levels of GC-measured cholesterol were greatly reduced in Abcg8 - / - mice compared to wild-type mice , yet mRNA levels of HMG-CoA reductase and enzyme activity are also reduced without any significant change in mRNA of the Srebps .
# ::tok Hepatic levels of GC-measured cholesterol were greatly reduced in Abcg8 - / - mice compared to wild-type mice , yet mRNA levels of HMG-CoA reductase and enzyme activity are also reduced without any significant change in mRNA of the Srebps .
# ::alignments 36-37|0.0.0.3.0 34-35|0.0.0.3 33-34|0.0.0.3.1 32-33|0.0.0.3.2 30-31|0.0.0 29-30|0.0.0.1 27-28|0.2 26-27|0.2.1 25-26|0 24-25|0.1 23-24|0.1.0.0.0+0.1.0.0+0.1.0 21-22|0.0 20-21|0.0.1 19-20|0.0.0.2 17-18|0.0.0.2.1.0 14-15|0.0.0.2.1 13-14|0.0.0.2.0.2 11-12|0.0.0.2.0.0 9-10|0.2.0.0.0+0.2.0.0+0.2.0 7-8|0.0.0.2.0 6-7|0.0.0.2.0.1 4-5|0.0.0.0.0 3-4|0.0.0.0.0.0 1-2|0.0.0.0 0-1|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:15.950
(a4 / and 
      :op1 (l / level 
            :ARG1-of (r / reduce-01 
                  :ARG0 (l2 / level 
                        :mod (c4 / cholesterol 
                              :mod (g2 / gc-measur)) 
                        :mod (h / hepatic)) 
                  :mod (a2 / also) 
                  :op1-of (y / yet 
                        :ARG0-of (r3 / reduce-01 
                              :ARG1 (s2 / slash) 
                              :extent (g / great) 
                              :location (m4 / mouse)) 
                        :ARG1-of (c2 / compare-01 
                              :ARG2 (m3 / mouse))) 
                  :prep-without (c / change-01 
                        :ARG1 (m / mrna) 
                        :ARG1-of (s / significant-02) 
                        :mod (a / any))) 
            :mod (m2 / mrna)) 
      :op2 (r2 / reductase 
            :mod (o / organization 
                  :name (n / name 
                        :op1 "HMG-CoA"))) 
      :op3 (a3 / activity-06 
            :ARG0 (c3 / country 
                  :name (n2 / name 
                        :op1 "Abcg8")) 
            :ARG1 (e / enzyme)))

# ::snt The basis for this is not clear at present , unless the increase in non-plant sterols leads to a suppression of SREBP activation .
# ::tok The basis for this is not clear at present , unless the increase in non-plant sterols leads to a suppression of SREBP activation .
# ::alignments 22-23|0 19-20|0.1 16-17|0.1.0.0 15-16|0.1.0.1 12-13|0.1.0 8-9|0.0.1 6-7|0.0 5-6|0.0.2 3-4|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:16.048
(a / activation 
      :ARG0-of (c / clear-06 
            :ARG1 (t / this) 
            :compared-to (p / present) 
            :polarity -) 
      :ARG1-of (s / suppress-01 
            :ARG0 (i / increase-01 
                  :ARG0-of (l / lead-03) 
                  :ARG1 (s2 / sterol))))

# ::snt Sitosterol has been shown to directly inhibit Cyp7a1 activity in vitro and we presume this may account for the reduced enzyme activity [ 39 ] .
# ::tok Sitosterol has been shown to directly inhibit Cyp7a1 activity in vitro and we presume this may account for the reduced enzyme activity [ 39 ] .
# ::alignments 23-24|0.0.0.0 21-22|0.1.0.1.0.1 20-21|0.1.0.1.0.1.1 19-20|0.1.0.1.0.1.0 16-17|0.1.0.1.0 15-16|0.1.0.1 14-15|0.1.0.1.0.0 13-14|0.1.0 12-13|0.1.0.0 11-12|0.1 8-9|0.0.0 6-7|0.0 5-6|0.0.1 3-4|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:16.249
(s / show-01 
      :ARG1 (i / inhibit-01 
            :ARG1 (a4 / activity-06 
                  :ARG1 39) 
            :ARG1-of (d / direct-02)) 
      :op1-of (a3 / and 
            :op2 (p2 / presume-01 
                  :ARG0 (w / we) 
                  :ARG1 (p / possible-01 
                        :ARG1 (a2 / account-01 
                              :ARG0 (t / this) 
                              :ARG1 (a / activity-06 
                                    :ARG1-of (r / reduce-01) 
                                    :mod (e / enzyme)))))))

# ::snt In preliminary studies , when knockout mice are placed on a low sitosterol diet , the activity of this enzyme , as well as the mRNA levels are increased ( E Klett and S Patel , unpublished observations ) .
# ::tok In preliminary studies , when knockout mice are placed on a low sitosterol diet , the activity of this enzyme , as well as the mRNA levels are increased ( E Klett and S Patel , unpublished observations ) .
# ::alignments 37-38|0.0.2 36-37|0.0.2.0 33-35|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 32-33|0.0 30-32|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 28-29|0 26-27|0.1.0.0.0.0 25-26|0.1.0.0.0 19-20|0.1.0 18-19|0.1.0.0 16-17|0.1 13-14|0.1.1 12-13|0.1.1.2 11-12|0.1.1.0 8-9|0.1.1.1 6-7|0.1.1.1.0 5-6|0.1.1.1.0.0 2-3|0.1.2 1-2|0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:17.407
(i / increase-01 
      :ARG0 (a / and 
            :op1 (t / thing 
                  :name (n2 / name 
                        :op1 (e / E) 
                        :op2 (k / Klett))) 
            :op2 (p / person 
                  :name (n / name 
                        :op1 "S" 
                        :op2 "Patel")) 
            :op3 (o / observation 
                  :mod (u / unpublish))) 
      :ARG1 (a2 / activity-06 
            :ARG0 (e2 / enzyme 
                  :mod (t2 / this 
                        :mod-of (m / mrna 
                              :mod-of (l / level)))) 
            :ARG1 (d / diet 
                  :ARG1-of (l2 / low-04) 
                  :ARG2-of (p2 / place-01 
                        :ARG1 (m2 / mouse 
                              :mod (k2 / knockout))) 
                  :mod (s / sitosterol)) 
            :ARG1-of (s2 / study-01 
                  :mod (p3 / preliminary))))

# ::snt Another prediction , based upon the enzyme and mRNA levels in knockout mice , is that if these mice are placed on a high cholesterol/high sitosterol diet , they may show significant accumulation of both sterols in the body .
# ::tok Another prediction , based upon the enzyme and mRNA levels in knockout mice , is that if these mice are placed on a high cholesterol/high sitosterol diet , they may show significant accumulation of both sterols in the body .
# ::alignments 38-39|0.2.0.0.0.0.4 35-36|0.2.0.0.0.0.2 34-35|0.2.0.0.0.0.2.0 32-33|0.2.0.0.0.0.1 31-32|0.2.0.0.0.0.1.0 30-31|0.2.0.0.0.0 29-30|0.2.0.0.0 28-29|0.2.0.0.0.0.0 26-27|0.2.0.0.0.0.3.2 25-26|0.2.0.0.0.0.3.2.1 23-24|0.2.0.0.0.0.3.2.0 20-21|0.2.0.0.0.0.3 18-19|0.2.0.0.0.0.3.1 17-18|0.2.0.0.0.0.3.1.0 12-13|0.2.0.0.0.0.3.0 11-12|0.2.0.0.0.0.3.0.0 9-10|0.2 8-9|0.1 7-8|0 6-7|0.0 3-4|0.2.0 1-2|0.2.0.0 0-1|0.2.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:17.781
(a2 / and 
      :op1 (e / enzyme) 
      :op2 (m3 / mrna) 
      :op3 (l / level 
            :ARG2-of (b3 / base-02 
                  :ARG1 (p3 / predict-01 
                        :ARG1 (p / possible-01 
                              :ARG1 (s3 / show-01 
                                    :ARG0 (t / they) 
                                    :ARG1 (a / accumulation 
                                          :ARG1-of (s2 / significant-02)) 
                                    :ARG2 (s / sterol 
                                          :mod (b2 / both)) 
                                    :condition (p2 / place-01 
                                          :ARG0 (m2 / mouse 
                                                :mod (k / knockout)) 
                                          :ARG1 (m / mouse 
                                                :mod (t2 / this)) 
                                          :ARG2 (d / diet 
                                                :ARG1-of (h / high-02) 
                                                :mod (s4 / sitosterol))) 
                                    :time (b / body))) 
                        :mod (a3 / another)))))

# ::snt This may also be relevant to the human disorder where some , although not all affected individuals , manifest premature coronary artery disease .
# ::tok This may also be relevant to the human disorder where some , although not all affected individuals , manifest premature coronary artery disease .
# ::alignments 22-23|0.0.2.0.0 21-22|0.0.2.0.0.0 20-21|0.0.2.0.0.2 19-20|0.0.2.0.0.1 18-19|0.0.2.0 16-17|0.0.2.0.1 15-16|0.0.2.0.1.0 14-15|0.0.2.0.1.2 13-14|0.0.2.0.1.1 10-11|0.0.0 8-9|0.0.2 7-8|0.0.2.1 4-5|0.0 2-3|0.0.3 1-2|0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:18.217
(p2 / possible-01 
      :ARG1 (r / relevant-01 
            :ARG0 (s / some) 
            :ARG1 (t / this) 
            :ARG2 (d2 / disord 
                  :ARG0-of (m / manifest-01 
                        :ARG1 (d / disease 
                              :mod (a / artery) 
                              :mod (p / premature) 
                              :mod (c / coronary)) 
                        :ARG2 (i / individual 
                              :ARG1-of (a2 / affect-01) 
                              :polarity - 
                              :quant (a3 / all))) 
                  :mod (h / human)) 
            :manner (a4 / also)))

# ::snt Abcg8/sterolin -2 deficient mice also allow us to examine the role of this protein in biliary sterol secretion .
# ::tok Abcg8/sterolin -2 deficient mice also allow us to examine the role of this protein in biliary sterol secretion .
# ::alignments 17-18|0.0.1.0 16-17|0.0.1.0.0 15-16|0.0.1.0.1 13-14|0.0.1.1 12-13|0.0.1.1.0 10-11|0.0.1 8-9|0.0 5-6|0 4-5|0.1 3-4|0.0.0 2-3|0.0.0.1 0-1|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:18.741
(a / allow-01 
      :ARG1 (e / examine-01 
            :ARG0 (m / mouse 
                  :mod (c / country 
                        :name (n / name 
                              :op1 "Abcg8/sterolin")) 
                  :mod (d / deficient)) 
            :ARG1 (r / role 
                  :mod (s / secretion 
                        :mod (s2 / sterol) 
                        :mod (b / biliary)) 
                  :poss (p / protein 
                        :mod (t / this)))) 
      :mod (a2 / also))

# ::snt The bile is sterol poor and upon stimulation by increasing bile salt excretion , Abcg8/sterolin -2 deficient mice can not respond , in contrast to the wild-type mice .
# ::tok The bile is sterol poor and upon stimulation by increasing bile salt excretion , Abcg8/sterolin -2 deficient mice can not respond , in contrast to the wild-type mice .
# ::alignments 27-28|0.3.1 23-24|0.3 20-21|0 19-20|0.2.0 18-19|0.2 17-18|0.0 16-17|0.0.1 14-15|0.0.0.0.0+0.0.0.0+0.0.0 12-13|0.1.1.0.0 11-12|0.1.1.0.0.0 10-11|0.1.1.0.0.0.0 9-10|0.1.1.0 7-8|0.1.1 5-6|0.1 4-5|0.1.0 3-4|0.3.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:19.174
(r / respond-01 
      :ARG0 (m2 / mouse 
            :mod (c2 / country 
                  :name (n / name 
                        :op1 "Abcg8/sterolin")) 
            :mod (d / deficient)) 
      :ARG1 (a / and 
            :op1 (p2 / poor 
                  :domain (b2 / bile)) 
            :op2 (s2 / stimulation 
                  :ARG0-of (i / increase-01 
                        :ARG1 (e / excretion 
                              :mod (s / salt 
                                    :mod (b / bile)))))) 
      :ARG1-of (p / possible-01 
            :polarity -) 
      :ARG1-of (c / contrast-01 
            :ARG0 (s3 / sterol) 
            :ARG2 (m / mouse)))

# ::snt Thus , Abcg8/sterolin -2 is necessary for cholesterol secretion but not necessary for plant sterol secretion .
# ::tok Thus , Abcg8/sterolin -2 is necessary for cholesterol secretion but not necessary for plant sterol secretion .
# ::alignments 15-16|0.1.1 14-15|0.1.1.0 13-14|0.1 10-11|0.0.1 9-10|0 8-9|0.0.0 7-8|0.0 2-3|0.1.0.0.0+0.1.0.0+0.1.0 0-1|0.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:19.269
(c / contrast-01 
      :ARG0 (c2 / cholesterol 
            :mod-of (s3 / secretion) 
            :op1-of -) 
      :ARG1 (p / plant 
            :location (c3 / country 
                  :name (n / name 
                        :op1 "Abcg8/sterolin")) 
            :location-of (s / secretion 
                  :mod (s2 / sterol 
                        :mod (t / thu)))))

# ::snt It could be argued that although the biliary sterol output is comparable to that seen in wild-type mice that this is inappropriately low , since the tissue and plasma pools of sitosterol are so elevated in the knockout mice .
# ::tok It could be argued that although the biliary sterol output is comparable to that seen in wild-type mice that this is inappropriately low , since the tissue and plasma pools of sitosterol are so elevated in the knockout mice .
# ::alignments 38-39|0.3.0.0 37-38|0.3.0.0.0 34-35|0.3.0 31-32|0.3.1 29-30|0.3 28-29|0.2 27-28|0 26-27|0.1 24-25|0.3.0.1 22-23|0.0.0.1.0 21-22|0.0.0.1.0.2 19-20|0.0.0.1.0.1 17-18|0.0.0.1.1.0.0 14-15|0.0.0.1.1.0 11-12|0.0.0.1 9-10|0.0.0.1.1 8-9|0.0.0.1.0.0 7-8|0.0.0.1.1.0.1 3-4|0.0.0 1-2|0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:20.509
(a / and 
      :op1 (p3 / possible-01 
            :ARG1 (a2 / argue-01 
                  :ARG1 (i2 / it) 
                  :ARG2 (c / comparable-03 
                        :ARG0 (l / low-04 
                              :ARG0 (s4 / sterol) 
                              :ARG1 (t2 / this) 
                              :mod (i / inappropriately)) 
                        :ARG1 (o / output 
                              :ARG0-of (s3 / see-01 
                                    :ARG1 (m2 / mouse) 
                                    :ARG2 (b / biliary)))))) 
      :op2 (t / tissue) 
      :op3 (p2 / plasma) 
      :op4 (p / pool 
            :ARG0-of (e / elevate-01 
                  :ARG1 (m / mouse 
                        :mod (k / knockout)) 
                  :time (s2 / since)) 
            :consist-of (s / sitosterol)))

# ::snt Despite this caveat , the findings of sitosterol in significant quantities in the bile suggests that mechanisms other than via the sterolins can ` export ' some of these sterols .
# ::tok Despite this caveat , the findings of sitosterol in significant quantities in the bile suggests that mechanisms other than via the sterolins can ` export ' some of these sterols .
# ::alignments 29-30|0.1.1 28-29|0.1.1.0 26-27|0.1.1.1 24-25|0.1 22-23|0.1.2 21-22|0.1.3 17-18|0.1.0.0 16-17|0.1.0 14-15|0 13-14|0.2 10-11|0.1.2.0 9-10|0.1.2.0.0 7-8|0.0.0.0 5-6|0.0.0+0.0 2-3|0.3.0 1-2|0.3.0.0 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:21.335
(s4 / suggest-01 
      :ARG0 (t2 / thing 
            :ARG1-of (f / find-01 
                  :ARG0 (s6 / sitosterol))) 
      :ARG1 (e / export-01 
            :ARG0 (m / mechanism 
                  :mod (o / other)) 
            :ARG1 (s / sterol 
                  :mod (t / this) 
                  :quant (s2 / some)) 
            :ARG1-of (p / possible-01 
                  :ARG0 (q / quantity 
                        :ARG1-of (s5 / significant-02))) 
            :ARG2 (s3 / sterolin)) 
      :manner (b / bile) 
      :time (d / despite 
            :op1 (c / caveat 
                  :mod (t3 / this))))

# ::snt Interestingly , although humans who are heterozygous for genetic defects in either ABCG5 or ABCG8 seem to be phenotypically normal , mice heterozygous for Abcg8/sterolin -2 deficiency show that sterol secretion is impaired , but not absent .
# ::tok Interestingly , although humans who are heterozygous for genetic defects in either ABCG5 or ABCG8 seem to be phenotypically normal , mice heterozygous for Abcg8/sterolin -2 deficiency show that sterol secretion is impaired , but not absent .
# ::alignments 36-37|0.0.1.0 35-36|0.0.1.0.0 34-35|0 32-33|0.0 30-31|0.0.1 29-30|0.0.1.1 27-28|0.1 26-27|0.1.1 24-25|0.1.0.0.0+0.1.0.0+0.1.0 21-22|0.0.2.0.0.0 19-20|0.0.2.0 15-16|0.0.2.0.0 13-14|0.0.2.0.0.1 11-12|0.0.2.0.0.1.1 9-10|0.0.2.0.0.1.0 8-9|0.0.0 6-7|0.0.2.0.0.1.0.1 3-4|0.0.2 0-1|0.0.2.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:22.435
(c / contrast-01 
      :ARG1 (i / impair-01 
            :ARG0 (g / gene) 
            :ARG1 (s / secretion 
                  :ARG1-of (a / absent-01 
                        :polarity -) 
                  :mod (s2 / sterol)) 
            :ARG2 (h2 / human 
                  :ARG1-of (n2 / normal-02 
                        :ARG1-of (s4 / seem-01 
                              :ARG0 (m / mouse) 
                              :location (o / or 
                                    :ARG1-of (d2 / defect-01 
                                          :ARG0 (i2 / interesting) 
                                          :beneficiary-of (h / heterozygou)) 
                                    :mod (e / either)))))) 
      :ARG2 (s3 / show-01 
            :ARG0 (c2 / country 
                  :name (n / name 
                        :op1 "Abcg8/sterolin")) 
            :ARG1 (d / deficiency)))

# ::snt Note that under steady-state conditions on a rodent chow diet , heterozygous animals show no significant elevations in plasma or tissue sitosterol levels , suggesting that the activity of these proteins may not be rate limiting .
# ::tok Note that under steady-state conditions on a rodent chow diet , heterozygous animals show no significant elevations in plasma or tissue sitosterol levels , suggesting that the activity of these proteins may not be rate limiting .
# ::alignments 35-36|0.0.2.1.0 34-35|0.0.2.1.0.1 32-33|0.0.1.0.0 31-32|0.0.2.1 30-31|0.0.2.1.0.0.0 29-30|0.0.2.1.0.0.0.0 27-28|0.0.2.1.0.0 24-25|0.0.2 22-23|0.1.2 21-22|0.1.1.0 20-21|0.1.1 19-20|0.1 18-19|0.1.0 16-17|0.0.1 15-16|0.0.1.0 14-15|0.0.3 13-14|0.0 12-13|0.0.2.0 11-12|0.0.2.0.0 9-10|0.0.0.1 8-9|0.0.0 7-8|0.0.0.0 4-5|0.0.4 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:24.380
(n / note-01 
      :ARG1 (s4 / show-01 
            :ARG0 (c / chow 
                  :mod (r2 / rodent) 
                  :mod-of (d / diet)) 
            :ARG1 (e / elevation 
                  :ARG1-of (s3 / significant-02 
                        :ARG2 -)) 
            :ARG2 (s / suggest-01 
                  :ARG0 (a2 / animal 
                        :mod (h / heterozygou)) 
                  :ARG1 (p / possible-01 
                        :ARG1 (l / limit-01 
                              :ARG1 (a / activity-06 
                                    :ARG0 (p2 / protein 
                                          :mod (t / this))) 
                              :ARG2 (r / rate)))) 
            :polarity - 
            :time (c2 / condition)) 
      :op1-of (o / or 
            :op2 (p3 / plasma) 
            :op3 (t2 / tissue 
                  :mod-of (s2 / sitosterol)) 
            :op4 (l2 / level)))

# ::snt Furthermore , the heterozygous Abcg8 + / - mice showed higher levels of biliary sitosterol relative to the wild-type mice .
# ::tok Furthermore , the heterozygous Abcg8 + / - mice showed higher levels of biliary sitosterol relative to the wild-type mice .
# ::alignments 19-20|0 15-16|0.0 14-15|0.0.0 13-14|0.0.0.0 11-12|0.0.0.1 10-11|0.0.0.1.1 9-10|0.0.0.1.0 8-9|0.0.0.1.0.0 6-7|0.0.0.1.0.1.0 3-4|0.0.0.1.0.1 0-1|0.0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:24.695
(m / mouse 
      :beneficiary-of (r / relative 
            :mod (s / sitosterol 
                  :mod (b / biliary) 
                  :mod-of (l / level 
                        :ARG1-of (s2 / show-01 
                              :ARG0 (m2 / mouse) 
                              :time (h2 / heterozygou 
                                    :poss-of (s3 / slash))) 
                        :ARG1-of (h / high-02 
                              :ARG0 (f / furthermore))))))

# ::snt While the rate of total biliary sterol secretion is reduced compared to wild-type mice , since the heterozygous mice are not sitosterolemic , either the activity of these proteins is not rate limiting or other mechanisms can compensate for a 50 % loss of activity .
# ::tok While the rate of total biliary sterol secretion is reduced compared to wild-type mice , since the heterozygous mice are not sitosterolemic , either the activity of these proteins is not rate limiting or other mechanisms can compensate for a 50 % loss of activity .
# ::alignments 44-45|0.0.0.1.0.3.0.1.0 42-43|0.0.0.1.0.3.0.1 41-42|0.0.0.1.0.3.0.0.0.0 40-41|0.0.0.1.0.3.0.0.0.0.0 37-38|0.0.0.1.0.3.0 36-37|0.0.0.1.0.3.0.2 35-36|0.0.0.1.0.3.0.0 34-35|0.0.0.1.0.3.0.0.0 33-34|0.0.0.1.0.3 32-33|0.0.0.1.0 31-32|0.0.0.1.0.1 30-31|0.0.0.1.0.4 28-29|0.0.0.1.0.0.0 27-28|0.0.0.1.0.0.0.0 25-26|0.0.0.1.0.0 23-24|0.0.0.1.0.2 20-21|0.0.0.1.0.0.1.0 18-19|0.1 17-18|0 15-16|0.0.0.1.0.3.0.1.0.0 13-14|0.0.1 10-11|0.0 9-10|0.0.0 7-8|0.0.0.0.0 6-7|0.0.0.0.0.0 5-6|0.0.0.0.0.1 4-5|0.0.0.1.0.0.1 2-3|0.0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:26.103
(h / heterozygou 
      :ARG1-of (c2 / compare-01 
            :ARG0-of (r2 / reduce-01 
                  :ARG1 (r3 / rate 
                        :mod (s2 / secretion 
                              :mod (s3 / sterol) 
                              :mod (b / biliary))) 
                  :ARG1-of (w / while-01 
                        :ARG0 (l2 / limit-01 
                              :ARG1 (a2 / activity-06 
                                    :ARG0 (p3 / protein 
                                          :mod (t / this)) 
                                    :ARG1 (t2 / total-01 
                                          :ARG1 -)) 
                              :ARG2 (r / rate) 
                              :mod (e / either) 
                              :op1-of (o2 / or 
                                    :op2 (c / compensate-01 
                                          :ARG0 (m / mechanism 
                                                :mod (o / other 
                                                      :location (p / percentage-entity 
                                                            :value 50))) 
                                          :ARG1 (l / loss 
                                                :mod (a / activity-06 
                                                      :ARG1 (s / since))) 
                                          :ARG1-of (p2 / possible-01))) 
                              :polarity -))) 
            :ARG2 (m3 / mouse)) 
      :mod-of (m2 / mouse))

# ::snt On the other hand , since feeding is intermittent , a slow , but continuous secretion during post-prandial periods could easily negate any mild temporary increase in tissue and plasma plant sterol levels in heterozygous animals .
# ::tok On the other hand , since feeding is intermittent , a slow , but continuous secretion during post-prandial periods could easily negate any mild temporary increase in tissue and plasma plant sterol levels in heterozygous animals .
# ::alignments 35-36|0.0.0 34-35|0.0 32-33|0.3.1.1.2 31-32|0.3.1.1.2.0 30-31|0.3.1.1.1.0 29-30|0.3.1.1.1 28-29|0.3.1.1 27-28|0.3.1.1.0 25-26|0.3.1 24-25|0.3.1.2 23-24|0.3.1.4 22-23|0.3.1.3 21-22|0.3 19-20|0.3.2 18-19|0.2.0 15-16|0.3.0 14-15|0.3.0.0 13-14|0 11-12|0.1 8-9|0.2.1 6-7|0.2 5-6|0.2.2 3-4|0.3.1.0 2-3|0.3.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:28.302
(c2 / contrast-01 
      :ARG0 (h / heterozygou 
            :mod-of (a / animal)) 
      :ARG1 (s3 / slow) 
      :ARG1-of (f / feed-01 
            :ARG0 (p4 / period) 
            :ARG2 (i2 / intermittent) 
            :op1-of (s4 / since)) 
      :ARG2 (n / negate-01 
            :ARG0 (s2 / secretion 
                  :ARG1-of (c / continue-01)) 
            :ARG1 (i / increase-01 
                  :ARG0 (h2 / hand 
                        :mod (o / other)) 
                  :ARG1 (a2 / and 
                        :op1 (t / tissue) 
                        :op2 (p2 / plasma 
                              :mod-of (p / plant)) 
                        :op3 (l / level 
                              :mod (s / sterol))) 
                  :duration (t2 / temporary) 
                  :mod (a3 / any) 
                  :time (m / mild)) 
            :ARG1-of (p3 / possible-01)))

# ::snt This may be amenable to testing by placing these animals on a high plant sterol diet and measuring the plasma sterol levels .
# ::tok This may be amenable to testing by placing these animals on a high plant sterol diet and measuring the plasma sterol levels .
# ::alignments 21-22|0.0.1.0.1.2 20-21|0.0.1.0.1.2.0 19-20|0.0.1.0.1.1.0 17-18|0.0.1.0.1.1 16-17|0.0.1.0.1 15-16|0.0.1.0.1.0 14-15|0.0.1.0.1.0.2 13-14|0.0.1.0.1.0.1 12-13|0.0.1.0.1.0.0 9-10|0.0.1.0.0 8-9|0.0.1.0.0.0 7-8|0.0.1.0 5-6|0.0.1 3-4|0.0 1-2|0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:28.531
(p4 / possible-01 
      :ARG1 (a3 / amenable 
            :domain (t3 / this) 
            :prep-to (t2 / test-01 
                  :ARG1 (p3 / place-01 
                        :ARG1 (a2 / animal 
                              :mod (t / this)) 
                        :op1-of (a / and 
                              :op2 (d / diet 
                                    :ARG1-of (h / high-02) 
                                    :location (p2 / plant) 
                                    :mod (s2 / sterol)) 
                              :op3 (m / measure-01 
                                    :ARG1 (p / plasma)) 
                              :op4 (l / level 
                                    :mod (s / sterol)))))))

# ::snt Recently , Kosters et al. reported that Abcg5/Abcg8 mRNA expression in a variety of different mouse strains correlated with biliary cholesterol secretion rates [ 30 ] .
# ::tok Recently , Kosters et al. reported that Abcg5/Abcg8 mRNA expression in a variety of different mouse strains correlated with biliary cholesterol secretion rates [ 30 ] .
# ::alignments 24-25|0.1.2 22-23|0.1.1 21-22|0.1.1.0 20-21|0.1.1.2 19-20|0.1.1.1 17-18|0.1 16-17|0.1.0.1.0 15-16|0.1.0.1.0.1 14-15|0.1.0.1.0.0 12-13|0.1.0.1 9-10|0.1.0 8-9|0.1.0.0 5-6|0 2-5|0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:28.848
(r2 / report-01 
      :ARG0 (t / thing 
            :name (n / name 
                  :op1 "Kosters" 
                  :op2 "et" 
                  :op3 "al.")) 
      :ARG1 (c2 / correlate-01 
            :ARG0 (e / express-01 
                  :ARG0 (m2 / mrna) 
                  :ARG1 (v / variety 
                        :mod-of (s2 / strain 
                              :ARG1-of (d / differ-02) 
                              :mod (m / mouse)))) 
            :ARG1 (r / rate 
                  :mod (s / secretion) 
                  :mod (b / biliary) 
                  :mod (c / cholesterol)) 
            :time 30) 
      :time (r3 / recent))

# ::snt In their studies , although diosgenin-fed mice showed a marked increase in biliary cholesterol output , mRNA levels of Abcg5 and Abcg8 were not altered .
# ::tok In their studies , although diosgenin-fed mice showed a marked increase in biliary cholesterol output , mRNA levels of Abcg5 and Abcg8 were not altered .
# ::alignments 24-25|0 23-24|0.2 20-21|0.0.0 17-18|0.0 16-17|0.0.1 14-15|0.3.1.0 13-14|0.3.1.0.0 12-13|0.1.0 10-11|0.3.1 9-10|0.3.1.1 7-8|0.3 6-7|0.3.0 5-6|0.3.0.0 2-3|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:29.145
(a / alter-01 
      :ARG1 (l / level 
            :extent-of (a2 / and) 
            :mod (m / mrna)) 
      :ARG2 (s2 / study-01 
            :ARG1 (b / biliary)) 
      :polarity - 
      :purpose (s / show-01 
            :ARG0 (m3 / mouse 
                  :mod (d / diosgenin-f)) 
            :ARG1 (i / increase-01 
                  :ARG1 (o / output 
                        :mod (c / cholesterol)) 
                  :ARG1-of (m2 / mark-01))))

# ::snt Using Western blot analyses , the protein level of Abcg5 was also not altered by diosgenin , although Abcg8 was not measured .
# ::tok Using Western blot analyses , the protein level of Abcg5 was also not altered by diosgenin , although Abcg8 was not measured .
# ::alignments 21-22|0.5 20-21|0.5.1 18-19|0.5.0 15-16|0.0 13-14|0 12-13|0.4 11-12|0.3 9-10|0.2.1 7-8|0.2 6-7|0.2.0 3-4|0.1.0 2-3|0.1.0.0 1-2|0.1.0.0.0.1+0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:29.304
(a2 / alter-01 
      :ARG0 (d / diosgenin) 
      :ARG0-of (u / use-01 
            :ARG1 (a5 / analysis 
                  :ARG1-of (b / blot-01 
                        :ARG2 (w / world-region 
                              :name (n / name 
                                    :op1 "West") 
                              :wiki "Western_world")))) 
      :ARG1 (l / level 
            :mod (p / protein) 
            :mod (a4 / Abcg5)) 
      :mod (a3 / also) 
      :polarity - 
      :time (m / measure-01 
            :ARG1 (a / Abcg8) 
            :polarity -))

# ::snt They concluded that a parallel route for biliary cholesterol secretion might be operational , independent of the sterolins .
# ::tok They concluded that a parallel route for biliary cholesterol secretion might be operational , independent of the sterolins .
# ::alignments 17-18|0.1.0.0.1.0 14-15|0.1.0.0.1.1+0.1.0.0.1 12-13|0.1.0 10-11|0.1 9-10|0.1.0.0.2 8-9|0.1.0.0.2.0 7-8|0.1.0.0.2.0.0 5-6|0.1.0.0 4-5|0.1.0.0.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:29.636
(c2 / conclude-01 
      :ARG0 (t / they) 
      :ARG1 (p / possible-01 
            :ARG1 (o / operate-01 
                  :ARG1 (r / route 
                        :ARG1-of (p2 / parallel-01) 
                        :ARG1-of (d / depend-01 
                              :ARG2 (s / sterolin) 
                              :polarity -) 
                        :beneficiary (s2 / secretion 
                              :mod (c / cholesterol 
                                    :mod (b / biliary)))))))

# ::snt While biliary cholesterol secretion is not completely absent in the Abcg8-deficient mice it would appear that sterolin-2 plays a major role in this process .
# ::tok While biliary cholesterol secretion is not completely absent in the Abcg8-deficient mice it would appear that sterolin-2 plays a major role in this process .
# ::alignments 23-24|0.0.2 22-23|0.0.2.1 20-21|0.0.0 19-20|0.0.0.0 17-18|0.0 14-15|0 11-12|0.1.3 7-8|0.1 6-7|0.1.2 5-6|0.0.1 3-4|0.1.0 2-3|0.1.0.0 1-2|0.0.2.0 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:29.857
(a / appear-02 
      :ARG1 (p2 / play-02 
            :ARG1 (r / role 
                  :ARG1-of (m / major-02)) 
            :polarity - 
            :prep-in (p / process-02 
                  :ARG1 (b / biliary) 
                  :mod (t / this))) 
      :condition (a2 / absent-01 
            :ARG1 (s / secretion 
                  :mod (c2 / cholesterol)) 
            :ARG1-of (w / while-01) 
            :ARG1-of (c / complete-02) 
            :location (m2 / mouse)))

# ::snt In a genetic screen of plasma plant sterol levels , Sehayek et al. identified three loci that may be responsible for controlling plasma plant sterol levels and not one of these loci mapped to the murine STSL region [ 43 ] .
# ::tok In a genetic screen of plasma plant sterol levels , Sehayek et al. identified three loci that may be responsible for controlling plasma plant sterol levels and not one of these loci mapped to the murine STSL region [ 43 ] .
# ::alignments 39-40|0.2.0.0.0.0.1.0 37-38|0.2 36-37|0.2.0.1.0+0.2.0.1+0.2.0 35-36|0.2.1 32-33|0 31-32|0.1 30-31|0.1.0 27-28|0.0 26-27|0.2.0.0.0.0.1.1.0.1 25-26|0.2.0.0.0 24-25|0.2.0.0.0.2 23-24|0.2.0.0.0.1 22-23|0.2.0.0.0.1.0 21-22|0.2.0.0 19-20|0.2.0.0.0.0 17-18|0.2.0.0.0.0.1 15-16|0.2.0.0.0.0.1.1 14-15|0.2.0.0.0.0.1.1.1 13-14|0.2.0.0.0.0.1.1.0 10-13|0.2.0.0.0.0.1.1.0.0.0.2+0.2.0.0.0.0.1.1.0.0.0.1+0.2.0.0.0.0.1.1.0.0.0.0+0.2.0.0.0.0.1.1.0.0.0+0.2.0.0.0.0.1.1.0.0 8-9|0.2.0.0.0.0.1.1.0.2.0 7-8|0.2.0.0.0.0.1.1.0.2.0.0 6-7|0.2.0.0.0.0.1.1.0.2.0.0.0 5-6|0.2.0.0.0.0.1.1.0.2.0.0.0.0 3-4|0.2.0.0.0.0.1.1.0.2 2-3|0.2.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:30.876
(m2 / map-01 
      :ARG0 - 
      :ARG1 (l / locus 
            :mod (t / this)) 
      :ARG2 (r / region 
            :mod (c / country 
                  :ARG0-of (c2 / control-01 
                        :ARG1 (l2 / level 
                              :ARG1-of (r2 / responsible-01 
                                    :ARG0 (g / gene) 
                                    :ARG1-of (p3 / possible-01 
                                          :ARG0 43 
                                          :op1-of (l3 / locus 
                                                :ARG1-of (i / identify-01 
                                                      :ARG0 (t2 / thing 
                                                            :name (n2 / name 
                                                                  :op1 "Sehayek" 
                                                                  :op2 "et" 
                                                                  :op3 "al.")) 
                                                      :ARG2 (a / and) 
                                                      :time (s3 / screen 
                                                            :quant-of (l4 / level 
                                                                  :mod (s2 / sterol 
                                                                        :mod (p4 / plant 
                                                                              :mod (p5 / plasma)))))) 
                                                :quant 3))) 
                              :location (p / plant 
                                    :mod (p2 / plasma)) 
                              :mod (s / sterol))) 
                  :name (n / name 
                        :op1 "STSL")) 
            :mod (m / murine)))

# ::snt Thus , there is support for at least four loci that may be involved in regulating plasma plant sterol levels .
# ::tok Thus , there is support for at least four loci that may be involved in regulating plasma plant sterol levels .
# ::alignments 19-20|0.0 18-19|0 17-18|0.0.0.1.1.1 16-17|0.0.0.1.1.1.0 15-16|0.0.0 13-14|0.0.0.1 11-12|0.0.0.1.1 9-10|0.0.0.1.0 8-9|0.0.0.0 4-5|0.0.0.1.0.0 0-1|0.0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:31.148
(s / sterol 
      :mod-of (l / level 
            :ARG1-of (r / regulate-01 
                  :ARG0 4 
                  :ARG2-of (i / involve-01 
                        :ARG1 (l2 / locus 
                              :ARG1-of (s2 / support-01)) 
                        :ARG1-of (p3 / possible-01 
                              :ARG0 (t / thu) 
                              :ARG2 (p / plant 
                                    :mod (p2 / plasma)))))))

# ::snt To date the STSL locus is the only one proven to be involved in dietary sterol trafficking and the identity of the others remains to be elucidated .
# ::tok To date the STSL locus is the only one proven to be involved in dietary sterol trafficking and the identity of the others remains to be elucidated .
# ::alignments 26-27|0.0.0.1.2.0.0 23-24|0.0.0.1.2.0.0.1 22-23|0.0.0.1.2 19-20|0.0.0.1.2.0 17-18|0.0.0.1.2.0.0.1.0 16-17|0.0.0.1 15-16|0.0.0.1.1 14-15|0.0.0.1.2.0.0.0 12-13|0.0.0 9-10|0.0.0.0 7-8|0.0.0.0.0 4-5|0 3-4|0.0.1.0+0.0.1+0.0 1-2|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:31.555
(l / locu 
      :mod (c / country 
            :ARG1-of (i2 / involve-01 
                  :ARG1-of (p / prove-01 
                        :ARG0 (o2 / only)) 
                  :ARG2 (t / traffic-01 
                        :ARG0 (d2 / date) 
                        :ARG1 (s / sterol) 
                        :ARG2 (o / other 
                              :poss-of (i / identity 
                                    :ARG1-of (e / elucidate-01 
                                          :ARG0 (d / dietary) 
                                          :ARG1-of (r / remain-01 
                                                :op1-of (a / and))))))) 
            :name (n / name 
                  :op1 "STSL")))

# ::snt We , as well as others , have proposed Abcg5/sterolin -1 and Abcg8/sterolin -2 to function as obligate heterodimers .
# ::tok We , as well as others , have proposed Abcg5/sterolin -1 and Abcg8/sterolin -2 to function as obligate heterodimers .
# ::alignments 18-19|0.0 17-18|0 15-16|0.0.0 11-12|0.0.0.0 8-9|0.0.0.0.0 5-6|0.0.0.0.0.0.0 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:31.652
(o / obligate-01 
      :ARG1 (h / heterodimer 
            :ARG1-of (f / function-01 
                  :ARG2 (a / and 
                        :ARG1-of (p / propose-01 
                              :ARG0 (w / we 
                                    :poss-of (o2 / other)))))))

# ::snt Thus knocking out Abcg8/sterolin -2 alone is equivalent to a functional loss of both sterolins .
# ::tok Thus knocking out Abcg8/sterolin -2 alone is equivalent to a functional loss of both sterolins .
# ::alignments 14-15|0.0.1 13-14|0.0.1.0 11-12|0.0 10-11|0.0.0 7-8|0 5-6|0.1.1 3-4|0.1.0.0.0+0.1.0.0+0.1.0 1-2|0.1 0-1|0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:31.706
(e / equivalent 
      :beneficiary (l / loss 
            :mod (f / functional) 
            :poss (s / sterolin 
                  :mod (b / both))) 
      :domain (k / knock-down-02 
            :ARG1 (c / country 
                  :name (n / name 
                        :op1 "Abcg8/sterolin")) 
            :manner (a / alone) 
            :op1-of (t / thu)))

# ::snt It has been shown that Abcg8/sterolin -2 expression is required for correct apical trafficking of Abcg5/sterolin -1 to the apical surface in a polarized cell line and more recently in vivo by over-expression experiments [ 18,19 ] .
# ::tok It has been shown that Abcg8/sterolin -2 expression is required for correct apical trafficking of Abcg5/sterolin -1 to the apical surface in a polarized cell line and more recently in vivo by over-expression experiments [ 18,19 ] .
# ::alignments 33-34|0.0.0.1 30-31|0.0.0.1.1 28-29|0.0.0.0.0 27-28|0.0.0.0.0.0 26-27|0.0.0.2.3 25-26|0.0.0.0.1.0 24-25|0.0.0.0.1.0.0 23-24|0.0.0.0.1 20-21|0.0.0.2.0 19-20|0.0.0.2.0.0 15-16|0.0.0.2.1.0.0+0.0.0.2.1.0+0.0.0.2.1 13-14|0.0.0.2 12-13|0.0.0.1.0 11-12|0.0.0.2.2 9-10|0.0.0 7-8|0.0.0.0 5-6|0.0.0.0.2.0.0+0.0.0.0.2.0+0.0.0.0.2 3-4|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:33.206
(s2 / show-01 
      :ARG1 (i / it 
            :ARG0-of (r2 / require-01 
                  :ARG2 (e2 / express-01 
                        :ARG0 (r / recent 
                              :degree (m / more)) 
                        :ARG1 (p / polarize-01 
                              :ARG1 (l / line 
                                    :mod (c / cell))) 
                        :ARG2 (c3 / country 
                              :name (n2 / name 
                                    :op1 "Abcg8/sterolin"))) 
                  :ARG2-of (e / experiment-01 
                        :ARG0 (a3 / apical) 
                        :ARG1 (v / vivo)) 
                  :ARG3 (t / traffic-01 
                        :ARG0 (s / surface 
                              :mod (a2 / apical)) 
                        :ARG1 (p2 / person 
                              :name (n / name 
                                    :op1 "Abcg5/sterolin")) 
                        :ARG1-of (c2 / correct-02) 
                        :ARG2 (a / and)))))

# ::snt In experiments shown here , using three separately developed anti-Abcg5 / sterolin-1 antibodies , we have obtained inconsistent data regarding the trafficking of Abcg5/sterolin -1 in Abcg8 - / - mice .
# ::tok In experiments shown here , using three separately developed anti-Abcg5 / sterolin-1 antibodies , we have obtained inconsistent data regarding the trafficking of Abcg5/sterolin -1 in Abcg8 - / - mice .
# ::alignments 30-31|0.0.1.0.0.0.0.0 28-29|0.0.1.0.0.0.0.1.0 23-24|0.0.1.0.1.0.0.0.0+0.0.1.0.1.0.0.0+0.0.1.0.1.0.0 21-22|0.0.1.0.1.0 19-20|0.0.1.0.1 18-19|0.0.1 17-18|0.0.2+0.0 16-17|0.0.1.0 14-15|0.0.1.0.0 12-13|0 10-11|0.1 8-9|0.0.1.0.0.0.0 7-8|0.0.1.0.0.0.0.1 6-7|0.0.0 5-6|0.0.1.0.0.0.1.0 3-4|0.0.1.0.0.0.1.1 2-3|0.0.1.0.0.0.1 1-2|0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:33.545
(a / antibodi 
      :ARG1-of (c / consistent-01 
            :ARG0 3 
            :mod-of (d / data 
                  :ARG1-of (o / obtain-01 
                        :ARG0 (w / we 
                              :ARG0-of (e / experiment-01 
                                    :ARG1 (d2 / develop-02 
                                          :ARG0 (m / mouse) 
                                          :ARG1-of (s3 / separate-02 
                                                :ARG0 (s / slash))) 
                                    :ARG1-of (s4 / show-01 
                                          :ARG1-of (u / use-01) 
                                          :location (h / here)))) 
                        :ARG2-of (r / regard-01 
                              :ARG1 (t / traffic-01 
                                    :ARG1 (p / person 
                                          :name (n / name 
                                                :op1 "Abcg5/sterolin")))))) 
            :polarity -) 
      :op1-of (s2 / slash))

# ::snt Based upon classical N-glycosylation maturation it would appear that Abcg5/sterolin -1 , in the Abcg8 - / - mice , does not exit the endoplasmic reticulum .
# ::tok Based upon classical N-glycosylation maturation it would appear that Abcg5/sterolin -1 , in the Abcg8 - / - mice , does not exit the endoplasmic reticulum .
# ::alignments 25-26|0.0.1 22-23|0.0 21-22|0.0.2 18-19|0.0.3 16-17|0.1.0 9-10|0.0.0.0.0+0.0.0.0+0.0.0 7-8|0 4-5|0.1.1 2-3|0.1.1.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:33.711
(a / appear-02 
      :ARG1 (e / exit-01 
            :ARG0 (p / person 
                  :name (n / name 
                        :op1 "Abcg5/sterolin")) 
            :ARG1 (r / reticulum) 
            :polarity - 
            :time (m / mouse)) 
      :ARG1-of (b / base-02 
            :ARG0 (s / slash) 
            :ARG2 (m2 / maturation 
                  :mod (c / classics))))

# ::snt However , by immunohistochemistry it appears that Abcg5/sterolin -1 is apically expressed in the Abcg8-deficient mice regardless of the anti-Abcg5 / sterolin-1 antibody used .
# ::tok However , by immunohistochemistry it appears that Abcg5/sterolin -1 is apically expressed in the Abcg8-deficient mice regardless of the anti-Abcg5 / sterolin-1 antibody used .
# ::alignments 23-24|0.1.1.0 22-23|0.1.1.0.0 20-21|0.1.1.0.0.0 16-17|0.1.1.0.1.0+0.1.1.0.1 15-16|0.1.1 11-12|0.1 7-8|0.1.0.0.0+0.1.0.0+0.1.0 5-6|0 3-4|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:33.843
(a2 / appear-02 
      :ARG0 (i / immunohistochemistry) 
      :ARG1 (e / express-01 
            :ARG1 (p / person 
                  :name (n / name 
                        :op1 "Abcg5/sterolin")) 
            :manner (m / mouse 
                  :ARG1-of (u / use-01 
                        :ARG0 (a / antibody 
                              :mod (s / slash)) 
                        :manner (r / regard-01 
                              :polarity -)))))

# ::snt Interestingly , in a report of Abcg5/Abcg8 localization in canine gallbladder epithelial cells , these two proteins were found intracellularly under baseline conditions [ 44 ] .
# ::tok Interestingly , in a report of Abcg5/Abcg8 localization in canine gallbladder epithelial cells , these two proteins were found intracellularly under baseline conditions [ 44 ] .
# ::alignments 24-25|0.0 22-23|0.2.0 21-22|0.2.0.0 18-19|0 16-17|0.1 15-16|0.1.1 14-15|0.1.0 12-13|0.3.0 11-12|0.3.0.0 10-11|0.3.0.0.0 9-10|0.3.0.1 7-8|0.3.1 4-5|0.3 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:34.022
(f / find-01 
      :ARG0 44 
      :ARG1 (p / protein 
            :mod (t / this) 
            :quant 2) 
      :manner (i / interesting 
            :mod-of (c / condition 
                  :mod (b / baseline))) 
      :medium (r / report 
            :location (c2 / cell 
                  :mod (e / epithelial 
                        :mod (g / gallbladd)) 
                  :mod (c3 / canine)) 
            :topic (l / localization)))

# ::snt But when given liver X receptor alpha ( LXR ) agonist , Abcg5/sterolin -1 and Abcg8/sterolin -2 appeared to be expressed at the apical surface .
# ::tok But when given liver X receptor alpha ( LXR ) agonist , Abcg5/sterolin -1 and Abcg8/sterolin -2 appeared to be expressed at the apical surface .
# ::alignments 24-25|0.0.1.1 23-24|0.0.1.1.0 20-21|0.0.1 17-18|0.0 15-16|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 14-15|0.0.0 12-13|0.0.1.0.1.0+0.0.1.0.1+0.0.1.0 10-11|0.0.1.0.0.0 8-9|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 6-7|0.0.1.0.0.1 5-6|0.0.1.0.0.1.0 4-5|0.0.1.0.0.1.0.0 3-4|0.0.1.0.0.2 2-3|0.0.1.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:34.838
(c2 / contrast-01 
      :ARG2 (a2 / appear-01 
            :ARG0 (a3 / and 
                  :op1 (o / organization 
                        :name (n3 / name 
                              :op1 "LXR")) 
                  :op2 (c / country 
                        :name (n / name 
                              :op1 "Abcg8/sterolin"))) 
            :ARG1 (e / express-01 
                  :ARG0 (p / person 
                        :ARG0-of (g / give-01 
                              :ARG1 (a4 / agonist) 
                              :ARG2 (a5 / alpha 
                                    :mod (r / receptor 
                                          :mod (x / x))) 
                              :ARG3 (l / liver)) 
                        :name (n2 / name 
                              :op1 "Abcg5/sterolin")) 
                  :ARG1 (s / surface 
                        :mod (a / apical)))))

# ::snt In these studies the UTSW anti-Abcg5 / sterolin-1 antibody was used .
# ::tok In these studies the UTSW anti-Abcg5 / sterolin-1 antibody was used .
# ::alignments 10-11|0 8-9|0.0 6-7|0.0.0 4-5|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 2-3|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:34.872
(u / use-01 
      :ARG1 (a / antibody 
            :op2-of (s / slash 
                  :op1 (o / organization 
                        :name (n / name 
                              :op1 "UTSW")))) 
      :ARG2 (s2 / study-01 
            :mod (t / this)))

# ::snt It is apparent with these conflicting data that the trafficking of these transporters is not as clear-cut .
# ::tok It is apparent with these conflicting data that the trafficking of these transporters is not as clear-cut .
# ::alignments 16-17|0.0.1 14-15|0.0.1.0 12-13|0 11-12|0.1 9-10|0.0 6-7|0.0.0.0 5-6|0.0.0 4-5|0.0.0.0.1 2-3|0.0.0.0.0 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:34.935
(t / transporter 
      :ARG1-of (t3 / traffic-01 
            :ARG2 (c2 / conflict-01 
                  :ARG0 (d / data 
                        :compared-to-of (a / apparent 
                              :domain (i / it)) 
                        :mod (t4 / this))) 
            :domain-of (c / clear-cut 
                  :polarity -)) 
      :mod (t2 / this))

# ::snt In a recent paper , Mangrivite et al. showed that the apical sorting of rat SPNT in polarized renal epithelial cells was independent of N-glycosylation [ 45 ] .
# ::tok In a recent paper , Mangrivite et al. showed that the apical sorting of rat SPNT in polarized renal epithelial cells was independent of N-glycosylation [ 45 ] .
# ::alignments 26-27|0.2.0.0 22-23|0.1.1+0.1 20-21|0.1.0.0.0.0 19-20|0.1.0.0.0.0.1 18-19|0.1.0.0.0 17-18|0.1.0.0.0.0.0 15-16|0.1.0 14-15|0.1.0.0 12-13|0.2.0 11-12|0.2.0.1 8-9|0 5-8|0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 3-4|0.2 2-3|0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:35.587
(s3 / show-01 
      :ARG0 (t / thing 
            :name (n / name 
                  :op1 "Mangrivite" 
                  :op2 "et" 
                  :op3 "al.")) 
      :ARG1 (d / depend-01 
            :ARG0 (s / SPNT 
                  :mod (r2 / rat 
                        :mod (r / renal 
                              :mod-of (c / cell 
                                    :ARG1-of (p / polarize-01) 
                                    :mod (e / epithelial))))) 
            :polarity -) 
      :time (p2 / paper 
            :ARG4-of (s2 / sort-01 
                  :ARG0 45 
                  :ARG1 (a / apical)) 
            :mod (r3 / recent)))

# ::snt Therefore , at this time , we can neither exclude the possibility that Abcg5/sterolin -1 expression is functional in our Abcg8/sterolin -2 deficient mice nor can we rule it out .
# ::tok Therefore , at this time , we can neither exclude the possibility that Abcg5/sterolin -1 expression is functional in our Abcg8/sterolin -2 deficient mice nor can we rule it out .
# ::alignments 27-28|0.0.0 26-27|0.0.0.0 25-26|0.0.0.1 23-24|0.1.0.0.1.0 22-23|0.1.0.0.1.0.1 20-21|0.1.0.0.1.0.0.0.0+0.1.0.0.1.0.0.0+0.1.0.0.1.0.0 19-20|0.1.0.0.1.0.2 17-18|0.1 15-16|0 13-14|0.0.1.0+0.0.1+0.0 11-12|0.1.0 9-10|0.1.0.0 7-8|0.1.0.0.1 6-7|0.1.0.0.0 4-5|0.1.0.0.2 3-4|0.1.0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:36.222
(e / express-01 
      :ARG0 (p2 / person 
            :ARG1-of (r / rule-03 
                  :ARG0 (w / we) 
                  :ARG1-of (p / possible-01)) 
            :name (n2 / name 
                  :op1 "Abcg5/sterolin")) 
      :domain-of (f / functional 
            :ARG1-of (p3 / possible-01 
                  :ARG1-of (e2 / exclude-01 
                        :ARG0 (w3 / we) 
                        :ARG1-of (p4 / possible-01 
                              :ARG0 (m / mouse 
                                    :mod (c / country 
                                          :name (n / name 
                                                :op1 "Abcg8/sterolin")) 
                                    :mod (d / deficient) 
                                    :poss (w2 / we))) 
                        :time (t / time 
                              :mod (t2 / this))))))

# ::snt We have no functional assay for these proteins at present .
# ::tok We have no functional assay for these proteins at present .
# ::alignments 9-10|0.1 7-8|0 6-7|0.2 4-5|0.0 3-4|0.0.0 2-3|0.0.1 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:36.255
(p2 / protein 
      :beneficiary-of (a / assay 
            :mod (f / functional) 
            :polarity - 
            :poss (w / we)) 
      :location (p / present) 
      :mod (t / this))

# ::snt More extensive fractionation experiments are underway to better determine the exact compartmental location of Abcg5/sterolin -1 in the Abcg8 - / - mice .
# ::tok More extensive fractionation experiments are underway to better determine the exact compartmental location of Abcg5/sterolin -1 in the Abcg8 - / - mice .
# ::alignments 22-23|0.0.1.0 20-21|0 14-15|0.1.0.0+0.1.0+0.1 12-13|0.0.2.0.0 11-12|0.0.2.0.0.0 10-11|0.0.2.0.0.1 8-9|0.0.2.0 7-8|0.0.2.0.1 5-6|0.0.2 3-4|0.0 2-3|0.0.0 1-2|0.0.1 0-1|0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:36.484
(s / slash 
      :ARG0-of (e2 / experiment-01 
            :ARG1 (f / fractionation) 
            :ARG1-of (e3 / extensive-03 
                  :ARG0 (m / mouse)) 
            :domain-of (u / underway 
                  :domain (d / determine-01 
                        :ARG1 (l / location 
                              :mod (c / compartmental) 
                              :mod (e / exact)) 
                        :manner (g / good))) 
            :manner (m2 / more-than)) 
      :op1 (p / person 
            :name (n / name 
                  :op1 "Abcg5/sterolin")))

# ::snt In this context , Plsch et al. have described an Abcg5/sterolin -1 deficient mouse that maintains the ability to secrete biliary cholesterol to the same extent as the wild-type mice and , when fed a LXR agonist , had higher Abcg8 mRNA expression and tended to secrete more biliary cholesterol than wild-type mice [ 46 ] .
# ::tok In this context , Plsch et al. have described an Abcg5/sterolin -1 deficient mouse that maintains the ability to secrete biliary cholesterol to the same extent as the wild-type mice and , when fed a LXR agonist , had higher Abcg8 mRNA expression and tended to secrete more biliary cholesterol than wild-type mice [ 46 ] .
# ::alignments 54-55|0.0.1.2.0.0.0.0 52-53|0.0.0 49-50|0 48-49|0.1 47-48|0.1.0 46-47|0.0 44-45|0.0.1 43-44|0.0.1.1 42-43|0.0.1.0 41-42|0.0.1.0.0 40-41|0.0.1.1.0 39-40|0.0.1.1.0.0 36-37|0.0.1.2.0.0.0.1 35-36|0.0.1.2.0.0.0.1.0.0.0+0.0.1.2.0.0.0.1.0.0+0.0.1.2.0.0.0.1.0 33-34|0.0.1.2.0.0.0 30-31|0.0.1.2 29-30|0.0.1.2.2 25-26|0.0.1.2.0 24-25|0.0.1.2.0.0 21-22|0.0.1.2.1.1.0.0 20-21|0.0.1.2.1.1.0.0.0 19-20|0.0.1.2.1.1.0 17-18|0.0.1.2.1.1 15-16|0.0.1.2.1 13-14|0.0.1.2.1.0 12-13|0.0.1.2.1.0.1 10-11|0.0.1.2.1.0.2.0.0+0.0.1.2.1.0.2.0+0.0.1.2.1.0.2 8-9|0.0.1.2.1.0.0 4-7|0.0.1.2.1.0.0.0.0.2+0.0.1.2.1.0.0.0.0.1+0.0.1.2.1.0.0.0.0.0+0.0.1.2.1.0.0.0.0+0.0.1.2.1.0.0.0 2-3|0.0.1.2.1.0.0.1 1-2|0.0.1.2.1.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:38.982
(c / cholesterol 
      :ARG1-of (s / secrete-01 
            :ARG0 (m / mouse) 
            :ARG2-of (t / tend-01 
                  :ARG1 (e / express-01 
                        :ARG0 (m3 / mrna)) 
                  :op2-of (a / and 
                        :op1 (a2 / Abcg8 
                              :ARG1-of (h / high-02))) 
                  :op3-of (a4 / and 
                        :domain-of (e2 / extent 
                              :ARG1-of (s2 / same-01 
                                    :purpose (f / feed-up-03 
                                          :ARG0 46 
                                          :ARG1 (a3 / agonist 
                                                :mod (o / organization 
                                                      :name (n / name 
                                                            :op1 "LXR")))))) 
                        :op1 (m5 / maintain-01 
                              :ARG0 (m6 / mouse 
                                    :ARG1-of (d2 / describe-01 
                                          :ARG0 (t2 / thing 
                                                :name (n3 / name 
                                                      :op1 "Plsch" 
                                                      :op2 "et" 
                                                      :op3 "al.")) 
                                          :ARG2 (c3 / context 
                                                :mod (t3 / this))) 
                                    :mod (d / deficient) 
                                    :mod (p / person 
                                          :name (n2 / name 
                                                :op1 "Abcg5/sterolin"))) 
                              :ARG1 (a5 / ability 
                                    :purpose (s3 / secrete-01 
                                          :ARG1 (c2 / cholesterol 
                                                :mod (b2 / biliary))))) 
                        :op2 (m4 / mouse)))) 
      :mod (b / biliary 
            :degree (m2 / more)))

# ::snt It has been argued that Abcg5/sterolin -1 and Abcg8/sterolin -2 are dependent upon each other for secretion of hepatic sterols into bile [ 19 ] .
# ::tok It has been argued that Abcg5/sterolin -1 and Abcg8/sterolin -2 are dependent upon each other for secretion of hepatic sterols into bile [ 19 ] .
# ::alignments 23-24|0.0 21-22|0.2.0.2 19-20|0.2.0.0.0 18-19|0.2.0.0.0.0 16-17|0.2.0.0 14-15|0.2.0.1 13-14|0.2.0.1.0 11-12|0.2.0 8-9|0.2.2.0.0+0.2.2.0+0.2.2 7-8|0.2 5-6|0.2.1.0.0+0.2.1.0+0.2.1 3-4|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:39.258
(a2 / argue-01 
      :ARG0 19 
      :ARG1 (i / it) 
      :op1-of (a / and 
            :ARG1-of (d / depend-01 
                  :ARG0 (s2 / secretion 
                        :mod (s / sterol 
                              :mod (h / hepatic))) 
                  :compared-to (o / other 
                        :mod (e / each)) 
                  :prep-with (b / bile)) 
            :op2 (p / person 
                  :name (n2 / name 
                        :op1 "Abcg5/sterolin")) 
            :op3 (c / country 
                  :name (n / name 
                        :op1 "Abcg8/sterolin"))))

# ::snt Given the data presented here and from the Abcg5-deficient mouse this does not appear to be the case .
# ::tok Given the data presented here and from the Abcg5-deficient mouse this does not appear to be the case .
# ::alignments 17-18|0.2 13-14|0 12-13|0.2.0 10-11|0.0 9-10|0.1.0.0.0 5-6|0.1.0.0.1 4-5|0.1.1 3-4|0.1 2-3|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:39.374
(a / appear-02 
      :ARG0 (t / this) 
      :ARG0-of (p / present-01 
            :ARG1 (d / data 
                  :ARG1-of (g / give-01 
                        :ARG2 (m / mouse) 
                        :op1-of (a2 / and))) 
            :location (h / here)) 
      :ARG1 (c / case-03 
            :ARG1 -))

# ::snt Perhaps in the previously published model a non-physiologic state has been made that generates these data .
# ::tok Perhaps in the previously published model a non-physiologic state has been made that generates these data .
# ::alignments 15-16|0.1 14-15|0.1.0 13-14|0 12-13|0.0 8-9|0.2.0.1 5-6|0.2 4-5|0.2.0 3-4|0.2.0.2 0-1|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:39.545
(g / generate-01 
      :ARG0 (t2 / that) 
      :ARG1 (d / data 
            :mod (t / this)) 
      :time (m / model 
            :ARG1-of (p / publish-01 
                  :ARG0 (p3 / perhaps) 
                  :ARG2 (s / state) 
                  :time (p2 / previous))))

# ::snt Taken together , these animal models suggest that Abcg5/sterolin -1 and Abcg8/sterolin -2 have independent function in vivo or that there are proteins other than the sterolins that can secrete biliary sterols .
# ::tok Taken together , these animal models suggest that Abcg5/sterolin -1 and Abcg8/sterolin -2 have independent function in vivo or that there are proteins other than the sterolins that can secrete biliary sterols .
# ::alignments 31-32|0.2.2.0.1 30-31|0.2.2.0.1.0 29-30|0.2.2.0 28-29|0.2.2 26-27|0.2.2.0.0 23-24|0.3.0 22-23|0.2.2.0.2 18-19|0.1 17-18|0.2.0.1 15-16|0.2.0 14-15|0.2.0.0.0+0.2.0.0 11-12|0.2.1.0.0+0.2.1.0+0.2.1 10-11|0.2 8-9|0.1.0.0.0+0.1.0.0+0.1.0 6-7|0 5-6|0.0 4-5|0.0.1 3-4|0.0.0 1-2|0.3.1 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:40.589
(s4 / suggest-01 
      :ARG0 (m / model 
            :mod (t / this) 
            :mod (a2 / animal)) 
      :ARG1 (o2 / or 
            :op1 (p3 / person 
                  :name (n2 / name 
                        :op1 "Abcg5/sterolin"))) 
      :op1-of (a / and 
            :ARG0-of (f / function-01 
                  :ARG1 (d / depend-01 
                        :polarity -) 
                  :location (v / vivo)) 
            :op2 (c / country 
                  :name (n / name 
                        :op1 "Abcg8/sterolin")) 
            :op3 (p / possible-01 
                  :ARG1 (s2 / secrete-01 
                        :ARG0 (s3 / sterolin) 
                        :ARG1 (s / sterol 
                              :mod (b / biliary)) 
                        :ARG2 (p2 / protein)))) 
      :purpose (t3 / take-01 
            :ARG0 (o / other) 
            :mod (t2 / together)))

# ::snt The major findings in this study are : ( 1 ) disruption of only one of the two genes comprising the STSL locus is necessary and sufficient to cause sitosterolemia , ( 2 ) that the loss of Abcg8/sterolin -2 leads to the loss of biliary cholesterol secretion and ( 3 ) Abcg5/sterolin -1 appears to be still apically-expressed despite the absence of Abcg8/sterolin -2 .
# ::tok The major findings in this study are : ( 1 ) disruption of only one of the two genes comprising the STSL locus is necessary and sufficient to cause sitosterolemia , ( 2 ) that the loss of Abcg8/sterolin -2 leads to the loss of biliary cholesterol secretion and ( 3 ) Abcg5/sterolin -1 appears to be still apically-expressed despite the absence of Abcg8/sterolin -2 .
# ::alignments 61-62|0.1.1.1.0.0 57-58|0.1.1.1.2 54-55|0.1.1.1 52-53|0.1.1.1.0.1.0+0.1.1.1.0.1+0.1.1.1.0 50-51|0.1.1.1.1 48-49|0.1.1 47-48|0.1.1.0.1.0 46-47|0.1.1.0.1.0.0 45-46|0.1.1.0.1.0.1 40-41|0.1 38-39|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 36-37|0.1.0 32-33|0.1.1.0.1.2.0 29-30|0.1.1.0.0 28-29|0.1.1.0 26-27|0.1.1.0.1 25-26|0.1.1.0.1.3 22-23|0.2 21-22|0.2.0.0.0+0.2.0.0+0.2.0 19-20|0 18-19|0.0 17-18|0.0.1 13-14|0.0.0 11-12|0.1.1.0.1.1 9-10|0.1.1.0.1.3.0 5-6|0.1.1.0.1.2 4-5|0.1.1.0.1.2.2 2-3|0.1.1.0.1.2.1+0.1.1.0.1.2.1.0 1-2|0.1.1.0.1.2.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:42.075
(c5 / comprise-01 
      :ARG1 (g / gene 
            :op1-of (o / only) 
            :quant 2) 
      :ARG1-of (l / lead-03 
            :ARG0 (l2 / loss 
                  :poss (c2 / country 
                        :name (n2 / name 
                              :op1 "Abcg8/sterolin"))) 
            :op1-of (a3 / and 
                  :ARG0-of (c3 / cause-01 
                        :ARG1 (s3 / sitosterolemia) 
                        :ARG2-of (s4 / suffice-01 
                              :ARG0 (s2 / secretion 
                                    :mod (c / cholesterol) 
                                    :mod (b / biliary)) 
                              :ARG1 (d / disruption) 
                              :ARG1-of (s5 / study-01 
                                    :ARG0 2 
                                    :ARG2-of (f / find-01 
                                          :ARG1 (t2 / thing 
                                                :ARG1-of (m / major-02))) 
                                    :mod (t / this)) 
                              :op1-of (a4 / and 
                                    :li 1))) 
                  :op2 (a2 / appear-02 
                        :ARG1 (p / person 
                              :ARG1-of (a / absent-01) 
                              :name (n / name 
                                    :op1 "Abcg5/sterolin")) 
                        :li 3 
                        :mod (s / still)))) 
      :ARG2 (l3 / locu 
            :mod (c4 / country 
                  :name (n3 / name 
                        :op1 "STSL"))))

# ::snt These data strongly support the direct role of Abcg8/sterolin -2 as a key player in biliary cholesterol secretion , although biliary sitosterol secretion was apparently preserved .
# ::tok These data strongly support the direct role of Abcg8/sterolin -2 as a key player in biliary cholesterol secretion , although biliary sitosterol secretion was apparently preserved .
# ::alignments 25-26|0.0.0 24-25|0.0.0.2 22-23|0.0.0.0 20-21|0.0.0.0.0 17-18|0.3.0.0 16-17|0.3.0.0.0 15-16|0.3.0.0.1 13-14|0.3.0+0.3 12-13|0.3.1 8-9|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 6-7|0.1 5-6|0.1.0 3-4|0 2-3|0.2 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:42.671
(s3 / support-01 
      :ARG0 (d2 / data 
            :ARG0-of (p / preserve-01 
                  :ARG1 (s / secretion 
                        :mod (b / biliary)) 
                  :ARG2 (c2 / country 
                        :name (n / name 
                              :op1 "Abcg8/sterolin")) 
                  :manner (a / apparent)) 
            :mod (t2 / this)) 
      :ARG1 (r / role 
            :ARG1-of (d / direct-02)) 
      :ARG1-of (s4 / strong-02) 
      :ARG2 (t / thing 
            :ARG0-of (p2 / play-12 
                  :ARG1 (s2 / secretion 
                        :mod (c / cholesterol) 
                        :mod (b2 / biliary))) 
            :ARG1-of (k / key-02)))

# ::snt These data suggest that there are mechanisms other than Abcg8/sterolin -2 that allow for the secretion of sitosterol into bile .
# ::tok These data suggest that there are mechanisms other than Abcg8/sterolin -2 that allow for the secretion of sitosterol into bile .
# ::alignments 19-20|0.2.2 17-18|0.2.1.0 15-16|0.2.1 12-13|0.2 9-10|0.0.0.0+0.0.0+0.0 7-8|0.2.0.0 6-7|0.2.0 2-3|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:42.834
(s3 / suggest-01 
      :ARG0 (c / country 
            :name (n / name 
                  :op1 "Abcg8/sterolin")) 
      :ARG1 (d / data 
            :mod (t / this)) 
      :manner (a / allow-01 
            :ARG0 (m / mechanism 
                  :mod (o / other)) 
            :ARG1 (s2 / secretion 
                  :mod (s / sitosterol)) 
            :ARG4 (b / bile)))

# ::snt None declared .
# ::tok None declared .
# ::alignments 1-2|0 0-1|0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:42.859
(d / declare-01 
      :ARG0 (p / person 
            :quant (n / none)))

# ::snt ELK carried out molecular genetics studies , quantitative RT-PCR , and dynamic bile collection for Figure 9 .
# ::tok ELK carried out molecular genetics studies , quantitative RT-PCR , and dynamic bile collection for Figure 9 .
# ::alignments 16-17|0.1.0 15-16|0.1.3.0.1 13-14|0.1.3.0 12-13|0.1.3.0.0 11-12|0.1.3.0.2 10-11|0.1.3 7-8|0.1.0.0 5-6|0.1 4-5|0.1.1 3-4|0.1.2 1-2|0 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:43.717
(c2 / carry-01 
      :ARG0 (c3 / country 
            :name (n / name 
                  :op1 "ELK")) 
      :ARG1 (s / study-01 
            :ARG0 (9 / 9 
                  :mod-of (q / quantitative)) 
            :ARG1 (g / genetic) 
            :mod (m / molecule) 
            :op1-of (a / and 
                  :op2 (c / collect-01 
                        :ARG1 (b / bile) 
                        :ARG2 (f / figure) 
                        :mod (d / dynamic)))))

# ::snt KL carried out molecular genetic studies and made the targeting construct .
# ::tok KL carried out molecular genetic studies and made the targeting construct .
# ::alignments 10-11|0.1 9-10|0.1.0 6-7|0 5-6|0.0.1 4-5|0.0.1.1 3-4|0.0.1.0 1-2|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:43.793
(a / and 
      :op1 (c2 / carry-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "KL")) 
            :ARG1 (s / study-01 
                  :mod (m / molecule) 
                  :mod (g / gene))) 
      :op2 (c / construct-01 
            :ARG1-of (t / target-01)))

# ::snt The knockout mice were isolated in the NM laboratory .
# ::tok The knockout mice were isolated in the NM laboratory .
# ::alignments 8-9|0.0 7-8|0.0.0.0.0+0.0.0.0+0.0.0 4-5|0 2-3|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:43.840
(i / isolate-01 
      :ARG0 (l / laboratory 
            :mod (c / country 
                  :name (n / name 
                        :op1 "NM"))) 
      :ARG1 (m / mouse 
            :mod (k / knockout)))

# ::snt HY performed Northern blotting .
# ::tok HY performed Northern blotting .
# ::alignments 3-4|0 2-3|0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:43.852
(b / blot-01 
      :ARG1-of (p / perform-02) 
      :mod "Northern_Ireland")

# ::snt ELK , AK , EV and MHL performed Western blotting and immunohistochemistry experiments .
# ::tok ELK , AK , EV and MHL performed Western blotting and immunohistochemistry experiments .
# ::alignments 12-13|0 11-12|0.1 10-11|0.2 9-10|0.2.1 8-9|0.0.1+0.0.0.0+0.0.0+0.0 7-8|0.2.0 5-6|0.2.0.1 4-5|0.2.0.1.1.0.0+0.2.0.1.1.0+0.2.0.1.1 2-3|0.2.0.1.0.1+0.2.0.1.0.0.0+0.2.0.1.0.0+0.2.0.1.0 0-1|0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:44.028
(e / experiment-01 
      :ARG1 (w / world-region 
            :name (n / name 
                  :op1 "West") 
            :wiki "Western_world") 
      :mod (i / immunohistochemistry) 
      :op3-of (a / and 
            :op1 (p / perform-02 
                  :ARG0 (c2 / country 
                        :name (n4 / name 
                              :op1 "ELK")) 
                  :ARG1 (a2 / and 
                        :op1 (p2 / product 
                              :name (n3 / name 
                                    :op1 "AK-47") 
                              :wiki "AK-47") 
                        :op2 (c / country 
                              :name (n2 / name 
                                    :op1 "EV")))) 
            :op2 (b / blot-01)))

# ::snt AK and NL performed bile collection experiments and bile characterization for Figure 8 .
# ::tok AK and NL performed bile collection experiments and bile characterization for Figure 8 .
# ::alignments 12-13|0.0.0.0.1 11-12|0.5 9-10|0.4 8-9|0.4.0 7-8|0.0.0 6-7|0.2 5-6|0.1 4-5|0.0.0.1 3-4|0.0 2-3|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 1-2|0 0-1|0.3.1+0.3.0.0+0.3.0+0.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:44.370
(a2 / and 
      :ARG0-of (p / perform-02 
            :ARG1 (a / and 
                  :op1 (c3 / country 
                        :name (n / name 
                              :op1 "NL") 
                        :quant 8) 
                  :op2 (b2 / bile))) 
      :ARG1-of (c2 / collect-01) 
      :ARG1-of (e / experiment-01) 
      :op1 (p2 / product 
            :name (n2 / name 
                  :op1 "AK-47") 
            :wiki "AK-47") 
      :op2 (c / characterization 
            :mod (b / bile)) 
      :op3 (f / figure))

# ::snt MA performed FPLC analysis .
# ::tok MA performed FPLC analysis .
# ::alignments 3-4|0 2-3|0.0.0.0+0.0.0+0.0 1-2|0.1 0-1|0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:44.410
(a / analyze-01 
      :ARG1 (o / organization 
            :name (n / name 
                  :op1 "FPLC")) 
      :ARG1-of (p / perform-02 
            :ARG0 (c / country 
                  :name (n2 / name 
                        :op1 "MA"))))

# ::snt SS , AK and RK performed GC sterol analyses .
# ::tok SS , AK and RK performed GC sterol analyses .
# ::alignments 8-9|0.0.0 7-8|0.0.0.0 6-7|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 5-6|0.0 4-5|0.3.0.0+0.3.0+0.3 3-4|0 2-3|0.2.1+0.2.0.0+0.2.0+0.2 0-1|0.1.1+0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:44.573
(a2 / and 
      :ARG0-of (p / perform-02 
            :ARG1 (a / analysis 
                  :mod (s / sterol 
                        :mod (c / country 
                              :name (n / name 
                                    :op1 "GC"))))) 
      :op1 (m / military 
            :name (n4 / name 
                  :op1 "SS") 
            :wiki "SS_(Nazi_Germany)") 
      :op2 (p2 / product 
            :name (n3 / name 
                  :op1 "AK-47") 
            :wiki "AK-47") 
      :op3 (c2 / country 
            :name (n2 / name 
                  :op1 "RK")))

# ::snt JC assisted with dynamic bile collection and mouse surgery .
# ::tok JC assisted with dynamic bile collection and mouse surgery .
# ::alignments 8-9|0.1 7-8|0.1.0 6-7|0 5-6|0.0 4-5|0.1.1 3-4|0.0.0 1-2|0.0.1 0-1|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:44.648
(a / and 
      :op1 (c / collect-01 
            :ARG0 (d / dynamic) 
            :ARG2-of (a2 / assist-01 
                  :ARG0 (o / organization 
                        :name (n / name 
                              :op1 "JC")))) 
      :op2 (s / surgery-01 
            :ARG2 (m / mouse) 
            :op1-of (b / bile)))

# ::snt ROE , AG , NM , GS and SBP were responsible for supervision , data analyses of experiments and for providing funding of these experiments .
# ::tok ROE , AG , NM , GS and SBP were responsible for supervision , data analyses of experiments and for providing funding of these experiments .
# ::alignments 24-25|0.1.0.0 23-24|0.1.0.0.1 21-22|0.1.0 20-21|0.1 18-19|0 17-18|0.0 15-16|0.0.0 14-15|0.0.0.0 12-13|0.1.0.0.0.0.0.0.0 10-11|0.1.0.0.0.0.0.0 8-9|0.1.0.0.0.0.3.0.0+0.1.0.0.0.0.3.0+0.1.0.0.0.0.3 7-8|0.1.0.0.0.0 6-7|0.1.0.0.0.0.2 4-5|0.1.0.0.0.0.1.0.0+0.1.0.0.0.0.1.0+0.1.0.0.0.0.1 2-3|0.1.0.0.0 0-1|0.1.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:44.896
(a / and 
      :op1 (e2 / experiment-01 
            :location-of (a2 / analysis 
                  :mod (d / data))) 
      :op2 (p / provide-01 
            :ARG1 (f / fund-01 
                  :ARG1 (e / experiment-01 
                        :ARG2 (a4 / ag 
                              :op2-of (a3 / and 
                                    :op1 (r2 / roe 
                                          :ARG0-of (r / responsible-01 
                                                :ARG1 (s / supervise-01))) 
                                    :op3 (c / country 
                                          :name (n2 / name 
                                                :op1 "NM")) 
                                    :op4 (g / g) 
                                    :op5 (o / organization 
                                          :name (n / name 
                                                :op1 "SBP")))) 
                        :mod (t / this)))))

# ::snt ELK and SBP wrote the paper .
# ::tok ELK and SBP wrote the paper .
# ::alignments 5-6|0.1 3-4|0 2-3|0.0.1.0.0+0.0.1.0+0.0.1 1-2|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:45.096
(w / write-01 
      :ARG0 (a / and 
            :op1 (c / country 
                  :name (n2 / name 
                        :op1 "ELK")) 
            :op2 (o / organization 
                  :name (n / name 
                        :op1 "SBP"))) 
      :ARG1 (p / paper))

# ::snt The pre-publication history for this paper can be accessed here : .
# ::tok The pre-publication history for this paper can be accessed here : .
# ::alignments 9-10|0.0.1 8-9|0.0 6-7|0 5-6|0.0.0.0 4-5|0.0.0.0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:45.141
(p / possible-01 
      :ARG1 (a / access-01 
            :ARG1 (h2 / history 
                  :topic (p2 / paper 
                        :mod (t / this))) 
            :location (h / here)))

# ::snt We would like to thank Dr B Stieger for kindly providing anti-Bsep antibody and Dr H Hobbs for providing the UTSW anti-Abcg5 / sterolin-1 antibody .
# ::tok We would like to thank Dr B Stieger for kindly providing anti-Bsep antibody and Dr H Hobbs for providing the UTSW anti-Abcg5 / sterolin-1 antibody .
# ::alignments 24-25|0.0.0.1.0 22-23|0.0.0.1.0.0 20-21|0.0.0.1.1.0.0+0.0.0.1.1.0+0.0.0.1.1 18-19|0.0.0.1 15-17|0.0.1+0+0.0+0.0.0 13-14|0.0.0.0 12-13|0.0.0.0.0.0 10-11|0.0.0.0.0 9-10|0.0.0.0.0.2 7-8|0.0.0.0.0.1.1 6-7|0.0.0.0.0.1.1.0.1+0.0.0.0.0.1.1.0.0.0+0.0.0.0.0.1.1.0.0+0.0.0.0.0.1.1.0 4-5|0.0.0.0.0.1 2-3|0.0.0.0.0.1.2 0-1|0.0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:46.506
(h / H 
      :op1-of (n2 / name 
            :name-of (t / thing 
                  :op1-of (a2 / and 
                        :ARG1-of (p2 / provide-01 
                              :ARG0 (a3 / antibody) 
                              :ARG2-of (t2 / thank-01 
                                    :ARG0 (w / we) 
                                    :ARG1 (s2 / stieg 
                                          :mod (l / location 
                                                :name (n3 / name 
                                                      :op1 "B") 
                                                :wiki -)) 
                                    :ARG1-of (l2 / like-02 
                                          :ARG0 w)) 
                              :manner (k / kindly))) 
                  :purpose (p / provide-01 
                        :ARG1 (a / antibody 
                              :op1-of (s / slash)) 
                        :ARG2 (o / organization 
                              :name (n / name 
                                    :op1 "UTSW")))) 
            :op2 (h2 / Hobbs)))

# ::snt We would also like to thank John Oatis , III for his excellent animal husbandry .
# ::tok We would also like to thank John Oatis , III for his excellent animal husbandry .
# ::alignments 14-15|0.0.0 13-14|0.0 12-13|0.0.0.0 9-10|0 6-8|0.0.0.0.0.1.1+0.0.0.0.0.1.0+0.0.0.0.0.1+0.0.0.0.0 5-6|0.0.0.0.0.0 3-4|0.0.0.0.0.0.1 2-3|0.0.0.0.0.0.1.0 0-1|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:46.668
(i / iii 
      :poss (a / animal 
            :mod-of (h / husbandry 
                  :ARG1-of (e / excellent-02 
                        :ARG0 (p / person 
                              :ARG1-of (t / thank-01 
                                    :ARG0 (w / we) 
                                    :ARG1-of (l / like-02 
                                          :mod (a2 / also) 
                                          :ARG0 w)) 
                              :name (n / name 
                                    :op1 "John" 
                                    :op2 "Oatis"))))))

# ::snt Grants from the American Heart Association , Beginning Grant-In-Aid Mid-Atlantic Affiliate ( KL ) , NIH Postdoctoral Training Grant T32 HL07260 ( ELK ) , the Netherlands Organization for Scientific Research ( NOW ) 902-23-193 ( AK ) as well as the National Institutes of Health Grant HL60613 ( SBP ) and DK56830 ( GS ) supported this work .
# ::tok Grants from the American Heart Association , Beginning Grant-In-Aid Mid-Atlantic Affiliate ( KL ) , NIH Postdoctoral Training Grant T32 HL07260 ( ELK ) , the Netherlands Organization for Scientific Research ( NOW ) 902-23-193 ( AK ) as well as the National Institutes of Health Grant HL60613 ( SBP ) and DK56830 ( GS ) supported this work .
# ::alignments 58-59|0.4.0.0 57-58|0.4.0.0.4 56-57|0.4.0 54-55|0.4.0.0.1 52-53|0.4.1.0+0.4.1+0.4 51-52|0 49-50|0.1.1.0.0+0.1.1.0+0.1.1 42-48|0.4.0.0.3.0.5+0.4.0.0.3.0.4+0.4.0.0.3.0.3+0.4.0.0.3.0.2+0.4.0.0.3.0.1+0.4.0.0.3.0.0+0.4.0.0.3.0+0.4.0.0.3 36-37|0.4.0.0.0.1+0.4.0.0.0.0.0+0.4.0.0.0.0+0.4.0.0.0 32-33|0.0.1.0 29-31|0.4.0.0.2.0.1+0.4.0.0.2.0.0+0.4.0.0.2.0+0.4.0.0.2 26-28|0.3.0.1+0.3.0.0+0.3.0+0.3 22-23|0.2.0.0+0.2.0+0.2 15-21|0.1.0.5+0.1.0.4+0.1.0.3+0.1.0.2+0.1.0.1+0.1.0.0+0.1.0+0.1 12-13|0.4.0.0.3.1.0.0+0.4.0.0.3.1.0+0.4.0.0.3.1 9-11|0.0.0.1+0.0.0.0+0.0.0+0.0 8-9|0.0.1.1.0 7-8|0.0.1 3-6|0.0.1.2.0.2+0.0.1.2.0.1+0.0.1.2.0.0+0.0.1.2.0+0.0.1.2 0-1|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:48.989
(a / and 
      :op1 (c2 / country 
            :name (n11 / name 
                  :op1 "Mid-Atlantic" 
                  :op2 "Affiliate") 
            :time-of (b / begin-01 
                  :ARG0 (n5 / now) 
                  :ARG1 (g3 / grant-01 
                        :ARG1 (g2 / grant-in-aid)) 
                  :ARG2 (o7 / organization 
                        :name (n12 / name 
                              :op1 "American" 
                              :op2 "Heart" 
                              :op3 "Association")))) 
      :op2 (o5 / organization 
            :name (n9 / name 
                  :op1 "NIH" 
                  :op2 "Postdoctoral" 
                  :op3 "Training" 
                  :op4 "Grant" 
                  :op5 "T32" 
                  :op6 "HL07260") 
            :part (o / organization 
                  :name (n2 / name 
                        :op1 "SBP"))) 
      :op3 (c / country 
            :name (n8 / name 
                  :op1 "ELK")) 
      :op4 (o4 / organization 
            :name (n7 / name 
                  :op1 "Netherlands" 
                  :op2 "Organization")) 
      :op5 (p / person 
            :ARG0-of (s / support-01 
                  :ARG1 (w / work-01 
                        :ARG0 (p2 / product 
                              :name (n4 / name 
                                    :op1 "AK-47") 
                              :wiki "AK-47") 
                        :ARG1 (g / g) 
                        :ARG3 (o3 / organization 
                              :name (n6 / name 
                                    :op1 "Scientific" 
                                    :op2 "Research")) 
                        :location (o2 / organization 
                              :name (n3 / name 
                                    :op1 "National" 
                                    :op2 "Institutes" 
                                    :op3 "of" 
                                    :op4 "Health" 
                                    :op5 "Grant" 
                                    :op6 "HL60613") 
                              :part (o6 / organization 
                                    :name (n10 / name 
                                          :op1 "KL"))) 
                        :mod (t / this))) 
            :name (n / name 
                  :op1 "DK56830")))

# ::snt Generation of mice deficient in Abcg8/sterolin -2 .
# ::tok Generation of mice deficient in Abcg8/sterolin -2 .
# ::alignments 5-6|0.0.0.0.0+0.0.0.0+0.0.0 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:49.009
(m / mouse 
      :consist (g / generation 
            :location (c / country 
                  :name (n / name 
                        :op1 "Abcg8/sterolin"))))

# ::snt The targeted disruption strategy of Abcg8 is as shown ( panel a ) .
# ::tok The targeted disruption strategy of Abcg8 is as shown ( panel a ) .
# ::alignments 10-11|0.1 8-9|0 3-4|0.0 2-3|0.0.1 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:49.039
(s / show-01 
      :ARG0 (s2 / strategy 
            :ARG1-of (t / target-01) 
            :mod (d / disruption)) 
      :ARG1 (p / panel))

# ::snt Southern blot analysis of BamHI digested mouse genomic DNA , probed with [ 32P ] - randomly labelled probe resulting in a 6.0 kb band for wild type , a 2.7 kb band for homozygous and two bands of 5.9 and 2.6 kb for the heterozygote ( panel b ) .
# ::tok Southern blot analysis of BamHI digested mouse genomic DNA , probed with [ 32P ] - randomly labelled probe resulting in a 6.0 kb band for wild type , a 2.7 kb band for homozygous and two bands of 5.9 and 2.6 kb for the heterozygote ( panel b ) .
# ::alignments 48-49|0.0.0.1.1.3 47-48|0.0.0.0 45-46|0.0.0.1.1.4 41-42|0.0.0.1.1.2 40-41|0 39-40|0.0.0.1.2 37-38|0.0.3 36-37|0.0.3.0 35-36|0.0 34-35|0.0.0.1.1.0.2.0 32-33|0.0.2 27-28|0.0.1 26-27|0.0.1.0 24-25|0.0.0.1.1.1 23-24|0.0.0.1.0 22-23|0.0.0.1.1.0.1.0 19-20|0.0.0.1.1 18-19|0.0.0.1 17-18|0.0.0 16-17|0.0.0.2 10-11|0.0.0.1.1.0.2 8-9|0.0.0.1.1.0.0 6-7|0.0.0.1.1.0.0.0 5-6|0.0.0.1.1.5 4-5|0.0.0.1.1.5.0.0.0+0.0.0.1.1.5.0.0+0.0.0.1.1.5.0 2-3|0.0.0.1.1.0 1-2|0.0.0.1.1.0.1 0-1|0.0.0.1.1.0.3.0.0+0.0.0.1.1.0.3.0+0.0.0.1.1.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:51.011
(a / and 
      :op4-of (a2 / and 
            :ARG2-of (l / label-01 
                  :ARG0 (p / panel) 
                  :ARG1 (p2 / probe-01 
                        :ARG1 (k / kb) 
                        :ARG1-of (r / result-01 
                              :ARG0 (a3 / analyze-01 
                                    :ARG1 (d / DNA 
                                          :mod (m / mouse)) 
                                    :ARG1-of (b5 / blot-01 
                                          :ARG0 6.0) 
                                    :ARG2 (p3 / probe-01 
                                          :ARG1 (h2 / homozygou)) 
                                    :manner (t3 / thing 
                                          :name (n2 / name 
                                                :op1 "Southern"))) 
                              :ARG2 (b4 / band) 
                              :op1-of 2.6 
                              :op1-of (b / b) 
                              :op1-of (h / heterozygote) 
                              :purpose (d2 / digest-01 
                                    :ARG1 (t2 / thing 
                                          :name (n / name 
                                                :op1 "BamHI")))) 
                        :ARG2 5.9) 
                  :mod (r2 / random)) 
            :op1 (t / type 
                  :mod (w / wild)) 
            :op2 (b3 / band) 
            :op3 (b2 / band 
                  :quant 2)))

# ::snt Northern blot analysis of hepatic RNA showed a loss of Abcg8/sterolin -2 mRNA in the homozygote and decreased Abcg8/sterolin -2 mRNA in the heterozygote , although Abcg5/sterolin -1 mRNA appeared relatively unaffected in the knockout mice ( panel c ) .
# ::tok Northern blot analysis of hepatic RNA showed a loss of Abcg8/sterolin -2 mRNA in the homozygote and decreased Abcg8/sterolin -2 mRNA in the heterozygote , although Abcg5/sterolin -1 mRNA appeared relatively unaffected in the knockout mice ( panel c ) .
# ::alignments 38-39|0.1.3.0 37-38|0.1.3.0.0 35-36|0.1.1 34-35|0.1.2 31-32|0.3+0 30-31|0.2 29-30|0.1 28-29|0.0 26-27|0.1.0.0.0+0.1.0.0+0.1.0 23-24|0.1.3.1.0 20-21|0.1.3.1 17-18|0.1.3 16-17|0.1.3.2 15-16|0.1.3.2.0.2 12-13|0.1.3.2.0.1.0 10-11|0.1.3.2.0.1.0.0.0.0+0.1.3.2.0.1.0.0.0+0.1.3.2.0.1.0.0 8-9|0.1.3.2.0.1 6-7|0.1.3.2.0 5-6|0.1.3.2.0.0.0 4-5|0.1.3.2.0.0.0.0 2-3|0.1.3.2.0.0 1-2|0.1.3.2.0.0.1 0-1|0.1.3.2.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:52.735
(a / affect-01 
      :ARG1 (m2 / mrna) 
      :ARG1-of (a2 / appear-01 
            :ARG0 (p2 / person 
                  :name (n / name 
                        :op1 "Abcg5/sterolin")) 
            :medium (m / mouse) 
            :time (k / knockout) 
            :time-of (d / decrease-01 
                  :ARG0 (c / c 
                        :mod (p / panel)) 
                  :ARG1 (m3 / mrna 
                        :location (h / heterozygote)) 
                  :op2-of (a3 / and 
                        :op1 (s / show-01 
                              :ARG0 (a4 / analyze-01 
                                    :ARG1 (r2 / rna 
                                          :mod (h3 / hepatic)) 
                                    :ARG2 (b / blot-01) 
                                    :manner "Northern_Ireland") 
                              :ARG1 (l / loss 
                                    :poss (m4 / mrna 
                                          :mod (c2 / country 
                                                :name (n2 / name 
                                                      :op1 "Abcg8/sterolin")))) 
                              :time (h2 / homozygote))))) 
      :degree (r / relative) 
      :polarity -)

# ::snt Probes were approximately 1.9 kb for Abcg5 and 2 kb for Abcg8 ( see Methods for more detail ) .
# ::tok Probes were approximately 1.9 kb for Abcg5 and 2 kb for Abcg8 ( see Methods for more detail ) .
# ::alignments 17-18|0.1 16-17|0.1.2 14-15|0.0 13-14|0 11-12|0.1.0 8-9|0.1.1.0 7-8|0.1.1.2 6-7|0.1.1.2.0.0.0+0.1.1.2.0.0+0.1.1.2.0 4-5|0.1.1.1 2-3|0.1.1.1.0 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:52.975
(s / see-01 
      :ARG1 (m2 / method) 
      :purpose (d / detail-01 
            :ARG0 (a / Abcg8) 
            :ARG1 (p / probe-01 
                  :ARG0 2 
                  :ARG2 (k / kb 
                        :quant (a3 / approximately)) 
                  :op1-of (a2 / and 
                        :op2 (t / thing 
                              :name (n / name 
                                    :op1 "Abcg5")))) 
            :degree (m / more)))

# ::snt RT-PCR analyses of hepatic cDNA showed no Abcg8/sterolin -2 message , downstream of exon 4 in the Abcg8 - / - mice , whether primers were located in exons 4 and 13 ( panel d ) , exons 9 and 13 or exons 10 and 13 ( panel e ) .
# ::tok RT-PCR analyses of hepatic cDNA showed no Abcg8/sterolin -2 message , downstream of exon 4 in the Abcg8 - / - mice , whether primers were located in exons 4 and 13 ( panel d ) , exons 9 and 13 or exons 10 and 13 ( panel e ) .
# ::alignments 47-48|0.5.0.0 45-46|0.4 44-45|0.5.0.6 43-44|0.2 42-43|0.5.0.5 41-42|0.5.0 40-41|0.3 39-40|0.5 38-39|0.6 37-38|0.5.0.4 34-35|0.5.0.3 33-34|0.5.0.3.0 31-32|0.1.0 30-31|0.5.0.1.2 29-30|0.5.0.1.2.0.0 28-29|0.5.0.2 26-27|0.5.0.1 24-25|0.5.0.1.0 21-22|0.8 19-20|0.5.0.6.0 14-15|0.5.0.1.1 13-14|0.5.0.3.1 11-12|0.5.0.3.0.0 9-10|0.1 7-8|0.5.0.1.2.0.1.0+0.5.0.1.2.0.1+0.5.0.1.2.0 6-7|0.7 5-6|0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:54.382
(s2 / show-01 
      :ARG0 (a4 / analysis 
            :mod (c2 / cdna 
                  :mod (h / hepatic))) 
      :ARG1 (m2 / message 
            :mod-of 13) 
      :op1-of 10 
      :op1-of 13 
      :op1-of 13 
      :op1-of (a2 / and 
            :op4-of (o / or 
                  :domain (p / panel) 
                  :location-of (l / locate-01 
                        :ARG1 (p3 / primer) 
                        :ARG2 4 
                        :time (a3 / and 
                              :op1 (c / country 
                                    :mod-of 4 
                                    :name (n / name 
                                          :op1 "Abcg8/sterolin")))) 
                  :op1 (e3 / exon) 
                  :op2 (d / d 
                        :mod (p2 / panel 
                              :mod-of (d2 / downstream)) 
                        :mod (e4 / exon)) 
                  :op3 (e2 / exon) 
                  :op5 (e / exon) 
                  :op6 (a / and 
                        :op1 (s / slash)))) 
      :op1-of 9 
      :polarity - 
      :time (m / mouse))

# ::snt Free versus esterified sterol levels in the livers of Abcg8 + / + , Abcg8 + / - and Abcg8 - / - mice .
# ::tok Free versus esterified sterol levels in the livers of Abcg8 + / + , Abcg8 + / - and Abcg8 - / - mice .
# ::alignments 23-24|0.0.3.0 21-22|0.0.2.1 18-19|0 16-17|0.0.2.0 11-12|0.0.0.0 7-8|0.0.3 4-5|0.0 3-4|0.0.1 2-3|0.0.2 1-2|0.0.4 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:54.500
(a / and 
      :mod (l2 / level 
            :ARG1-of (f / free-04 
                  :ARG0 (s3 / slash)) 
            :mod (s4 / sterol) 
            :mod (e / esterify 
                  :mod-of (s2 / slash) 
                  :poss-of (s / slash)) 
            :mod (l / liver 
                  :mod (m / mouse)) 
            :op1-of (v / versu)))

# ::snt Sterol contents of liver extracts of 12-week-old female mice fed a regular chow diet , determined by GC analysis show that the majority of sterols in all genotypes are unesterified .
# ::tok Sterol contents of liver extracts of 12-week-old female mice fed a regular chow diet , determined by GC analysis show that the majority of sterols in all genotypes are unesterified .
# ::alignments 27-28|0.0.0.0.0.0.0.0.3 26-27|0.0.0.0.0.0.0.0.3.0 24-25|0.0.0.0.0.0.0.0.2.0 22-23|0.0.0.0.0.0.0.0.2 19-20|0.0.0 18-19|0.0 17-18|0.0.1 15-16|0 13-14|0.0.0.0.0.0.0.0.0.0 12-13|0.0.0.0.0.0.0.0.0.0.1 11-12|0.0.0.0.0.0.0.0.0.0.0 9-10|0.0.0.0.0.0.0.0.0 8-9|0.0.0.0.0.0.0.0 7-8|0.0.0.0.0.0.0.0.1 4-5|0.0.0.0.0.0.0+0.0.0.0.0.0 3-4|0.0.0.0.0.0.0.1 1-2|0.0.0.0.0+0.0.0.0 0-1|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:55.192
(d / determined-02 
      :ARG0 (a2 / analyze-01 
            :ARG0-of (s2 / show-01 
                  :ARG1 (t2 / thing 
                        :ARG1-of (c2 / contain-01 
                              :ARG0 (t / thing 
                                    :ARG1-of (e / extract-01 
                                          :ARG2 (m2 / mouse 
                                                :ARG0-of (f / feed-up-03 
                                                      :ARG1 (d2 / diet 
                                                            :ARG1-of (r / regular-02) 
                                                            :mod (c / chow))) 
                                                :mod (f2 / female) 
                                                :mod-of (m / majority 
                                                      :quant-of (s / sterol)) 
                                                :mod-of (g / genotyp 
                                                      :quant (a / all))) 
                                          :mod (l / liver)))) 
                        :mod (s3 / sterol))) 
            :ARG1 (g2 / gc)))

# ::snt Esterified cholesterol ( panel a ) remains relatively constant for each genotype .
# ::tok Esterified cholesterol ( panel a ) remains relatively constant for each genotype .
# ::alignments 11-12|0.0.2 10-11|0.0.2.0 8-9|0.0.1 7-8|0.0.1.0 6-7|0.0 3-4|0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:55.256
(p / panel 
      :ARG0-of (r2 / remain-01 
            :ARG1 (c2 / cholesterol 
                  :mod (e2 / esterify)) 
            :ARG3 (c / constant 
                  :degree (r / relative)) 
            :purpose (g / genotype 
                  :mod (e / each))))

# ::snt However , no esterified sitosterol in the livers from Abcg8 + / + and Abcg8 + / - mice and very little from Abcg8 - / - mice was detected ( panel b ) .
# ::tok However , no esterified sitosterol in the livers from Abcg8 + / + and Abcg8 + / - mice and very little from Abcg8 - / - mice was detected ( panel b ) .
# ::alignments 32-33|0.0.0 31-32|0 29-30|0.0 27-28|0.0.1 25-26|0.0.2.2.3 21-22|0.0.2.2.2 20-21|0.0.2.2.2.0 19-20|0.0.2.2 18-19|0.0.2.2.1 16-17|0.0.2.1 13-14|0.0.2 11-12|0.0.2.0 7-8|0.0.0.0 3-4|0.0.2.2.0 2-3|0.0.2.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:55.624
(p / panel 
      :ARG2-of (d / detect-01 
            :ARG0 (b / b 
                  :mod (l2 / liver)) 
            :ARG1 (m / mouse) 
            :op4-of (a2 / and 
                  :op1 (s3 / slash) 
                  :op2 (s2 / slash) 
                  :op3 (a / and 
                        :op1 (e / esterify 
                              :polarity -) 
                        :op2 (m2 / mouse) 
                        :op3 (l / little 
                              :degree (v / very)) 
                        :op4 (s / slash)))))

# ::snt Small amounts of esterified campesterol were detected in each of the genotypes ( panel c ) .
# ::tok Small amounts of esterified campesterol were detected in each of the genotypes ( panel c ) .
# ::alignments 14-15|0.0 13-14|0 11-12|0.1.0.0 8-9|0.1.0 6-7|0.1 3-4|0.0.0 1-2|0.1.1 0-1|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:55.735
(p / panel 
      :mod-of (c / c 
            :poss (e2 / esterify)) 
      :op1 (d / detect-01 
            :ARG0 (e / each 
                  :mod-of (g / genotyp)) 
            :ARG1 (a / amount 
                  :mod (s / small))))

# ::snt Lipid profiles of the plasma of Abcg8 + / + , Abcg8 + / - and Abcg8 - / - mice .
# ::tok Lipid profiles of the plasma of Abcg8 + / + , Abcg8 + / - and Abcg8 - / - mice .
# ::alignments 20-21|0.0.1.0.0 18-19|0.0.1.1 15-16|0 13-14|0.1 8-9|0.0.1.0 4-5|0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:55.843
(a / and 
      :ARG0-of (p2 / profile-01 
            :ARG1 (p / plasma) 
            :mod (l / lipid 
                  :op1-of (s3 / slash 
                        :op2 (m / mouse)) 
                  :op1-of (s / slash))) 
      :op1 (s2 / slash))

# ::snt Lipoproteins were separated from pooled mouse plasma samples by FPLC .
# ::tok Lipoproteins were separated from pooled mouse plasma samples by FPLC .
# ::alignments 9-10|0.1.0.0.0.0.0.0+0.1.0.0.0.0.0+0.1.0.0.0.0 7-8|0+0.1 6-7|0.0 5-6|0.0.0 4-5|0.1.0 2-3|0.1.0.0.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:55.992
(s / sample-01 
      :ARG0 (p / plasma 
            :mod (m / mouse)) 
      :ARG1 (t / thing 
            :ARG1-of (p2 / pool-01 
                  :ARG0 (l / lipoprotein 
                        :ARG1-of (s2 / separate-01 
                              :ARG0 (o / organization 
                                    :name (n / name 
                                          :op1 "FPLC")))))))

# ::snt Total sterols ( panel a ) and triglyceride ( panel b ) profiles of the fractions are shown .
# ::tok Total sterols ( panel a ) and triglyceride ( panel b ) profiles of the fractions are shown .
# ::alignments 17-18|0 15-16|0.1.0 12-13|0.1 10-11|0.1.0.2.0 9-10|0.1.0.1 7-8|0.0.1 6-7|0.0 3-4|0.1.0.0 1-2|0.0.0 0-1|0.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:56.316
(s / show-01 
      :ARG0 (a / and 
            :op1 (s2 / sterol) 
            :op2 (t / triglyceride)) 
      :ARG1 (p / profile-01 
            :ARG1 (f / fraction-01 
                  :ARG0 (p3 / panel) 
                  :ARG1 (p2 / panel) 
                  :ARG1-of (t2 / total-01 
                        :ARG0 (b / b)))))

# ::snt There was no difference of cholesterol profiles in the groups , but there was a small triglyceride peak in Abcg8 - / - mice in fractions 21 -- 25 , corresponding to the LDL-size range , the significance of which is not known at present .
# ::tok There was no difference of cholesterol profiles in the groups , but there was a small triglyceride peak in Abcg8 - / - mice in fractions 21 -- 25 , corresponding to the LDL-size range , the significance of which is not known at present .
# ::alignments 44-45|0.0.1.0.2 42-43|0.0.1.0 41-42|0.0.1.0.1 37-38|0.0.1.0.0 34-35|0.0.1 30-31|0.0.3.1 28-29|0.0.3.2 26-27|0.0.1.0.0.0.0 25-26|0.0.3 23-24|0.0.2 21-22|0.0.1.1 17-18|0.0 16-17|0.0.0 15-16|0.0.4 11-12|0 9-10|0.0.1.0.0.0.1.0 6-7|0.0.1.0.0.0.1 5-6|0.0.1.0.0.0.1.1 3-4|0.0.1.0.0.0 2-3|0.0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:57.506
(c2 / contrast-01 
      :ARG1 (p2 / peak-01 
            :ARG0 (t / triglyceride) 
            :ARG0-of (r / range-01 
                  :ARG0-of (k / know-02 
                        :ARG1 (s / significant-02 
                              :ARG1 (d / differ-02 
                                    :ARG0 21 
                                    :ARG1 (p3 / profile-01 
                                          :ARG0 (g / group) 
                                          :ARG1 (c3 / cholesterol)))) 
                        :polarity - 
                        :time (p / present)) 
                  :ARG1 (s2 / slash)) 
            :ARG1 (m / mouse) 
            :ARG3 (f / fraction-01 
                  :ARG1 - 
                  :ARG1-of (c / correspond-01) 
                  :quant 25) 
            :mod (s3 / small)))

# ::snt Analyses of mRNA expression and enzyme activity in mouse livers .
# ::tok Analyses of mRNA expression and enzyme activity in mouse livers .
# ::alignments 9-10|0.0.0 8-9|0.0.0.0 6-7|0.0 5-6|0 4-5|0.0.1 3-4|0.0.1.1 2-3|0.0.1.1.0 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:57.572
(e / enzyme 
      :mod-of (a / activity-06 
            :ARG1 (l / liver 
                  :mod (m / mouse)) 
            :op3-of (a2 / and 
                  :op1 (a3 / analyse) 
                  :op2 (e2 / express-01 
                        :ARG1 (m2 / mrna)))))

# ::snt Panel ( a ) shows RT-PCR quantitation of mRNA levels for Abcg5 , Abcg8 , Hmgr , Cyp7a1 , Abca1 , Mdr2 , Lxr , Srebp-1c and Srebp-2 in mouse livers from Abcg8 + / + ( open bars ) , Abcg8 + / - ( hatched bars ) and Abcg8 - / - ( filled bars ) .
# ::tok Panel ( a ) shows RT-PCR quantitation of mRNA levels for Abcg5 , Abcg8 , Hmgr , Cyp7a1 , Abca1 , Mdr2 , Lxr , Srebp-1c and Srebp-2 in mouse livers from Abcg8 + / + ( open bars ) , Abcg8 + / - ( hatched bars ) and Abcg8 - / - ( filled bars ) .
# ::alignments 56-57|0.1 55-56|0 52-53|0.2.8.3 49-50|0.2.0.2 47-48|0.2.8.0.0 46-47|0.2.8.0 43-44|0.2.8.2 38-39|0.3.0 37-38|0.3 34-35|0.0 30-31|0.2.8.4 29-30|0.2.8.4.0 27-28|0.2.9.0.0+0.2.9.0+0.2.9 26-27|0.2 25-26|0.2.8.1.0+0.2.8.1+0.2.8 23-24|0.2.7 21-22|0.2.6 19-20|0.2.5 17-18|0.2.4 15-16|0.2.3 13-14|0.2.2 11-12|0.2.1.0.0+0.2.1.0+0.2.1 9-10|0.2.0.1.0 8-9|0.2.0.1.0.0 6-7|0.2.0.1 4-5|0.2.0 0-1|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:58.849
(f / fill-01 
      :ARG0 (s3 / slash) 
      :ARG1 (b / bar) 
      :ARG2 (a2 / and 
            :ARG3-of (s4 / show-01 
                  :ARG0 (p2 / panel) 
                  :ARG1 (q / quantitation 
                        :mod (l3 / level 
                              :mod (m3 / mrna))) 
                  :location (a / and)) 
            :op1 (t2 / thing 
                  :name (n3 / name 
                        :op1 "Abcg5")) 
            :op2 (a4 / Abcg8) 
            :op3 (h2 / Hmgr) 
            :op4 (c / Cyp7a1) 
            :op5 (a3 / Abca1) 
            :op6 (m2 / Mdr2) 
            :op7 (l2 / Lxr) 
            :op8 (p / person 
                  :ARG0-of (h / hatch-01 
                        :ARG1 (b2 / bar)) 
                  :name (n2 / name 
                        :op1 "Srebp-1c") 
                  :op1-of (s2 / slash) 
                  :op1-of (s / slash) 
                  :part (l / liver 
                        :mod (m / mouse))) 
            :op9 (t / thing 
                  :name (n / name 
                        :op1 "Srebp-2"))) 
      :purpose (o / open-04 
            :ARG1 (b3 / bar)))

# ::snt Knockout mice showed an ~ 60 % reduction in mRNA for Abcg5/sterolin -1 and an 80 % reduction in the message for HMG CoA reductase .
# ::tok Knockout mice showed an ~ 60 % reduction in mRNA for Abcg5/sterolin -1 and an 80 % reduction in the message for HMG CoA reductase .
# ::alignments 24-25|0.2.1.0.0 22-24|0.2.1.0.0.0.0.1+0.2.1.0.0.0.0.0+0.2.1.0.0.0.0+0.2.1.0.0.0 20-21|0.2.1.0 17-18|0.2.1 16-17|0.2.1.1 15-16|0.2.1.1.0 13-14|0.2 11-12|0.2.0.0.0+0.2.0.0+0.2.0 9-10|0.1.0 7-8|0.1 6-7|0.1.1 5-6|0.1.1.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:59.638
(s / show-01 
      :ARG0 (m3 / mouse 
            :mod (k / knockout)) 
      :ARG1 (r3 / reduce-01 
            :ARG1 (m2 / mrna) 
            :ARG2 (p3 / percentage-entity 
                  :value 60)) 
      :ARG2 (a / and 
            :op1 (p2 / person 
                  :name (n2 / name 
                        :op1 "Abcg5/sterolin")) 
            :op2 (r2 / reduce-01 
                  :ARG1 (m / message 
                        :beneficiary (r / reductase 
                              :mod (t / thing 
                                    :name (n / name 
                                          :op1 "HMG" 
                                          :op2 "CoA")))) 
                  :ARG2 (p / percentage-entity 
                        :value 80))))

# ::snt Relatively no message for Abcg8/sterolin -2 was detected in the knockout mice .
# ::tok Relatively no message for Abcg8/sterolin -2 was detected in the knockout mice .
# ::alignments 11-12|0.2 10-11|0.2.0 7-8|0 4-5|0.0.0.0+0.0.0+0.0 2-3|0.1 1-2|0.3 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:10:59.698
(d / detect-01 
      :ARG0 (c / country 
            :name (n / name 
                  :op1 "Abcg8/sterolin")) 
      :ARG1 (m2 / message 
            :domain-of (r / relatively)) 
      :location (m / mouse 
            :mod (k / knockout)) 
      :polarity -)

# ::snt Panel ( b ) shows the enzyme activities for HMG-CoA reductase and CYP7a1 in livers from Abcg8 + / + , Abcg8 + / - and Abcg8 - / - mice .
# ::tok Panel ( b ) shows the enzyme activities for HMG-CoA reductase and CYP7a1 in livers from Abcg8 + / + , Abcg8 + / - and Abcg8 - / - mice .
# ::alignments 30-31|0.1.0 28-29|0.3.1 25-26|0.3 23-24|0.1.3 18-19|0.1.4 14-15|0.3.0 12-13|0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 11-12|0.1.1 10-11|0.1.1.0 9-10|0.1.1.1.1.0.0+0.1.1.1.1.0+0.1.1.1.1 7-8|0.1 6-7|0.1.2 4-5|0 2-3|0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:00.013
(s4 / show-01 
      :ARG0 (p / panel) 
      :ARG1 (a3 / activity-06 
            :ARG0 (m / mouse) 
            :ARG1 (a2 / and 
                  :op1 (r / reductase) 
                  :op2 (t / thing 
                        :name (n / name 
                              :op1 "CYP7a1") 
                        :quant (t2 / thing 
                              :name (n2 / name 
                                    :op1 "HMG-CoA")))) 
            :mod (e / enzyme) 
            :op1-of (s2 / slash) 
            :op1-of (s3 / slash)) 
      :ARG2 (b / b) 
      :op1-of (a / and 
            :op2 (l / liver) 
            :op3 (s / slash)))

# ::snt Activities of HMG-CoA reductase and CYP7a1 were significantly reduced in the Abcg8 - / - mouse liver ( * P < 0.05 , see text for discussion ) .
# ::tok Activities of HMG-CoA reductase and CYP7a1 were significantly reduced in the Abcg8 - / - mouse liver ( * P < 0.05 , see text for discussion ) .
# ::alignments 26-27|0.0.1 24-25|0.0.0 23-24|0.0 19-20|0 16-17|0.0.1.0.0.0.2 15-16|0.0.1.0.0.0.2.0 13-14|0.0.1.0.0.0.0 8-9|0.0.1.0.0.0 7-8|0.0.1.0.0.0.1 5-6|0.0.1.0.2.0.0+0.0.1.0.2.0+0.0.1.0.2 4-5|0.0.1.0 3-4|0.0.1.0.1 2-3|0.0.1.0.2.1.0.0+0.0.1.0.2.1.0+0.0.1.0.2.1 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:00.295
(p / P60 
      :ARG0-of (s / see-01 
            :ARG1 (t / text) 
            :ARG2 (d / discuss-01 
                  :ARG0 (a / and 
                        :op1 (a2 / activiti 
                              :ARG1-of (r / reduce-01 
                                    :ARG0 (s2 / slash) 
                                    :ARG2 (s3 / significant-02) 
                                    :location (l / liver 
                                          :mod (m / mouse)))) 
                        :op2 (r2 / reductase) 
                        :op3 (t2 / thing 
                              :name (n / name 
                                    :op1 "CYP7a1") 
                              :quant (t3 / thing 
                                    :name (n2 / name 
                                          :op1 "HMG-CoA")))))))

# ::snt N-glycosylation of Abcg5/sterolin -1 analyses in Abcg8 - / - mouse liver .
# ::tok N-glycosylation of Abcg5/sterolin -1 analyses in Abcg8 - / - mouse liver .
# ::alignments 11-12|0 10-11|0.0 8-9|0.0.0.2 6-7|0.0.0.0.0 4-5|0.0.0.0 2-3|0.0.0.1.0+0.0.0.1+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:00.326
(l / liver 
      :mod (m / mouse 
            :mod-of (p / person 
                  :mod-of (a2 / analysis 
                        :location (a / Abcg8)) 
                  :name (n / name 
                        :op1 "Abcg5/sterolin") 
                  :op1-of (s / slash))))

# ::snt Mouse liver homogenate stained with SC anti-Abcg5 / sterolin-1 after treatment with Endo-H or PNGaseF shows a 75 kDa band present in both genotypes , which is resistant to deglycosylation ( panel a ) .
# ::tok Mouse liver homogenate stained with SC anti-Abcg5 / sterolin-1 after treatment with Endo-H or PNGaseF shows a 75 kDa band present in both genotypes , which is resistant to deglycosylation ( panel a ) .
# ::alignments 31-32|0.0.0.1.1.0 27-28|0 23-24|0.1 22-23|0.1.1 20-21|0.1.0 19-20|0.0.0.1.1.1 18-19|0.0.0.1.0.1.0 17-18|0.0.0.1.1.1.0 15-16|0.0.0.1.1 13-14|0.0.0.1.0.1 12-13|0.0.0.1.0.1.1.0.0+0.0.0.1.0.1.1.0+0.0.0.1.0.1.1 10-11|0.0.0.1.0 9-10|0.0.0.1 7-8|0.0.0.1.0.0.1 5-6|0.0.0.1.0.0.2+0.0.0.1.0.0.0.0+0.0.0.1.0.0.0+0.0.0.1.0.0 3-4|0.0.0 2-3|0.0.0.0 1-2|0.0.0.0.0 0-1|0.0.1.0+0.0.1+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:00.848
(r / resist-01 
      :ARG0 (p3 / person 
            :ARG1-of (s4 / stain-01 
                  :ARG0 (h / homogenate 
                        :mod (l / liver)) 
                  :time (a / after 
                        :op1 (t2 / treat-03 
                              :ARG0 (s3 / state 
                                    :name (n2 / name 
                                          :op1 "SC") 
                                    :op1-of (s2 / slash) 
                                    :wiki "South_Carolina") 
                              :ARG1 (o / or 
                                    :domain-of (k / kDa) 
                                    :op1 (t / thing 
                                          :name (n / name 
                                                :op1 "Endo-H")))) 
                        :op2 (s / show-01 
                              :ARG0 (p / panel) 
                              :ARG1 (b2 / band 
                                    :quant 75)))) 
            :name (n3 / name 
                  :op1 "Mouse")) 
      :ARG1 (g / genotyp 
            :location-of (p2 / present) 
            :mod (b / both)))

# ::snt Staining of wild-type liver homogenate with preimmune serum showed no detectable bands .
# ::tok Staining of wild-type liver homogenate with preimmune serum showed no detectable bands .
# ::alignments 11-12|0.1 10-11|0.1.0 9-10|0.2 8-9|0 7-8|0.0 4-5|0.0.0.0 3-4|0.0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:00.890
(s / show-01 
      :ARG0 (s2 / serum 
            :ARG2-of (s3 / stain-01 
                  :ARG1 (h / homogenate 
                        :mod (l / liver)))) 
      :ARG1 (b / band 
            :mod (d / detectable)) 
      :polarity -)

# ::snt Lower portion of panel ( a ) shows the same aliquots stained for anti-transferrin as a control for deglycosylation .
# ::tok Lower portion of panel ( a ) shows the same aliquots stained for anti-transferrin as a control for deglycosylation .
# ::alignments 18-19|0.1.1.0 16-17|0.1.1 11-12|0.1 10-11|0.1.0 9-10|0.1.0.0 7-8|0 3-4|0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:01.033
(s3 / show-01 
      :ARG0 (p / panel 
            :quant (p2 / portion 
                  :ARG1-of (l / lower-01))) 
      :ARG1 (s / stain-01 
            :ARG0 (a / aliquot 
                  :ARG1-of (s2 / same-01)) 
            :ARG2 (c / control-01 
                  :ARG1 (d / deglycosylation))))

# ::snt AMC anti-Abcg5 / sterolin-1 staining of mouse liver homogenate shows a ` mature ' ~ 90 kDa band in the wild-type mice but not in the Abcg8 - / - mice ( panel b ) .
# ::tok AMC anti-Abcg5 / sterolin-1 staining of mouse liver homogenate shows a ` mature ' ~ 90 kDa band in the wild-type mice but not in the Abcg8 - / - mice ( panel b ) .
# ::alignments 33-34|0.1.0.0.0.1 32-33|0.1.0.0.0.3 30-31|0.1.0.0.0.4 28-29|0.1.0.0.2.1 26-27|0.1.0.0.0.2 23-24|0.1.0.0.0.0 22-23|0 21-22|0.1.0.1 17-18|0.1 15-16|0.0 12-13|0.1.0.0.0 9-10|0.1.0 8-9|0.1.0.0 7-8|0.1.0.0.2 6-7|0.1.0.0.2.0 4-5|0.1.0.0.1 2-3|0.1.0.0.1.1 0-2|0.1.0.0.1.0.0.1+0.1.0.0.1.0.0.0+0.1.0.0.1.0.0+0.1.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:01.777
(c / contrast-01 
      :ARG2 90 
      :domain-of (b2 / band 
            :ARG1-of (s2 / show-01 
                  :ARG0 (h / homogenate 
                        :ARG1-of (m3 / mature-02 
                              :ARG0 - 
                              :op1-of (b / b) 
                              :op1-of (a / Abcg8) 
                              :op1-of (p / panel) 
                              :op1-of (m / mouse)) 
                        :ARG1-of (s3 / stain-01 
                              :ARG2 (t / thing 
                                    :name (n / name 
                                          :op1 (a2 / AMC) 
                                          :op2 (a3 / anti-Abcg5))) 
                              :op1-of (s4 / slash)) 
                        :mod (l / liver 
                              :mod (m4 / mouse) 
                              :mod-of (s / slash))) 
                  :time (m2 / mouse))))

# ::snt A 75 kDa form is present which is sensitive to deglycosylation .
# ::tok A 75 kDa form is present which is sensitive to deglycosylation .
# ::alignments 10-11|0 8-9|0.0 5-6|0.0.0 3-4|0.0.0.0 2-3|0.0.0.0.0 1-2|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:01.804
(d / deglycosylation 
      :ARG1-of (s / sensitive-03 
            :op1-of (p / present 
                  :domain (f / form 
                        :mod (k / kDa) 
                        :mod 75))))

# ::snt Mouse liver homogenate stained with UTSW anti-Abcg5 / sterolin-1 shows a ` mature ' ~ 90 kDa band and an ` immature ' 75 kDa band in the wild-type mice but no signal is detected in the Abcg8 - / - mice .
# ::tok Mouse liver homogenate stained with UTSW anti-Abcg5 / sterolin-1 shows a ` mature ' ~ 90 kDa band and an ` immature ' 75 kDa band in the wild-type mice but no signal is detected in the Abcg8 - / - mice .
# ::alignments 41-42|0.0.1.0 39-40|0.1.3 37-38|0.0.2 34-35|0.0 32-33|0.0.0 31-32|0.1.0.0 30-31|0 29-30|0.1.1.0 25-26|0.2 23-24|0.2.0 21-22|0.3.3 18-19|0.1 17-18|0.1.2 16-17|0.3.2 15-16|0.3.0 12-13|0.0.1 9-10|0.1.0 7-8|0.1.0.1 3-4|0.3 2-3|0.3.1 1-2|0.3.1.0 0-1|0.1.1.1.0+0.1.1.1+0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:02.465
(c / contrast-01 
      :ARG1 (d / detect-01 
            :ARG1 (s2 / signal) 
            :ARG1-of (m3 / mature-02 
                  :ARG0 (m / mouse)) 
            :ARG2 (a / Abcg8)) 
      :ARG2 (a2 / and 
            :ARG1-of (s3 / show-01 
                  :ARG0 - 
                  :op1-of (s4 / slash)) 
            :op1 (p / person 
                  :mod (m2 / mouse) 
                  :name (n / name 
                        :op1 "Mouse")) 
            :op2 (b2 / band) 
            :op3 (s / slash)) 
      :domain-of (b / band 
            :quant 75) 
      :purpose-of (s5 / stain-01 
            :ARG0 90 
            :ARG1 (h / homogenate 
                  :mod (l / liver)) 
            :op1-of (k / kDa) 
            :op1-of (i / immature)))

# ::snt Treatment with Endo-H or PNGaseF results in a lower molecular weight protein in the wild-type mice .
# ::tok Treatment with Endo-H or PNGaseF results in a lower molecular weight protein in the wild-type mice .
# ::alignments 15-16|0.1.0 11-12|0.1 10-11|0.1.1.0 9-10|0.1.1 8-9|0.1.1.0.0 5-6|0 3-4|0.0.0 2-3|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:02.596
(r / result-01 
      :ARG1 (t2 / treatment 
            :op1-of (o / or 
                  :op2 (t / thing 
                        :name (n / name 
                              :op1 "Endo-H")))) 
      :ARG2 (p / protein 
            :location (m / mouse) 
            :mod (m2 / molecule 
                  :quant-of (w / weight 
                        :ARG1-of (l / low-04)))))

# ::snt Abcg5/Abcg8 - / - liver homogenate used for negative control .
# ::tok Abcg5/Abcg8 - / - liver homogenate used for negative control .
# ::alignments 9-10|0.2 8-9|0.2.0 6-7|0 5-6|0.1 4-5|0.1.0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:02.652
(u / use-01 
      :ARG0 (s / slash) 
      :ARG1 (h / homogenate 
            :mod (l / liver)) 
      :ARG2 (c / control-01 
            :mod (n / negative)))

# ::snt Immunohistochemical evaluation of mouse Abcg5/sterolin -1 expression in liver and intestine .
# ::tok Immunohistochemical evaluation of mouse Abcg5/sterolin -1 expression in liver and intestine .
# ::alignments 10-11|0.1.1 9-10|0.1 8-9|0.1.0 6-7|0 3-4|0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:02.682
(e / express-01 
      :ARG1 (e2 / evaluate-01 
            :ARG1 (m / mouse)) 
      :op1-of (a / and 
            :op2 (l / liver) 
            :op3 (i / intestine)))

# ::snt COS-1 cells were transiently transfected with pCMV-mouse Abcg5 or pCMV-mouse Abcg8 constructs , allowed to express for 48 hours then fixed and incubated with antibody .
# ::tok COS-1 cells were transiently transfected with pCMV-mouse Abcg5 or pCMV-mouse Abcg8 constructs , allowed to express for 48 hours then fixed and incubated with antibody .
# ::alignments 24-25|0.1.1.0.1 22-23|0.1 21-22|0 20-21|0.1.1.0 19-20|0.1.1.0.2 18-19|0.1.1.2+0.1.1 17-18|0.1.1.1 15-16|0.0.1 13-14|0.0 11-12|0.0.1.0 10-11|0.0.1.0.0 8-9|0.1.0 7-8|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 3-4|0.1.1.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:03.279
(a2 / and 
      :op1 (a3 / allow-01 
            :ARG0 (c2 / cell) 
            :ARG1 (e / express-01 
                  :ARG1 (c / construct 
                        :mod (a4 / Abcg8)))) 
      :op2 (i / incubate-01 
            :ARG0 (o / or 
                  :op1 (t3 / thing 
                        :name (n / name 
                              :op1 "Abcg5"))) 
            :ARG2 (t2 / temporal-quantity 
                  :ARG1-of (f / fix-03 
                        :ARG0 (t4 / transiently) 
                        :location (a / antibody) 
                        :time (t / then)) 
                  :quant 48 
                  :unit (h / hour))))

# ::snt pCMV empty vector transfected COS-1 cells incubated with SC anti-Abcg5 / sterolin-1 showed no significant fluorescence ( panel a ) .
# ::tok pCMV empty vector transfected COS-1 cells incubated with SC anti-Abcg5 / sterolin-1 showed no significant fluorescence ( panel a ) .
# ::alignments 17-18|0 15-16|0.0.0.1.0.0 14-15|0.0.0.1.0.0.0 13-14|0.0.0.1.0.1 12-13|0.0.0.1.0 10-11|0.0.0.0.0 8-9|0.0.0.0.1.1+0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 6-7|0.0.0.0 5-6|0.0.0 3-4|0.0.0.1 2-3|0.0.0.1.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:04.206
(p / panel 
      :ARG0-of (e / empty-02 
            :ARG1 (c / cell 
                  :ARG1-of (i / incubate-01 
                        :ARG0 (s3 / slash) 
                        :ARG2 (s4 / state 
                              :name (n / name 
                                    :op1 "SC") 
                              :wiki "South_Carolina")) 
                  :mod (t / transfect 
                        :ARG0-of (s2 / show-01 
                              :ARG1 (f / fluorescence 
                                    :ARG1-of (s / significant-02)) 
                              :polarity -) 
                        :mod (v / vector)))))

# ::snt Abcg5 transfected COS-1 cells incubated with SC anti-Abcg5 / sterolin-1 antibody showed a membrane distribution ( panel b ) , where as Abcg8 transfected cells incubated with SC anti-Abcg5 antibody showed no significant fluorescence ( panel c ) .
# ::tok Abcg5 transfected COS-1 cells incubated with SC anti-Abcg5 / sterolin-1 antibody showed a membrane distribution ( panel b ) , where as Abcg8 transfected cells incubated with SC anti-Abcg5 antibody showed no significant fluorescence ( panel c ) .
# ::alignments 36-37|0.1.2.1.0.0 35-36|0.1.2.1.0 33-34|0 32-33|0.0 31-32|0.1.4 30-31|0.1 29-30|0.1.2.1.1.0 27-28|0.1.2.1.1.2+0.1.2.1.1.1.0+0.1.2.1.1.1+0.1.2.1.1 25-26|0.1.0.0 24-25|0.1.0 22-23|0.1.1 17-18|0.0.0 16-17|0.1.2.2 14-15|0.1.2.1 13-14|0.1.2.1.2 11-12|0.1.2 10-11|0.1.2.0 8-9|0.1.3 6-7|0.1.0.0.1.1.1+0.1.0.0.1.1.0.0+0.1.0.0.1.1.0+0.1.0.0.1.1 4-5|0.1.0.0.1 3-4|0.1.0.0.1.0 1-2|0.1.0.0.1.0.0 0-1|0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:07.183
(f / fluorescence 
      :ARG1-of (s / significant-02 
            :ARG0 (b / b)) 
      :ARG1-of (s2 / show-01 
            :ARG0 (c2 / cell 
                  :ARG1-of (i / incubate-01 
                        :ARG0 (t2 / thing 
                              :name (n3 / name 
                                    :op1 "Abcg5")) 
                        :ARG2 (i2 / incubate-01 
                              :ARG1 (c3 / cell 
                                    :mod (t / transfect)) 
                              :ARG2 (s6 / state 
                                    :name (n2 / name 
                                          :op1 "SC") 
                                    :wiki "South_Carolina")))) 
            :ARG2 (a2 / Abcg8) 
            :condition-of (s4 / show-01 
                  :ARG0 (a3 / antibody) 
                  :ARG1 (d / distribute-01 
                        :ARG0 (p / panel 
                              :mod-of (c / c)) 
                        :ARG1 (s3 / state 
                              :mod-of (a / antibody) 
                              :name (n / name 
                                    :op1 "SC") 
                              :wiki "South_Carolina") 
                        :ARG2 (m / membrane)) 
                  :ARG2 (p2 / panel)) 
            :op1-of (s5 / slash) 
            :polarity -))

# ::snt Abcg5 and Abcg8 co-transfected COS-1 cells incubated with SC anti-Abcg5 / sterolin-1 antibody resulted in a fluorescence pattern similar to Abcg5 alone ( panel d ) .
# ::tok Abcg5 and Abcg8 co-transfected COS-1 cells incubated with SC anti-Abcg5 / sterolin-1 antibody resulted in a fluorescence pattern similar to Abcg5 alone ( panel d ) .
# ::alignments 24-25|0.0 23-24|0 21-22|0.1.3 18-19|0.1.1.0.0 17-18|0.1.1.0.0.0 16-17|0.1.1.0.0.0.1 13-14|0.1.1.0.0.0.0 12-13|0.1.1.0.0.0.0.0 10-11|0.1.1.0.0.0.0.1 8-9|0.1.2.1+0.1.2.0.0+0.1.2.0+0.1.2 6-7|0.1 5-6|0.1.0 3-4|0.1.0.0 1-2|0.1.1 0-1|0.1.1.0.1.0+0.1.1.0.1+0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:07.923
(p / panel 
      :mod-of (d / d) 
      :op1 (i / incubate-01 
            :ARG0 (c / cell 
                  :mod (c2 / co-transfect)) 
            :ARG1 (a3 / and 
                  :op1 (t / thing 
                        :ARG2-of (r / resemble-01 
                              :ARG1 (p2 / pattern 
                                    :ARG2-of (r2 / result-01 
                                          :ARG0 (a2 / antibody) 
                                          :ARG1 (s / slash)) 
                                    :mod (f / fluorescence))) 
                        :name (n2 / name 
                              :op1 "Abcg5"))) 
            :ARG2 (s2 / state 
                  :name (n / name 
                        :op1 "SC") 
                  :wiki "South_Carolina") 
            :op1-of (a / alone)))

# ::snt The yellow bar represents 20 m .
# ::tok The yellow bar represents 20 m .
# ::alignments 5-6|0.1 4-5|0.1.0 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:07.950
(r / represent-01 
      :ARG0 (b / bar-01 
            :ARG1-of (y / yellow-02)) 
      :ARG1 (m / m 
            :quant 20))

# ::snt Wild-type intestine incubated with SC pre-immune serum ( panel e ) , or SC anti-Abcg5 / sterolin-1 antibody pre-incubated with the blocking peptide ( panel f ) showed no specific signals .
# ::tok Wild-type intestine incubated with SC pre-immune serum ( panel e ) , or SC anti-Abcg5 / sterolin-1 antibody pre-incubated with the blocking peptide ( panel f ) showed no specific signals .
# ::alignments 30-31|0.0.1.1.2.0.0 29-30|0.0.1.1.2.0.0.0 28-29|0.0.1.1.2.0.1 27-28|0.0.1.1.2.0 25-26|0.0.1.2 24-25|0 22-23|0.0.0 21-22|0.0 18-19|0.0.1.1.2 17-18|0.0.1.1.2.1 15-16|0.0.1.1.1.1 13-15|0.0.1.1.1.0.1+0.0.1.1.1.0.0+0.0.1.1.1.0+0.0.1.1.1 12-13|0.0.1.1 8-9|0.0.1.1.2.0.0.0.0 6-7|0.0.1.1.0 4-5|0.0.1.1.0.0.1+0.0.1.1.0.0.0.0+0.0.1.1.0.0.0+0.0.1.1.0.0 2-3|0.0.1 1-2|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:09.148
(p / panel 
      :ARG0-of (b / block-01 
            :ARG1 (p2 / peptide) 
            :ARG2 (i / incubate-01 
                  :ARG1 (i2 / intestine) 
                  :ARG2 (o / or 
                        :op1 (s6 / serum 
                              :mod (s7 / state 
                                    :name (n2 / name 
                                          :op1 "SC") 
                                    :wiki "South_Carolina")) 
                        :op2 (t / thing 
                              :name (n / name 
                                    :op1 (s5 / SC) 
                                    :op2 (a2 / anti-Abcg5)) 
                              :op1-of (s4 / slash)) 
                        :op3 (p3 / pre-incubat 
                              :ARG0-of (s3 / show-01 
                                    :ARG1 (s / signal 
                                          :ARG1-of (s2 / specific-02 
                                                :ARG0 (p4 / panel))) 
                                    :polarity -) 
                              :mod (a / antibody))) 
                  :op1-of (f / f))))

# ::snt Wild-type , Abcg8 + / - and Abcg8 - / - intestine ( panels g , h and i respectively ) incubated with SC anti-Abcg5 / sterolin-1 antibody , showed no difference in expression patterns , despite the loss of Abcg8/sterolin -2 in the knockout mice .
# ::tok Wild-type , Abcg8 + / - and Abcg8 - / - intestine ( panels g , h and i respectively ) incubated with SC anti-Abcg5 / sterolin-1 antibody , showed no difference in expression patterns , despite the loss of Abcg8/sterolin -2 in the knockout mice .
# ::alignments 45-46|0.1.3.1.0 44-45|0.1.3.1.0.0 40-41|0.1.3.1.2.0.0+0.1.3.1.2.0+0.1.3.1.2 38-39|0.1.3.1.2.1 34-35|0.1.3 33-34|0.1.3.1 31-32|0.1 30-31|0.2 29-30|0 27-28|0.1.2 25-26|0.1.3.1.1.2.1 23-24|0.1.3.1.1.2.2.1+0.1.3.1.1.2.2.0.0+0.1.3.1.1.2.2.0+0.1.3.1.1.2.2 21-22|0.1.3.1.1.2 19-20|0.0.0 18-19|0.1.3.0 17-18|0.1.3.1.1 16-17|0.1.3.1.1.1 14-15|0.1.3.1.1.0 13-14|0.1.3.1.1.0.0 11-12|0.1.3.1.1.2.0 9-10|0.1.0 6-7|0.0 4-5|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:10.036
(s / show-01 
      :ARG0 (a3 / and 
            :mod (r / respective)) 
      :ARG1 (d / differ-02 
            :ARG0 (s4 / slash) 
            :ARG1 (s5 / slash) 
            :ARG2 (a / antibody) 
            :prep-in (p / pattern-01 
                  :ARG0 (i2 / i) 
                  :mod (e / express-01 
                        :ARG0 (m / mouse 
                              :mod (k / knockout)) 
                        :ARG1 (a2 / and 
                              :op1 (g / g 
                                    :ARG1-of (p2 / panel-01)) 
                              :op2 (h / h) 
                              :op3 (i / incubate-01 
                                    :ARG0 (i3 / intestine) 
                                    :ARG1 (s2 / slash) 
                                    :ARG2 (s3 / state 
                                          :name (n2 / name 
                                                :op1 "SC") 
                                          :wiki "South_Carolina"))) 
                        :op1-of (c / country 
                              :name (n / name 
                                    :op1 "Abcg8/sterolin") 
                              :poss-of (l / loss))))) 
      :polarity -)

# ::snt Single arrowhead shows intestinal villus and double arrowhead shows crypt .
# ::tok Single arrowhead shows intestinal villus and double arrowhead shows crypt .
# ::alignments 9-10|0.1.2 8-9|0.1.2.0 7-8|0.1.2.0.0 6-7|0.1.2.1 5-6|0.1 4-5|0.1.1 3-4|0.1.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:10.326
(s2 / show-01 
      :ARG0 (a3 / arrowhead 
            :ARG1-of (s3 / single-02)) 
      :ARG1 (a2 / and 
            :mod (i / intestine) 
            :op1 (v / villu) 
            :op2 (c / crypt 
                  :ARG1-of (s / show-01 
                        :ARG0 (a / arrowhead)) 
                  :mod (d / double))))

# ::snt The yellow bar represents 50 m .
# ::tok The yellow bar represents 50 m .
# ::alignments 5-6|0.1 4-5|0.1.0 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:10.346
(r / represent-01 
      :ARG0 (b / bar-01 
            :ARG1-of (y / yellow-02)) 
      :ARG1 (m / m 
            :quant 50))

# ::snt Antibody staining of liver sections was also performed at the AMC Liver Center .
# ::tok Antibody staining of liver sections was also performed at the AMC Liver Center .
# ::alignments 10-13|0.0.0.0.0.0.2+0.0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 7-8|0.0.0.0 6-7|0.0.0.0.1 4-5|0.0 3-4|0 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:10.451
(l / liver 
      :mod-of (s / section 
            :ARG1-of (s2 / stain-01 
                  :ARG1-of (p / perform-02 
                        :ARG2 (o / organization 
                              :name (n / name 
                                    :op1 "AMC" 
                                    :op2 "Liver" 
                                    :op3 "Center")) 
                        :mod (a / also)) 
                  :mod (a2 / antibody))))

# ::snt As a control , an antibody to Bsep/Abcb11 was used and showed a clear apical distribution in both wild-type ( panel j ) and Abcg8 knockout mice ( panel k ) .
# ::tok As a control , an antibody to Bsep/Abcb11 was used and showed a clear apical distribution in both wild-type ( panel j ) and Abcg8 knockout mice ( panel k ) .
# ::alignments 29-30|0.1.0.0.0 28-29|0.1.0.0 26-27|0.2.1.3.0 25-26|0.2.1.3.0.0 23-24|0.2.1.3 21-22|0.2.1.1.0.0 20-21|0.2.1.1.0 17-18|0.0 15-16|0.2.1 14-15|0.2.1.2 13-14|0.2.1.1 11-12|0.2 10-11|0 9-10|0.1 7-8|0.2.1.0.0.0+0.2.1.0.0+0.2.1.0 5-6|0.2.0 2-3|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:11.202
(a3 / and 
      :mod (b / both) 
      :op1 (u / use-01 
            :ARG2 (c2 / control-01 
                  :ARG0 (p / panel 
                        :mod-of (k / k)))) 
      :op2 (s / show-01 
            :ARG0 (a4 / antibody) 
            :ARG1 (d / distribute-01 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 "Bsep/Abcb11")) 
                  :ARG1-of (c / clear-06 
                        :ARG0 (p2 / panel 
                              :mod-of (j / j))) 
                  :ARG2 (a2 / apical) 
                  :op1-of (a / and 
                        :op2 (m / mouse 
                              :mod (k2 / knockout))))))

# ::snt Using AMC antibody against Abcg5/sterolin -1 ( see text ) , in both wild-type ( panel l ) and Abcg8 knockout liver ( panel m ) , the pattern of expression was also apical and unchanged although the signal is fainter compared to that for Bsep/Abcb11 ( see text for discussion ) .
# ::tok Using AMC antibody against Abcg5/sterolin -1 ( see text ) , in both wild-type ( panel l ) and Abcg8 knockout liver ( panel m ) , the pattern of expression was also apical and unchanged although the signal is fainter compared to that for Bsep/Abcb11 ( see text for discussion ) .
# ::alignments 50-51|0.0.0.0.1.0 48-49|0.0.0.0.1.0.1.0 47-48|0.0.0.0.1.0.1 45-46|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 43-44|0.0.0.0.1.1.1.0.0 41-42|0.0.0.0.1.1.1.0 40-41|0.0.0.0.1.1 38-39|0.0.0.0.1.1.1 35-36|0.0.0.0.2+0.0.0.0 34-35|0.0.0.0.1 33-34|0.0.0.1 32-33|0.0.0.0.1.2 30-31|0.0.0.2 28-29|0.0.0 24-25|0.0.0.0.1.0.0 23-24|0.0.0.0.1.0.0.0 21-22|0.1 20-21|0.1.0 18-19|0 15-16|0.0.0.0.1.1.0 12-13|0.0.0.0.1.3 8-9|0.0.0.2.1.0 7-8|0.0.0.2.1 4-5|0.0.0.2.0.0.0+0.0.0.2.0.0+0.0.0.2.0 2-3|0.0.1 1-2|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:12.997
(a4 / and 
      :ARG2-of (u / use-01 
            :ARG0 (p / pattern 
                  :ARG0-of (c2 / change-01 
                        :ARG1 (t2 / thing 
                              :name (n / name 
                                    :op1 "Bsep/Abcb11")) 
                        :op1-of (a / and 
                              :ARG0-of (d / discuss-01 
                                    :ARG1 (m / m 
                                          :mod (p2 / panel)) 
                                    :purpose-of (s / see-01 
                                          :ARG1 (t / text))) 
                              :concession (f / faint-01 
                                    :ARG0 (p3 / panel) 
                                    :ARG1 (s2 / signal 
                                          :ARG1-of (c / compare-01 
                                                :ARG0 (t3 / that)))) 
                              :mod (a3 / also) 
                              :mod (b / both)) 
                        :polarity -) 
                  :domain-of (a2 / apical) 
                  :mod (e / express-01 
                        :ARG0 (p4 / person 
                              :name (n2 / name 
                                    :op1 "Abcg5/sterolin")) 
                        :ARG1 (s3 / see-01 
                              :ARG1 (t4 / text)))) 
            :ARG1 (a5 / antibody 
                  :mod (o / organization 
                        :name (n3 / name 
                              :op1 "AMC")))) 
      :op1 (l / liver 
            :mod (k / knockout)))

# ::snt Arrows indicate bile canaliculi .
# ::tok Arrows indicate bile canaliculi .
# ::alignments 3-4|0.1 2-3|0.1.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:13.009
(i / indicate-01 
      :ARG0 (a / arrow) 
      :ARG1 (c / canaliculus 
            :mod (b / bile)))

# ::snt Immunohistochemical evaluation of mouse Abcg5/sterolin -1 expression in liver .
# ::tok Immunohistochemical evaluation of mouse Abcg5/sterolin -1 expression in liver .
# ::alignments 8-9|0.1 6-7|0 3-4|0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:13.031
(e / express-01 
      :ARG1 (e2 / evaluate-01 
            :ARG1 (m / mouse)) 
      :location (l / liver))

# ::snt Wild-type liver incubated with UTSW anti-Abcg5 / sterolin-1 resulted in apical expression ( panel a ) .
# ::tok Wild-type liver incubated with UTSW anti-Abcg5 / sterolin-1 resulted in apical expression ( panel a ) .
# ::alignments 13-14|0 11-12|0.0.1 10-11|0.0.1.1 8-9|0.0 6-7|0.0.0 4-5|0.0.1.0.0.0.0.0+0.0.1.0.0.0.0+0.0.1.0.0.0 2-3|0.0.1.0.0 1-2|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:13.162
(p / panel 
      :ARG0-of (r / result-01 
            :ARG1 (s / slash) 
            :ARG2 (e / express-01 
                  :ARG0 (l / liver 
                        :ARG1-of (i / incubate-01 
                              :ARG0 (o / organization 
                                    :name (n / name 
                                          :op1 "UTSW")))) 
                  :mod (a / apical))))

# ::snt Merged image clearly shows the apical distribution .
# ::tok Merged image clearly shows the apical distribution .
# ::alignments 6-7|0.1 5-6|0.1.0 3-4|0 2-3|0.2 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:13.181
(s / show-01 
      :ARG0 (i / image 
            :ARG1-of (m / merge-01)) 
      :ARG1 (d / distribute-01 
            :ARG1 (a / apical)) 
      :ARG1-of (c / clear-06))

# ::snt Likewise Abcg8 - / - liver incubated with the same UTSW anti-Abcg5 / sterolin-1 antibody resulted in a similar apical expression pattern relative to the wild type ( panel b ) .
# ::tok Likewise Abcg8 - / - liver incubated with the same UTSW anti-Abcg5 / sterolin-1 antibody resulted in a similar apical expression pattern relative to the wild type ( panel b ) .
# ::alignments 29-30|0.2.0 28-29|0.3.0.0 26-27|0.3.3.0 25-26|0.3.3.0.0 22-23|0.3.3 21-22|0.3 20-21|0.3.0 19-20|0.3.2 18-19|0.3.1 15-16|0 14-15|0.0 12-13|0.1 10-11|0.3.1.1.0.0+0.3.1.1.0+0.3.1.1 9-10|0.2 6-7|0.0.0 5-6|0.0.0.0 3-4|0.0.0.1 0-1|0.3.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:13.832
(r3 / result-01 
      :ARG0 (a2 / antibody 
            :ARG0-of (i / incubate-01 
                  :ARG1 (l / liver) 
                  :time (s3 / slash))) 
      :ARG1 (s / slash) 
      :ARG1-of (s2 / same-01 
            :ARG0 (b / b)) 
      :ARG2 (p2 / pattern 
            :ARG1-of (e / express-01 
                  :ARG0 (p / panel)) 
            :ARG1-of (r2 / resemble-01 
                  :ARG0 (l2 / likewise) 
                  :ARG2 (o / organization 
                        :name (n / name 
                              :op1 "UTSW"))) 
            :mod (a / apical) 
            :mod (r / relative 
                  :beneficiary (t / type 
                        :mod (w / wild)))))

# ::snt White arrows indicate bile canaliculi and asterisk indicates a bile duct .
# ::tok White arrows indicate bile canaliculi and asterisk indicates a bile duct .
# ::alignments 10-11|0.1.1 9-10|0.1.1.0 7-8|0.1 6-7|0.1.0.1 5-6|0.1.0 4-5|0.1.0.0 3-4|0.1.0.0.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:13.880
(i2 / indicate-01 
      :ARG0 (a3 / arrow 
            :mod (w / white)) 
      :ARG1 (i / indicate-01 
            :ARG0 (a2 / and 
                  :op1 (c / canaliculus 
                        :mod (b2 / bile)) 
                  :op2 (a / asterisk)) 
            :ARG1 (d / duct 
                  :mod (b / bile))))

# ::snt The yellow bar represents 50 m .
# ::tok The yellow bar represents 50 m .
# ::alignments 5-6|0.1 4-5|0.1.0 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:13.900
(r / represent-01 
      :ARG0 (b / bar-01 
            :ARG1-of (y / yellow-02)) 
      :ARG1 (m / m 
            :quant 50))

# ::snt Biliary sterol , phospholipid and bile salt analyses .
# ::tok Biliary sterol , phospholipid and bile salt analyses .
# ::alignments 7-8|0.2 6-7|0.2.0 5-6|0.2.1 4-5|0 3-4|0.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:13.926
(a2 / and 
      :op1 (s2 / sterol 
            :mod (b2 / biliary)) 
      :op2 (p / phospholipid) 
      :op3 (a / analysis 
            :mod (s / salt) 
            :mod (b / bile)))

# ::snt Bile salt , sterol and phospholipid contents from male Abcg8 + / + ( n = 8 ) , Abcg8 + / - ( n = 7 ) , and Abcg8 - / - ( n = 5 ) mice were examined as described in Methods .
# ::tok Bile salt , sterol and phospholipid contents from male Abcg8 + / + ( n = 8 ) , Abcg8 + / - ( n = 7 ) , and Abcg8 - / - ( n = 5 ) mice were examined as described in Methods .
# ::alignments 45-46|0.0.0.3.1.1 43-44|0.0.0.3.1 41-42|0.0.0.3 39-40|0.0.0.3.0 37-38|0.0.0.3.1.0 32-33|0.0.0.1.3 29-30|0.0.0 26-27|0.0.0.3.1.2 21-22|0.0.0.0.0.1 16-17|0.0.0.3.2 11-12|0.0.0.2 8-9|0.0.0.1.2 6-7|0+0.0 5-6|0.0.0.1.1 4-5|0.0.0.1 3-4|0.0.0.1.0 1-2|0.0.0.0 0-1|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:14.648
(c / contain-01 
      :ARG1 (t / thing 
            :op3-of (a / and 
                  :op1 (s5 / salt 
                        :mod (t2 / thing 
                              :name (n / name 
                                    :op1 "Bile") 
                              :op1-of (s2 / slash))) 
                  :op2 (a2 / and 
                        :op1 (s4 / sterol) 
                        :op2 (p / phospholipid) 
                        :op3 (m3 / male) 
                        :op4 (s / slash)) 
                  :op4 (s3 / slash) 
                  :op5 (e / examine-01 
                        :ARG1 (m2 / mouse) 
                        :ARG2 (d / describe-01 
                              :ARG1 5 
                              :ARG2 (m / method) 
                              :op1-of 7) 
                        :op1-of 8))))

# ::snt Bile salt secretion following a 10 minute collection was lower in Abcg8 + / - and Abcg8 - / - mice compared to wild type ( panel a ) , but these differences were not statistically significant .
# ::tok Bile salt secretion following a 10 minute collection was lower in Abcg8 + / - and Abcg8 - / - mice compared to wild type ( panel a ) , but these differences were not statistically significant .
# ::alignments 36-37|0.0 35-36|0.0.1 34-35|0.0.2 32-33|0.0.0 31-32|0.0.0.1 30-31|0 26-27|0.1.0.0.0 24-25|0.0.0.0.2 23-24|0.0.0.0.2.0 21-22|0.0.0.0 20-21|0.0.0.0.3 18-19|0.0.0.0.1 15-16|0.2 13-14|0.2.0 9-10|0.1 7-8|0.1.0.0.1 6-7|0.1.0.0.1.0.1+0.1.0.0.1.0 5-6|0.1.0.0.1.0.0 3-4|0.1.0.0 2-3|0.1.0 1-2|0.1.0.1 0-1|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:15.913
(c / contrast-01 
      :ARG1 (s / significant-02 
            :ARG1 (d / differ-01 
                  :ARG1 (c2 / compare-01 
                        :ARG0 (t4 / thing 
                              :name (n / name 
                                    :op1 "Bile")) 
                        :ARG1 (s3 / slash) 
                        :ARG2 (t2 / type 
                              :mod (w / wild)) 
                        :mod-of (m / mouse)) 
                  :mod (t / this)) 
            :mod (s2 / statistics) 
            :polarity -) 
      :ARG2 (l / low-04 
            :ARG1 (s5 / secretion 
                  :ARG1-of (f / follow-01 
                        :ARG0 (p / panel) 
                        :ARG2 (c3 / collect-01 
                              :duration (t3 / temporal-quantity 
                                    :quant 10 
                                    :unit (m2 / minute)))) 
                  :mod (s6 / salt))) 
      :op2-of (a / and 
            :op1 (s4 / slash)))

# ::snt Biliary sterol and phospholipid were significantly reduced in the Abcg8 - / - mice compared to the wild-type ( panels b and c ) .
# ::tok Biliary sterol and phospholipid were significantly reduced in the Abcg8 - / - mice compared to the wild-type ( panels b and c ) .
# ::alignments 22-23|0.1 21-22|0 20-21|0.0 19-20|0.0.0 14-15|0.2.0.4 13-14|0.2.0.3 11-12|0.2.0.0 6-7|0.2.0 5-6|0.2.0.2 3-4|0.2.2 2-3|0.2 1-2|0.2.1 0-1|0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:16.258
(a / and 
      :op1 (b / b 
            :ARG1-of (p / panel-01)) 
      :op2 (c / c) 
      :op3-of (a2 / and 
            :manner-of (r / reduce-01 
                  :ARG0 (s / slash) 
                  :ARG1 (b2 / biliary) 
                  :ARG2 (s2 / significant-02) 
                  :location (m / mouse) 
                  :time (c2 / compare-01)) 
            :op1 (s3 / sterol) 
            :op2 (p2 / phospholipid)))

# ::snt * P < 0.05 .
# ::tok * P < 0.05 .
# ::alignments 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:16.261
(p / P60)

# ::snt The lower panel shows biliary bile salt , sterol and phospholipid secretion rates from female Abcg8 + / + ( n = 5 ) , Abcg8 + / - ( n = 4 ) , and Abcg8 - / - ( n = 3 ) mice measured following 90-minute bile salt depletion followed by stepwise TUDC infusion as described in the text .
# ::tok The lower panel shows biliary bile salt , sterol and phospholipid secretion rates from female Abcg8 + / + ( n = 5 ) , Abcg8 + / - ( n = 4 ) , and Abcg8 - / - ( n = 3 ) mice measured following 90-minute bile salt depletion followed by stepwise TUDC infusion as described in the text .
# ::alignments 61-62|0.1.2.0.1.1.0.1.2 58-59|0.1.2.0.1.1.0.1 56-57|0.1.2.0.1.1.0.0 55-56|0.1.2.0.1.1.0.0.1.0.0+0.1.2.0.1.1.0.0.1.0+0.1.2.0.1.1.0.0.1 54-55|0.1.2.0.1.1.0.0.0 52-53|0.1.2.0.1.1.0 51-52|0.1.2.0.1.1 50-51|0.1.2.0.1.1.1 49-50|0.1.2.0.1.1.0.1.1 47-48|0.1.2.0.1 46-47|0.1.2.0 45-46|0.1.2 43-44|0.1.2.0.1.1.0.1.0 38-39|0.1.1 35-36|0.1 32-33|0.1.2.0.0 27-28|0.1.0 22-23|0.1.2.0.1.0 17-18|0.2.0.1 15-16|0.2.3.0 14-15|0.2.3 12-13|0.2.2 11-12|0.2.2.0 10-11|0.2.2.0.0 9-10|0.2 8-9|0.2.1 6-7|0.2.0 5-6|0.2.0.0 4-5|0.1.2.0.2 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:19.324
(s9 / show-01 
      :ARG0 (p2 / panel 
            :ARG1-of (l / low-04)) 
      :ARG1 (a / and 
            :op1 (s4 / slash) 
            :op2 (s3 / slash) 
            :op3 (m2 / mouse 
                  :ARG1-of (m / measure-01 
                        :ARG0 4 
                        :ARG1-of (f2 / follow-01 
                              :ARG0 5 
                              :ARG2 (d2 / depletion 
                                    :ARG2-of (f / follow-01 
                                          :ARG0 (i / infusion 
                                                :mod (s / stepwise) 
                                                :poss (o / organization 
                                                      :name (n / name 
                                                            :op1 "TUDC"))) 
                                          :purpose (d / describe-01 
                                                :ARG0 3 
                                                :ARG1 (b / bile) 
                                                :ARG2 (t / text))) 
                                    :mod (s2 / salt))) 
                        :op1-of (b3 / biliary)))) 
      :op1-of (a3 / and 
            :op2 (s8 / salt 
                  :mod (b2 / bile) 
                  :poss (s5 / slash)) 
            :op3 (s7 / sterol) 
            :op4 (r / rate 
                  :mod (s6 / secretion 
                        :mod (p / phospholipid))) 
            :op5 (f3 / female 
                  :mod-of (a2 / Abcg8))))

# ::snt Bars represent phase TUDC infusion rates .
# ::tok Bars represent phase TUDC infusion rates .
# ::alignments 5-6|0.1 4-5|0.1.0 3-4|0.1.1.0.0+0.1.1.0+0.1.1 2-3|0.1.2 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:19.467
(r2 / represent-01 
      :ARG0 (b / bar-01) 
      :ARG1 (r / rate 
            :mod (i / infusion) 
            :mod (o / organization 
                  :name (n / name 
                        :op1 "TUDC")) 
            :mod (p / phase)))

# ::snt No differences were observed in the ability of the Abcg8 - / - mice to secrete bile salts ( panel d ) , but there is a marked inability of the knockout mice to secrete sterols ( panel e ) and a trend towards a reduced ability to secrete phospholipid ( panel f ) compared to wild type .
# ::tok No differences were observed in the ability of the Abcg8 - / - mice to secrete bile salts ( panel d ) , but there is a marked inability of the knockout mice to secrete sterols ( panel e ) and a trend towards a reduced ability to secrete phospholipid ( panel f ) compared to wild type .
# ::alignments 57-58|0.1.1.1.0.2.1.1 56-57|0.1.1.1.0.2.1.1.0 54-55|0.1.1.1.0.2.1 52-53|0.1.1.1.0.2.1.0 51-52|0.1.1.1.0.0 49-50|0.1.1.1.0.1 48-49|0.1.1.1.0 46-47|0.1.1.1.0.2 45-46|0.1.1.1.0.2.0 42-43|0.1.1.1 40-41|0.1.1 37-38|0.1.1.0 35-36|0.1.2 34-35|0.1 32-33|0.1.0 31-32|0.1.0.0 28-29|0.1.3.1+0.1.3 27-28|0.1.3.0 23-24|0 20-21|0.1.1.1.1 19-20|0.1.1.1.1.0 17-18|0.0.0.0.0 16-17|0.0.0.0.0.0 15-16|0.0.0.0 13-14|0.0.0.0.1 11-12|0.0.0.1 6-7|0.0.1 3-4|0.0 1-2|0.0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:22.062
(c2 / contrast-01 
      :ARG1 (o / observe-01 
            :ARG1 (d2 / differ-01 
                  :ARG0-of (s5 / secrete-01 
                        :ARG1 (s4 / salt-01 
                              :ARG1 (b / bile)) 
                        :ARG2 (m3 / mouse)) 
                  :ARG1 (s6 / slash)) 
            :ARG2 (a4 / ability) 
            :polarity -) 
      :ARG2 (s3 / secrete-01 
            :ARG0 (m / mouse 
                  :mod (k / knockout)) 
            :ARG1 (a2 / and 
                  :op1 (p3 / panel) 
                  :op2 (t2 / trend-01 
                        :ARG0-of (s / secrete-01 
                              :ARG1 (p / panel) 
                              :manner (p2 / phospholipid) 
                              :purpose-of (a / ability 
                                    :ARG1-of (r / reduce-01) 
                                    :ARG1-of (c / compare-01 
                                          :ARG0 (f / f) 
                                          :ARG2 (t / type 
                                                :mod (w / wild))))) 
                        :ARG1 (d / d 
                              :mod (p4 / panel)))) 
            :ARG2 (s2 / sterol) 
            :domain-of (a3 / ability 
                  :ARG1-of (m2 / mark-01) 
                  :polarity -)))

# ::snt Biliary cholesterol and sitosterol secretion .
# ::tok Biliary cholesterol and sitosterol secretion .
# ::alignments 4-5|0.2 3-4|0.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:22.089
(a / and 
      :op1 (c / cholesterol 
            :mod (b / biliary)) 
      :op2 (s2 / sitosterol) 
      :op3 (s / secretion))

# ::snt Biliary sterols were analyzed by GC analyses in Abcg8 + / + ( n = 4 ) , Abcg8 + / - ( n = 3 ) and Abcg8 - / - ( n = 4 ) mice following 30-minute bile salt depletion followed by a continuous TUDC infusion as described in Methods .
# ::tok Biliary sterols were analyzed by GC analyses in Abcg8 + / + ( n = 4 ) , Abcg8 + / - ( n = 3 ) and Abcg8 - / - ( n = 4 ) mice following 30-minute bile salt depletion followed by a continuous TUDC infusion as described in Methods .
# ::alignments 52-53|0.0.1 50-51|0.0 48-49|0 47-48|0.3.0.0+0.3.0+0.3 46-47|0.2 43-44|0.1 42-43|0.1.0 41-42|0.1.0.1 40-41|0.1.0.1.0 38-39|0.1.0.0 37-38|0.1.0.0.1 35-36|0.2.0 30-31|0.2.2.1 27-28|0.2.2 25-26|0.2.1 20-21|0.0.0 15-16|0.1.0.0.0 10-11|0.2.2.0 6-7|0.1.0.0.2.0 5-6|0.1.0.0.2.0.0.0.0+0.1.0.0.2.0.0.0+0.1.0.0.2.0.0 3-4|0.1.0.0.2 1-2|0.1.0.0.2.1 0-1|0.1.0.0.2.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:24.509
(i / infusion 
      :ARG0-of (d / describe-01 
            :ARG1 (s3 / slash) 
            :ARG2 (m / method)) 
      :ARG0-of (f / follow-01 
            :ARG1 (d2 / depletion 
                  :ARG2-of (f2 / follow-01 
                        :ARG0 4 
                        :ARG1 (m2 / mouse) 
                        :ARG2-of (a3 / analyze-01 
                              :ARG0 (a2 / analysis 
                                    :mod (o2 / organization 
                                          :name (n2 / name 
                                                :op1 "GC"))) 
                              :ARG1 (s5 / sterol 
                                    :mod (b2 / biliary)))) 
                  :mod (s / salt 
                        :mod (b / bile)))) 
      :ARG1-of (c / continue-01 
            :ARG0 4 
            :ARG2 3 
            :op3-of (a / and 
                  :op1 (s4 / slash) 
                  :op2 (s2 / slash))) 
      :poss (o / organization 
            :name (n / name 
                  :op1 "TUDC")))

# ::snt Abcg8 - / - mice were unable to secrete cholesterol into bile with forced TUDC administration relative to the wild-type mice ( panel a , * P < 0.05 ) .
# ::tok Abcg8 - / - mice were unable to secrete cholesterol into bile with forced TUDC administration relative to the wild-type mice ( panel a , * P < 0.05 ) .
# ::alignments 26-27|0.0.0.0.0.0.2 22-23|0.0.0.0.0.0.3 20-21|0 16-17|0.0 15-16|0.0.0.0 14-15|0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 13-14|0.0.0 11-12|0.0.0.0.0.0.1 9-10|0.0.0.0.0 8-9|0.0.0.0.0.0 4-5|0.0.0.0.0.0.0 2-3|0.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:24.785
(m / mouse 
      :beneficiary-of (r / relative 
            :ARG0-of (f / force-01 
                  :ARG2 (a / administrate-01 
                        :ARG0 (c / cholesterol 
                              :ARG1-of (s / secrete-01 
                                    :ARG0 (m2 / mouse) 
                                    :ARG2 (b / bile) 
                                    :op1-of (p / P60) 
                                    :op1-of (p2 / panel))) 
                        :ARG1 (o / organization 
                              :name (n / name 
                                    :op1 "TUDC")) 
                        :ARG2 (s2 / slash)))))

# ::snt Interestingly , the Abcg8 - / - mice were able to still secrete sitosterol ( panel b ) and campesterol ( panel c ) .
# ::tok Interestingly , the Abcg8 - / - mice were able to still secrete sitosterol ( panel b ) and campesterol ( panel c ) .
# ::alignments 22-23|0.0.1.1.0 21-22|0.0.1.1 18-19|0 16-17|0.0.1.0 15-16|0.2 12-13|0.0 11-12|0.0.3 9-10|0.0.1 7-8|0.0.0 5-6|0.1 3-4|0.0.2 0-1|0.0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:25.057
(a / and 
      :ARG1-of (s / secrete-01 
            :ARG0 (m / mouse) 
            :ARG1-of (p3 / possible-01 
                  :ARG0 (b / b) 
                  :ARG2 (p / panel 
                        :mod-of (c / c) 
                        :mod-of (i / interesting))) 
            :ARG2 (a2 / Abcg8) 
            :mod (s2 / still)) 
      :op1 (s3 / slash) 
      :op2 (p2 / panel))

# ::snt Heterozygous mice showed an increased ability to secrete all sterols with forced TUDC administration , although the results were not statistically significant .
# ::tok Heterozygous mice showed an increased ability to secrete all sterols with forced TUDC administration , although the results were not statistically significant .
# ::alignments 21-22|0.0.0.0.0.0.0 20-21|0.0.0.0.0.0.0.0 19-20|0.0.0.0.0.0.0.1 17-18|0.0.0.0.0+0.0.0.0.0.0 13-14|0.0.0.0.1 12-13|0.0.0.0.1.0.1.0+0.0.0.0.1.0.1+0.0.0.0.1.0 11-12|0.0.0.0.1.0.0 9-10|0.0.0.0 8-9|0.0.0.0.2 7-8|0.0.0 5-6|0.1 4-5|0.1.0 2-3|0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:25.582
(s5 / show-01 
      :ARG0 (m / mouse 
            :ARG0-of (s4 / secrete-01 
                  :ARG1 (s3 / sterol 
                        :ARG1-of (r / result-01 
                              :ARG2 (t / thing 
                                    :ARG1-of (s / significant-02 
                                          :mod (s2 / statistics) 
                                          :polarity -))) 
                        :ARG1-of (a / administrate-01 
                              :ARG0 (o / organization 
                                    :ARG1-of (f / force-01) 
                                    :name (n / name 
                                          :op1 "TUDC"))) 
                        :quant (a2 / all))) 
            :mod (h / heterozygou)) 
      :ARG1 (a3 / ability 
            :ARG1-of (i / increase-01)))

# ::snt Oligonucleotide primers used for quantitative RT-PCR .
# ::tok Oligonucleotide primers used for quantitative RT-PCR .
# ::alignments 4-5|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:25.603
(q / quantitative 
      :ARG0-of (u / use-01 
            :ARG1 (p / primer)))

# ::snt Mouse plasma and tissue sterol analyses .
# ::tok Mouse plasma and tissue sterol analyses .
# ::alignments 5-6|0.1 4-5|0.1.0 2-3|0 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:25.643
(a2 / and 
      :op1 (p / person 
            :name (n / name 
                  :op1 "Mouse")) 
      :op2 (a / analysis 
            :mod (s / sterol)))

# ::snt Animals used in these studies were 12 weeks of age , a mixture of male and female and fed a regular chow diet .
# ::tok Animals used in these studies were 12 weeks of age , a mixture of male and female and fed a regular chow diet .
# ::alignments 22-23|0.2.1 21-22|0.2.1.1 20-21|0.2.1.0 18-19|0.2 17-18|0.2.2 16-17|0.1 15-16|0 14-15|0.2.2.0 12-13|0.0 9-10|0.2.0.0.0.0 7-8|0.2.1.0.0.1+0.2.1.0.0 6-7|0.2.1.0.0.0 4-5|0.2.0.0.0 3-4|0.2.0.0.0.1 1-2|0.2.0.0 0-1|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:25.989
(a2 / and 
      :op1 (m2 / mixture) 
      :op2 (f2 / female) 
      :op3 (f / feed-up-03 
            :ARG0 (a4 / animal 
                  :ARG1-of (u / use-01 
                        :ARG2 (s / study-01 
                              :ARG1 (a3 / age-01) 
                              :mod (t2 / this)))) 
            :ARG1 (d / diet 
                  :ARG1-of (r / regular-02 
                        :ARG0 (t / temporal-quantity 
                              :quant 12 
                              :unit (w / week))) 
                  :mod (c / chow)) 
            :op2-of (a / and 
                  :op1 (m / male))))

# ::snt * P < 0.05 for - / - versus + / + and - / - versus + / - .
# ::tok * P < 0.05 for - / - versus + / + and - / - versus + / - .
# ::alignments 18-19|0.1 14-15|0.1.0.2 12-13|0.1.0 10-11|0.1.0.1 8-9|0 6-7|0.1.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:26.022
(v / versu 
      :mod (p / P60) 
      :mod-of (s / slash 
            :op4-of (a / and 
                  :op1 (s4 / slash) 
                  :op2 (s3 / slash) 
                  :op3 (s2 / slash))))

# ::snt ND , not detectable .
# ::tok ND , not detectable .
# ::alignments 3-4|0.0 2-3|0.0.0 0-1|0.1.0+0.1+0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:11:26.033
(c / country 
      :mod (d / detectable 
            :polarity -) 
      :name (n / name 
            :op1 "ND"))

